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1 The present study was based on the hypothesis that antidepressant 
efficacy is related to an ability to modify patterns of social 
behaviour or free-running circadian locomotor activity rhythms in 
rats.
2 Acute treatment of short-term isolated resident rats with 
non-sedative doses of the antidepressants clomipramine, 
fluoxetine, iprindole, mianserin and phenelzine, dose-relatedly 
reduced aggressive behaviour directed towards unknown intruder 
rats during social interaction (SI). Similarly, acute 
haloperidol (antipsychotic) or diazepam (anxiolytic) treatment 
dose-relatedly reduced aggressive behaviour, but these effects 
were associated with overt sedation. Conversely, only resident 
rats treated chronically with the antidepressants exhibited 
increased aggressive behaviour during SI which returned to the 
pre-treatment level by 7 or 14 (phenelzine-treated only; an 
effect thought to be related to the recovery of central monoamine 
oxidase activity) days post-treatment.
3 In rats housed in triads, subdominant members treated chronically 
with clomipramine or mianserin, at doses which increased 
aggressive behaviour during SI, exhibited an increased 
hierarchical position at the expense of the level of dominance 
exhibited by non-treated dominant rats.
4 Chronic treatment with clomipramine, fluoxetine or mianserin, at 
c1inically-equivalent doses, had no effect on the phase-position 
of the free-running circadian locomotor activity rhythm expressed
x i
by single or grouped rats. Conversely, clomipramine and 
fluoxetine, but not mianserin, disrupted circadian locomotor 
rhythmicity from 7 and 20 days of drug treatment, respectively.
In conclusion, it is argued that the diametrically different 
effects of acute and chronic antidepressant treatment on rodent 
social behaviour are indicative of reduced and increased social 
drive respectively, which, in the rat, is manifest by 
appropriate changes in aggressive behaviour exhibited during SI.
It is further argued that the increase in social drive following 
chronic antidepressant treatment predicts antidepressant efficacy, 
while an ability to modify the free-running circadian locomotor 
activity rhythms of rodents is neither a predictor nor necessary 
characteristic of antidepressant efficacy.
CHAPTER 1 CLINICAL AND PHARMACOLOGICAL PERSPECTIVES OF AFFECTIVE 
DISORDERS - DEPRESSION
CHAPTER 1 CLINICAL AND PHARMACOLOGICAL PERSPECTIVES OF AFFECTIVE 
DISORDERS - DEPRESSION
1.1 Introduction
The objective of this chapter is to provide the reader with a concise 
introduction to the affective disorders, principally depression. 
Initially the clinical aspects of depressive illness will be 
described. The biochemical findings implicating abnormalities in the 
central serotonin and noradrenaline neurotransmitter systems will 
then be reviewed, followed by a description of the pharmacological 
treatment regimes available to the clinician. A review of the 
evidence implicating the involvement of circadian rhythm 
abnormalities in depression will be provided, followed by an 
appraisal of the current theories on the aetiology of depression. 
Finally, the methods currently employed to identify potential 
antidepressants will be appraised.
1.2 The Affective Disorders - Depression
1.2.1 Definition
The affective disorders are those conditions in which the main 
feature is an alteration of mood, or affect, to such a degree as to 
cause distress or to disrupt normal life. In these conditions mood 
may be abnormally elevated as in mania, or lowered as in depression. 
In addition, the central feature of the anxiety states is also a 
change in mood and as such are also included under the rubric 
'Affective Disorders’ (Hamilton, 1979a).
Most people experience fluctuations in mood between the acceptable 
limits of the happy-sad continuum. Where the self-assessment of mood 
tends to sadness then the individual may complain of feeling
depressed. Generally the experience is transient with no sequelae 
and as such is a normal, sometimes appropriate, emotion. However, 
the degree of depression may become so severe as to be clinically 
regarded as an illness causing severe distress, disrupti/ng normal 
daily living patterns and being potentially fatal through attempted 
suicide, the ultimate expression of the disease state. It is 
therefore important not to confuse depressive illness, henceforth
denoted by the term "depression", and depressed mood. It is the
former aspect of depression, i.e. depressive illness, which
attracts the attention of the clinician and provides the central 
theme of this thesis.
1.2.2 Classification
Much controversy has surrounded the classification of depressive 
illness. It is now recognized that the most important distinction 
between the different types of depression is that between unipolar, 
where patients show recurrent attacks of depression only, and 
bipolar depression, where patients exhibit fluctuations between 
episodes of depression and mania. The course of the two disorders 
can be distinguished by different characteristics. Angst (1981) 
observed that bipolar depression exhibited a more malignant course 
illustrated by earlier age of onset, higher frequency and total 
number of episodes during life with a shorter cycle length. In 
addition, bipolar depressives exhibited a lower rate of spontaneous 
remission with the consequence that bipolar psychoses had a longer 
duration than unipolar depressive disorders. Futhermore, patients 
with bipolar depression had a higher risk of developing severe 
organic brain syndrome. Surprisingly, however, the suicide rate 
was lower in the group of bipolar patients. Conversely, unipolar
depression exhibited a better prognosis illustrated by later age of 
onset with a lower number of episodes and greater time periods 
between episodes. While the duration of each episode was longer the 
total duration of the illness was shorter with such patients showing 
fuller remissions. Generally unipolar patients exhibited higher 
suicide rates than bipolar patients. Bipolar depression may be 
genetically distinguishable from unipolar depression (Angst and 
Scharfetter, 1979; Perris, 1976, cited by Katz and Hirshfield, 
1978).
Within the group of depressions it is generally recognised that there 
are a number of subgroups; depression, therefore, would not appear 
to be a unitary condition. The main division advocated by Hamilton 
(1979a) has been into two types according to the clinical 
manifestations. The first is characterised by a retarded pattern of 
symptoms and has been described as vital, physiological or, more 
commonly, endogenous depression. In this situation the origins of 
the illness are largely unknown but once precipitated the illness 
continues on its own course. The second type may best be described 
as anxious depression, implying that various symptoms of anxiety 
dominate the profile of the condition. The syndrome has also been 
termed reactive or exogenous depression, implying that the condition 
occurs in reponse to an identifiable event. These two sub-divisions 
of depression have also been termed psychotic and neurotic depression 
respectively. Psychotic depression implies a more severe and 
incapacitating illness, most likely of organic origin, 
characterised by delusions, loss of insight and even hallucinations, 
whereas neurotic depression is milder and assumed to arise from 
neurotic conflict. The psychotic-neurotic distinction may be
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considered to represent not two separate sub-groups of depressive 
illness but rather opposing ends of a continuum (Paykel et al . ,
1971), such that neurotic depression may mean simply the absence of 
any or all of the major characteristics of psychosis, i.e delusions 
and hallucinations, (Katz and Hirschfeld, 1978). A small group of 
depressed patients may be distinguished by the presence of 
hypochondriacal symptomology. Whether such patients indicate a true, 
independent sub-group is not clear since such patients may exhibit 
retarded behavioural patterns, i.e. endogenous depression, or 
agitation-anxiety, i.e. anxious depression, (Hamilton, 1979a). 
Another sub-group is termed involutional depression or involutional 
melancholia and is described as a syndrome which occurs with late 
onset (usually between 50 to 60 years of age) in individuals with a 
rigid obsessional personality. It is characterised by anxiety, 
agitation, hypochondriasis and sometimes paranoia. By their nature 
the terms used to identify possible sub-groups of depression 
introduce aetiological and symptomatic considerations that are not 
always accurate or justified. Indeed, whether the pattern of 
symptoms distinguishing involutional depression truly identifies a 
separate syndrome is a topic of much debate (Hamilton, 1979a).
The affective disorders may also be sub-divided according to the 
primary-secondary distinction introduced at the Williamsburg 
Conference in 1969 by Robins and Gruze (cited by Katz and Hirschfeld, 
1978). The primary affective disorders were defined as depressive 
(or manic) episodes occurring in patients whose previous histories 
were free of psychiatric disturbance or contained previous episodes 
of depression or mania but no other psychiatric illnesses. Secondary 
affective disorders were defined as those occurring in patients with
a pre-existing, diagnosable psychiatric illness other than primary 
affective disorder. This nosological distinction was proposed 
primarily for research (rather than clinical) purposes, and indeed 
primary and secondary depressives may be clinically 
indistinguishable. Even so, " the distinction predicts that primary 
depressive patients will have more affective psychopathology in their 
first degree relatives, while the psychopathology of patients with 
secondary depression will resemble those of other patients with their 
underlying condition rather than those with primary depression.
1.2.3 Epidemiology of Depression
The prevalence of depressive illness has been extensively studied 
both in terms of incidence in the general population and the number 
of people interviewed by general practitioners and psychiatrists.
Such studies have indicated an annual rate for depression of 
approximately 0.35% for a given population, the most common social 
group being women aged between 20-H0 years, of whom only 10-15% 
warrant hospitalisation (quoted by Green and Costain, 1981). The 
vast majority of patients thus receive treatment while being fully 
integrated into normal society, and are therefore subjected to the 
normal pressures of everyday life throughout the period of their 
depressed state. Successful treatment of the depressed patient must 
therefore result in a change in that patient’s response to 
environmental and social stimulation, which prior to treatment the 
patient would have found intolerable.
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^.2.^ Symptomology and Diagnosis of Depression
1.2.4.1 Symptomology
The principal features of depression, i.e depressed mood, feelings 
of guilt and suicidal tendencies, have been described in depth by 
Hamilton (1979a), from which the following description of depressive 
illness has been obtained. In the mild stages of the illness the 
principal features of depression are not obvious and the patients 
usually complain of lack of energy and tiredness, low mood (which 
frequently fluctuates throughout the day and generally improves as 
the day proceeds), difficulties with sleep, and loss of interest, 
appetite and libido or sexual drive resulting in impotence or 
frigidity. Related to the loss of interest is an increased 
difficulty in coping with work, which the patient tends to avoid, 
associated with indecisiveness and lack of self-confidence. Sleep 
disturbance increases such that patients display early wakening, 
interrupted sleep, difficulties in falling asleep and unpleasant 
dreams. The increased loss of appetite subsequently results in 
weight loss. As the severity of the illness increases the depressed 
mood becomes constant and unresponsive to stimuli which normally 
elevate mood. The patient feels isolated and tends to avoid company. 
Patients become self-reproachful and blame themselves for their 
failure to overcome their depression and their presumed neglect of 
their family such that they become increasingly preoccupied with 
their deficiencies and feelings of guilt. Suicidal tendencies begin 
with the increased feeling that life is not worth living and thoughts 
of death become a preoccupation.
Symptoms of anxiety are common in depressives. The patients become 
anxious, tense, irritable, forgetful and ill-tempered, have
difficulty in concentrating and worry about trivial matters. The 
somatic manifestations of anxiety (i.e. headaches, sweating, 
palpitations, trembling, indigestion and flatulence) may become 
prominent and overlap with the physiological symptoms. In the more 
severe stages of the illness the pupils become dilated and the hands 
tremor.
Modified psychomotor performance (i.e. retardation or agitation) is 
not always present during the early stages of the illness. In the 
milder stages of depression both retardation and agitation may be 
present but as the illness progresses one eventually tends to mask 
the other. Initially retarded depressives tend to walk slowly or sit 
motionlessly, not rigidly but with reduced body movements and 
poverty of facial expression, reflecting a deficiency of alertness 
and increased unresponsiveness to environmental stimuli. In the 
early stages speech is low and monotonous but not slowed, even 
though there may be a delay in responding to questioning. This does 
not necessarily reflect a slowness of thinking but rather a 
preoccupation with continuous miserable thoughts. As the illness 
progresses the retarded depressives show increasing periods of 
sitting motionless with a rigid posture. Both speech and thoughts 
become slowed such that eventually the patient becomes mute and 
unresponsive to questioning. In the most severe stages it becomes 
increasingly difficult to persuade the patient to eat or drink, 
sleep becomes grossly disturbed, and the fixed miserable facial 
expression completes the isolation from human contact. At this stage 
the patients may express, if they can be persuaded to talk, 
delusions of guilt and experience of hallucinations. Agitation first 
appears as restlessness involving pacing and fidgeting. As the
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agitation increases the patients fidget constantly, are unable to 
sit still and pace restlessly. In the more severe stages of 
agitation patients continually wring their hands, pull at their 
clothes, hair or faces and moan. The severe symptoms are now very 
rarely observed since the vast majority of patients respond well to 
antidepressant treatment (Hamilton, 1979a; Green and Costain,
1981) .
Conversely, the symptoms of mania are characterised by an abnormal 
elevation of mood. During the initial stages of the illness the 
patient exhibits increased activity, optimism and cheerfulness. The 
patient becomes excessively friendly, sexually and socially 
uninhibited and tactless, is occupied with many different tasks, 
schemes and ideas, and talks continuously. Although mood is highly 
elevated the patient cannot tolerate criticism or advice and can 
quickly become irritable and quick to violent anger. In work the 
patient makes overestimated judgements and makes decisions that 
cannot be met either financially or practically. It is typical that 
the patient shows little insight and when challenged insists that 
he/she has never felt better and asserts that his/her thinking and 
ideas are clearer than ever before. As the illness progresses so 
sleep requirements diminish and appetite and libido increase. The 
patient eventually exhibits ceaseless activity and talking, euphoria 
and rage; hallucinations and delusions may also be present (Hamilton, 
1979a; Green and Costain, 1981).
1.2.H.2 Diagnosis and Rating Scales
Only the persistence of the initial symptoms of depression, to the 
point where normal life becomes difficult, prompts the patient to
seek consultation with a general practitioner. If depressive illness 
is suspected then the patient is referred to a consultant psychiatrist. 
The clinical features of the early stages of depression are clearly 
of primary importance for diagnosis, classification and management.
In order to standardize the assessment and evaluation of the 
described symptoms a number of rating scales have been developed.
The types of rating scales used fall into two broad groups depending 
on whether the rating is based on clinical interview (observer 
scales) or solely by the patient (self-assessment scales).
The most widely used observer rating scale is that produced by 
Hamilton (1960), sometimes referred to as the Hamilton Rating Scale 
(HRS) or Hamilton Diagnostic Scale (HDS). Ratings are based on 
clinical interview and the scale designed to cover the previous week. 
The scale contains 17 variables, including both mental and physical 
symptoms, which are scored and the values summed to produce an 
overall rating of the severity of the illness. A major criticism of 
the HRS is that due to its design ratings cannot be obtained more 
frequently than at weekly intervals. Thus the system cannot identify 
specific short-term changes in the symptomology of depression. Over 
the long-term, however, the HRS has proved to be a useful indicator 
not only of the time-course of depression and its severity but also 
of the general remission from depression during treatment.
Self-assessment scales are of most value when assessments have to be 
made frequently and there are a number in current use. The Beck 
Depression Inventory (BDI; Beck et al., 1961) appears to be the
most popular and, for self-assessment purposes, consists of 13 
items to be graded by the patient (see also Hamilton, 1979b). Other
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examples of self-assessment scales are the Zung Self-Assessment 
Depression Scale, the Lubin Adjective Check List, the Popoff Index 
of Depression and the Wakefield Scale (see Hamilton, 1979b, and 
references cited therein). The scales differ in the number of items 
used and their validity has been examined by determining the 
correlation to the HRS. In some cases this has resulted in a 
refinement of the scale to increase its correlation to the HRS such 
that whether the scales provide additional information to the HRS is 
open to question. In addition it is impossible for patients to 
assess the incidence or severity of certain symptoms, e.g. loss of 
insight and delusions, and retardation, agitation and 
hypochondriasis, respectively, and such self-assessment scales are 
also open to the biases of the patient. Generally, therefore, 
observer ratings, such as the HRS, appear to be more valid and 
provide a clearer overall appreciation of the symptomology of 
depression than the self-assessment scales. The classification into 
diagnostic categories is aided by the International Classification of 
Diseases system and the Diagnostic and Statistical Manual (see Gelder 
et al., 1983).
Other rating scales may be employed to examine specific symptoms of 
depression. For example, the Hostility and Direction of Hostility 
Questionnaire (HDHQ) attempts to quantify the psychological problems 
associated with a failure of interpersonal relationships and 
exaggerated levels of aggression or hostility (see Priest et al., 
1980, and references cited therein). The questionnaire consists of 
51 items grouped into 5 scales measuring both extrapunitive (outward) 
hostility (i.e. the urge to act out hostility, criticism of others 
and projected hostility) and intropunitive (inward) hostility (i.e.
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self-criticism and guilt). Hostility levels are high in depressive 
illness, especially those directed towards oneself (i.e. 
intropunitive scales). Both the total hostility and the degree of 
intropunitive hostility decrease as the patient recovers from the 
illness (Priest et al., 1980).
1.3 Neurotransmitter Abnormalities in Depression
1.3.1 Historical Perspectives
Three observations led to the development of the idea that 
alterations in central monoamine metabolism and function could 
precipitate a mood change and that such changes may be central to the 
pathogenesis of depressive illness.
During the early 1950’s the anti-tuberculosis drugs isoniazid and, 
more especially, its isopropyl derivative, iproniazid, were 
observed to produce mood-elevating effects in man. Subsequently 
Zeller et al. (1952) showed that iproniazid, in contrast to 
isoniazid, was capable of inhibiting the enzyme monoamine oxidase 
(MAO), the major degradative enzyme of the monoamine transmitters 
serotonin, i.e. 5-hydroxytryptamine (5-HT), noradrenaline (NA) and 
dopamine (DA) (Cooper et al., 1978).
Secondly, in 1954 Wooley and Shaw proposed that 5-HT might be 
involved in the regulation of mood (cited by Green and Costain,
1981). Their hypothesis was based on consideration of the 
hallucinogenic effects of lysergic acid diethylamide (LSD) and its 
structural similarity to 5-HT. In addition it was known that LSD was 
a 5-HT antagonist on smooth muscle in vitro.
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The view that central monoamines were involved in mood regulation was 
further supported by the clinical observation that the alkaloid 
reserpine, which during the 1950’s was used to treat hypertension, 
could precipitate a severe depressive episode clinically 
indistinguishable from endogenous depression. It was subsequently 
demonstrated that reserpine had the ability to deplete the central 
monoamines 5-HT (see Carlsson et al., 1957b, and references cited
therein), NA and DA. In addition, Carlsson et al. (1957a) 
demonstrated that the reserpine-induced effects in animals could be 
reversed by 3,4-dihydroxyphenylalanine (L-DOPA), the precursor of DA 
and NA (Cooper et al., 1978), either alone or, more effectively, 
in combination with 5-hydroxytryptophan (5-HTP), the precursor of 
5-HT (Cooper et al., 1978).
In the light of these observations numerous studies have attempted to 
identify biochemical changes that may occur in depressive illness.
Two general approaches have been used. The first has been to examine 
for biochemical changes in tissues obtained from depressive patients 
such as blood, cerebrospinal fluid (CSF), urine, platelets and 
post-mortem brain tissue. This approach, with reference to 
serotonergic and noradrenergic neurotransmitter systems in the 
central nervous system (CNS), will be briefly reviewed here (section 
1.3.2). The release of inhibitory and releasing factors from the 
hypothalamus (which control the release of hormones originating from 
the anterior lobe of the pituitary), and the pineal hormone 
melatonin, are ultimately under the control of central monoamine 
systems. Central monoamine activity may therefore be reflected in 
the release of anterior hypophyseal hormones or melatonin, and many 
studies have attempted to identify possible hormonal markers in
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depressed patients that may be indicative of abnormal central 
monoamine activity. The findings of such studies on the secretion of 
adenohypophyseal hormones will be described briefly in section 1.3.3, 
while the control of melatonin release and abnormalities of melatonin 
secretion in depression will be described briefly in sections 1.6.2 
and 1.6.3 respectively. The second approach is to examine the ways 
that drugs effective in treating depressive illness alter the 
biochemical function of the brain in experimental animals, or 
biochemical parameters of depressed patients, and will be reviewed 
in section 1.H.5.
It should be noted that changes in electrolyte distribution have been 
observed in some depressed patients. Electrolytes, such as sodium, 
potassium, calcium and magnesium, have profound biological 
importance regarding, for example, the resting potential of neurons 
and other excitable cells, propagation of action potentials, and 
consequently the release of neurotransmitters. For the sake of 
brevity these changes will not be reviewed here. Instead, the 
interested reader is directed to the review by Coppen (1967).
1.3.2 Neurotransmitter Abnormalities
1.3.2.1 The Serotonin System
The observation by Ashcroft et al. (1966) that 5-hydroxyindole 
compounds in the CSF of patients were lowered in depression sparked a 
variety of studies on the biochemical markers of the indoleamine 
system in depressed patients. This research area has been 
extensively reviewed by a number of authors (e.g. Ridges, 1976; 
Murphy et al., 1978; Green and Costain, 1979, 1981; Sugrue,
1981a; Dunner, 1983). Only a brief review will be provided here.
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Asberg et al . (1976) reported that concentrations of 
5-hydroxyindoleacetic acid (5-HIAA). the primary metabolite of 5-HT 
in the CNS (Green, 1978; Fuller, 1985) in the CSF of depressed 
patients exhibited a bimodal distribution; one group having normal 
and the other lower 5-HIAA levels. The latter group showed an 
increased tendency to attempt suicide (see also Shaw et al., 1967). 
Furthermore, decreased levels of 5-HT and 5-HIAA have been detected 
in some, but not all, studies on post-mortem brain samples from 
suicides (see review by Murphy, 1978). Consequently, it has been 
suggested that low CSF 5-HIAA levels may be predictive in identifying 
individuals with a greater predisposition to commit suicide (Oreland 
et al., 1981; Agren, 1983; van Praag, 1986b), although this 
view has recently been questioned by Secunda et al. (1986) who found 
no correlation between CSF 5-HIAA levels and suicide attempts.
Indeed, although suicide is assumed to be the ultimate expression of 
depression, whether all individuals who attempt suicide are also 
depressed is questionable. Van Praag and co-workers have utilized 
the ability of probenecid to inhibit the acid transport system in the 
brain, thereby blocking 5-HIAA egress from the CSF to the blood 
stream, to study 5-HT turnover in depression. A decreased 5-HIAA 
accumulation following probenecid treatment is assumed to suggest 
decreased 5-HT turnover. These studies (van Praag and de Haan,
1979; van Praag, 1979, 1986a, and references cited therein)
indicated that 5-HIAA accumulation after probenecid treatment was 
invariably reduced in patients with endogenous depression. 
Furthermore, in half of the cases 5-HIAA accumulation returned to 
normal following recovery. Those patients who had apparently 
recovered from depression but still showed persistent low CSF 5-HIAA
levels after probenecid, and their family members, exhibited
increased depression rates (van Praag, 1979). These observations 
suggest that disturbed 5-HT function predisposes the individual to 
depressive episodes rather than being a causal factor. A major 
problem with CSF 5-HIAA studies is determining the origin and 
significance of the 5-HIAA measured. Indeed, some studies indicate 
that the majority of CSF 5-HIAA may be spinal in origin (see Green 
and Costain, 1979); furthermore, whether central 5-HIAA levels 
reflect central 5-HT function is questionable since, in rodents at 
least, it appears that 5-HT is synthesized in excess of functional 
needs (Green and Grahame-Smith, 1975). The level of CSF 5-HIAA may,
therefore, merely reflect changes in the intraneuronal metabolism by 
MAO (see also the behavioural studies of Wolf et al., 1985).
5-HT does not cross the blood-brain barrier from the peripheral 
circulation and must therefore by synthesized in the brain from its 
precursor L-tryptophan, an essential amino acid obtained from 
dietary protein (Cooper et al., 1978). Central 5-HT synthesis is,
at least in part, dependent on the brain tryptophan level which, in 
turn, is dependent not only on the free plasma tryptophan 
concentration but, more importantly, on the level of the latter in 
relation to that of other large neutral circulating amino acids which 
compete for the same uptake process into the brain (Wurtman and 
Fernstrom, 1976; Mandell and Knapp, 1977; Green and Costain,
1981; Wurtman et al., 1981). Thus decreased plasma tryptophan 
levels would ultimately influence tryptophan availability for central 
5-HT synthesis, and indeed some reports indicate that both free and 
total plasma tryptophan levels are reduced in depressives (Fiore et 
al., 1979; Moller et al., 1980), however, others have failed to
confirm this view (Green and Costain, 1979, and references cited
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therein; Dam et al., 1984). The majority of tryptophan is
metabolized in the liver by tryptophan pyrrolase which may be induced 
by corticosteroids (Green and Costain, 1979). The reduced plasma 
tryptophan levels may therefore simply reflect increased peripheral 
tryptophan metabolism induced by high cortisol levels which have been 
observed in some depressed patients (see section 1.3.3 below). If a 
simple deficiency of tryptophan availability produced depression then 
lowered CSF tryptophan levels should be observed in depressives and 
5-HT precursor administration (with tryptophan or 5-HTP) should be an 
extremely effective antidepressant. Some studies have indeed 
demonstrated lower CSF tryptophan levels in depressives; however 
this is not invariably so (see Green and Costain, 1979, and 
references cited therein). Moreover, while precursor treatments 
increase central 5-HIAA levels in depressed patients (indicating that 
the enzymatic processes involved in 5-HT synthesis are not impaired, 
but may only reflect increased intraneuronal 5-HT metabolism by MAO) 
only a sub-group of depressives respond to such treatment (van Praag, 
1981b, and references cited therein).
Blood platelets are the only non-neuronal cells that have the ability 
to accumulate, store and metabolize substances which are either 
established or putative neurotransmitters, and this particularly 
applies to 5-HT. Furthermore, the processes involved in 5-HT 
uptake, storage and metabolism (by MAO type B) by platelets appears 
to be similar to that observed for 5-HT in the brain (see review by 
Boullin, 1978). Consequently the platelet has been advocated as a 
model for central 5-HT function; however this view is at best 
somewhat tenuous. Decreased platelet accumulation of 5-HT in 
depressed patients has been observed in some studies (Hallstrom et
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al ., 1976; Arora et al., 1984; Healy et al., 1986a, 1986b;
Healy and Leonard, 1987) but not in others (Shaw et al., 1971, 
cited by Green and Costain, 1979). The discrepancy between these 
results may be due to platelet 5-HT uptake exhibiting a circadian 
rhythm in normals but not in depressed patients (Healy et al.,
1986a, 1986b) which is restored on recovery. Furthermore, platelet
5-HT also shows marked seasonal variation in depressed patients 
(Arora et al., 1984; Egrise et al., 1986). Studies on platelet
MAO activity have yielded contradictory results (see review by 
Rotman, 1983) with a number of studies showing little relationship 
between platelet MAO activity and the degree of depression (see also 
Honecker et al., 1981; Maubach et al., 1981).
Most 5-HIAA in the urine is thought to arise from the gut with only a 
small fraction originating from the CNS (see Green and Costain,
1979). Such measures, therefore, have limited value, if any, as 
markers of central 5-HT activity, and thus will not be discussed 
here.
The general consensus of opinion in the literature is that the data, 
especially that arising from CSF studies, indicate the possibility 
of lowered 5-HT concentration or metabolism in depression.
1.3.2.2 The Noradrenaline System
The functional status of central catecholaminergic systems in 
depression has been extensively investigated by measurement of 
metabolite levels in urine, plasma and , to a lesser extent, CSF. 
These areas have been extensively reviewed by a number of authors 
(e.g. Schildkraut and Kety, 1967; Schildkraut, 1978; Green and
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Costain. 1979; Sugrue, 1981a; van Praag, 1981a; Dunner 1983). 
The findings of these investigations, with respect to the 
noradrenergic system, will only be summarized here.
The major metabolite of NA originating from the CNS is thought to be 
3-methoxy-4-hydroxyphenylglycol (MHPG) (Cooper et al., 1978), or
its sulphate ester conjugate, and thus changes in the level of MHPG 
in the urine, plasma or CSF are thought to reflect central 
noradrenergic activity. Studies of MHPG levels in depressed patients 
have generally yielded equivocal results. Thus, urinary or plasma 
levels of MHPG in patients with endogenous depression have been shown 
to be lower (Maas et al., 1974, cited by Ridges, 1976; Wehr et
al., 1980; Agren. 1983; Puzynski et al., 1984; Secunda et al.,
1986), normal (Oreland et al., 1981) or raised (Agren, 1983;
Halaris, 1984) compared to normal controls (see also review articles 
cited above). Furthermore. Puzynski et al. (1984) observed that 
reduced urinary MHPG levels were observed in all types of affective 
illness without being related to the type of depressive syndrome, 
while the reduced levels of urinary, plasma or CSF MHPG levels 
observed by Agren (1983) or Secunda et al. (1986) appeared to 
identify potential suicides in a similar manner to reduced CSF 5-HIAA 
levels (see section 1.3.2.1). The studies of Schildkraut and 
co-workers (see Schildkraut, 1978, and references cited therein) 
suggest that MHPG concentrations in unipolar depressive patients are 
invariably higher than that observed in patients with bipolar 
depression. Furthermore, urinary MHPG levels of bipolar patients 
were relatively lower during periods of depressive and higher during 
manic or hypomanic episodes than during periods of remission. These 
observations would strongly argue against a homogeneous population of
depressive patients. Indeed, the level of MHPG excretion in 
unipolar patients has been reported to correlate with response to 
specific antidepressant drugs. Thus, patients with low urinary MHPG 
levels reportedly respond to drugs which selectively (albeit 
slightly) increase central noradrenergic activity (i.e. desipramine 
and imipramine), while patients with higher levels of MHPG respond 
to drugs which also increase central serotonergic activity (i.e. 
amitriptyline) (see Schildkraut, 1978, and Dunner, 1983, and 
references cited therein). It is claimed that these results indicate 
that low urinary MHPG levels and favourable response to imipramine or 
desipramine is indicative of decreased central noradrenergic 
activity, while high urinary MHPG levels and favourable response to 
amitriptyline is indicative of decreased central serotonergic 
activity; at best this view would appear somewhat tenuous. It 
should be noted at this point that the drugs indicated above inhibit 
the re-uptake of central NA and 5-HT with varying degrees of relative 
selectivity, which for these drugs is slight or, for amitriptyline, 
at best marginal; the mode of action of these antidepressants will 
be discussed in section 1.5.3.
The general consensus of opinion in the literature is that studies of 
MHPG levels indicate the possibility of abnormal noradrenergic 
activity or NA metabolism in patients with affective disorders.
1.3.3 Endocrine Abnormalities in Depression
A number of abnormalities in the release of hormones originating from 
the adenohypophysis have been observed in some depressed patients. 
Since the release of these hormones is ultimately controlled by 
central monoamine neurotransmitters such observations are indicative
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of abnormalities in central monoamine function, and will only be 
briefly described here.
Some depressed patients exhibit a blunted growth hormone (GH) 
response to challenge with pharmacological agents which increase GH 
secretion (van Praag, 1981a; Siever et al., 1983; Meltzer et al.,
1984). Furthermore, Garver et al. (1975, cited by van Praag,
1981a) demonstrated a correlation between human GH response to 
insulin and renal MHPG excretion. The urinary concentration of MHPG 
is regarded as a crude indicator of central NA metabolism (Cooper et 
al., 1978; Green and Costain, 1981), and thus the correlation
indicates that the GH response to insulin diminishes, as central NA 
turnover diminishes. These observations suggest that central 
noradrenergic systems may be deficient in depression.
Abnormalities in luteinizing hormone (LH) (van Praag, 1981a) and 
prolactin (Linkowski et al., 1980; see also Meltzer et al., 1984)
levels in postmenopausal women with unipolar depression have been 
observed. These observations suggest that the noradrenergic system 
which ultimately controls LH release, and the inhibitory 
dopaminergic or stimulatory serotonergic systems controlling 
prolactin release may be abnormal in depression (see van Praag,
1981a).
A blunted thyroid-stimulating hormone (TSH) response to 
thyrotropin-releasing hormone (TRH) (Gold et al., 1980; Sternbach 
et al., 1985) or low 24h levels of serum TSH (Kjellman et al. (1984)
have been observed in some depressed patients. These effects are 
thought to be secondary to decreased sensitivity of the pituitary
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thyrotrophs following a prolonged increase in TRH stimulation (see 
van Praag, 1981a; Kjellman et al., 198H). In addition, there is
increasing evidence that the thyroid hormones exert a considerable 
influence over the central function of monoamine neurotransmitters 
(e.g. see Atterwill, 1981; Vaccari, 1982; Heal et al., 1987).
Furthermore, TRH has been used, with some success, to treat 
unipolar depression in women (Pecknold and Ban, 1977).
The adrenal cortex secretes cortisol under the influence of adrenal 
corticotrophic hormone (ACTH) from the pituitary, which is secreted 
in response to the hypothalamic corticotrophin releasing factor 
(CRF). Cortisol secretion is maintained predominantly by the levels 
of cortisol exerting a negative feedback on both ACTH and CRF; in 
addition there is evidence of a noradrenergic system with a tonic 
inhibitory effect on CRF production (see van Praag, 1981a). Some 
depressed patients exhibit abnormalities in the hypothalamus- 
pituitary-adrenal axis as indicated by the hypersecretion of cortisol 
(e.g. see van Praag, 1981a; Claustrat et al., 198H) and
corticosterone (Arana et al., 1985). These observations suggest
that in a subgroup of depressed patients there is a failure in the 
negative feedback system. Furthermore, normal subjects treated with 
dexamethasone (a synthetic steroid) at the nadir of the circadian 
rhythm of cortisol secretion (see Wetterberg et al., 1982) secrete
virtually no cortisol the next day, while patients with vital 
depressions may exhibit resistance to the effect of dexamethasone 
(see Carroll, 1985). Resistance to the dexamethasone suppression 
test (DST) is thought to have some clinical value firstly, in 
differentiating some affective disorders (Arana et al., 1985;
Baldessarini and Arana, 1985); secondly, in identifying depressed
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patients with a high risk of attempted suicide (Robbins and Alessi
(1985), although this ability has been questioned (Secunda et al.,
1986); and lastly, in predicting the response to drug therapy 
(Amsterdam et al . , 1983; Christensen et al., 1985), including the
potential of early relapse (Greden et al., 1980), or specific
somatic antidepressant treatments such as sleep deprevation 
(Nasrallah and Coryell, 1982). The use of the DST in psychiatry has 
been a topic of discussion since its inception and its diagnostic and 
predictive value is still controversal (see Carroll, 1985; 
Baldessarini and Arana, 1985; Schatzberg, 1985).
In conclusion therefore, sub-populations of depressed patients have 
been shown to exhibit hypersecretion of corticosteroids, while major 
sub-groups of depressed patients demonstrate a diminished GH response 
to insulin-hypoglycemia, a blunted TSH response to TRH and low 
levels of plasma LH. Hypersecretion of cortisol is also observed on 
hyperactivity of the adrenal cortex (Cushings syndrome) or when 
hypersecretion of ACTH from the pituitary (Cushings disease) induces 
overactivity of the adrenal cortex resulting in increased secretion 
of cortisol. In both cases the neuroendocrine abnormalities listed 
above are observed. Furthermore, evidence suggests that 
administration of exogenous corticosteroids may precipitate these 
same neuroendocrine abnormalities. These observations suggest that 
hypersecretion of corticosteroids may be the underlying cause of the 
other neuroendocrine changes observed in depressed patients (see 
Kendler and Davis, 1977). In support of this hypothesis, Horton et 
al. (1986) observed that depressed patients who failed to suppress 
plasma cortisol levels in the DST also exhibited a blunted GH 
response to the alpha2 agonist, clonidine.
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1.4 Treatment of Depression
1.4.1 Historical Aspects
The earliest of the current treatments for depression was 
electroconvulsive therapy (ECT), introduced in 1938 by Cerletti and 
Bini (cited by Green and Costain, 1981). The usefulness of ECT in 
depression became apparent with clinical experience, and, while it 
is not a pharmacological treatment, it is reasonable to assume that 
its effects are mediated via central neurotransmitter systems. ECT 
remains, however, the least understood and the least critically 
assessed of the antidepressant treaments. The major pharmacological 
advances in the treatment of depression arose with the advent of the 
monoamine oxidase inhibitors (MAOI’s) and tricyclic antidepressants 
(TCA's) in the 1950's. The efficacy of these compounds is thought to 
be due to the resulting increase in the synaptic concentration of 
central 5-HT and/or NA following either inhibition of MAO, the major 
degrBdative enzyme of these neurotransmitters, or inhibition of the 
active re-uptake processes, respectively. More recently, a new 
generation of putative antidepressants have been developed which, 
although some are cyclic in structure, bear little structural 
similarity to the previously available antidepressant drugs. Some 
compounds have been developed as relatively specific re-uptake 
inhibitors (generally for 5-HT), while others are demonstrably 
effective clinically but whose mode of action cannot be attributed to 
inhibition of either MAO or neurotransmitter re-uptake. These latter 
compounds are generally known as the atypical antidepressants.
The following sections provide a brief introduction to the 
development and clinical use of the various classes of drugs 
currently available to the clinician, i.e. MAOI’s, monoamine
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re-uptake inhibitors (TCA’s and the more recent "second generation" 
monoamine-specific re-uptake inhibitors) and the atypical 
antidepressants, together with a brief description of their 
pharmacological and biochemical effects following acute and chronic 
treatment. The use of ECT or lithium in depression, and the effect 
of equivalent treatments on various behavioural animal models or 
biochemical measures, will not be discussed here except where such 
effects are pertinent in comparison to a particular drug-induced 
effect. Instead, the interested reader is directed to the reviews 
of Green and Costain (1979, 1981), Crow and Johnstone (1979) and
Shaw (1979).
1.4.2 Monoamine Oxidase Inhibitors
The observation of the mood-elevating effects of iproniazid in man, 
and the subsequent demonstration by Zeller et al. (1952) that 
iproniazid inhibited MAO activity, led to the development of the 
group of compounds known as the MAOI’s. The historical development 
of the MAOI’s for the treatment of depression has been reviewed by 
Kline and Cooper (1980).
1.4.2.1 Monoamine Oxidase
MAO is a flavoprotein associated with the outer mitochondrial 
membrane (Youdim and Findberg, 1983). It is widely distributed in 
almost all mammalian tissue, including the CNS, with varying 
degrees of activity. Only about 6-8% of brain MAO is located 
intraneuronally, where it is the most important enzyme involved in 
the metabolism of 5-HT and the catecholamines (Cooper et al., 1978;
Green and Costain, 1981), with the majority of brain MAO located 
extraneuronally (Youdim and Findberg, 1983). Studies have indicated
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that MAO is not a single entity but is composed of a number of 
closely related enzymes (Youdim and Findberg, 1983, and references 
cited therein). It is now established that MAO exists in at least 
two major forms (Johnston, 1968; Fuller. 1972), types A and B. 
which differ in their substrate specificity, sensitivity to 
inhibitors and location within the brain (Youdim and Findberg,
1983). Thus, MAO-A preferentially deaminates 5-HT. NA and AD, 
while MAO-B deaminates non-polar amines such as benzylamine, 
beta-phenylethylamine, phenylethanolamine and tryptamine. DA and 
tyramine are substrates for both subtypes of the enzyme (Fuller,
1972; Cooper et al., 1978; Youdim and Findberg, 1983). In
addition, MAO-A activity is thought to be predominantly, but not 
exclusively, associated with the neuron and MAO-B activity with 
extraneuronal cells (Youdim and Findberg, 1983). It should be 
noted, however, that the characteristics of the enzymes are not the 
same in all tissues and species. Thus, in human brain cortex and 
caudate nucleus DA is predominantly deaminated by MAO-B, while in 
rat brain caudate DA is deaminated by MAO-A (Garrick et al., 1979;
Youdim and Findberg, 1983). Furthermore, MAO-A appears to be the 
predominant form present in rodent brain, including rat, mouse and 
hamster, while MAO-B predominates in primate and human brain 
(Garrick et al., 1979).
1.4.2.2 Inhibitors of Monoamine Oxidase
The three main classes of the MAOI’s are the hydrazines (e.g. 
iproniazid, phenelzine, isocarboxazide, nialamide), the 
eyelopropylamines (e.g. tranylcypramine) and the acetylenic 
propargylamines (e.g. clorgyline, deprenyl, pargyline) (Youdim and 
Findberg, 1983). All of these compounds inhibit MAO irreversibly.
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The hydrazines and tranylcypramine are non-selective inhibitors of 
MAO, while clorgyline is selective for MAO-A, and deprenyl (also 
known as selegeline) and pargyline are selective for MAO-B (Johnston, 
1968; Fuller, 1972; Youdim and Findberg, 1983).
In 1957 iproniazid was introduced into the clinic for the treatment 
of depression, and other non-selective MAOI's soon followed. The 
MAOI’s exhibit a different therapeutic spectrum from other 
psychotropic drugs, and are demonstrably effective in neurotic 
depression and anxiety, mixed anxiety-depression and 
hypochondriasis, and phobic anxiety (particularly agrophobia), but 
not psychotic depression (Paykel, 1979a; Tyrer, 1979).
Furthermore, MAOI’s may often be effective when other treatments 
(e.g. with TCA's) have failed (Tyrer, 1979). However, conflicting 
data concerning their efficacy, concern over their safety, and the 
introduction of the TCA's (see section 1.H.3) led to a decline in 
their clinical use. The major clinical cause for concern was, and 
remains, the so-called "cheese reaction". This severe drug-induced 
reaction is a hypertensive crisis which occurs following ingestion of 
foods or medication containing high concentrations of tyramine or 
related sympathomimetic amines (Green and Costain, 1981; Youdim and 
Findberg, 1983). Tyramine, a substrate for both forms of MAO, is 
normally metabolized by MAO-A in the gut (Youdim and Findberg,
1983). However, following non-selective inhibition of MAO, 
tyramine is taken up by the vascular noradrenergic nerve endings 
where it displaces NA, thereby inducing the hypertensive reaction.
In addition to the elevated blood pressure and, possibly, increased 
pulse rate, patients commonly experienced nausea and vomiting. 
Generally patients recover but occasionally angina, cardiac arrest.
pulmonary oedema, intracranial and subarachnoid haemorrhage occur 
(Kline and Cooper, 1980). Antidepressant treatment with MAOI’s can 
be associated with numerous side effects and adverse reactions. The 
acute toxic effects observed following overdose include agitation, 
hallucinations, hyperpyrexia, hyperreflexia, changes in blood 
pressure, and convulsions. During long term therapy autonomic side 
effects include dry mouth, constipation, dizziness, postural 
hypotension, impotence and delayed ejaculation, while CNS effects 
include agitation, insomnia, irritability and motor restlessness
(Kline and Cooper, 1980). In some cases MAOI's have been shown to
convert a retarded depression into an agitated depression. In 
addition, hypomania or precipitation of psychosis in patients with a 
history of schizophrenia has been reported. The incidence of liver 
toxicity with iproniazid, manifest by jaundice, hepatocellular 
damage, elevated liver enzymes and biliary stasis, resulted in the 
withdrawal of iproniazid as an antidepressant (Kline and Cooper,
1980).
Renewed interest in the use of MAOI’s for the treatment of depression 
followed the identification of the two subtypes of MAO and the 
introduction of the selective inhibitors clorgyline and deprenyl 
(Johnston, 1968; Fuller, 1972). If one accepts that 5-HT and/or 
NA deficiency play important roles in depression and since both 5-HT 
and NA are preferred substrates for MAO-A, then it may be argued 
that selective inhibitors of MAO-A would be preferred to selective 
inhibitors of MAO-B. However, since gut MAO is predominantly type A 
then administration of selective MAO-A inhibitors would still render 
the patient susceptible to the "cheese reaction". Both clorgyline 
and deprenyl exhibit antidepressant efficacy (see Fuller, 1981, and
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Mann et al., 1984, and references cited therein), although whether
MAO-A inhibitors exhibit increased efficacy over MAO-B inhibitors, 
or whether MAO-B inhibitors, which would not be expected to render 
the patient susceptible to the "cheese reaction", possess any 
increased safety advantages over selective inhibitors of MAO-A, 
remains a topic of debate (Mann et al., 1984).
A more recent approach has been the development of rapidly reversible 
selective MAO-A inhibitors such as moclobemide, MD 780515 and FLA 
336(+). In animal studies these compounds, unlike clorgyline or the 
non-selective irreversible MAOI’s, do not appear to potentiate 
tyramine sensitivity and, furthermore, moclobemide exhibits 
antidepressant efficacy with apparent lower potential for tyramine 
potentiation (Mann et al., 1984). Whether such compounds prove to
possess any advantages, in terms of efficacy and safety, over 
clinically available antidepressants remains to be evaluated.
In animal studies acute administration of MAOI’s results in the 
accumulation of 5-HT, NA and DA together with a reduction in the 
respective metabolite levels (Youdim and Findberg, 1983; Wiliner,
1985) consistent with reduced MAO activity. Furthermore, acute
treatment with MAOI's demonstrably potentiates and increases the 
duration of effect of 5-HT-induced behaviours (Ortmann et al.,
1980). While MAO inhibition may be achieved with low doses of these 
agents, higher doses may cause other pharmacological effects such as 
inhibition of monoamine uptake and receptor blockade, although these 
effects are thought to be secondary to inhibition of MAO activity in 
terms of their ability to elevate synaptic neurotransmitter levels 
and their antidepressant effect (Kline and Cooper, 1980; Youdim and
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Findberg, 1983). Current evidence suggests that up to 80% of MAO 
must be inhibited before any behavioural or therapeutic effects are 
observed (Kline and Cooper, 1980; Green and Costain, 1981), and 
while this level of MAO inhibition and peak brain amine levels may be 
readily attained, i.e. within 7 days (Robinson et al., 1979), such
effects would not appear to correlate with the latency for clinical 
response, where at least 2-4 weeks of treatment are required before 
any therapeutic benefit is observed (Oswald et al., 1972; Kline and
Cooper, 1980; Green and Costain, 1981). Moreover, Robinson et 
al. (1979) demonstrated that during chronic MAOI treatment of rodents 
brain amine and metabolite levels returned to near pre-treatment 
levels at a time equivalent to the onset of clinical remission in 
patients. Furthermore, the same studies suggest that chronic 
treatment with some, but not all, MAOI’s results in increased 
activity of the enzymes involved in monoamine synthesis (see also 
Campbell et al., 1979), while other workers suggest that amine
synthesis (especially that of 5-HT) may be reduced following chronic 
MAOI treatment (see Youdim and Findberg, 1983, and Wiliner, 1985, 
and references cited therein). Such observations suggest that the 
antidepressant effect of MAOI’s is not due directly to inhibition of 
MAO activity per se nor the resultant increase in neurotransmitter 
levels, but rather to secondary adaptive changes that are induced in 
response to the initial abnormally high levels of central 5-HT, NA 
and, possibly, DA. The adaptive changes in neurotransmitter 
function following chronic MAOI treatment will be discussed in 
section 1.4.5.
1.4.2.3 Inhibitors of Monoamine Oxidase and Monoamine Precursors
L-Tryptophan, but not L-DOPA, has been reported to potentiate the
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antidepressant effect of MAOI’s (see Green and Costain, 1981, van 
Praag, 1981b, and Mann et al., 1984). The antidepressant effect
of the serotonin precursors L-tryptophan or 5-HTP, with or without 
concomitant MAOI treatment, together with the lack of antidepressant 
effect of L-DOPA (see Goodwin et al., 1970), has often been quoted 
in support of the causative role of a deficiency of 5-HT, rather 
than of the catecholamines, in depression (Coppen, 1967, Murphy et 
al., 1978; van Praag, 1979, 1981a, 1981b; van Praag et al.,
1987), and consequently has spurred research into "5-HT specific" 
antidepressants. Since 5-HT and NA are both preferred substrates for 
MAO-A, attention has focused on the development of drugs which 
specifically inhibit the re-uptake of 5-HT, rather than the 
catecholamines, in an attempt to increase 5-HT function as opposed 
to attempting specifically to inhibit MAO activity associated with 
serotonin neurons (see section 1.4.3.2). Whether the rationale for 
the development of 5-HT-specific antidepressants is justified is open 
to question, however, since the combination of L-tryptophan with 
MAOI’s also increases tryptamine levels in central catecholamine 
neurons, where it displaces the catecholamines thereby increasing 
central catecholamine turnover (Green and Costain, 1981). 
Furthermore, whether the increased 5-HT turnover observed following 
serotonin precursor treatment is indicative of increased serotonergic 
function is debatable since intraneuronal metabolism of 5-HT by MAO 
may account for the increased 5-HIAA levels without increased 5-HT 
release (Green and Grahame-Smith, 1975). In addition, while 
serotonin precursor treatment has been claimed to be antidepressant 
in patients that exhibit low CSF 5-HIAA levels (van Praag, 1979, 
1981b), whether administration of L-tryptophan or 5-HTP alone are 
indeed antidepressant in all depressed patients is equivocal and a
topic of debate (see Murphy et al., 1978). The efficacy of 
serotonin precursors may therefore simply serve to identify a 
"5-HT-deficient subgroup" of depressives (van Praag, 1981b), and 
thus demonstrate the heterogeneity of the depressed patient 
population.
1.*t.3 Monoamine Re-Uptake Inhibitors
During clinical investigation of a series of phenothiazine analogues 
for sedative or hypnotic properties, Kuhn (1958) observed that 
imipramine, a dibenzazepine compound differing from the
phenothiazines only by replacement of a sulphur atom with an ethylene
linkage, was relatively ineffective in quieting psychotic patients, 
but demonstrated beneficial effects when administered to certain 
depressed patients. This observation led to the development of other 
chemically related "tricyclic" antidepressants (TCA’s). It is now 
generally accepted that one important mechanism of action of the
TCA’s is their ability to inhibit the re-uptake processes of 5-HT
and/or NA (see Carlsson, 1970).
1.*1.3.1 5-HT and NA Re-uptake Processes
Since the early 1970’s it has become accepted that associated with 
neurons are specific transport systems for the particular transmitter 
synthesized and released by those neurons. Thus, neurons which 
release NA possess a specific transport system capable of 
transporting released NA back into the cytoplasm of the neuron, 
whereupon it is either metabolized intraneuronally, or stored in 
granules where it becomes available for further release. Similar 
specific uptake systems are associated with dopaminergic and 
serotonergic neurons (Iversen, 1975). The re-uptake processes are
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the primary method of removal (and hence inactivation) of the 
neurotransmitter from the synapse (Iversen, 1975; Cooper et al., 
1978; Green and Costain, 1981). The evidence for the re-uptake 
processes of the monoamine neurotransmitters have been extensively 
reviewed by Iversen (1975), and will only be briefly described here.
Autoradiographic and histochemical studies have indicated that the 
uptake and retention of exogenous NA occurs primarily in 
postganglionic sympathetic neurons or in catecholamine-containing 
neurons in the CNS. In addition, the ability to accumulate 
exogenous catecholamine appears to be a property of all parts of 
catecholaminergic neurons, including the preterminal area and cell 
body. The uptake of catecholamines appears to be an active process 
since it proceeds against a concentration gradient. Thus, in vitro 
studies have demonstrated that various tissues, including brain, 
are able to concentrate NA from the incubation medium. The 
properties of the NA uptake system in central NA neurons appear to be 
similar, if not indistinguishable, from those of the peripheral 
sympathetic neurons (Iversen, 1975). The uptake process for NA is 
saturable, and temperature and sodium dependant. Thus, like other 
similar processes, the NA uptake process may be inhibited by agents 
such as ouabain which block the NA*/K‘”-ATPase (sodium pump). The 
affinity of NA for the uptake system is high, although a variety of 
amines structurally related to NA may serve as alternative 
substrates, but with lower affinity, for the NA uptake system. 
Furthermore, in most species, the uptake process exhibits 
stereochemical selectivity in favour of the naturally occurring 
(-)-isomer of NA.
32
Central serotonergic neurons possess their own uptake system for 5-HT 
(Iversen, 1975). Thus, biochemical or autoradiographic studies 
indicate 5-HT accumulation in serotonergic neurons following 
administration of 5-HT into the CSF. Like the NA uptake system, the 
process of 5-HT uptake exhibits high affinity for 5-HT, is saturable 
and both temperature and sodium dependant, and may be inhibited by 
ouabain. Unlike the NA uptake system, however, the 5-HT uptake 
system is immediately inhibited by metabolic inhibitors (Iversen, 
1975). The study of 5-HT uptake is complicated by the fact that the 
amine is readily taken up into catecholaminergic neurons by the NA 
and DA uptake systems. Thus, the uptake of 5-HT into brain slices 
or synaptosomes exhibits two saturable components; a high affinity 
uptake into serotonergic neurons and a lower affinity uptake into 
catecholaminergic neurons. However, with the exception of 
sympathetic nerve terminals in the pineal gland, it is unlikely that 
central catecholaminergic neurons are exposed to high concentrations 
of 5-HT, so, under normal conditions, the physiological relevance 
of 5-HT uptake into central catecholaminergic neurons is 
questionable.
The uptake process of exogenous monoamines by storage vesicles 
appears to be different from those mediating uptake into nerve 
terminals. For the catecholamines at least the vesicle uptake system 
has a lower affinity (about 1000 times) and is not dependent on the 
presence of Na‘” or K~ ions (Iversen, 1975). Furthermore, the 
vesicle uptake systems are insensitive to many of the inhibitors 
which block the neuronal uptake processes.
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Exogenous monoamines may also be taken up into non-neuronal tissues. 
The properties of these uptake processes are different from those of 
the neuron terminal. Thus, extraneuronal uptake of NA demonstrates 
no stereochemical selectivity for the (-)- and (+)-isomers of NA, 
and, while it is a saturable process, it displays much lower 
affinity for the catecholamine substrates (Iversen, 1975). 
Furthermore, potent inhibitors of neuronal catecholamine re-uptake 
are relatively less potent on extraneuronal catecholamine uptake.
1.*+.3.2 Inhibitors of 5-HT and NA Re-uptake Processes
It is accepted that the high affinity energy dependant re-uptake 
systems for 5-HT, NA and DA are the most important mechanisms by 
which the synaptic action of these neurotransmitters is terminated 
(Iversen, 1975; Fuller and Wong, 1977). Drugs which block the 
re-uptake processes will therefore prolong the actions of these 
monoamines in the CNS. The relative potencies of the TCA's to 
inhibit 5-HT, NA and DA re-uptake have been thoroughly investigated 
(see Waldmeier et al., 1976; Iversen and Mackay, 1979, and
references cited therein; Sulser and Mobley, 1980) and these 
compounds exhibit a spectrum of activity across all three 
monoaminergic systems. The TCA's include imipramine, 
desmethy1imipramine (desipramine), amitriptyline, nortriptyline, 
3-chloroimipramine (clomipramine), doxepin and diothepin. The 
structure-activity relationship of the TCA'S has been reviewed by 
Zeelen (1980). Most conventional TCA’s potently inhibit 5-HT and NA 
re-uptake by central serotonergic and noradrenergic neurons 
respectively, but exhibit relatively lower potency to inhibit DA 
re-uptake by central dopaminergic neurons (see Sulser and Mobley,
1980). Thus, the ability of the TCA's to inhibit 5-HT and NA
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re-uptake, as opposed to DA re-uptake, by monoaminergic neurons in 
the CNS is the most outstanding pharmacological activity shared by 
these compounds, and is thought to be integral to their efficacy as 
antidepressants (Coppen, 1967; Schildkraut and Kety, 1967; 
Carlsson, 1970; Sulser et al., 1978; Sulser and Mobley, 1980;
Sugrue, 1981a, 1981b). Furthermore, monoamine re-uptake
inhibition is the key property by which new antidepressants have been 
identified, and a number of compounds have been developed which 
reportedly have highly selective actions on 5-HT or NA re-uptake.
While the MAOI’s are more effective in neurotic depression, the 
TCA's appear to be more effective in patients with psychotic or 
endogenous patterns of depression provided the illness is neither 
severe nor associated with delusions (Paykel, 1979a). All of the 
TCA's have similar unwanted side effects, the most frequent of which 
are dryness of mouth, difficulty with visual accommodation and in 
initiating micturition, constipation, palpitations and postural 
hypotension (Mindham, 1979), while urinary retention, paralytic 
ileus and heart failure are occasionally observed. Other side 
effects include sweating, dizziness, tremor, ataxia,
Parkinsonism, lactation, oedema and skin rashes, while drowsiness 
may also be experienced during the first few days of treatment 
(Mindham, 1979). The severity of the side effects vary according to 
the drug preparation employed. The majority of the side effects are 
indicative of anticholinergic properties; indeed the TCA's are 
potent ligands for the muscarinic cholinergic receptor as determined 
by [3H]-quinuc1idinyIbenzilate ([3H]-QNB) binding (Peroutka and 
Snyder, 1980; Green and Nutt, 1983). Furthermore, the majority 
of TCA’s show similar potency ratios for the histamine H-, receptor
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(determined by [3H]-mepyramine binding) as for the muscarinic 
receptor (Hall and Ogren, 1981; Green and Nutt, 1983), and 
potently inhibit histamine-sensitive adenylate cyclase (see Green and 
Costain, 1981). It is possibly the anti-histaminic property that is 
related to the sedative side effects of these compounds (Green and 
Nutt, 1983). It is unlikely, however, that the anticholinergic or 
antihistaminic properties of these drugs are related to their 
therapeutic efficacy since neither the classical anticholinergics nor 
potent histamine antagonists have been reported to possess 
antidepressant properties (Green and Nutt, 1983).
During the last decade several compounds have been developed which 
display greater selectivity between the 5-HT and NA re-uptake 
processes. These compounds are generally dissimilar in structure 
from the TCA’s. Those compounds which selectively inhibit 5-HT 
re-uptake (as determined by inhibition of [3H]-5-HT uptake in 
synaptosomes or blockade of the p-chloroamphetamine-induced depletion 
of brain 5-HT) include citalopram, femoxetine, fluoxetine, 
fluvoxamine, paroxetine and zimelidine (Iversen and Mackay, 1979; 
Green and Costain, 1981; Shopsin et al., 1981; Hyttel, 1982;
Harms, 1983; Norman and Burrows, 1983; Thomas et al., 1987),
while those selective for the NA re-uptake process (as determined by
the inhibition of [3H]-NA uptake in synaptosomes or blockade of the
6-0HDA-induced depletion of NA) include maprotiline, nisoxetine, 
nomifensine and viloxazine (Gerhards et al., 1974; Iversen and
Mackay, 1979; Green and Costain, 1981; Shopsin et al., 1981;
Norman and Burrows, 1983).
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Acute treatment with the TCA’s or the more recent monoamine-specific 
re-uptake inhibitors reversesthe behavioural syndrome induced 
following depletion of central monoamine stores with reserpine or 
tetrabenazine (Moller Nielsen, 1980), and this effect is thought to 
be indicative of the re-uptake inhibiting properties of these 
compounds. However, it cannot be assumed that blockade of monoamine 
re-uptake results in increased stimulation of post-synaptic monoamine 
receptors. It is generally accepted that acute treatment with either 
the TCA's or the 5-HT- or NA-specific compounds reduces both the 
firing rate of the respective central monoamine neurons and the rate 
of monoamine synthesis (Bymaster and Wong, 1974; Gal lager and 
Aghajanian, 1974; Fuller and Wong, 1977; Carlsson and Lindqvist, 
1978; Green and Costain, 1981; Fuller, 1985; Wiliner, 1985). 
This effect is almost certainly due to a regulatory feedback 
mechanism resulting from an enhanced action of the monoamine at the 
respective pre-synaptic receptors (see Fuller and Wong, 1977; Green 
and Costain, 1981). Furthermore, inhibition of monoamine re-uptake 
would be expected to potentiate 5-HT- or NA-mediated behaviours. 
However, the majority of monoamine re-uptake inhibitors also 
interact strongly with post-synaptic receptors (see Peroutka and 
Snyder, 1980). It is apparent that several antidepressant drugs 
have affinities for 5-HT2 binding sites labelled by [3H]-spiperone 
(see Peroutka and Snyder, 1979) in vitro at concentrations in the 
same range as those affecting amine re-uptake (Ogren and Fuxe,
1985). Thus the ability of some monoamine re-uptake inhibitors 
(notably amitriptyline, desipramine, imipramine and nortriptyline) 
to block certain 5-HT-mediated behaviours, e.g. L-5-HTP- and 
d-LSD-induced head twitch in mice and the potency of 5-HT antagonists 
to block tryptamine-induced clonic seizures in rats, have been shown
to correlate with their potency to displace [3H]-spiperone in vitro, 
indicative of 5-HT2-receptor blocking activity in the CNS (see 
Leysen, 1985; Ogren and Fuxe, 1985). Several monoamine re-uptake 
inhibitors may therefore also be considered as 5-HT2 antagonists (for 
the classification of 5-HT receptors the reader is directed to 
Bradley et al., 1986). Exceptions to this are the specific 5-HT
re-uptake inhibitors which have low affinity for 5-HT! and 5-HT2 
binding sites labelled by [3H]-d-LSD, 5-HT2 binding sites labelled
by [3H]-spiperone or 5-HT, binding sites labelled by [3H]-5-HT 
(Peroutka and Snyder, 1979), e.g fluoxetine and zimelidine (see Wong 
et al., 1983; Ogren and Fuxe, 1985; Willner, 1985). While such 
compounds demonstrably potentiate L-5-HTP-induced behaviours (Ortmann 
et al., 1980) this ability is only demonstrated by those monoamine
re-uptake inhibitors which also possess marked affinity for 
post-synaptic 5-HT2 receptors at doses far higher than would be 
expected from their potency on 5-HT re-uptake (cf. Moller Nielsen, 
1980, and Wong et al., 1983). In addition, a number of monoamine
re-uptake inhibitors also show marked affinity for alpha,- and 
alpha2-adrenoceptors (Hall and Ogren, 1981; Wong et al., 1983) and 
consequently may modify clonidine-induced hypoactivity (Heal et al., 
1983). In acute studies therefore the action of these compounds on 
monoamine re-uptake mechanisms and the blockade of post-synaptic 
receptors results in functionally opposite effects, and which effect 
predominates ultimately determines the effect of such compounds on 
serotonin-mediated behaviours.
As experienced with the MAOI’s, clinical response to the monoamine 
re-uptake inhibitors is not observed until at least 2-H weeks of drug 
treatment (Oswald et al., 1972). Thus inhibition of 5-HT and/or NA
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re-uptake following acute treatment alone would not account for the 
antidepressant efficacy of these compounds. Furthermore, not all 
compounds which inhibit monoamine re-uptake are antidepressant. For 
example, cocaine, a moderately potent inhibitor of NA re-uptake 
(see Sulser and Mobley, 1980) does not possess any antidepressant 
activity (Green and Costain, 1981). It therefore seems more likely 
that the antidepressant effect of the monoamine re-uptake inhibitors 
is due to secondary adaptive changes induced in response to the 
initial elevated levels of 5-HT and NA.
1.H.4 Atypical Antidepressants
The atypical antidepressants are those compounds which are 
demonstrably antidepressant in the clinic but possess little or no 
inhibitory action on MAO activity or monoamine re-uptake. The two 
principal members of this group of compounds are iprindole and 
mianserin, although flupenthixol. a D^-DA antagonist (Seeman,
1981) and the beta2-adrenoceptor agonist salbutamol have both been 
reported to possess antidepressant properties (see Iversen and 
Mackay, 1979; Mindham, 1979), and thus may be categorised as 
members of the atypical antidepressants.
Iprindole, in comparison to the monoamine re-uptake inhibitors, has 
little effect on serotonin or catecholamine re-uptake in vitro or in 
vivo (Rosloff and Davis, 197H; Sulser and Mobley, 1980; Hyttel,
1982), and is only weakly effective in reversing the behavioural 
effects of reserpine or tetrabenazine treatment in rodents (Moller 
Nielsen, 1980). Furthermore, iprindole exhibits little affinity 
for central monoamine receptors, indeed the binding data of Peroutka 
and Snyder (1980) and Hall and Ogren (1981) suggest that iprindole
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has a higher affinity for H, histamine receptors than for other 
various monoamine receptors. In comparison to the MAOI's or the 
monoamine re-uptake inhibitors, the lack of observable acute effect 
of iprindole on central neurotransmitter systems makes it an unlikely 
candidate for an antidepressant; however, iprindole exhibits 
clinical antidepressant efficacy (Hicks, 1965; Daneman, 1967; 
Sterlin et al., 1968).
The antidepressant potential of mianserin was initially predicted on 
the basis of the similarity of its effect on the human encephalogram 
to that seen with the TCA's (see reviews by Itil and Soldatos, 1980, 
and Itil, 1983), and its antidepressant efficacy has been 
confirmed in a number of studies (see review by Brogden et al.,
1978, and section 3.3.H). The most frequently reported side effect 
with mianserin is drowsiness which, as with the TCA’s, is usually 
transient and disappears after the first few days of treatment (see 
Jaskari et al., 1977). Mianserin is at best only moderately active
as an inhibitor of 5-HT or NA re-uptake in vitro (Hyttel, 1982) and 
essentially devoid of effect on 5-HT re-uptake in vivo (Goodlet et 
al., 1977). Its ability to reduce brain concentrations of NA and
increase central NA turnover is thought to be due to antagonist 
activity at central pre-synaptic alpha2-adrenoceptors (Baumann and 
Maitre, 1977). It should be noted that the catecholamines, like 
5-HT (Moret, 1985), are able to control their own release via an 
action on autoreceptors located on the pre-synaptic nerve terminals 
and cell bodies of catecholaminergic neurons (see Starke, 1981; 
Chesselet et al., 198H; and the electrophysiological studies of 
Aghajanian and co-workers reviewed by Aghajanian and Rogawski,
1983). In addition, mianserin also possesses marked affinity for
central H-, histamine receptors, alpha1-adrenoceptors and 5-HTa 
receptors (see Wong et al., 1983), and also exhibits antagonist
activity at 5-HT1c (as defined by Pazos et al., 1985) receptors
(Fozard, 1987) and at 5-HT receptors in the periphery (Saxena et 
al.. 1971). As with the TCA’s, the anti-histaminic properties of
mianserin may account for the incidence of drowsiness observed in the 
clinic. Furthermore, in comparison to the TCA's, the reduced 
frequency of reported anti-cholinergic side effects corresponds with 
its lower affinity for central muscarinic receptors (cf. Jaskari et 
al., 1977, and Wong et al., 1983).
The atypical antidepressants, like other compounds used in the 
treatment of depression, only exhibit antidepressant efficacy after 
2-H weeks of treatment, and thus any direct effect of these 
compounds following acute treatment may not be directly attributable 
to their antidepressant efficacy.
1.^.5 Biochemical changes following chronic antidepressant treatment
As indicated throughout the preceding sections there is generally no 
correlation between the acute effects of all the currently available 
antidepressant drugs on central neurotransmitter systems to the 
latency of their antidepressant effect observed in the clinic. Such 
observations demonstrate that chronic treatment with these compounds 
is a prerequisite for clinical efficacy, indicating that long-term 
modification of central neurotransmitter function induced by chronic 
antidepressant treatment is necessary for the remission from 
depression.
In rats, chronic treatment with the MAOI's phenelzine and 
tranylcypromine leads to an initial increase in central 5-HT, NA and 
DA levels, but is followed by a gradual decline in the brain 
monoamines towards control levels with continued treatment (Robinson 
et al., 1979). Furthermore, the same studies showed that chronic
phenelzine treatment was associated with an adaptive increase in 
tryptophan hydroxylase activity, while chronic tranylcypromine 
treatment was associated with an increase in aromatic amino acid 
decarboxylase activity. No change in tyrosine hydroxylase activity 
was observed during chronic treatment with either drug. In another 
series of experiments by this group (see Campbell et al., 1979)
chronic treatment with clorgyline resulted in a persistent elevation 
of brain NA levels while the initial rise in 5-HT levels returned to 
control levels by 21 days of treatment. Conversely, chronic 
treatment with high, but not low, doses of pargyline led to 
increased 5-HT levels following 21 days of treatment only, but had 
little effect on NA levels throughout the duration of treatment. 
Neither clorgyline or pargyline treatment had any significant effect 
on tyrosine hydroxylase or tryptophan hydroxylase activity or on 
5-HIAA levels. The electrophysiological studies of Blier et al.
(1986) indicated that continuous exposure to clorgyline, but not 
pargyline or deprenyl, reduced the firing rate of 5-HT, but not NA, 
neurons. Furthermore, the stimulation-induced suppression of 5-HT 
neuron firing rate was increased by clorgyline and pargyline, but 
not by deprenyl, while none of the treatments modified the 
stimulation-induced suppression of NA neuron firing rate (Blier et 
al., 1986). While acute treatment with the TCA’s generally reduces
brain NA turnover, long-term administration tends to increase NA 
turnover (as indicated by increased MHPG levels), probably via pre-
and post-synaptic feedback mechanisms (Roffman et al.. 1977;
Sugrue, 1980, 1981a, 1981b). In contrast however, both acute and
chronic treatment with the TCA’s or 5-HT selective re-uptake 
inhibitors generally have the same effect on 5-HT turnover. Thus 
desipramine does not affect 5-HT turnover acutely nor following 
chronic treatment, while clomipramine and zimelidine both decrease 
5-HT turnover when given either acutely or chronically (Sugrue,
1981b; Willner, 1985). It is thought that any reduction in 
neurotransmitter synthesis or neuronal activity following chronic 
antidepressant treatment are indicative of partial compensation in 
response to excessive monoamine levels induced by MAO inhibition or 
inhibition of NA and/or 5-HT re-uptake (Willner, 1985), while the 
differences between the effects of chronic treatment with particular 
drugs are more likely to reflect differences in the feedback 
mechanisms of the neurotransmitter systems.
The atypical antidepressants mianserin and iprindole have different 
effects on NA and 5-HT when given either acutely or chronically. 
Mianserin appears to increase NA, but not 5-HT, turnover following 
acute and chronic administration, while, conversely, iprindole 
only increases 5-HT turnover following chronic treatment (Sugrue, 
1980, 1981b; Willner, 1985).
Current data therefore indicate a general lack of common effect on 
the turnover of central 5-HT and NA in rodents following chronic 
treatment with the various antidepressant drugs. This lack of common 
effect may, in part, also be explained by the ability of these 
drugs to interact with central pre- and post-synaptic 5-HT and NA 
receptors, and with other neurotransmitter systems, which may
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modify either the induction or expression of various compensatory 
processes in response to changes in the synaptic concentrations of 
5-HT and/or NA.
Various antidepressants (especially the TCA'S and mianserin) exhibit 
marked affinity for central neurotransmitter receptors (see sections
1.4.3.2 and 1.4.4). Consequently investigators have studied the 
effect of chronic antidepressant treatment on the binding 
characteristics of central neurotransmitter receptors.
While both the TCA’s and atypical antidepressants generally exhibit 
low affinity for displacing [3H]-dihydroalprenalol ([3H]-DHA) from 
central beta-adrenoceptors (Hall and Ogren, 1981), chronic, but 
not acute, treatment with most TCA’s leads to a reduction in the 
number of beta-adrenoceptors without modifying the affinity of the 
ligand (Banerjee et al., 1977; Peroutka and Snyder, 1980;
Se1 Iinger-Barnette et al., 1980; Green and Nutt, 1983).
Furthermore, the ability to down-regulate beta-adrenoceptors, 
following chronic treatment only, appears to be a feature also 
shared by the MAOI's (including clorgyline, but not deprenyl, 
suggesting that continued inhibition of MAO-A may be an important 
feature of this effect), iprindole and electroshock, but possibly 
not mianserin (Banerjee et al., 1977; Sel1inger-Barnette et al.,
1980; Sethy and Harris, 1981; Finberg and Youdim, 1983; Green 
and Nutt, 1983; Kellar and Bergstrom, 1983; Sulser, 1983;
Sulser et al . , 1983). Interestingly chronic treatment with cocaine,
which inhibits NA re-uptake but exhibits no antidepressant 
properties, or other non-antidepressant psycho-active compounds 
including examples of antipsychotics, anxiolytics, barbituates,
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anticholinergics and psycho-stimulants, do not down-regulate 
beta-adrenoceptors (Sel1inger-Barnette et al., 1980; Sethy and
Harris, 1981). Whether the ability to down-regulate 
beta-adrenoceptors per se is important for the antidepressant effect 
of these compounds is questionable since the 5-HT selective re-uptake 
inhibitors, fluoxetine and zimelidine, generally do not induce this 
response following chronic treatment (Peroutka and Snyder, 1980; 
Green and Nutt, 1983). In one study, however, Sethy and Harris 
(1981) observed that continuous infusion with zimelidine for 7 days 
reduced beta-adrenoceptor number in rat cortex, indicating that 
under the right conditions 5-HT-selective re-uptake inhibitors may 
also possess the property of inducing beta-adrenoceptor 
down-regulation. Chronic treatment with the beta2-adrenoceptor 
agonist, clenbuterol, has also been observed to down-regulate 
central beta-adrenoceptors (Frazer et al., 1986). Current evidence
indicates that beta-adrenoceptors are coupled to a stimulatory 
guanine nucleotide-binding protein through which adenylate cyclase 
activity is Emulated (Lefkowitz and Hoffman, 1980; Strosberg et 
al., 1982). Thus stimulation of beta-receptors in the CNS, either
by the natural transmitter (NA) or beta-adrenoceptor agonists, leads 
to increased production of cyclic adenosine 5'-monophosphate (cAMP) 
(Sulser, 1978; Frazer et al ., 1986). It is not surprising
therefore that antidepressant treatments, including electroshock, 
which down-regulate beta-adrenoceptors also induce a subsensitivity 
of the NA-dependent adenylate cyclase system to stimulation by NA or 
isoprenaline (Vetulani et al., 1976a; Frazer and Mendels, 1977;
Gillespie et al., 1979; Green and Nutt, 1983; Sulser, 1983). 
Interestingly, chronic treatment with mianserin, nisoxetine (a 
NA-selective re-uptake inhibitor) or zimelidine all reduce the
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sensitivity of the NA-dependent adenylate cyclase system under 
treatment conditions which did not reduce the density of central 
beta-adrenoceptors (Mishra et al., 1980; Green and Nutt, 1983;
Sulser, 1983). Conversely, chronic treatment with fluoxetine 
neither down-regulates beta-adrenoceptor binding nor reduces the 
sensitivity of the NA-dependent adenylate cyclase system (Peroutka 
and Snyder, 1980; Mishra et al., 1981). The
antidepressant-induced subsensitivity of the NA-dependent adenylate 
cyclase system appears to be dependent on the maintained integrity of 
the noradrenergic input. Thus, Janowsky et al. (1982) showed that 
unilateral electrolytic lesions of the locus coeruleus, which 
reduced the NA (but not 5-HT) content of the ipsilateral frontal 
cortex, abolished the deapramine-induced reduction in the cAMP 
response to NA in slices of the ipsilateral frontal cortex. 
Conversely, chronic desipramine treatment still reduced the cAMP 
response to NA in slices of the contralateral (non-lesioned) frontal 
cortex. These observations suggest that the reduced sensitivity of 
the NA-dependent adenylate cyclase system may be induced in response 
to increased availability of NA rather than 5-HT. In support of this 
view, Mishra et al. (1981) demonstrated that raphe lesions which 
selectively reduced the level of 5-HT did not induce any change in 
the sensitivity of the NA-dependent adenylate cyclase system or the 
density of beta-adrenoceptor binding sites. In contrast, lesions of 
the medial forebrain bundle, which reduced the levels of 5-HT, NA 
and DA, also increased the responsiveness of the NA-dependent 
cyclase system but had no effect on the density of beta-adrenoceptors 
(Mishra et al., 1981). Conversely, Vetulani et al. (1976b) had
previously shown that prolonged reduction in central monoamine 
availability induced by chronic reserpine treatment, or chemical
sympathectomy with 6-hydroxydopamine (6-OHDA) increased the 
responsiveness of the NA-dependent adenylate cyclase system. The 
same studies showed that protection of noradrenergic neurons against 
the neurotoxic action of 6-OHDA afforded by desipramine treatment 
also prevented the development of increased responsiveness of the 
NA-dependent adenylate cyclase system. Thus the 6-OHDA-induced 
changes in the reactivity of the cAMP generating system appear to be 
related to changes in the availability of NA rather than that of 
other neurotransmitters. Prolonged elevation or reduction of central 
NA availabli1ity therefore leads to a compensatory decrease or 
increase in the responsiveness of the NA-dependent adenylate cyclase 
system, respectively. It may be argued that the ability of some 
antidepressants that exhibit a margin of 5-HT selectivity, but which 
also reduce the reactivity of the NA-dependent cAMP generating 
system, may preclude such a conclusion. For example, the TCA’s 
with terminal tertiary amines show marginal selectivity in their 
ability to inhibit 5-HT, rather than NA, re-uptake in vitro 
(Iversen and Mackay, 1979). The in vivo conversion of compounds 
such as amitriptyline and clomipramine to their secondary amine 
metabolites (nortriptyline and desmethylclomipramine, respectively), 
however, results in increased selectivity for NA, rather than 5-HT, 
re-uptake (Fuller and Wong, 1977). The metabolites of these 
compounds may therefore be ultimately responsible or the apparent 
ability of amitriptyline and clomipramine to induce the 
subsensitivity of the NA-dependent adenylate cyclase system in vivo 
(Mishra et al., 1981).
Generally the studies cited above indicate that at least 2-4 weeks of 
continuous antidepressant treatment is required to induce the
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decrease in beta-adrenoceptor number or reduce the responsiveness of 
the NA-dependent adenylate cyclase system. The studies of Wiech and 
Ursillo (1980) suggest that the rate of desipramine-induced decrease in 
central beta-adrenoceptor number may be accelerated by concomitant 
blockade of the alpha2-mediated negative feedback system with the 
alpha2-antagonist yohimbine. Thus it may be argued that the 
antidepressant-induced down-regulation of beta-adrenoceptors and/or 
sensitivity of the NA-dependent adenylate cyclase system only follows 
a desensitization of the alpha2-mediated negative feedback system, 
which would provide a possible explanation of the latency of 
antidepressant efficacy experienced in the clinic. In support of 
this view, Smith et al. (1981) demonstrated that chronic treatment 
with amitriptyline decreased [3H]-clonidine binding to pre-synaptic 
(sic) central alpha2-adrenoceptors. Furthermore, Heal et al. (1987) 
have shown that repeated electroshock or chronic desipramine 
treatment reduced the number of [3H]-idaxozan binding sites, which 
are believed to be predominantly post-synaptic alpha2-adrenoceptor 
binding sites. In contrast however, Sethy et al. (1983) 
demonstrated that continuous infusion with a broad spectrum of 
antidepressant drugs, including amitriptyline, desipramine, 
iprindole, mianserin, nomifensine and zimelidine, for 7 days, 
failed to decrease the number of [3H]-clonidine binding sites. The 
effect of chronic antidepressant treatment on the number of central 
alpha2-binding sites is therefore equivocal. However, the 
behavioural data of Heal et al. (1983, 1987) indicates that chronic
amitriptyline, desipramine or mianserin treatment, or indeed 
repeated electroshock, induces a progressive decrease in 
clonidine-induced hypoactivity in rats; indicative of an adaptive 
decrease in the function of central alpha2-adrenoceptors. In
accordance with these animal studies, Smith et al. (1983) observed a 
decrease in the number of [3H]-clonidine binding sites on blood 
platelet membranes following treatment of endogenously depressed 
patients with TCA's or ECT.
A number of antidepressants, e.g. amitriptyline, clomipramine, 
desipramine, imipramine, mianserin and nortriptyline, exhibit 
relatively high affinities for central alpha.,-adrenoceptors labelled 
with [3H]-WB4101 (Peroutka and Snyder. 1980; Hall and Ogren,
1981). Chronic antidepressant treatment, however, generally has no 
effect on either the number of alpha-,-adrenoceptors nor the affinity 
of the antidepressants for these binding sites labelled with either 
[3H]-WB4101 (Peroutka and Snyder, 1980) or [3H]-prazosin (Menkes et 
al., 1983; Mogilnicka et al., 1987). Chronic antidepressant
treatment, however, does appear to enhance the ability of the 
alpha1-agonist, phenylephrine, to compete for the sites labelled by 
[3H]-prazosin (Menkes et al., 1983). Behavioural studies have also
demonstrated that chronic antidepressant treatment potentiates both 
the exploratory activity of rodents induced by phenylephrine 
(principally following desipramine treatment; Mogilnicka et al., 
1987) and aggressive behaviour in both mice (Maj et al., 1980) and
rats (Maj et al., 1979) induced by acute treatment with clonidine
and apomorphine, respectively. These results are interpreted as 
being indicative of an antidepressant-induced functional 
supersensitivity to alpha,-adrenoceptor agonists. However, it 
should be noted that potentiation of phenylephrine-induced 
exploratory activity was not observed following chronic 
amitriptyline, imipramine or desipramine treatment, or following 
repeated electroshock, by the earlier study of Green et al. (1986).
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The foregoing observations suggest that, generally, a common 
biochemical effect of chronic antidepressant treatment may be the 
down-regulation of central beta-adrenoceptors (and hence reduced 
sensitivity of the NA-dependent adenylate cyclase system), together 
with a desensitization of the alpha-, receptor-mediated negative 
feedback system and, possibly, the increased agonist affinity of 
central alpha1-adrenoceptors. Such observations may, at least in 
part, explain the antidepressant effect of these compounds, and 
furthermore, implies that the primary target of antidepressants may 
be the central noradrenergic system at the exclusion of other 
neurotransmitter (e.g. 5-HT) systems. It should be noted, however, 
that central noradrenergic and serotonergic systems are not 
independent. Indeed, Svensson et al. (197H) demonstrated that the 
clonidine-induced reduction the firing rate of NA neurons in the 
nucleus locus coeruleus was reflected in a concomitant reduction in 
the firing rate of 5-HT neurons in the nucleus raphe dorsalis. 
Furthermore, the response of the 5-HT neurons was dependent on the 
maintained integrity of the noradrenergic input to the raphe. Thus 
any overall change in the level of noradrenergic activity would be 
expected to be reflected by concomitant changes in the level of 
activity exhibited by other neurotransmitter systems on which 
noradrenergic systems impinge. In addition, Nimgaonkar et al. 
(1985) have shown that the down-regulation of rat cortical 
beta-adrenoceptors following chronic desipramine or clenbuterol 
treatment, or repeated electroshock, was abolished if serotonergic 
neurons were previously lesioned with the neurotoxin 
5,7-dihydroxytryptamine. Conversely, desipramine and electroshock 
both down-regulated cortical beta-adrenoceptors following 5-HT 
synthesis inhibition with p-chlorophenylalanine (pCPA). These
observations indicate that the antidepressant-induced decrease in 
beta-adrenoceptor number is not dependent on an action of 5-HT 
per se, but, as suggested by Nimgaonkar et al . (1985), may be 
modulated by an unknown factor, normally present at 5-HT terminals 
in the cortex, which is removed by the neurotoxic lesion. The 
studies of Svensson et al. (197H) and Nimgaonkar et al. (1985) 
clearly demonstrate the interdependence of noradrenergic and 
serotonergic neurotransmitter systems in certain areas of the rodent 
CNS (see also Racagni et al., 1983).
Chronic treatment with examples of MAOI’s (tranylcypromine, 
pargyline), TCA's (amitriptyline, imipramine, desipramine, 
clomipramine), the 5-HT selective re-uptake inhibitor, zimelidine, 
the atypical antidepressants (iprindole, mianserin), and the 
serotonin agonist trifluoromethylphenyl piperazine (TFMPP) generally 
reduce the number of 5-HT2 receptors labelled with [3H]-spiperone or 
[3H]-ketanserin (TFMPP only) without affecting affinity (Peroutka and 
Snyder, 1980; Blackshear and Sanders-Bush, 1982; Anderson, 1983;
Stolz et al., 1983; Blackshear et al., 1986; Green et al. ,
1986); mianserin also down-regulates 5-HT2 receptor number following 
acute treatment (Blackshear and Sanders-Bush, 1982). Chronic 
treatment with fluoxetine has yielded equivocal results (cf. Peroutka 
and Snyder, 1980, and Stolz et al., 1983), while repeated
electroshock invariably increases 5-HT2 receptor number (Kellar and 
Bergstrom, 1983; Green et al., 1986). Green et al . (1986) and
Stolz et al . (1983) have also demonstrated that the drug- or 
electroshock-induced change in 5-HT2 receptor number is reflected by 
concomitant changes in the 5-HT2 receptor-mediated head-twitch 
response in mice (see also Blackshear and Sanders-Bush, 1982) or the
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behavioural syndrome in rats, respectively, induced by precursor 
loading or 5-HT agonist treatment. 5-HT2 receptors are thought to 
mediate the ability of 5-HT to stimulate phosphotidylinsitol 
hydrol/Iysis (Conn and Sanders-Bush, 1984). The
antidepressant-induced reduction in 5-HTz receptor number, however, 
does not appear to be dependent on intact 5-HT neuron terminals. 
Clements-Jewery and Robson (1982) showed that pre-treatment of rats 
with the serotonergic neurotoxin, p-chloroamphetamine (pCA), did 
not inhibit the down-regulation of 5-HTz receptors. These authors 
suggest that their observations may indicate a possible post-synaptic 
locus of action for amitriptyline. However, an alternative 
explanation may be that other neurotransmitter systems are involved 
in the maintenance of 5-HTz receptor number.
Only chronic treatment with imipramine, MAOI’s (especially those 
which inhibit MAO-A) or 5-HT agonists (e.g quipazine and TFMPP) 
reduce the number of 5-HT, receptors labelled with [3H]-5-HT without 
affecting the affinity of the binding site for the ligand (Savage et 
al., 1979, 1980a, 1980b; Peroutka and Snyder, 1980), while
other compounds (e.g. serotonin re-uptake inhibitors) have no effect 
(Peroutka and Snyder, 1980; Savage et al., 1980b; Stolz et al.,
1983). Furthermore, drugs which deplete brain 5-HT (i.e. 
para-chlorophenylalanine (pCPA) or 5,7-dihydroxytryptamine (5,7-DHT), 
which alone increased the number of [3H]-5-HT binding sites) 
prevented the clorgyline-induced reduction in [3H]-5-HT number, 
indicating that the effect of the MAOI’s is probably mediated by 
increased exposure of the 5-HT, receptors to 5-HT (Savage et al., 
1980a). A number of 5-HT, receptor subtypes have been proposed (see 
review by Hartig, 1989). It has been suggested that 5-HT,A or
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5-HT1b receptors (as defined by Pedigo et al., 1981), located on
serotonergic cell bodies (Verge et al., 1986) or terminals (Engel et
al., 1986) respectively, serve as 5-HT autoreceptors mediating the
inhibitory effects of 5-HT on its own release (Moret, 1985). The 
5-HT1a site is thought to be linked to adenylate cyclase (Conn and 
Sanders-Bush, 1987). Pharmacological studies using the putative 
5-HT1a agonist, 8-OHDPAT (Tricklebank, 1985), however, have
suggested that a functional change in pre-synaptic 5-HT1A receptors 
follow chronic antidepressant treatment. Administration of 8-OHDPAT 
induces a hypothermic response in mice which is nearly abolished 
following chronic, but not acute, treatment with amitriptyline, 
desipramine, mianserin, zimelidine and tranylcypromine, and also 
after repeated electroshock (Green et al., 1986). Furthermore, 
chronic non-selective and chronic MAO-A inhibition reduces the 
ability of 8-OHDPAT to inhibit forskolin-stimulated adenylate cyclase 
activity indicative of down-regulation of 5-HT1A receptors (Sleight 
et al., 1988). These observations suggest a possible
down-regulation of pre-synaptic 5-HT1A receptors following chronic 
antidepressant treatment. The recent discovery of apparent subgroups 
of central 5-HT receptors, and the development of specific ligands 
for these receptors, should provide the pharmacological tools by 
which the effect of chronic antidepressant treatment on the 
population and function of 5-HT receptor subtypes may be clarified.
Some workers have suggested that chronic antidepressant treatment may 
induce parallel changes in the sensitivity of gamma-aminobutyric acid 
(GABA) receptors to those observed for central beta-adrenoceptors. 
Chronic treatment with imipramine or nomifensine, or with the GABA 
agonists baclofen, progabide (which demonstrably increases NA
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turnover; Lloyd et al., 1983) or 4,5,6,7-tetrahydroisoxazolo
(5,4-C) pyridine-3-ol (THIP), all induce a reduction in 
beta-adrenoceptor number, labelled with [3H]-DHA, in both rat 
cortex and hippocampus, while imipramine, nomifensine and THIP, 
but not baclofen, also induce a concomitant reduction in the number 
of high and low GABA receptors, labelled with [3H]-GABA (Lloyd et 
al., 1983; Suzdak and Gianutsos 1985). Hill and Bowery (1981) have
demonstrated that [3H]-GABA labels a specific subgroup of GABA 
receptors, denoted GABAa receptors, while [3H]-baclofen labels 
another subgroup of GABA receptors, denoted GABAb receptors. 
Furthermore, THIP has been shown to bind specifically to GABAa 
receptors (Hill and Bowery, 1981) while progabide exhibits agonist 
activity at both GABAa and GABAb receptors (Bowery et al., 1982).
Conversely, Lloyd et al. (1985) have shown that chronic 
antidepressant treatment (including pargyline, TCA's. 5-HT- or 
NA-selective re-uptake inhibitors and mianserin), or repeated 
electroshock, increases the number of GABAb receptors in the rat 
frontal cortex but not hippocampus. Cross and Horton (1984), 
however, have demonstrated that chronic (21 day) treatment with 
desipramine or zimelidine, at doses which down-regulated 5-HT2 
receptors in the rat frontal cortex, failed to alter the number of 
GABAb binding sites in the whole cortex. Thus, the current data 
indicate that chronic antidepressant treatment may down-regulate 
GABAa receptors but, as shown in one study at least, up-regulate 
GABAb receptors (thereby modifying the function of GABAergic 
systems), which, if these effects are shown to be a feature shared 
by other antidepressant treatments, may be important regarding the 
mode of action of antidepressants. Furthermore, the ability of 
GABA-mimetics to down-regulate beta-adrenoceptors, possibly as a
result of increasing NA release, indicates a functional link between 
central GABAergic and noradrenergic systems. If the ability to
down-regulate beta-adrenoceptors is indicative of antidepressant 
efficacy then GABA agonists may prove to be potential antidepressants 
(Lloyd et al.. 1983).
Finally, many antidepressants exhibit relatively high affinities for 
histamine H-, and muscarinic receptors compared to their affinities 
for other neurotransmitter receptors (see sections 1.4.3.2 and 
1.4.4), however, chronic treatment with these compounds does not 
appear to effect muscarinic receptor density (Peroutka and Snyder, 
1980).
1.5 Circadian Rhythms and Depression
1.5.1 Introduction
The revolution of the earth around the sun, and its rotation about
its own axis once in every 24 hours, determines the seasonal changes
and the day-night variations in light intensity, respectively. Such
events produce highly predictable rhythmic changes in the external 
environment to which living organisms have adapted in order to keep 
their internal milieu as constant as possible, in accordance with 
Claude Bernard’s concept of homeostasis. Thus, an organisms 
adaptation to rhythmic changes in the external environment is 
reflected in rhythmic changes in behavioural, physiological and 
biochemical systems that follow a similar time schedule to those 
changes in the environment. Rhythmic changes associated with the 24 
hour day-night schedule thus give rise to circadian (Latin : circa = 
about, diem = day) changes in behavioural, physiological and
biochemical processes of organisms. Virtually all eukaryotic 
organisms exhibit circadian rhythms in their behaviour, physiology 
and biochemistry. In addition to circadian rhythms, a wide variety 
of biological rhythms occur with periods ranging from milliseconds 
(e.g. electrical activity of the brain) to several years. Rhythms 
with periods less than 2*4 hours are termed ultradian (see 
Hildebrandt, 1988), while those with periods greater than 2H hours 
are termed infradian (see also definitions for other period lengths 
given in Cornelissen et al., 1988). In addition, rhythms with
frequencies of 1 cycle per 28 days (e.g. menstrual cycle in women) or 
1 cycle per year (e.g. hibernation) are termed circalunarand 
circannual, respectively. This section will focus primarily on 
circadian rhythms, and, where appropriate, circannual rhythms, in 
the behaviour and biochemistry of experimental animals, and the 
relationship of rhythm disorders to depression.
1.5.2 Circadian Rhythms
Richter (1922) was probably the first scientist to publish the 
results of a systematic study on rodent behaviour that suggested 
rodents exhibit rhythmic activity when housed under constant 
environmental conditions. However, it was the study of wild mice 
(Peromyscus) by Johnson (1926) that led to the conclusion that "the 
animal has an exceptionally substantial and durable self-winding and 
self-regulatory physiological clock...." (Johnson, 1939). Little 
research to identify the physiological mechanism(s) involved in 
circadian clock generation and control was undertaken until the 
1960's, whereupon the investigations of Richter (1965, 1967)
opened-up the modern era of research on mammalian neuronal clocks.
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The most obvious circadian rhythm which dominates an animals 
behaviour is the sleep-wake cycle. Sleep is composed of alternating 
ultradian rhythms of rapid-eye movement (REM) and slow-wave (SW) 
sleep (Mullen, 1983; Koella, 198*4). Even under constant 
environmental conditions sleep-wake and REM-SW sleep cycles persist, 
indicating that they are endogenously generated (Weitzman et al.,
1979). Sleep-wake cycles in man are typical of circadian rhythms in 
that when allowed to free-run under constant environmental conditions 
(e.g. constant light or dark, temperature, humidity) the period of 
oscillation is approximately, but not exactly, 2H hours (Weitzman et 
al., 1979; Wever, 198H). Similarly, the sleep-wake cycle of
laboratory rodents, as indicated by circadian rhythms of locomotor 
activity of rats, mice or hamsters, exhibit free-running periods 
close to 2H hours (e.g. Mitler et al., 1977; Eastman and
Rechtschaffen, 1983), although it should be noted that variation in 
light intensity may modify the period of free-running circadian 
activity rhythms (Fuller and Edgar, 1986). Other examples of rodent 
physiological systems which are subject to circadian control include 
feeding and drinking (Strubbe et al., 1986) and thermore/gulation
(Eastman and Rechtschaffen, 1983). The occurrence of circadian 
rhythms in mammalian physiology has been extensively reviewed by 
Rusak and Zucker (1979).
It is characteristic of free-running circadian rhythms that they 
synchronize, or entrain, with a phase-relationship to an external 
time cue (termed "zeitgeber") provided the period of the cue is close 
to 2H hours (Aschoff et al., 1975). Animal studies have shown that 
if the phase of the zeitgeber is shifted then the circadian rhythm 
will re-entrain in order to re-establish the constant phase-angle to
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the zeitgeber (Aschoff et al., 1975). The duration of
re-entrainment and its direction, i.e. whether the re-entrainment 
occurs by advancing or delaying the phase-shift of the circadian 
rhythm, are determined by a number of factors including the degree 
and direction of phase shift of the zeitgeber and the period of the 
circadian rhythm being studied. The re-entrainment of circadian 
rhythms after phase-shift of the zeitgeber has been reviewed by 
Aschoff et al . (1975). In the natural environment the most potent 
(and therefore important) zeitgeber for the entrainment of circadian 
rhythms is the light-dark cycle (Aschoff et al., 1975) since this
allows regulation of internal events and externally directed 
behaviours in order to maximize survival of the species. Indeed, 
circadian rhythms may remain entrained during constant darkness as 
long as the normal transition between light and dark is indicated by 
short photoperiods (Strubbe et al., 1986). Periodic food
availability also acts as a strong zeitgeber for rodent activity 
(Stephan, 198*4), however, periodic water availability does not 
appear to be a potent zeitgeber for circadian activity rhythms in the 
rat (Mistlberger and Rechtschaffen, 1985). In humans social 
constraints, rather than the light-dark cycle, predominantly 
predetermines sleep episodes during the sleep-wake cycle (Wever,
198*4) .
The generation and maintenance of circadian rhythms is a function of 
the CNS. Richter (1967), using the free-running activity rhythm of 
blinded rats as a marker of circadian rhythmicity, found that only 
lesions of the hypothalamus resulted in a loss of circadian locomotor 
activity. Subsequently, it was demonstrated that complete lesions 
of the suprachiasmatic nuclei* (SCN) of the hypothalamus induced a
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loss of rhythmicity of adrenal corticosterone secretion (Moore and 
Eichler, 1972), of drinking and locomotor activity (Stephan and 
Zucker, 1972), and of temperature and sleep rhythms in the rat 
(Eastman et al., 198H). Partial lesions of the SCN, however, have 
been observed to result in the generation of weak and variable 
free-running temperature and sleep rhythms (Eastman et al., 198H),
or a shift in the period length of free-running rhythms (Rietveld, 
198H). It is now known that the SCN are involved in the generation 
of circadian rhythmicity of a wide variety of physiological functions 
(see Rusak and Zucker, 1979). If the SCN is an endogenous pacemaker 
for circadian rhythms, then the ability of the light-dark cycle to 
act as a zeitgeber must indicate the coupling of a visual pathway to 
the endogenous pacemaker; thereby mediating the entraining effects 
of the zeitgeber. The identification of a direct link between the 
retina and the SCN via the retinohypothalamic tract in hamsters 
(Rusak and Boulos, 1981) suggests one neuronal pathway by which 
light entrainment may be achieved. Direct retinohypothalamic tracts 
to the SCN have been demonstrated in a number of species (see Moore, 
1983). In addition to the retinohypothalamic tract, the SCN also 
receives projections from the anterior hypothalamus, paraventricular 
nucleus, lateral hypothalamus, retrochiasmatic hypothalamus, 
midbrain periaquaductal gray, midbrain raphe nucleus, 
paraventricular thalamic nucleus, ventral lateral geniculate 
nucleus, the contralateral SCN, and several nuclei of the tuberal 
hypothalamus. With the exception of the midbrain raphe nuclei and 
the ventral lateral geniculate nucleus, projections from the SCN 
include those areas from which it receives projections and, in 
addition, the lateral septal nucleus (Rusak and Zucker, 1979;
Moore, 1983; Silverman and Pickard, 1983; Steinbusch and
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Nieuwenhuys, 1983). The SCN has no long ascending or descending 
projections, and thus the major processing of the SCN output 
probably occurs at the hypothalamic level. These examples indicate 
the potential of the SCN to influence the function of a variety of 
brain areas. Whether the SCN, which appear to be mutually coupled, 
independent oscillators (Moore, 1983), are the sole source of the 
circadian pacemaking machinery is questionable. There is good 
evidence that complete ablation of both SCN may result in internal 
desynchronization of circadian rhythms rather than in a complete loss 
of rhythmicity. For example, Stephan (1984) showed that the 
activity of rats with SCN lesions, maintained under constant dark, 
entrained to restricted food availability, and, furthermore, the 
rats anticipated food access with an increase in activity prior to 
food availability. When food was freely available, however, 
activity became arrhythmic. In addition, the studies of Clarke and 
Coleman (1986) demonstrated the persistence of wheel-running and 
drinking rhythms in SCN-lesioned rats where periods of food 
deprivation and ad lib food availability were alternated. These 
observations indicate the existence of a second, albeit weak, 
oscillator outside the SCN that may entrain to a zeitgeber such as 
food availability, but that free-runs in the absence of an 
entraining signal. Furthermore, the studies of Stephan (1986a, 
1986b, 1986c) suggest that 1ight-entrainable and feeding-entrainable
rhythms in the rat are under the control of two underlying circadian 
oscillators that are not functionally independent, but are only 
weakly coupled. Evidence for multi-oscillators have also been 
obtained from studies in other species, e.g. squirrel monkey 
(Moore-Ede et al., 1979). The location and properties of circadian
oscillators outside the SCN remain unknown, although Moore and
co-workers have suggested the lateral geniculate nuclei (Johnson et 
al.. 1988; Morin et al., 1988), the lateral hypothalamic nucleus,
the retrochiasmatic area and the ventromedial nucleus (Moore, 1982;
1983) as possible candidates in the rat. The current evidence 
suggests that either the SCN is the primary oscillator within the CNS 
which drives the secondary oscillators, or the SCN provides a means 
by which the coupling of independent neuronal oscillators is achieved 
for circadian rhythm generation (Moore, 1982).
Little is known about the substances that mediate transmission in the 
SCN.* Axons containing vasopressin, vasoactive inestinal polypeptide 
and somatostatin have been identified in the SCN of the rat, and 
their distribution suggests that these peptidergic neurons comprise a 
significant population of SCN interneurons indicative of 
interconnections between divisions of the SCN (Moore, 1983). 
Furthermore, significant quantities of 5-HT and substance P have 
been found in the SCN, while acetylcholine and NA have been shown to 
be present in the area immediately surrounding the border of the 
nucleus (Moore, 1983; Silverman and Pickard, 1983).
In mammals, the pineal gland is driven by sympathetic input directly 
controlled by the SCN, mediated, at least in the Syrian hamster, 
by beta-adrenoceptors on the pinealocytes (Reiter et al . , 1986),
and displays a rhythm of indoleamine metabolism that is reflected in 
the circadian rhythm of 5-HT-N-acety1 transferase activity and 
melatonin secretion (Klein et al., 1979). Peak enzyme activity and
melatonin levels occur, in phase, during the dark period of the 
light/dark cycle in both diurnal and nocturnal animals (Lewy, 1983; 
Reiter, 1984). Light immediately suppresses melatonin secretion
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(Lewy, 1983). Furthermore, administration of melatonin has been 
shown to entrain free-running activity rhythms of rats except where 
the animals had previously received complete lesions of the SCN 
(Cassone et al., 1986), or partly entrain circadian rhythms of
previously disrupted activity induced by gradual increases in the 
photoperiod (Chesworth et al., 1987). These results suggest that
the behavioural effects of melatonin depend on an intact circadian 
system (including the SCN) and that the action of melatonin may be on 
the coupling mechanism between oscillators generating circadian 
locomotor activity rhythms, respectively. In both of these studies 
the onset of activity entrained to the administration of melatonin, 
suggesting that nocturnal animals equate melatonin administration 
with the onset of darkness. The pineal content of 5-HT, 5-HIAA, NA
and DA exhibit distinct circadian rhythms (Tang et al., 1985) with
peak 5-HT and 5-HIAA levels occurring during the light period, while 
that of NA or DA occurring during darkness. Similarly, circadian 
rhythms for NA levels in the SCN, locus coeruleus and dorsal raphe 
nucleus have been observed in rats housed under 12 hour light/12 hour 
dark conditions, with peak amine levels occurring at the beginning, 
middle and end of the light period, respectively (Semba et al.,
1984). In the same study, the 5-HT content of both the medial and
dorsal raphe nuclei exhibited circadian rhythmicity with peak levels 
occurring in the middle of the light period. Circadian variation in 
the CSF content of 5-HT and DA, and their acid metabolites, have 
also been observed in both the rat (Hutson et al., 1984) and, for
5-HT, the monkey (Taylor et al., 1985). The studies of Lemmer and 
Berger (1978) also demonstrated diurnal variation in DA, but not NA, 
levels in rat brain. In the rat, circadian rhythms have also been 
observed in, for example, the activity of some neurotransmitter
synthessing enzymes, e.g. tryptophan hydroxylase, although 
equivocal results have been reported (see Redfern and Martin, 1987); 
in neurotransmitter and release levels, and that of their 
metabolites, in discrete brain areas (see Kafka, 1987); in MAO 
activity (Bhaskaran and Radha, 1984); and , lastly, in the 
content and, in some cases, release of hypothalamic neuropeptides, 
including bombesin, cholecystokinin, neurotensin, substance P and 
vasoactive intestinal polypeptide (Nicholson et al., 1983). 
Furthermore, the circadian activities of some neuropeptides in the 
pineal gland are thought to induce concomitant modulation of the rate 
of protein synthesis which is reflected in changes in enzyme activity 
(Schotman and Bohus, 1983). Radio-ligand binding studies have 
demonstrated seasonal, circadian and possibly, in the case of 
beta-adrenoceptors and D2-DA receptors, ultradian rhythms in the 
number of receptors for various neurotransmitters in rat brain, e.g. 
alpha2- and beta-adrenoceptors (Wirz-Justice et al., 1980; Kafka et
al., 1981; Krauchi et al., 1984); D2-DA receptors (Naber et al.,
1980); 5-HT, and 5-HT2 receptors, labelled by [3H]-spiperone and
[3H]-5-HT, r/pectively (Bruinink et al., 1983; Wesemann et al.,
1983); and muscarinic cholinergic, opiate and benzodiazepine 
receptors (Kafka et al., 1983). The circadian variation in alpha2-
and beta-adrenoceptors in the rat appears to be functionally 
significant since increased food intake at dawn is associated with 
increased alpha2-adrenoceptor binding, while the reduction in food 
intake at dusk is associated with reduced beta-adrenoceptor binding 
(Krauchi et al., 1984). Redfern and Moser (1985) have demonstrated
that the head-twitch response of mice (thought to be mediated by 
stimulation of 5-HT2 receptors), but not the 5-HT behavioural 
syndrome (significant components of which are thought to be
5-HT .,-receptor mediated), induced by
5-methoxy-N,N-dimethy1tryptamine (5-MeODMT), exhibited significant 
circadian variation with peak response occurring during mid-light. 
These observations are in agreement with the results of Bruinink et 
al. (1983) who demonstrated a higher number of 5-HTz binding sites
during the light-period. The circadian rhythmicity of the 
5-HTz-receptor population is thus approximately 180° out of phase 
with peak 5-HT release (see above), and the function of the change 
in 5-HTz-receptor population may be to dampen the consequences of 
pre-synaptic oscillations (Redfern and Martin, 1987). Although only 
a limited number of examples have been provided here, there is ample 
evidence indicating that the activity and function of the majority, 
if not all, of the major neurotransmitter systems are under some 
form of circadian control.
1.5.3 Circadian Rhythm Abnormalities and Depression 
Initial clinical evidence implicating circadian or circannual rhythm 
abnormalities in affective disorders arose from three observations. 
Firstly, it is generally recognised that external factors which 
exhibit circadian rhythmicity may alter the mood of depressed 
patients throughout the day. Thus patients may feel particularly 
depressed either in the morning after awakening or in the evening 
(Kripke, 1983). Secondly, the phase-position of the circadian 
rhythm governing the spontaneous termination of sleep may be shifted 
abnormally early such that depressed patients experience early 
wakening. Furthermore, Wehr et al. (1979a) have demonstrated that 
advancing the sleep-wake cycle of some depressed patients produces a 
temporary antidepressant effect. Lastly, it has been observed that 
the degree of depression in some patients follows a seasonal pattern
such that patients feel worse during the winter months than during 
summer, or vica versa, i.e. Seasonal Affective Disorder (SAD) (see 
Wehr, 1988). Furthermore, some patients with uni-polar depression 
exhibit fluctuations between "good" days and "bad" (i.e. depressed) 
days with clock-like regularity (e.g. M8h depressive cycles; see 
Doerr et al., 1979). In some cases, bipolar patients exhibit a
regular alternation between depressive and manic episodes with a 
complete cycle period as short as two to eight wee//ks (Wehr, 1988). 
Such cases are indicative of rapid cycling forms of affective 
i11 ness.
Depressive patients exhibit marked differences in their sleep 
patterns compared to normal individuals. The studies of Borbely et 
al. (198H) suggest that the development of a sleep-dependent process 
is deficient in the sleep regulation of depre^ed patients. The most 
persistent finding is shortened REM latency which is found in 
virtually all primary, but not secondary, depressive illness 
(Kupfer, 1976). A common explanation of these findings is that the 
circadian rhythm of REM sleep is abnormally advanced with respect to 
normal sleeping patterns (Wehr and Wirz-Justice, 1982; Kripke,
1983; Mendlewicz et al., 1983; Wehr and Goodwin, 1983b).
However, other groups have suggested that the early occurrence of 
REM sleep may be due to reduced amplitude of the circadian rhythm of 
REM sleep without phase advance (Schulz and Lund, 1985), or that 
REM sleep abnormalities in depressives are limited to the initial 
stages of sleep and decreased SW sleep production is more consistent 
in depressives than REM sleep abnormalities (Beersma et al., 1983).
Furthermore, short REM latency has been observed by some workers to 
occur in depressed patients that exhibit a small difference between
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day and night values of body temperature (Schulz and Lund, 1983), 
however it is doubtful whether these observations may serve as a 
marker for depression since similar observations were made in some 
patients after remission and in some control subjects. Phase-advance 
of the circadian rhythm of temperature in depressives compared to 
controls has been observed by some workers (Wehr et al., 1982; Wehr
and Goodwin, 1983b), but not by others (Beersma et al., 1983). In 
addition, Avery et al. (1982) noted that while there was no evidence 
that the nightly temperature minimum of depressives occurred any 
earlier compared to control subjects, a number of patients exhibited 
a delay in the nightly temperature minimum following recovery.
Abnormalities in the circadian rhythms of a number of 
neurotransmitter (principally indoleamine and catecholamine) systems 
have also been observed in some depressed patients. For example, 
Malatino et al. (1981) demonstrated that the circadian rhythm of the 
plasma tryptophan levels for depressive patients was 180° out of 
phase compared to that of controls. However, Dam et al. (1984) 
observed little difference between the circadian variation of plasma 
tryptophan levels of endogenously depressed patients and controls. 
Serotonin uptake in blood platelets exhibits circadian rhythmicity 
(Healy et al., 1986a, 1986b), and abnormalities in the circadian
rhythm (Healy et al., 1986a, 1986b) and the seasonal variation
(Arora et al., 1984; Egrise et al., 1986) of serotonin uptake in 
blood platelets of depressed patients compared to controls have been 
observed. Furthermore, the studies of Healy et al. (1986a, 1986b)
suggest that while depressed patients exhibit no circadian 
rhythmicity in platelet 5-HT uptake, % remission from depression is 
associated with restoration of the normal variation in platelet 5-HT
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uptake. Urinary MHPG excretion exhibits circadian rhythmicity, and 
Wehr et al. (1980) have observed that in some bipolar depressed 
patients peak urinary MHPG excretion is advanced by at least 3 hours 
compared to controls. Furthermore, abnormalities in MHPG levels in 
the urine and plasma of depressed patients tend to normalize with 
successful antidepressant treatment (Halaris, 1984). Abnormalities 
in the circadian variation of plasma levels of cAMP, 
dopamine-beta-hydroxylase, cortisol, melatonin, prolactin and TSH 
for unipolar and bipolar depressed patients have been observed 
(Mendlewicz and van Cauter, 1979; Wirz-Justice and Arend, 1979; 
Markianos and Lykouras, 1981; Lewy, 1983; Mendlewicz et al., 
1983; Claustrat et al., 1984; Beck-Friis et al., 1985) which,
for cortisol and melatonin at least, may normalize during clinical 
remission (Wetterberg et al., 1982).
The sensitivity of SAD to changes in season implies that the illness 
can be precipitated by changes in the physical environment. 
Furthermore, manipulation of the environment may be of use in the 
treatment of SAD. Indeed, winter depression has been shown to 
respond very well to phototherapy using bright light, while heat is 
strongly implicated in summer depression (Wehr, 1988).
Halberg (1968; cited by Wehr and Goodwin, 1983a) proposed that 
rapidly cycling episodes of bipolar depression might be caused by 
abnormal phase-angles of certain circadian rhythms that were no 
longer entrained to the light-dark cycle, but free-ran; thereby 
generating differences in frequency, through beat phenomenon, of 
one cycle every few weeks. In accordance with this hypothesis, 
Kripke and co-workers (Kripke et al., 1978) described circadian
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rhythms of less than 2Hh period length in patients with rapidly 
cycling bipolar depression. Lithium has been shown to slow or delay 
circadian rhythms in both experimental animals (Kripke and Wyborney,
1980) and manic-depressive patients (Kripke et al., 1978; Kripke,
1983). If circadian rhythms in bipolar depressives are either too 
fast or too phase advanced, then, it has been argued (Kripke et 
al., 1978; Kripke, 1983), the ability of lithium to slow or delay
circadian rhythms may explain its therapeutic efficacy in affective 
disorders. In a subgroup of bipolar depressive patients, TCA’s 
(e.g. desipramine) have been observed to reduce the duration of both 
manic and depressive phases, thereby accelerating the cycling rate 
between mania and depression (Wehr et al., 1979b; Wehr and Goodwin, 
1983b). This finding has obvious treatment implications and, 
furthermore, indicates that rhythms of mood may be modified by 
antidepressant drugs.
The examples cited above serve to illustrate that circadian rhythm 
abnormalities in a number of physiological and biochemical parameters 
may occur in the affective disorders; for more information the 
interested reader is directed to the reviews by Wehr et al. (1982), 
Wehr and Goodwin (1983b) and Wehr (1988).
In the opinion of some authors (see Wehr et al., 1982; Kripke,
1983; Wehr and Goodwin, 1983b) a number of circadian rhythms in 
depressed patients (e.g. REM sleep, temperature, and plasma 
cortisol and urinary MHPG levels) are either abnormally advanced in 
relation to sleep position or blunted (i.e. reduced amplitude) 
compared to those observed in normal subjects. The former being so 
then advancing the sleep period to an earlier time should correct the
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internal phase disturbance. Indeed, some studies have shown that 
phase-advance of the circadian sleep-wake cycle to re-establish the 
normal phase-angle of certain circadian rhythms to the sleep-wake 
cycle, or total or partial sleep deprivation, provide a temporary 
remission from depression (Wehr et al., 1979a; Wehr and
Wirz-Justice, 1982). Furthermore, since antidepressants may
normalize the circadian rhythm abnormalities observed in some 
patients, it has been suggested by some workers (e.g. Wirz-Justice, 
1983) that the clinical efficacy of antidepressants may be related to 
an ability to re-align the phase-position of certain abnormally 
positioned circadian rhythms.
1.5.4 Antidepressants and Circadian Rhythms in Animal Studies 
A number of biochemical and behavioural studies in animals suggest 
that antidepressant drugs may modify circadian rhythms. Redfern and 
Martin (1985) showed that chronic treatment with clomipramine and 
zimelidine, but not imipramine, delayed the time of peak free 
plasma tryptophan in rats, while imipramine lowered the free 
tryptophan levels and abolished the normal 24 hour variation in free 
tryptophan levels. Furthermore, Wirz-Justice et al. (1982) showed 
that the nocturnal elevation of pineal melatonin, which normally 
returns to base levels at light onset, persisted into the light 
period following chronic clorgyline treatment. Similarly, chronic 
clorgyline treatment has been shown to modify the normal circadian 
variation in the number of alpha!- and beta-adrenoceptors, 
muscarinic cholinergic, opiate, benzodiazepine and dopamine 
receptors (Wirz-Justice et al., 1982). Following clorgyline
treatment some or all of the rhythm characteristics (i.e. amplitude, 
24h mean number of receptors, and phase) were affected, although
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clorgyline commonly delayed the phase-position of binding to alpha,- 
and beta-adrenoceptors, opiate and benzodiazepine receptors.
Similar changes in circadian receptor binding characteristics have 
been observed following chronic imipramine and fluphenazine (a 
dopamine antagonist) treatment, while sleep deprivation only delayed 
the phase-position of binding to alpha,-adrenoceptors but reduced the 
amplitude of binding to alpha,- and beta-adrenoceptors, 
benzodiazepine, muscarinic cholinergic and dopamine receptors (Naber 
et al., 1982; Wirz-Justice, 1983; Wirz-Justice and Wehr, 1983).
In behavioural studies, chronic treatment with imipramine and 
clorgyline have been demonstrated to slow or dissociate the circadian 
rest-activity cycle of female hamsters maintained under constant 
low-red light (Wirz-Justice and Campbell, 1982), while chronic 
treatment with clorgyline or pargyline have both been demonstrated to 
delay the activity onset of hamsters entrained to a 1Hh:10h 
light-dark cycle (Wehr et al., 1982). Chronic treatment with 
clorgyline has also been demonstrated to firstly increase the 
circadian period, activity/rest ratio and total activity of hamsters 
maintained under constant darkness (Duncan et al., 1986); and
secondly, delay activity onset, dissociate activity or induce 
arrhythmic activity in hamsters maintained under continuous bright 
light (Duncan et al . , 1988). In comparison, however, repeated
electroshock had no effect on the free-running circadian locomotor 
activity rhythms of rats or mice housed under constant environmental 
conditions (Mitchell et al . , 1987). Lastly, Baltzer and Weiskrantz
(1975) demonstrated that chronic treatment with imipramine. 
maprotiline or pargyline facilitated adjustment of entrained 
locomotor activity of rats to 12h phase-shift in the light-dark
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cycle, while non-antidepressant compounds were ineffective.
However, an ability to modify circadian rhythms is not necessarily 
limited to compounds with known or potential clinical antidepressant 
efficacy. For example, Borsook et al. (1984) reported lengthening 
as well as shortening of periods in activity and temperature in 
squirrel monkeys after oral administration of the GABA-ergic 
compound, valproate, while Rietveld and Wirz-Justice (1986) showed 
that chronic treatment with either valproate or methamphetamine 
shortened the free-running period of food intake, drinking activity 
and wheel-running activity in blinded rats. It should be noted that 
the ability of MAOI’s or valproate to either delay the activity onset 
of entrained hamsters or modify the free-running circadian activity 
and temperature rhythms in the squirrel monkey, respectively, is 
thought to be mediated by the SCN (Kruse, 1988; Borsook et al., 
1984, respectively). Conversely, however, methamphetamine has 
been shown to induce irregular rhythms in the temperature of 
SCN-lesioned, blinded rats which, prior to methamphetamine 
administration, exhibited either complete arrhythmicity or severe 
amplitude reduction, or period shortening following the lesion 
(Rietveld et al., 1988). Furthermore, the methamphetamine-induced
rhythmicity was shown to entrain to food-restriction. Such 
observations suggest that while the SCN may be the primary target for 
compounds such as MAOI's, other psychotropic compounds may modify or 
induce circadian rhythms independant of the SCN. Furthermore, while 
there is evidence that some antidepressants, or compounds thought to 
be potentially antidepressant, may modify behavioural or biochemical 
indices of circadian rhythms in rodents, it should be noted that 
only a limited number of compounds have been studied. It therefore 
remains to be shown whether all clinically antidepressant treatments
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possess common effects on behavioural or biochemical indices of 
circadian rhythms and, perhaps most importantly, whether such 
effects may be equated to the reversal of circadian rhythm 
abnormalities observed during the remission of depression in some 
patients.
1.6 Hypotheses on the Aetiology of Depression
1.6.1 The Classical Monoamine Hypothesis
The classical monoamine hypothesis of depression states that 
depression is caused by an absolute or relative deficiency of 5-HT 
(Coppen, 1967) and/or NA (Schildkraut and Kety, 1967) available for 
neurotransmission within the CNS. The hypothesis was derived 
primarily from studies on the acute pharmacological effects elicited 
by the majority of clinically effective MAOI's and TCA’s available 
during the 1960's and' 1970's. In addition, the antidepressant 
efficacy of the serotonin precursors, tryptophan and 5-HTP (see 
review by van Praag, 1981b), together with clinical studies on the 
concentrations of monoamines and their metabolites in the CSF or 
post-mortem brain samples (e.g. Ashcroft et al., .1966) supports this
view. There are two major, equally important, criticisms of the 
hypothesis. Firstly, the hypothesis is primarily limited to a 
consideration of the drug-induced modification of pre-synaptic 
neuronal function, and thus effectively ignores any indirect 
drug-induced modification of the post-synaptic signal trarfduction 
mechanisms. Secondly, the hypothesis does not accommodate the 
discrepancy in the time course between the biochemical and 
pharmacological effects elicited by antidepressant drugs and their 
clinical therapeutic action which generally requires several weeks of
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continuous treatment (Oswald et al., 1972). Furthermore, the
pharmacological profile of the atypical antidepressants mianserin 
and, more especially, iprindole, together with the lack of 
antidepressant efficacy of the NA re-uptake inhibitor cocaine, 
suggests that an ability to potentiate monoamine function, either by 
inhibition of 5-HT or NA re-uptake or MAO activity following acute 
treatment, is not necessarily a prerequisite for antidepressant 
activity. In addition, the 5-HT2 receptor blocking activity of 
mianserin is not in accord with the classical monoamine deficiency 
theory of depression. While it would not be denied that increased 
monoamine function resulting from antidepressant treatment is 
probably inherent in the initiation of the therapeutic efficacy of 
the majority of antidepressants, such effects do not necessarily 
indicate a deficiency of 5-HT or NA in the pathogenesis of 
depression.
1.6.2 The Alternative Monoamine Hypothesis
Studies on the delayed post-synaptic receptor mediated events induced 
by chronic antidepressant treatment in rodents have led to an 
alternative monoamine hypothesis for the pathogenesis of depression 
that is in closer accord with the clinical latency of these 
compounds. Generally, chronic antidepressant treatment, including 
electroshock, leads to down-regulation of beta-adrenoceptor number 
and hence reduced sensitivity of the NA-dependent adenylate cyclase 
system (see section 1.H.5), while a persistent reduction in central 
NA availability leads to increased sensitivity of the cAMP generating 
system (Vetulani et al., 1976b). These observations led to the
hypothesis, initially proposed by Vetulani, Sulser and colleagues 
(see Vetulani et al., 1976a; Sulser et al., 1978), that in
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depression there may be a post-synaptic supersensitivity to NA and 
that antidepressant treatments, including ECT, bring about a 
desensitization of enhanced noradrenergic function and hence a return 
to behavioural normality. In this context the low levels of 
monoamine metabolites observed in the CSF of some depressed patients 
prior to antidepressant treatment may be due to a compensatory 
decrease in monoamine biosynthesis rather than directly related to 
the pathogenesis of depression. This hypothesis has been extended to 
include the observed down-regulation of both the alpha2 
receptor-mediated negative feedback system (which may be necessary 
for the succeeding down-regulation of beta-adrenoceptors) and central 
post-synaptic 5-HT2 receptors. Although there are exceptions, the 
aforementioned changes in receptor density, and their consequences 
for signal transduction, normally only follow chronic antidepressant 
treatment. The hypothesis therefore accommodates not only the known 
pharmacological and biochemical effects observed following chronic 
treatment with the atypical antidepressants, mianserin and 
iprindole, but also the latency of effect required for remission 
from depression experienced in the clinic.
1.6.3 The Circadian Rhythm Phase-Advance Hypothesis
It has been suggested by some workers that certain forms of 
depression may be produced following a disruption or 
de-synchronization of circadian rhythms (Wehr and Wirz-Justice,
1982; Wehr et al., 1982; Kripke, 1983). The hypothesis is based
on the observation that the phase-position of the circadian rhythm 
governing the spontaneous termination of sleep may be shifted 
abnormally early; thus depressed patients often experience early 
wakening. Furthermore, Wehr et al. (1979a) have shown that
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advancing the sleep-wake cycle of some depressed patients produces a 
tempory antidepressant effect. Wehr and Wirz-Justice (1982) have 
therefore proposed that the phase-position of certain circadian 
rhythms are advanced in relation to other circadian rhythms in some 
depressed patients, and the resultant modified phase-relationship 
between circadian rhythms is manifest as depression. In addition, 
it has been argued that the free-running hypothesis of Halberg (see 
section 1.6.2), to explain the rapid-cycling of manic-depressive 
episodes in some bipolar patients, may be viewed as an extreme 
development of the phase-advance hypothesis of depression (see 
Kripke, 1983; Wehr and Goodwin, 1983a). Likewise, it has been 
suggested that SAD may be due to phase-shift of circadian rhythms 
relative to the timing of sleep (see Wehr, 1988, for discussion).
It therefore follows that if phase advances in circadian rhythms were 
a primary pathophysiologic mechanism of depression then 
antidepressants may exert their therapeutic effect by reversing 
excessive phase advance.
1.7 Identification of Potential Antidepressants
The aim of this section is to briefly summarize the pharmacological, 
behavioural and biochemical techniques employed to identify potential 
antidepressants or elucidate the pathophysiological processes of 
depression.
1.7.1 Animal Models of Depression
Animal models of depression may be divided into two general 
categories.
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Firstly, many models have been developed for the purpose of 
identifying novel compounds of potential clinical antidepressant 
efficacy. These tests include reversal or protection of the 
behavioural effects of monoamine depletion (following treatment with 
reserpine, tetrabenazine, 6-OHDA or pCA) or monoamine synthesis 
inhibition (by pCPA or alpha-methy1-para-tyrosine); potentiation of 
directly or indirectly acting sympathomimetics (e.g. L-DOPA plus a 
MAOI, amphetamine) either centrally or peripherally; potentiation 
of the lethal effects of the aIpha2-antagonist, yohimbine, in mice; 
potentiation of the behavioural syndrome induced by serotonin 
precursor loading (e.g. 5-HTP or tryptophan plus a MAOI); inhibition 
of muricide behaviour (rats); inhibition of seizure activity 
elicited from the amygdala, rather than the cortex, in rats induced 
by low-intensity electrical stimulation (known as kindling); 
reversal of the behavioural effects of olfactory bulbectomy (rats); 
and inhibition of isolation-induced hyperactivity in rats (Moller 
Nielsen, 1980; Katz, 1981; Willner, 198H). It should be noted 
that each test makes no assumptions about the relationship of the 
test procedure to the underlying mechanisms of depression nor about 
such mechanisms per se. In each case the tests are employed because 
of their empirical utility and thus only identify ”me-too" compounds. 
Furthermore, each test progressively loses its power to detect novel 
compounds as the chemical structure of the latter progressively 
differs from that of the more traditional antidepressants upon whose 
detection the rationale for each test was based. In addition, the 
empirical power of each test varies and the potency order of 
compounds identified by a particular test may not follow that 
observed in the clinic (Willner, 198H). A further criticism of 
these tests is that each has the ability to identify false positives
(i.e. compounds proving positive in the test but which have no 
antidepressant efficacy). For example, the effects of reserpine may 
be reversed by L-DOPA, amphetamine, histamine antagonists, LSD and 
beta-adrenoceptor antagonists, but mianserin is not detected by this 
test; muricide may be blocked by psychostimulants, antihistamines 
and anticholinergics, but not by mianserin; MAOI’s do not normalize 
the behaviour of olfactory bulbectomized rats (Cairncross et al.,
1979); and, lastly, tests which employ MAOI’s as adjuvants to 
monoamine precursor loading obviously cannot identify novel MAOI’s 
(Willner, 198H). Perhaps the most important criticism of these 
tests is that they identify potential antidepressant compounds 
following acute treatment, and thus effectively ignore the relevance 
of chronic treatment regimes which are required in the clinic. It 
may be claimed that such tests have been successful in identifying 
potential "me-too" antidepressants, however it may also be argued 
that reliance on such tests has effectively hindered the 
identification and development of potential antidepressants of novel 
structure and mode of action. The only animal behaviour that 
consistently and clearly responds differently to acute or chronic 
antidepressant treatment is aggressive behaviour (see review by File 
and Tucker, 1986). Thus antidepressants, among other classes of 
psychotropic compounds, reduce various types of rodent aggressive 
behaviour following acute treatment (e.g. Horovitz et al., 1966;
Crowley, 1972; Malick, 1976; Sheard et al., 1977; Gibbons et 
al., 1978b; Delini-Stula and Vassout, 1979), while only chronic
treatment regimes clearly identify examples of antidepressants as 
shown by the drug-induced increase in aggressive behaviour (e.g. 
Eichelman and Barchas, 1975; Mogilnicka and Przewlocka, 1981;
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Willner et al . , 1981; Prasad and Sheard, 1982; Valdman and
Poshivalov, 1986).
The second class of animalmode 1 has been concerned with the 
theoretical basis of depressed behaviour rather than with drug 
screening and development. Such models include learned helplessness, 
where chronic exposure to uncontrollable stress produces performance 
deficits in subsequent learning tasks, decreased locomotion and 
aggression, and loss of appdite and weight (see reviews by Katz, 
1981; Weiss et al . , 1982; and Willner, 1984); behavioural
despair, where mice or rats assume an immobile posture following a 
frenzied attempt to escape on being forced to swim in a confined 
space (Porsolt et al . , 1977); chronic unpredictable stress, where 
rats are chronically exposed to number of mild unpredictable 
stressors (see Willner et al.. 1987, for details); maternal or
peer separation models in a number of species (Katz, 1981), 
including non-human primates, where the initial manifestations of 
protest are soon followed by those of despair (Willner, 1984); and 
intracranial self-stimulation (ICSS; see Willner, 1984, File and 
Tucker, 1986). Chronic, but not acute, antidepressant treatment 
generally reduces the performance or behavioural deficits observed in 
the learned helplessness, chronic unpredictable stress and 
separation models (Willner, 1984; File and Tucker, 1986), thus 
demonstrating accordance with the clinical latency of these 
compounds. However, the theoretical validity of these models to 
endogenous depression has been questioned (Willner, 1984). The 
behavioural despair test may be criticized on the basis that the 
period of immobility during forced swimming is demonstrably sensitive 
to acute antidepressant treatment, including single electroshock,
and, furthermore, the test may identify false positives such as 
amphetamine and caffeine (Porsolt et al ., 1977). The
tai1-suspension test, where immobility is also taken as an index of 
behavioural despair (Steru et al., 1985) may also be similarly
criticized, although the generalised predictive value of the 
behavioural despair would not be denied. ICSS may be criticized on 
three points. Firstly, there is no consistent single effect of 
antidepressants on brain-stimulation reward (thus some compounds 
enhance self-stimulation, especially those that may facilitate 
dopaminergic transmission, while others decrease the reward value of 
electrical stimulation); secondly, the antidepreg’ant-induced 
modification of ICSS depends largely on electrode placement; and 
lastly, no clear differences can be discerned between acute and 
chronic treatment regimes (File and Tucker, 1986).
It may be argued that animal models utilizing biological rhythm 
disturbance have a theoretical basis since they attempt to mirror the 
circadian rhythm disturbances observed in some depressed patients. 
Such models fall into two categories. Firstly, compounds are tested 
for their ability to modify the adjustment of activity patterns 
exhibited by animals to phase-shifts in the daily light-dark cycles. 
Chronic treatment with some antidepressants has “ been demonstrated to 
facilitate adjustment to phase-shift, while non-antidepressant 
compounds were ineffective (Baltzer and Weiskrantz, 1975).
Secondly, compounds have been tested for their ability to modify the 
free-running activity rhythms of animals. In this case, chronic 
treatment with imipramine or clorgyline to female hamsters, housed 
under constant environmental conditions, has been found to slow or 
dissociate free-running circadian locomotor activity rhythms
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(Wirz-Justice and Campbell, 1982). The effect of antidepressants on 
circadian rhythms has received scant attention in the literature, 
and it is not known whether all antidepressant treatments, including 
electroshock, modify circadian rhythms in a similar manner to the 
examples given above. Furthermore, it is unlikely that the 
theoretical basis of the studies described above is justified. Thus, 
in both cases cited above the phase position of the particular 
circadian rhythm monitored is assumed to be in its normal position in 
relation to other circadian rhythms; indeed circadian rhythms may 
become desynchronized during chronic antidepressant treatment 
(Wirz-Justice and Campbell, 1982). Conversely, the abnormal phase 
position of some circadian rhythms in depressed patients prior to 
drug treatment are thought to be re-synchronized following drug 
treatment. It is therefore unlikely that the studies cited above 
mirror the circadian rhythm disturbances in depression. These 
studies may therefore only prove to be of empirical interest.
1.7.2 Biochemical Methods
Biochemical studies employed in antidepressant research may be 
divided into two categories.
The first category is comprised of those studies primarily concerned 
with pre-synaptic neuronal function. Such studies include the 
ability of antidepressants to modify neurotransmitter uptake, either 
in vitro or in vivo, and simply demonstrate selectivity for a 
particueir neurotransmitter re-uptake system. The ability of 
antidepressants to protect against monoamine depletion, induced by, 
for example, reserpine, tetrabenazine or pCA, only enable similar 
conclusions. The effect of acute antidepressant treatment on the
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levels of monoamines or their metabolites, or the activity of the 
enzymes involved therein, have only demonstrated the ability of 
antidepressants to modify pre-synaptic neuronal function.
Furthermore, similar studies involving chronic antidepressant 
treatment have generally only demonstrated the ability of 
neurotransmitter systems to modify their activity according to 
changes in the synaptic or intraneuronal concentration of the 
respective neurotransmitter. Specific high-affinity binding sites 
for [3H]-imipramine have been described in the brain and platelets of 
several mamalian species, including man (see review by Briley,
1985). The binding sites for [3H]-imipramine are located on 
serotonin nerve terminals and appear to be related to. but not 
identical with, the transporter mechanism that translocates 5-HT 
through the neuronal and platelet membrane (Langer and Raisman,
1983). The [3H]-imipramine binding site appears to be a regulatory 
unit capable of modulating 5-HT re-uptake (Briley, 1985).
Similarly, [3H]-desipramine binds to high affinity sites (Biegon and 
Samuel, 1979) thought to be associated with NA re-uptake in the 
brain (Rehavi et al., 1981, 1982) and periphery (Langer et al .,
1981). A number of TCA’s bind directly to the [3H]-imipramine site 
(e.g. clomipramine, amitriptyline, desipramine) while 5-HT and 
non-tricyclic inhibitors of 5-HT re-uptake appear to bind to the 5-HT 
recognition site of the re-uptake complex and inhibit [3H]-imipramine 
binding by an indirect mechanism (Briley, 1985). Binding to the 
[3H]-imipramine site has been used as a method of examining the 
interaction of putative antidepressants with the 5-HT re-uptake 
system. Such studies have undoubtedly led to a greater understanding 
of monoamine re-uptake systems, however, their use as screening 
tests for potential antidepressants is largely limited to empirical
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value. Similar conclusions may only be drawn from similar studies 
examining the binding sites labelled by other radio-labe1 led 
monoamine re-uptake inhibitors.
The second category of biochemical tests is comprised of those 
experimental techniques concerned primarily with post-synaptic 
function and include such tests which identify neurotransmitter 
binding sites and the activity of second messenger systems. Such 
studies have demonstrated that a number of antidepressants exhibit 
comparatively high affinities for some neurotransmitter receptors, 
and have provided possible explanations for a number of side-effects 
associated with some antidepressant treatments. It is only the 
effect of chronic antidepressant treatment on the binding 
characteristics of some radio-1igands, or the activity of some 
second messenger systems (particularly NA-dependent adenylate 
cyclase) that has enabled a greater understanding of the mechanisms 
by which antidepressants may induce their clinical effect. Even so, 
such studies make no assumptions about biochemical deficits that may 
be associated with depression.
In circadian rhythm research biochemical studies have concentrated on 
the expression of rhythmicity determined by the above techniques and 
their modification by antidepressant treatments. As such, these 
studies probably represent the only biochemical studies with a 
theoretical relationship to the possible circadian rhythm 
abnormalities observed in some depressed patients. However, since 
such studies are concerned primarily with circadian rhythms in the 
biochemistry of normal animals, they are open to the same criticisms 
as the animal models, and ultimately therefore, may only prove to
be of empirical value.
1.7.3 Comments
The majority of pharmacological, behavioural and biochemical tests 
used to study antidepressant drug action, or identify and develop 
potential antidepressants, have generally been derived from the 
previously determined mode of action of available antidepressants, 
or the ability of available antidepressants to modify abnormal animal 
behaviours or biochemistry induced by pharmacological tools which 
result in behavioural or biochemical deficits assumed to be 
consistent with a single facet of the pathology of depression. As 
such, these tests are primarily of empirical utility. Consequently, 
their power is limited to the identification of novel compounds whose 
primary mode of action is akin to those compounds already available 
to the clinician. Even when those animal models with a theoretical 
relationship to depression are considered there does not appear to be 
a definitive model of depression, and this largely reflects the 
level of understanding of the pathophysiology of the affective 
disorders. One facet of clinical depression is decreased interest in 
sexual and social activity (see section 1.2.4.1), and these 
emotional and behavioural changes are reversed by antidepressant 
treatment. In this respect it is disappointing that scientists have 
largely ignored the intrinsic effects of chronic antidepressant 
treatment on endogenous patterns of normal animal behaviour, but 
have instead concentrated on the ability of antidepressants to modify 
abnormal animal behaviours induced either by pharmacological tools or 
exotic experimental paradigms. As File and Tucker (1986) noted in 
their review on the effects of antidepressants on animal models of 
behaviours that are changed during clinical depression: "In general,
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the only type of social behaviour that is increased by antidepressant 
treatment is aggression in the rat. This effect is particularly 
marked for antidepressants that alter noradrenergic transmission and 
only occurs after chronic treatment." There are two important points 
to note here. Firstly, the increased expression of rodent 
aggressive behaviour induced by antidepressants may be consistent 
with the reversal of human aggressive behaviour from intropunitive 
hostility to extrapunitive hostility following clinical 
antidepressant treatment (Priest et al., 1980); and secondly, such
behavioural effects were only observed after chronic antidepressant 
treatment, which is consistent with the clinical latency of these 
compounds.
1.8 Conclusions
The symptomology of depressive illness has been well described and a 
number of rating scales have been developed by which the clinician 
may gauge both the severity of the illness and the response to 
antidepressant therapy. Clinical studies suggest that 2-3 weeks of 
continuous treatment is required before any remission from depression 
is observed.
Biochemical studies in depressed patients, together with the 
identification of the acute and chronic effects of antidepressant 
drug administration on central serotonergic and noradrenergic 
function in experimental animals, suggest that depression is 
associated with abnormalities in the function of central serotonergic 
and noradrenergic neurotransmitter systems. Such neurotransmitter 
abnormalities are also implicated in some circadian rhythm 
abnormalities, observed in a limited number of depressed patients,
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that may play a causative role in the symptomology of some depressive 
states. However, while such studies have led to three principal 
hypotheses on the aetiology of depression, the underlying 
patKphysiology of the disease state remains to be elucidated. It is 
unlikely that depression is a unitary disease and, consequently, 
the probability that a single patKphysiology underlies the various 
forms of depressive illness is small.
The majority of antidepressant drugs have been identified on the 
basis of their acute mode of action, thereby ignoring the clinical 
latency of antidepressant treatment. Furthermore, the methods 
currently employed to identify potential antidepressants are largely 
of empirical utility and thus make no assumptions about their 
relationship to the mechanisms that play a role in depression. It 
would not be denied, however. that the currently available 
antidepressant drugs have shown a high level of success, especially 
when one considers that the majority of depressed patients are able 
to remain within the community during treatment. Such patients are 
therefore exposed to the same environmental and social stimuli, 
which prior to therapy they found intolerable, throughout the 
duration of their illness. This indicates that the patients’ 
response to environmental and social stimuli must change with chronic 
antidepressant treatment. Clinical studies have suggested that the 
remission from depression is associated with a reduction in the 
intrapunitive manifestations (e.g. guilt) of the disease which. it 
is suggested, may also involve a drug-induced readjustment of 
abnormally positioned circadian rhythms. The possible involvement of 
circadian rhythm abnormalities in depression is a relatively new 
approach, and it remains to be seen whether an ability to modify
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circadian rhythms is common to all antidepressant treatments.
Although a high level of commonality has been identified in the 
biochemical effects following chronic treatment with antidepressants 
in experimental animals, it is surprising that researchers have 
largely ignored the logical extension of the common ability of 
antidepressant treatments, including ECT, to modify the reactive 
patterns of human behaviour, concomitant with the remission from 
depression, to studies on the ability of antidepressant treatments 
to modify the normal behavioural patterns of experimental animals.
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CHAPTER 2 AIMS OF THIS STUDY.
CHAPTER 2 AIMS OF THIS STUDY.
If antidepressants have the ability to modify either reactive 
behaviour patterns or the relative phase position of circadian 
rhythms of depressed patients then it is reasonable to assume that 
either the normal social behaviour patterns or endogenous circadian 
rhythms of laboratory animals may also be modified following chronic 
treatment with known antidepressant agents. This project is 
therefore based on the hypothesis that the efficacy of 
antidepressants is related to an ability to alter endogenous patterns 
of rodent behaviour in terms of either social behaviour or circadian 
locomotor activity rhythms.
The effects of acute and chronic treatment with clinically 
established antidepressants on the behavioural profile exhibited by 
resident rats during social interaction with unknown intruder 
conspecifics have been evaluated. This behavioural model maximizes 
the level of physical contact between subjects, thereby allowing the 
maximum expression of rodent social behaviours which may be observed 
and recorded. The antidepressants used in this study were chosen as 
representatives of the major classes as indicated by their acute 
pharmacology, i.e. the tricyclic antidepressant clomipramine, the 
MAOI phenelzine and the "atypical" antidepressants iprindole and 
mianserin. In addition, the effects of similar treatment regimes 
with the potential antidepressant fluoxetine, which specifically 
inhibits the re-uptake of 5-HT, and, for comparison, the 
antipsychotic haloperidol and the anxiolytic diazepam, on this 
animal model of rodent social behaviour have also been examined.
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The effects of acute and chronic administration of each drug on the 
exploratory locomotor activity of rats were examined to establish 
whether any of the observed drug effects on social behaviour could be 
attributed to drug-induced changes in the basal level of rodent 
activity.
The effects of chronic clomipramine and mianserin treatment on the 
rank position of subdominant rats were examined to establish whether 
the effect of similar drug treatment regimes on social behaviour 
might be indicative of drug-induced changes in social drive.
Finally, the effects of chronic clomipramine, fluoxetine and 
mianserin, administered at clinically-equivalent doses, on the 
free-running circadian locomotor activity of rats housed singly or in 
groups have been examined.
In summary, the purpose of these experiments has been to test the 
hypothesis that a feature common to the chemically-disparate group of 
drugs clinically labelled "antidepressant" is an ability to modify 
the various elements of social and aggressive behaviour and circadian 
rhythms.
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CHAPTER 3 OVERVIEW OF THE RATIONALE OF EXPERIMENTAL PROTOCOLS
CHAPTER 3 OVERVIEW OF THE RATIONALE OF EXPERIMENTAL PROTOCOLS 
The aim of this chapter is to provide a short introduction to the 
different series of experiments described in the following chapters 
together with the rationale supporting both the choice of 
experimental methodology and the various drugs examined.
3.1 Social behaviour
The primary objective of these studies was to examine the effect of 
chronic antidepressant treatment on rodent social behaviour. The 
method of quantifying rodent social behaviour was based on the social 
interaction test described by Silverman (1965). This method records 
the frequency of the repertoire of postures or behaviours exhibited 
by the subject animals. thus providing an accurate, quantifiable 
profile of rodent social behaviour.
Initial experiments examined the effects of acute, ascending doses 
of each drug in order to identify the minimum behaviourally-active 
dose of each compound which, in a separate series of experiments, 
was administered continuously for 14 days, by
subcutaneously-implanted osmotic mini-pumps. This method of chronic 
administration was chosen since constant drug delivery results in 
constant plasma/tissue levels of the drug, as opposed to the peak 
effects associated with bolus injection, and obviated the need for 
excessive handling of the subjects and thus reduced 
injection-associated stress.
The effects of acute and chronic drug administration on the 
exploratory locomotor activity of rats were examined concomitantly 
with the social interaction studies. Such studies were designed to
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identify whether any drug-induced effects on rodent social behaviour 
might result from drug-induced changes in basal activity rather than 
specific effects on social behaviour.
Lastly, the effect of chronic antidepressant treatment on the rank
position of subdominant rats maintained in social groups was examined 
to determine whether the effects of similar treatment regimes on the 
endogenous patterns of social behaviour might be indicative of 
drug-induced changes in social drive.
A detailed description of each experimental method is provided in the 
relevant chapter.
In all these experiments drugs, whether administered acutely or 
chronically, were given by the subcutaneous route since the extent 
to which absorption occurs via the hepatic portal system (with a
first pass through the liver), as opposed to the systemic
circulation, is uncertain following intraperitoneal administration, 
whether by injection or osmotic mini-pump. For substances that are 
extensively metabolized by the liver the intraperitoneal route may 
produce highly variable concentrations of the drug in the systemic 
circulation and therefore variable pharmacological/behavioural 
effects. Similarly, drugs absorbed via the gastric or intestinal 
mucosa following oral administration are also subject to the 
possibility of first-pass metabolism following removal of the drug to 
the hepatic circulation. The subcutaneous route of drug 
administration was therefore chosen for these experiments, although 
the rate of absorption may be slower than that observed following 
administration via alternative routes.
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3.2 Circadian locomotor activity
The objective of these studies was to examine the effect of chronic 
antidepressant treatment on the "free-running" circadian locomotor 
activity rhythms of rats. All experiments were performed with the 
subject animals housed in environmental cabinets to maintain constant 
environmental conditions as required by the experimenter.
The plethora of data generated by these experiments consists of 
continuously sampled counts of activity accumulated at discrete time 
points throughout the duration of the experiment, and are indicative 
'of complex waveforms containing cycles of activity that differ in 
their respective frequency, amplitude and phase position. Such data 
may be subjected to Time-Series analysis to identify the component 
frequencies (and amplitude) of activity. The accuracy of the 
statistical methods, however, is directly related to the number of 
fundamental cycles contained within the data sample analysed. The 
duration of each experiment was therefore determined not only by the 
required duration of drug treatment but also by the requirements of 
the statistical methods employed. The accuracy of the statistical 
methods is also reduced with the occurrence of missing data points or 
transiently high levels of activity that may occur, for example, 
following handling of the animals for drug administration or 
necessary husbandry. All experiments were therefore largely 
self-contained such that the subject animals were supplied with 
sufficient food and water to last at least 7 days (and longer if 
possible) thereby reducing interference with the animals to a minimum 
during the course of each experiment. For the same reason, animals 
were treated chronically with drugs or vehicle presented in the 
drinking water rather than by subcutaneous administration as employed
in the social behaviour studies.
3.3 Choice of drugs
The antidepressants examined in these studies were chosen as 
representatives of the clinically-established tricyclic 
(clomipramine), mono-amine oxidase inhibitor (phenelzine) and 
"atypical” (iprindole and mianserin) classes of antidepressants. The 
effects of fluoxetine, a potential antidepressant currently under 
development, were also examined. For comparison, the effects on 
rodent social behaviour of the antipsychotic haloperidol and the 
anxiolytic diazepam were examined. The chemical structures of these 
compounds are depicted in Fig. 3.1.
The following sections provide a brief resume of the background 
information pertinent to each of the antidepressants examined in the 
following studies. A review of the pharmacological actions of 
haloperidol and diazepam will not be provided here; for further 










Fig. 3.1 Chemical structures
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3.3.1 Clomipramine
During clinical investigation of a series of phenothiazine analogues 
for sedative or hypnotic properties, Kuhn (1958) observed that 
imipramine, a compound originally developed as an anti-histamine, 
was relatively ineffective in quieting psychotic patients but showed 
beneficial effects when administered to certain depressed patients. 
This observation led to the search for other chemically-related 
"tricyclic" compounds that also possessed antidepressant activity.
One of these compounds was the 3-chloro derivative of imipramine, 
called clomipramine. The metabolism of clomipramine resembles that 
of the parent compound imipramine. Thus the major metabolites are 
the mono-demethylated derivative (which, as for imipramine, is 
likely to participate in the therapeutic action of clomipramine) and 
several hydroxylated compounds (Bickel, 1980, and references cited 
therein) .
It is now widely accepted that one important mechanism of action of 
the tricyclic antidepressants is the ability to inhibit the 
high-affinity, energy requiring, re-uptake systems of NA and/or 
5-HT (Carlsson, 1970). In this respect clomipramine, and its 
des-methyl metabolite, are approximately equipotent on 5-HT and NA 
re-uptake with comparatively little or no significant effect on the 
re-uptake of DA (Sulser and Mobley, 1980).
In radio-ligand binding studies clomipramine exhibits marked affinity 
for histamine H-, and alpha^-NA receptors (see reviews by Green and 
Nutt, 1983; and Leysen, 1985).
Clomipramine, originally called chlorimipramine, was first used
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clinically in 1964 by Brandner (cited by Waxman, 1977) and since 
then it has become firmly established among the repertoire of 
antidepressants available to the clinician. The British National 
Formulary (BNF) recommends that initial treatment with clomipramine, 
presented as the hydrochloride salt, starts at 10 mg (by mouth) 
daily and the dose be increased gradually to the maintenance dose of 
30-150 mg or more in severe depression and phobic and obsessional 
states, although Paykel (1979b) suggests that the usual daily dose 
range is 75-200 mg.
Clomipramine was chosen for examination in these studies on the basis 
of its typical tricyclic antidepressant profile (see sections 1.4.3 
and 1.4.5, and references cited therein).
3.3.2 Fluoxetine
Fluoxetine is a new antidepressant which differs structually and 
pharmacologically from the tricyclic compounds. Fluoxetine has been 
reported to inhibit specifically the re-uptake of 5-HT into 
synaptosomes of rat brain (Wong et al., 1974) and in specific brain
regions in vivo (Wong et al., 1975), with comparatively little
effect on NA re-uptake in vitro (see also Harms, 1983; Iversen and 
Mackay, 1979, Waldmeier et al., 1976). Like other 5-HT re-uptake
inhibitors, fluoxetine reduces the level of 5HIAA without affecting 
the overall level of 5-HT (Perry and Fuller, 1974) and also reduces 
the firing rate of raphe neurons (Clemens et al., 1977), indicating 
that fluoxetine reduces 5-HT turnover, presumably through a negative 
feedback system. Unlike clomipramine or imipramine, N-demethylation 
of fluoxetine does not alter either its potency or selectivity to 
inhibit 5-HT re-uptake (Wong et al., 1975).
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In in vitro radio-ligand binding studies fluoxetine demonstrated low 
affinity for alpha- or beta-adrenoceptors, histamine H 1f muscarinic 
acetylcholine, 5-HT, opiate, GABA, benzodiazepine or DA receptors 
(Peroutka and Snyder, 1980; Wong et al., 1983). In one study
chronic treatment with fluoxetine, 10 mg Kg-1 i.p. daily, reduced 
the number of 5-HT., receptors in rat cerebral cortex (Wong et al . , 
1985), but this effect was not observed in the earlier study by 
Peroutka and Snyder (1980).
The down-regulation of beta-adrenoceptors and the subsensitivity of 
NA-stimulated adenylate cyclase induced by chronic treatment with 
tricyclic antidepressants have both been suggested as models of the 
time-dependent antidepressive response to antidepressants in humans 
(Banerjee et al., 1977; Vetulani et al., 1976a; Sulser et al.,
1978). Chronic treatment with fluoxetine, however, failed to 
down-regulate cortical beta-adrenoceptors (Wong et al., 1985) or to
reduce the sensitivity of NA-stimulated adenylate cyclase (Schmidt 
and Thornberry, 1977).
The selectivity of fluoxetine for inhibition of 5-HT re-uptake 
in vivo has recently been questioned. Fletcher et al. (1988) 
demonstrated that acute treatment with fluoxetine at doses within the 
range required for 5-HT re-uptake inhibition also reduced 
tetrabenazine-induced ptosis (indicative of catecholamine re-uptake 
inhibition) and potentiated and prolonged amphetamine-induced 
stereotypy (indicative of increased central dopaminergic activity). 
The involvement of central catecholamine systems, in addition to 
5-HT, in the mediation of the antidepressant effects of fluoxetine 
cannot therefore be discounted.
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In double-blind clinical trials fluoxetine, mean doses 55-60 mg 
day-1, demonstrated similar or better antidepressant efficacy than 
175-200 mg day-1 imipramine (Bremner, 1984) or 145-173 mg day-1 
amitriptyline (Feighner, 1985). Both reports indicated a lower 
incidence of side effects with fluoxetine than with either imipramine 
or amitriptyline which may reflect the 5-HT selectivity of 
fluoxetine. The review by Benfield et al. (1986) suggests a daily 
dose of 20 mg should be adequate for most patients with a maximum 
daily dose of 80 mg.
Fluoxetine was chosen for examination in these studies on the basis 
of its reported 5-HT specificity.
3.3.3 Iprindole
Iprindole is an example of those atypical antidepressants that have 
little in common with more conventional compounds. Iprindole appears 
to have no effect on 5-HT, NA or DA uptake either in vitro or in 
vivo, neither does it alter NA turnover when given chronically 
(Rosloff and Davis, 1974; Sulser and Mobley, 1980). Consequently 
iprindole does not possess the monoamine potentiating effects 
associated with the tricyclic antidepressants.
In in vitro radio-ligand binding studies iprindole demonstrates 
little or no affinity for alpha,-, alpha2- or beta-adrenoceptors, 
histamine H,, muscarinic acetylcholine, 5-HT or DA receptors (Green 
and Nutt, 1983; Peroutka and Snyder, 1980).
Chronic treatment with iprindole however, like desipramine, induces 
down-regulation of beta-adrenoceptors (Banerjee et al., 1977;
Peroutka and Snyder, 1980) and 5-HT2 receptors (Peroutka and Snyder,
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1980), and reduces the sensitivity of the NA-sensitive adenylate 
cyclase system (Vetulani et al., 1976a). Thus, while the chronic
effects of iprindole are in accord with those observed for the more 
conventional tricyclic antidepressants, an acute mode of action has 
yet to be elucidated.
Initial clinical trials indicated patients treated with iprindole, 
up to 90 mg daily (Hicks, 1965) and 30-80 mg daily (Daneman, 1967)
showed significant improvement compared to patients receiving
placebo. In a further study, Sterlin et al. (1968) reported 
iprindole, 45-120 mg daily, to be slightly faster acting, but 
somewhat less effective, compared to amitriptyline, 75-200 mg 
daily. Initial treatment with iprindole, presented as the
hydrochloride salt, starts at 15-30 mg (by mouth) 3 times daily and
the dose increased gradually as necessary to a maximum of 60 mg 3 
times daily, with the usual maintenance dose being 30 mg 3 times 
daily (BNF). Paykel (1979b) suggests that the usual daily dose range 
is 45-180 mg.
Iprindole was chosen for examination in these studies as an example 
of an atypical antidepressant with a novel mode of action.
3.3.4 Mianserin
The tetracyclic piperazine-azepine mianserin was originally developed 
during the early 1970’s in the search for potent antiserotonin and 
antihistamine compounds. Its potential use as an antidepressant was 
predicted on the basis that mianserin produced changes in the human 
electroencephalogram similar to those produced by tricyclic 
antidepressants (see reviews by Itil and Soldatos, 1980; I til,
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1983). A number of clinical trials have confirmed the predicted 
antidepressant potential of mianserin. For example, mianserin, 60
mg daily, was shown to be of similar antidepressant efficacy to 150
mg daily treatment with amitriptyline (Coppen et al., 1976; Vogel
et al., 1976; Jaskari et al . , 1977), clomipramine (Blaha et al.,
1980; De Buck, 1980; Pinder et al., 1980), imipramine {Murphy,
1975; Pichot et al., 1978; Pull et al., 1980) or maprotiline
(Khan and Moslehuddin, 1980). In these studies patients receiving 
mianserin complained of less side effects (especially those 
associated with anticholinergic activity) than those receiving 
amitriptyline, clomipramine or imipramine. It has also been claimed 
that mianserin possesses anxiolytic activity. In a study by Murphy
(1978) no significant differences in anxiolytic effect or in side 
effects were observed between mianserin, 30 mg daily, or diazepam. 
15 mg daily.
Initial treatment with mianserin, presented as the hydrochloride 
salt, starts at 30-M0 mg (by mouth) in divided doses and increased 
gradually as necessary to a maximum of 200 mg daily in divided doses, 
with the usual maintenance dose range of 30-90 mg (BNF). Paykel
(1979) suggests a slightly larger daily dose range of 20-120 mg.
In comparison to the tricyclic antidepressants, mianserin is only 
weakly or moderately active as an inhibitor of 5-HT or NA uptake in 
vitro respectively (Baumann and Maitre, 1977), and is essentially 
devoid of effect on rat brain 5-HT uptake and only weakly effective 
on NA uptake in vivo (Goodlet et al., 1977). Inhibition of
monoamine uptake would not therefore appear to account for the 
relatively high potency of mianserin as an antidepressant. In
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addition, mianserin, unlike conventional tricyclic antidepressants, 
tends to reduce the brain concentration, but increase the turnover, 
of NA. This effect appears to be due to pre-synaptic 
alpha2-antagonism (Baumann and Maitre, 1977). Such receptors are 
normally activ.ated by released NA to inhibit further transmitter 
release (Starke et al., 1975; Langer, 1977). Endberg and Svensson
(1980) demonstrated that systemic or microiontophoretic application 
of mianserin dose-dependently increased the firing rate of 
noradrenergic neurons in the nucleus locus coeruleus, and 
antagonized the inhibitory effects of the alpha2-agonist clonidine, 
given systemically, or microiontophoretically applied NA. Blockade 
of pre-synaptic alpha2-adrenoceptors reduces the efficiency of the 
physiological negative feedback system resulting in increased 
synaptic concentrations of the transmitter. Mianserin has also been 
shown to be a 5-HT antagonist in the periphery (Saxena et al., 1971)
and exhibits 5-HT1c and 5-HT-, antagonist properties at central 
serotonin receptors (Wong et al., 1983; Fozard, 1987). In
radio-ligand binding studies mianserin exhibits marked affinity for 
histamine H-, receptors, alpha.,- and alpha2-adrenoceptors and 5-HT2 
receptors (see reviews by Green and Nutt, 1983; and Leysen, 1985).
As seen with other antidepressants, chronic treatment of rats with 
mianserin leads to subsensitivity of the NA-stimulated adenylate 
cyclase system (Mishra et al., 1980).
Mianserin was chosen for examination in these studies as an example 
of an atypical antidepressant with an acute pharmacology that differs 
from that of the tricyclic antidepressants.
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3.3.5 Phenelzine
The hydrazine derivative phenelzine, although rapidly metabo1ised 
(Kline and Cooper, 1980) produces irreversible, non-specific 
inhibition of monoamine oxidase. Thus enzyme inhibition persists 
after disappearance of the MAOI and its metabolites from the body. 
Daily treatment with MAOI thus produces cumulative effects and 
enzymatic activity may only be restored by resynthesis of the enzyme. 
Indeed Robinson et al . (1979) demonstrated that chronic treatment of 
rats with phenelzine, 7.5 mg kg-1, resulted in maximal (i.e. at 
least 95%) inhibition of MAO activity after 7 days of treatment. In 
the same study brain tissue levels of 5-HT, NA and DA peaked within 
3-7 days of treatment and then progressively decreased towards 
control levels even though MAO activity was still maximally 
inhibited, indicating adaptation by neuro-biological mechanisms to 
primary changes in synaptic function returning the net effect of 
synaptic activity to the pretreatment state. In addition, 
tryptophan hydroxylase activity in the mesencephalic tegmentum was, 
paradoxically, increased by 21 days of treatment although no 
consistent effect on the amount or kinetic properties of striatal or 
hypothalamic tyrosine hydroxylase activity was observed.
Chronic treatment with MAOI's also decreased the sensitivity of the 
NA-dependent adenylate cyclase system (Vetulani et al., 1976a),
indicating similar chronic-treatment effects to those observed with 
other classes of antidepressants.
The clinical efficacy of MAOIs has been the target of some 
controversy. For example, the MRC trial of antidepressant 
treatments published in 1965 (cited by Green and Costain, 1981)
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indicated that phenelzine was less effective than placebo in treat*ng 
severe depressive illness. Even so. MAOI’s have been widely used 
both in the United Kingdom and United States of America for the 
treatment of depression since the early 1960s, although the FDA 
rates phenelzine as the only MAOI effective in the treatment of 
depression.
Initial treatment with phenelzine, presented as the sulphate salt, 
starts at 15 mg (by mouth) 3 times daily and increased if necessary 
to 4 times daily after 2 weeks. The dose is then reduced gradually 
to the lowest possible maintenance dose (BNF). Paykel (1979b) 
suggests that the usual daily dose range is H5-75 mg.
Phenelzine was chosen for examination in these studies as an example 
of the non-specific irreversible MAOI’s.
3.4 Doses
3.4.1 Social behaviour
All the doses of the compounds examined in these studies have been 
calculated on a molar basis to provide an accurate estimate of 
relative potency.
Clomipramine, 30 mg Kg-1 (equivalent to 95.3 umol Kg-1) sc., 
depresses body posture and reflexes in the Irwin-Profile of drug 
activity in mice (A. Johnson, personal communication). In addition, 
haloperidol and diazepam are demonstrably behaviourally-depressant in 
rodents at 0.11 mg Kg-1 sc (Brown et al., 1985), equivalent to 0.29
umol Kg-1, and 5 mg Kg_1sc (Delini-Stula and Vassout, 1979), 
equivalent to 17.5 umol Kg-1, respectively.
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Based on this information and the respective clinical potencies of 
the other antidepressant compounds, the effect of acute treatment 
with the following doses of each drug on rodent social behaviour and 









(mg Kg 1 base)
90 (3.14, 9.41 . 28.4 )
10 ( 0.34, 1 .02. 3.09)
9 ( 0.29. 0.86, 2.56)
3 ( 0.087. 0.26, 0.79)
9 ( 0.14, 0.41 , 1 .24)
1 ( 0.041, 0.12, 0.38)
30 ( 0.94, 2.85, 8.54)
3.4.2 Circadian locomotor activity
The daily dose of each test drug used in these studies (i.e. 
clomipramine, 20 mg Kg-1 base; fluoxetine, 2 and 6 mg Kg-1 pfb. 
and mianserin, 2 mg Kg-1 base) was based on previous data (Martin,
1982), on the relative potency on rodent social behaviour and, as 




The aim of this chapter is to provide a summary of the animals, 
drugs and materials used throughout these studies. A detailed 
description of the methods employed is provided in each of the 
relevant chapters.
H.1 Animals
Male Wistar rats (University of Bath stri&n) were used in all of the 
studies. All animals were housed either singly or in groups 
according to the requirements of the particular experiment with free 
access to standard laboratory chow (Labsure CRM diet) and, except 
where indicated in the methodology, tap water.
Extreme care was taken to ensure that animals within any particular 
group were obtained from the same weaning colony. In the social 
interaction studies, however, the resident and intruder animals 
were weaned on the same date but obtained from different weaning 
colonies. These precautions ensured that as far as possible all 
animals used in a particular series of experiments were both age- and 
weight-matched and, in the social interaction studies, that the 
intruder rats were unknown to the resident conspecifics.
H.2 Lighting conditions
Animals used in the social interaction or exploratory locomotor 
activity experiments were housed in standard rodent laboratory, solid 
based, perspex cages (320 x 500 x 165mm) in the experimental room 
under reverse-day1ight conditions (12h. on:12h. off; lights on 2000) 
for 5 weeks prior to the commencement of each experiment.
10H
The rank order and circadian locomotor activity experiments required 
strict control over the lighting conditions under which the animals 
were maintained. Animals used in these studies were therefore housed 
in the environmental cabinets described in section 4.3.
Up to H groups of animals were used in the rank order studies at any 
one time. Thus while these groups were all housed under a 12h:12h 
light/dark cycle, the time of onset of the dark phase for each group 
was staggered to enable monitoring of the social behaviour during the 
initial 30 min. of darkness for each group in turn.
At the start of each circadian locomotor activity study the animals 
were housed in environmental cabinets under normal-day1ight 
conditions (12h on:12h off; lights on 0700 or 0800). The circadian 
locomotor activity of the animals was then allowed to "free-run” 
under either complete darkness (single animals) or low intensity (2 
lux) red light (grouped animals) for at least 10 days prior to the 
onset of chronic drug administration, and until at least 10 days 
following the cessation of drug treatment.
4.3 Environmental cabinets
Two types of environmental cabinet were used in these studies. 
Firstly, those which housed standard rodent laboratory perspex cages 
to control the environmental conditions of animals housed either 
singly for the monitoring of circadian locomotor activity (grid-based 
cages) or in groups for the rank order studies (solid-based cages). 
Secondly, that which housed the locomotor activity monitor used to 
record both the circadian locomotor activity of grouped animals and 
the exploratory locomotor activity of individual rats.
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4.3.1 Circadian locomotor activity of individual rats and rank order 
studies
These environmental cabinets have been described by Hillier et al . 
(1973). They were constructed from 17mm blockboard and measured 610 
x 625 x 450mm (Fig 4.1). To maximize sound and light insulation the 
interior of the cabinet (including the door) was covered with 12mm 
polystyrene sheets and 10mm commercial draft-excluder taped around 
the door and walls. Internal lighting (range 720-800 lux) was 
achieved by a 12 inch 8W white-light flourescent tube (Osram) fitted 
to the ceiling of the cabinet with the choke (Thorn) placed 
externally on a metal heat-sink to prevent excessive heating of the 
interior. The internal light was connected to a time switch 
(Sangamo, Type 5254-1-171) to provide control of the internal 
lighting conditions. A 30mm-bore plastic tube connected the back of 
the cabinet to an extractor fan (Philips, Type HR 3408) to provide 
adequate ventilation of the cabinet and maintenance of the interior 
temperature at the same level with the experimental room, i.e. 23*2 
°C. Finally, a second plastic tube enabled a flexible water pipe to 
be connected from a reservoir placed above the cabinet to a water 
spout positioned in the food-hopper if required.
4.3.2 Circadian locomotor activity of grouped rats
A second environmental cabinet to house the activity monitor used to 
measure the circadian locomotor activity of grouped rats and the 
exploratory locomotor activity of individual rats, of dimensions 
1300 x 900 x 1400mm, was constructed from 17mm blockboard (Fig 4.2). 
Maximal sound and light insulation was obtained by lining the 
interior of the cabinet with 12mm polystyrene sheets and the door 




Flourescent Tube & \
Time Switch
Fig ur e  4. 1 D i a g r a m  showing the main features of the environmental 
cabinet used in the circadian locomotor acti v it y  of individual rats 
and rank order studies.
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Figure H.2 Dia g ra m  showing the main features of the environmental 
cabinet used in the circadian locomotor a ct i v i t y  of grouped rats and 
ex ploratory locomotor a ct ivity studies.
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achieved by a 12" 8W white-light flourescent tube (Osram) fitted to 
the rear wall of the cabinet with the choke (Thorn) placed externally 
on a metal heat-sink, to prevent excessive heating of the interior, 
and connected via a mains lead to a time switch (Smiths Industries, 
Type TS500) to provide control of the internal lighting conditions. 
Additional low intensity (6 lux) red lighting, to enable video 
recording of the animals behaviour during the dark phase of the 
light/dark cycle, was provided by two bayonet sockets, positioned 
on each side wall of the cabinet, fitted with 15W (GEC) red-light 
bulbs which remained on for the duration of each experiment. A 
30mm-bore plastic tube connected the back of the cabinet to an 
extractor fan (Philips, Type HR 3H08) and provided ventilation of 
the cabinet and maintenance of the interior temperature at the same 
level with the experimental room, i.e. 2312 °C. A 120 x 70mm hole 
cut into the roof of the cabinet allowed the video camera to be 
positioned above the activity monitor to enable recording of the 
animals behaviour when required. The video camera was enclosed in a 
wooden case, constructed from 17mm blockboard, and the frame lined 
with 10mm draft-excluder tape to provide light and sound insulation. 
Finally, a second plastic tube enabled a flexible water pipe to be 
connected from a reservoir placed above the cabinet to a water spout 
positioned in the wall of the activity monitor.
Recording apparatus 
*4.*1.1 Social behaviour
The social interaction and rank order experiments required recording 
of animal behaviour on to video tape, for analysis at a later date, 
via a video camera positioned immediately above the animals cage. 
Pilot recordings indicated that the normal wire cage-top, housing
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the food hopper and drinking bottle, obstructed the viewing area of
the camera. To overcome this problem the central section of the
cage-top (305 x 365mm) was removed so that just the food hopper and
the surrounding edge remained to grip the top edges of the cage. The
modified cage-top was sprayed with matt-black paint to reduce 
reflected light into the lens of the video camera. The arrangement 
of the apparatus required to record rodent social behaviour is 
depicted in Fig H.3.
H.H.1.1 Recording cabinet
To stop subject animals escaping by the modified cage top during 
recording of rodent social behaviour a cabinet was constructed from 
7mm ply-wood of internal dimensions 395 x 570 x 500mm. A 200mm high 
opening at the base of the front panel of the cabinet allowed normal 
rodent cages to be introduced into the cabinet at the start of each 
recording session. A removable sliding partition (395 x 313mm) was 
then positioned 175mm from the front panel to rest on the following 
edge of the food hopper.
4.^.1.2 Video camera and recorder
To enable recording of rodent social behaviour during the social 
interaction and rank order studies a low-light/infra red video camera 
(ITC Ikegami CTC-H500 Type G), working-range up to 6 lux) fitted 
with an auto-iris lens (Koike Auto-Eye Hexanon KS, 9mm F1.4) was 
positioned directly above the recording cabinet. A 15W red light was 
positioned near the video camera and provided low red illumination (H 
lux) of the recording area. The social behaviour was recorded on to 
VHS video tape by a JVC BR-6400TR video recorder and displayed on a 











Figure 4.3 D i ag r am  showing the arrangement of the appar a tu s  used to 
record rodent social behaviour (social interaction and rank order 
s t u d i e s ) .
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4.4.2 Circadian and exploratory locomotor activity
4.4.2.1 Practical considerations
Documented experiments employing infrared photocell units to monitor 
rodent locomotor activity have typically used 1 (e.g. Costall et al ., 
1982) to 3 (Francis et al., 1983) photocell units (i.e. photoemitter
and photodetector) positioned in the walls of an open-field chamber. 
Open-field monitors employing photocell units are perfectly adequate 
to capture the activity of isolated animals since even when the 
animal is at rest the monitor remains functional. When monitoring 
the overall activity of grouped animals, however, such monitors may 
be rendered ineffective if one or more of the animals rests along the 
path of one or more of the infrared beams. To overcome this problem 
a locomotor activity monitor was designed specifically to record the 
overall locomotor activity of grouped rats and is described in 
section 4.4.2.3.
4.4.2.2 Circadian locomotor activity of individual rats
The circadian locomotor activity of individual rats was measured in 
standard rodent laboratory grid-based perspex cages, 320 x 500 x 
165mm, adapted for this purpose (Fig 4.4). One pair of infrared 
photo cells (i.e. one emitter and one detector) were positioned in 
opposing side walls of the cage 40mm above the wire-grid floor and 
mid-way between the food hopper and the rear of the cage (i.e. 280mm 
from the front of the cage). The cage was positioned in the 
environmental cabinet described in section 3.3.1 and the leads from 
the photocell pair passed through the wall of the environmental 
cabinet to connect with the relevent interfaces (see section 
4.4.2.4). The cage was placed on wooden stilts above the 




F i gu r e H . 1! D i ag r am  showing the locomotor ac t iv i ty  monitor used to 
record the circadian locomotor activity of individual rats.
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disturbing the subject animals.
4.2.3 Circadian locomotor activity of grouped rats and exploratory 
locomotor activity of individual rats 
The circadian locomotor activity of grouped rats was recorded in an 
activity monitor (Fig 4.5), external dimensions 900 x 600 x 350mm, 
designed specifically to overcome the practical problems associated 
with the use of infrared photocells outlined above.
The walls of the monitor were constructed from 5mm black perspex and 
contained 7 photocell units. 3 photo-emitters and 3 photo-detectors 
were situated at 300mm intervals along the wall of the cage and 50mm 
above the wire-grid floor. The wire-grid floor was constructed from 
6 stainless steel grids (290 x 290mm) which were slotted into grooves 
cut along the length of clear perspex batons (10 x 10mm) to create a 
2 x 3  matrix. The side batons were then cemented to the side walls 
of the cage 50mm above the bottom edge. The cage lid was constructed 
from 5mm clear perspex with side strips to hold the lid tightly on 
the top of the cage. Integral to the lid were 2 square pillars, 120 
x 120 x 300mm constructed from 5mm black perspex, each containing 
the 3 relevant photo-units radiating to the photo-emitter or 
photo-detector positioned in the wall of the cage. The 7th photocell 
pair, positioned in the walls of the pillars 50mm above the grid 
floor, were directed between the two pillars. The cables to the 
photo-emitters and from the photo-detectors were wired to D-sockets 
(Radio Spares, 15-pin) situated in the wall of the environmental 
cabinet. The pillars and the photocell units were so positioned as 
to divide the floor into 6 equal areas. A close fitting sawdust 
tray, constructed from 5mm black perspex, was provided which could
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*4.5 Di a gr a m showing the locomotor acti v it y  monitor used to 
the circadian locomotor activity of grouped rats and the 
tory locomotor activity of individual rats.
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be removed to enable the sawdust to be changed, when required, 
without disturbing the subject animals. A food hopper, large enough 
to provide 3 animals with 7 days supply of laboratory chow (Labsure 
CRM diet), and drink dispenser, positioned in the wall of the cage, 
were provided to allow access to food and water/drug solution ad 
1ibitum. A tube from the drink dispenser was run through an air duct 
(50mm plastic tubing) in the wall of the environmental cabinet to 
allow daily measurement of fluid intake or change of drinking 
solution without disturbing the subject animals.
Although the primary objective in the design of this locomotor 
activity monitor was to overcome the practical problems outlined 
above, the monitor also provided a novel environment in which to 
monitor the exploratory locomotor activity of rats.
*+.*4.2.4 Infrared photocell units and computer hardware and software
The infrared photo-emitters (Scan-A-Matic; L33007) were powered by a
5 volt regulated power supply (Radio Spares switched-mode 70W). The 
state of each infrared photodetector (Scan-A-Matic; P33001) was
continuously monitored by a BBC microcomputer (Model B) via an 
interface network and software designed by R. Marshall, University 
of Wales College of Medicine, Cardiff (Marshall et al., 1985). Any
break in the infrared beam caused by an animal moving across the beam 
path was detected by the microcomputer, thus providing an index of 
locomotor activity. Accumulated counts of activity over a 
predetermined time period were stored on 5.25 inch floppy discs for 
analysis at a later date.
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In addition to the software provided by Marshall a number of programs 
were written to enable statistical analysis of circadian locomotor 
activity and are described in Appendix B.
*1.5 Preparation and implantation/removal of osmotic mini-pumps 
Chronic administration of drugs or drug-vehicle in the social 
interaction, exploratory locomotor activity and rank order 
experiments was achieved by subcutaneous implantation of osmotic 
mini-pumps (Alzet) designed to deliver a constant output of drug 
solution over 7 (Model 2001, exploratory locomotor activity studies) 
or 14 (Model 2002, social interaction and rank order studies) days. 
In reality the pumps deliver drug solutions continuously until the 
pump is exhausted; up to 10 or 18 days respectively. In the social 
interaction and rank order studies, drugs were administered for 14 
days and the behaviour of the animals examined at set time points 
following the cessation of drug treatment. For this reason the 
mini-pumps were removed 14 days after implantation.
Each mini-pump consists of a collapsible reservoir of flexible, 
impermeable material, surrounded by a sealed layer containing an 
osmotic agent; all of which is encapsulated by a semipermeable 
membrane. In an aqueous environment the osmotic agent imbibes water 
at a rate controlled by the semipermeable membrane. The hydrostatic 
pressure generated by the water gradually compresses the reservoir 
producing a constant flow of the contained drug solution through the 
delivery port. The 2001 and 2002 pumps deliver approximately 1 and 
0.5 ul hr-1 in vitro respectively. The in vivo flow rate, however, 
is typically between 5 and 15% lower than that calculated in vitro.
In all experiments, therefore, the in vivo flow rate used to 
determine the required drug concentration and the achieved doses
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quoted in the text was assumed to be 10% lower than the in vitro 
value quoted by the manufacturers. Since the delivery rate of the 
contained drug solution is constant the resulting dosage is 
determined by the concentration of the drug loaded into the pump.
Each mini-pump was prepared immediately prior to implantation. The 
concentration of drug loaded into each pump was calculated according 
to the assumed in vivo flow rate, the target dose to be administered 
over 24 hr. and the projected weight of the subject animal after 7 
days of drug treatment (i.e. the mid-point of chronic drug 
administration in the social interaction and rank order experiments).
Prior to surgical implantation or removal of the mini-pumps each 
animal was anaesthetised with fentanyl/fluanisone and midazolam (see 
section 4.6) under low intensity red light, the current lighting 
conditions for that group of animals. Once anaesthetised the animals 
were removed to the operating suite.
4.5.1 Implantation
After shaving and cleansing the surgical site with hibitane a small 
skin incision was made adjacent to the site chosen for pump placement 
(invariably along the mid-line of the back). A haemostat was 
inserted in one end of the wound to create a subcutaneous pocket for 
the pump. The pump was then inserted with the delivery portal away 
from the wound site, following which the site was dusted with 
cicatrin antibiotic powder and the wound sealed with wound clips 
(Mikron; 9mm Auto-clips).
4.5.2 Removal
The area of the skin near the portal end of the mini-pump was shaved
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and cleansed with hibitane. A small incision was made and the 
mini-pump removed through the wound. Following removal the placement 
site was inspected for tissue invagination, necrosis or infection. 
The wound was then dusted with cicatrin and sealed with wound clips. 
It should be noted at this point that no tissue damage resulting from 
implantation of the mini-pumps or chronic drug delivery by this 
method was observed.
After each operation the animals were replaced in their home cage, 
returned to the respective experimental room and placed on a heated 
bed to aid recovery from the anaesthesia.
4.6 Drugs and chemicals
Table 4.1 summarizes the drugs and chemicals used during these 
studies together with their source and, where applicable, the
vehicle in which they were prepared.
The choice of each drug-vehicle was made considering that in the 
social interaction, exploratory locomotor activity and rank order 
studies each compound was to be administered chronically via 
subcutaneously implanted osmotic mini-pumps which required 
comparatively high drug concentrations. Those compounds available as
the hydrochloride (i.e. clomipramine, iprindole and mianserin) or
sulphate (i.e. phenelzine) salts were adequately soluble in H20. 
Haloperidol and fluoxetine, available as the pure free base (pfb), 
were sufficiently soluble in 0.1M tartaric acid. Diazepam (pfb), 
which was found to be insoluble in H20 or 0.1M tartaric acid at the 
concentrations required for chronic administration via osmotic 
mini-pumps, was solubilized in 40% v/v propylene glycol,
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10% v/v ethanol, 1.5% v/v benzyl alcohol and made up to volume (i.e. 
48.5% v/v) with 5% w/v sodium benzoate in H20 according to the 
vehicle described by Turmel and De Montigny (1984). Where 
appropriate this vehicle (denoted diazepam-vehicle in the text) was 
employed as the control vehicle for the experiments examining the 
effects of diazepam upon social behaviour or exploratory locomotor 
activity.
All drug concentrations in the text are expressed in terms of the 
free base.
In the social interaction, exploratory locomotor activity and rank 
order studies all test drugs or vehicle were administered 
subcutaneously either acutely, dose volume 1 ml Kg-1, or 
chronically via osmotic mini-pumps as described above.
Prior to implantation or removal of the osmotic mini-pumps all rats 
were anaesthetised with fentanyl/fluanisone and midazolam prepared as 
follows; 4 ml of the commercially available fentanyl citrate, 0.315 
mg ml-1, and fluanisone (pfb), 10 mg ml-1, mixture (Hypnorm) was 
diluted with 8 ml of sterile H20, following which 4 ml of midazolam 
hydrochloride (Hypnovel), 5 mg ml-1 (base), was added. The final 
anaesthetic cocktail thus contained fentanyl citrate, 0.079 mg ml-1, 
fluanisone, 2.5 mg ml-1, and midazolam. 1.25 mg ml-1. The 
anaesthetic cocktail was administered intraperitoneally at a dose 
volume of 0.275 ml per 100g body weight. This dose was determined 
following strain-testing for induction of anaesthesia in the Bath 
University strain of Wistar rats and provided at least 30 min. of 
surgical anaesthesia.
In the circadian locomotor activity experiments all drugs used were 
presented to the animals in the drinking water. Clomipramine and 
mianserin were dissolved in "polished" H20 (see below for definition) 
while fluoxetine was initially dissolved in a minimal quantity of 
0.1M tartaric acid and then made up to volume with "polished" Hz0.
Polished H20 was obtained from the Milli-0 Reagent water system 
(Mi 11ipore Corp.)
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Propylene glycol (pfs) 







Table H.1 Drugs and chemicals
* Gifts from source which are gratefully acknowledged
a) Social interaction, exploratory locomotor activity and rank order 
studies
b) Circadian locomotor activity studies
122
CHAPTER 5 SOCIAL INTERACTION STUDIES IN THE RAT
CHAPTER 5 SOCIAL INTERACTION STUDIES IN THE RAT
5.1 Introduction
Grant and Mackintosh (1963) described the elements of social 
behaviour in the laboratory rat, mouse, hamster and guinea-pig, in 
terms of postures and acts, most of which were common to all four 
species. Grant (1963) demonstrated that the consecutive behavioural 
elements of the rat do not occur at random and may therefore have 
related but not identical functions. Such actions were shown to fall 
into behavioural pathways indicating an inherent progression from one 
behaviour to the next. Fig. 5.1 summarizes the individual 
behavioural postures and how they may be grouped into behavioural 
pathways according to the motivational category in which they occur. 
Silverman (1965) demonstrated that the ethological approach of Grant 
and Mackintosh could be employed to study the effect of drugs on 
rodent social behaviour. Such an approach to the study of drug 
activity on rodent behaviour is attractive since it does not resort 
to the modification of behaviours induced by a second drug. Thus the 
effects of a drug per se. on rodent behaviour may be studied.
5.1.1 Behavioural postures of rodent social behaviour
The following list describes the rodent social behavioural postures 
modified from Grant and Mackintosh (1963) grouped according to the 
respective motivational categories as employed by Silverman (1965). 
The majority of definitions of the behavioural postures used in these 
studies are as described by Silverman, however for practical reasons 
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Figure 5.1 S implified schematic representation of the p a thways of 
social behaviour of the rat.
Individual be h aviours or postures are grouped a cc o rding to 
motivational category. Closed arrows indicate the normal p r o gr e ss i on  
of behaviours. Open arrows indicate displacement activity.









Broadside stance with the ventral surface 
rotated to the conspecific but with the head 
orientated away from the other rat 
On hindlegs facing the conspecific (as 
Offensive Upright) but the head is orientated 
away from the conspecific 






Flag and Evade 
Retreat
Under food hopper 
6 MAINTENANCE
Orientation directed towards the other rat, 
often with Crouch
On all four paws with shoulders lowered, 
sometimes with one forepaw raised. The hind 
legs may be extended
As Crouch but on hind legs with forepaws on 
the wall of the cage. May be envisaged as 
Crouch with Rear
Head and forebody turned away from the 
conspecific, sometimes followed by rapid 
movement away (Retreat)
Rapid movement away from the conspecific 
usually to a place of safety 













Lick's own body fur
Invariably follows Attempt Mount or Mount 
Scratch own body fur usually with hind limbs 
Wriggles body
Wipe face with licked forepaws
The recording environment used in these studies consisted of an open 
topped cage, to enable unrestricted viewing of the experimental 
area, surrounded by a ply-wood enclosure (see section 4.4.1 for a 
complete description). This allowed the animals to explore not only 
the cage floor but also around the lip of the cage wall. In 
addition, full rearing behaviour could be displayed from both the
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cage floor and the cage wall. Animals could also display a 
Crouch-like posture while standing against the cage wall. The term 
"Crouch" in these studies was therefore taken to include Silverman’s 
definition of both Crouch and Elevated Crouch (where the legs are 
extended), whereas the term "Elevated Crouch" was employed to 
describe the static defensive posture against the side of the cage. 
Lastly, those postures defined as ’residual’ by Silverman were not 
recorded since they were observed very infrequently, if at all, and 
when they were observed they appeared to occur more by chance than 





The purpose of these studies was to observe the social behaviour of 
rats in a test situation that optimised the level of physical contact 
between the subjects. The housing conditions, familiarity of the 
partner and lighting levels have all been shown to affect social 
interaction (File and Pope, 1974). Rats housed singly demonstrate 
higher levels of both active and passive contact with partner animals 
than those housed in pairs. Unfamiliar partners increased the level 
of active, but not passive, contact as compared to when the partner 
was familiar. Latane (1969) suggests that rats require physical 
contact and that requirement is increased when rats are housed in 
isolation. Increasing the level of illumination of the test box 
results in a decrease in the time spent in social interaction (File 
and Hyde, 1978). In addition Latane (1969) reported low levels of 
aggression when two rats were placed in an open field which File and
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Pope (1974) suggest is due to the lack of territorial advantage 
between the animals. Only when one rat intrudes on the other's 
territory does social interaction include measureable levels of 
aggressive encounters.
File and Pope (1974) suggest that the effect of a centrally acting 
compound on social behaviour may be affected by the social rank of 
the treated animal. Housing the rats in groups of 3 to 6 animals per 
group allows a stable rank order to be established (Grant and Chance, 
1958). Silverman (1965) argues that the presence of a stable rank 
order is useful, and this is seen to be especially so where 
repeat-testing occurs, since only then are the various rank 
positions spread equally throughout all treatment groups.
Considering these observations and the need to provide an 
experimental environment to optimise the level of social interaction, 
all experiments were designed under the following conditions:
1 All animals were housed in closed social groups prior to and 
during each experiment in order to allow a stable social structure 
to develop and be maintained during the experimental period.
2 Test animals (i.e. resident) were isolated before each 
experimental day, while intruder animals were housed in social 
groups.
3 In each social interaction test the animals were unfamiliar to 
each other.
4 All experiments were carried out under low illumination.
5 All experiments were carried out in familiar conditions (i.e. in 
laboratory cages).
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6 All experiments were performed during the dark phase of the 
light-dark cycle when rats are normally most active.
The ontogeny of rodent behaviour is dependent on social interaction 
experienced prior to and following weaning (Bolles and Woods, 1964; 
Einon et al., 1978), thus animals within any resident or intruder
group were obtained from the same group of weaners. In order to 
maintain constancy of social experience each experiment commenced at 
the same time point following weaning.
All social interaction studies were carried out with the resident 
animals’ home cage positioned inside the recording cabinet described 
in sect ion 4.4.1
Preliminary observations (data not shown) indicated that isolated 
animals resident in their home cage for 3 days prior to observation 
acclimatized to the recording cabinet within 20 minutes foil/owing 
positioning of the home cage in the cabinet. During the first 10 
minutes resident animals showed periods of exploration (locomotion 
and rearing) interspersed with progressively longer periods of 
grooming and rest under the food hopper. By 30 minutes following 
introduction resident animals were invariably quiescent. Conversely, 
animals previously housed in groups exhibited high levels of activity 
for at least 20 minutes following introduction to a new cage 
positioned in the recording cabinet. Such activity consisted of 
almost continuous exploratory behaviour interspersed with short 
periods of grooming behaviour, which in this situation may be 
indicative of displacement activity implying motivational conflict 
(Bastock et al . , 1953; Silverman, 1965).
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Considering these observations social interaction experiments were 
designed as described below.
Initially a study of intruder-alone behaviours was performed in order 
to quantify the baseline behaviour of intruder animals without 
interference from the resident animal (see section 5.2.2.1).
The series of acute drug studies were designed to identify minimum 
effective doses on the resident animals' behavioural profile in the 
social interaction test (section 5.2.2.2). These doses were then 
administered on a daily basis, via osmotic mini-pumps (see sections
3.1 and 4.5) to study the effect of chronic treatment on the 
behavioural profile resident rats (section 5.2.2.3).
In order to study the progression of any behavioural change induced 
by chronic drug treatment a repeat-testing regime was employed in the 
chronic studies. To maintain consistency between chronic and acute 
drug studies a similar repeat-testing regime was used in all acute 
drug studies. It should be borne in mind that previous experience of 
social behaviour may condition subsequent behaviour in an agonistic 
situation (Taylor, 1979; Bolhuis et al., 1984), however, since
drug studies employed animals maintained in closed social groups the 
effects of conditioning would be spread equally thoughout each 
treatment group.




Two groups of 8 rats per group (designated "resident" and "intruder" 
respectively) (age-matched male Wister, Bath University stock, 
100-150g when removed from the colony), obtained from different 
parental groups to ensure that resident animals had never been in 
contact with the animals in the intruder group, were maintained 
under reverse-day1ight conditions (12h. on/12h. off, lights on 
2000h) for at least 5 weeks before the start of the experimental 
period with standard laboratory chow (Labsure CRM diet) and water 
available ad libitum. Each group of 8 rats were further subdivided 
into 2 groups of H animals at least three weeks prior to the 
experiment.
5.2.2 Basic Methodology
With one exception (see section 5.2.2.3) each group of animals in the 
social interaction studies was tested on *1 occasions only with all 
social interaction experiments performed on a strict weekly cycle. 
During each week before testing all animals were handled individually 
on at least 3 occasions in order to habituate each animal to the 
experimenter. The resident rats were separated 3 days before each 
test day and housed individually with food and water available ad 
1ibitum.
In order to enable identification all resident animals were 
head-marked immediately prior to each experiment. At the start of 
each social interaction test the resident animal in its home cage 
was positioned inside the recording cabinet for 30 minutes prior to 
introduction of the relevant intruder animal to allow adequate 
acclimatization of the resident rat to the recording cabinet. At the
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end of the acclimatization period the intruder rat was introduced 
into the resident animals home cage and the resulting social 
interaction recorded on video tape for the following 10 minute period 
(see section 5.2.2.3).
At the end of each recording all animals were returned to their 
respective group cages in order to maintain the social structure of 
each group.
5.2.2.1 Analysis Of Intruder-Alone Behaviours
Immediately prior to introduction of the intruder animal to the 
resident animals' cage the resident rat was removed and returned to 
its social group. The intruder animals behaviour was then recorded 
on to video tape for the following 10 minute period. Each intruder 
animal was monitored on one occasion only.
5.2.2.2 Effect of acute drug treatment of the resident rat
Resident animals were dosed subcutaneously (sc) with drug or vehicle 
(dose volume of 1ml Kg-1) and returned to their individual home cage. 
All drugs and doses used in the acute studies were chosen according 
to their known clinical use and pharmacological effects (see Table
5.1 and sections 3.3 and 3.4), and were administered on a mol Kg-1 
body weight basis in order to obtain an accurate indication of 
potency.
All acute drug studies were performed according to the experimental 
matrix indicated in Table 5.2, with two groups of resident rats 
being tested concurrently. The experimental matrix ensured that each 
animal received the drug vehicle and 3 doses of drug, and came into
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contact with each of the corresponding intruder animals. Likewise 
each intruder animal came into contact with each drug treatment.
Such a balanced dosing schedule also ensured the effect of rank 
position in both the resident and intruder groups was spread equally 
throughout all dosing groups.
5.2.2.3 Effect of chronic drug or drug-vehicle treatment of the 
resident rat
In these experiments resident animals were tested on the first 
occasion without any drug treatment, following which Alzet 
mini-osmotic pumps containing drug or vehicle were implanted sc under 
fentanyl/fluanisone/midazolam aneasthesia (see sections 4.5 and 4.6) 
and then returned to their group cage. Social interaction tests were 
carried out after 7 and 14 days of drug treatment and 7 days 
following removal of the mini-pumps. The mini-pumps were removed 
under fentanyl/fluanisone/midazolam anaesthesia immediately following 
the social interaction test on day 14 of drug treatment. Control 
experiments, where the mini-osmotic pumps contained the respective 
drug-vehicle, were designed as follows: experiments to study the
effect of chronic administration of clomipramine, iprindole, 
mianserin or phenelzine were controlled by using pumps containing 
polished H20; experiments studying the effect of chronic 
administration of fluoxetine or haloperidol were controlled by using 
pumps containing 0.1M tartar^ic acid; while the effect of chronic 
administration of diazepam was controlled by using pumps containing 
diazepam-vehicle as described in section 4.6.
All chronic drug studies were carried-out according to the 
experimental matrix indicated in Table 5.3, with two groups of
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resident rats being tested concurrently. As in the acute studies the 
experimental matrix ensured that each resident animal came into 
contact with each of the corresponding intruder animals.
The data obtained at 7 days following the cessation of chronic 
phenelzine treatment (see section 5.5.3.5) indicated that the 
behavioural profile of the resident rats had not returned to that 
observed prior to drug treatment. A further social interaction study 
was therefore performed at 14 days post-phenelzine treatment where 
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Table 5.1 Summary of drugs studied in the social interaction test
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Resident Animal No. 
1 2  3 4
Week 1 Treatment A B D
Intruder No. 1 2 3
Week 2 Treatment C D B
Intruder No. 2 1 4
Week 3 Treatment B A C
Intruder No. 3 4 1
Week 4 Treatment D C A
Intruder No. 4 3 2
Table 5.2 Acute Experimental Matrix
Resident Animal No 
2 3
Week 1 Pretreatment 
Intruder No.
Week 2 7 days treatment
Intruder No.
Week 3 14 days treatment
Intruder No.
Week 4 7 days post-treatment
Intruder No. 4
Table 5.3 Chronic Experimental Matrix
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5.3 Identification and capture of rodent social behaviour
5.3.1 Video analysis
The observation and recording of the various elements of rodent 
social activity indicated in section 5.1.1 are necessarily both 
intense and time consuming. The various elements may change very 
quickly since the behaviour of each animal is stimulated by, and in 
part dependent on, the behaviour exhibited by the conspecific. It 
is important to analyse the behaviour of both animals since 
drug-induced changes in the resident animals' behavioural profile 
produces concomitant changes in the behavioural profile of the 
conspecific intruder (Silverman, 1965). Recording each social 
interaction epoch on to video tape allows for analysis at a later 
date, and for the recording to be replayed in order to analyse the 
behaviour of each animal in turn. Thus an infrared video camera was 
positioned immediately above the recording cabinet and the recording 
area illuminated in low red light by means of a 15W red bulb 
suspended above the camera. The level of illumination was measured 
at 4 lux, which was sufficient for the camera to obtain adequate 
recordings of rodent social behaviour without interfering with the 
reverse-day1ight cycle in which the experimental rats were maintained 
(see also section 4.4.1).
5.3.2 Capture of behavioural data
To ease the handling of data arising from these studies a computer 
programme was developed for use with the BBC microcomputer (see 
Appendix A for details).
The programme, entitled Capture of Rodent Interaction Behaviours 
(C.R.I.B.), allows each of the behavioural postures of firstly the
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resident and then the intruder animal to be identified and recorded 
as they are observed on the recording, together with the latency of 
each behaviour.
The resulting data was then stored on disk for automated collation 
and statistical analysis at a later date.
5.4 Statistical Analysis
5.4.1 Comparison of behavioural profiles exhibited by resident and 
intruder rats during social interaction
The data for each motivational category were summed and the resulting 
behavioural profifes compared by X2 analysis.
5.4.2 Effect of acute or chronic drug treatment on the behavioural 
profile exhibited by resident and non-drugged intruder rats 
during social interaction
The data for each social interaction were collated and the number of 
behaviours within each motivational category expressed as a 
percentage of the respective total number of behaviours observed.
The mean and standard error of the mean (sem) for the percentage 
values of each motivational category within each treatment group were 
calculated. Data for each motivational category were expressed as 
the percentage of total behaviours observed since variation in the 
total number of behaviours may occur without any change in the 
proportion of each motivational category.
A number of different statistical methods have been applied to social 
interaction data including X2 analysis, t-test and the Mann-Whitney 
U-test (Silverman, 1978). Data arising from these studies were not
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subjected to parametric statistical analysis because of the sampling 
technique employed to obtain the data. In these experiments any 
significant differences between treatments were determined by use of 
the non-parametric Mann-Whitney U-test, although it should be noted 
that the use of X2 analysis would be equally relevent.
Where applicable the dose of a particular drug to reduce a behaviour 
by 50% (i.e. IDSo) was calculated by use of the least-squares method 
Where such values are quoted in the text the 95% fiducial limits are 
also indicated in parenthesis.
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5.5. Results
5.5.1 Preliminary behavioural studies
5.5.1.1 Behavioural profiles of resident and intruder rats exhibited 
during social interaction
Fig. 5.2 summarizes the control behavioural profile of both resident 
and intruder animals, where the resident animal was treated with 
H20, 1ml Kg-1 sc., 30 mins prior to introduction of the intruder 
animal. Xs analysis indicates the behavioural profiles of the 
resident and intruder to be highly significantly different (X2=5886, 
df=5, p<0.001).
5.5.1.1.1 Resident animals
The majority of the resident animals behaviours observed during the 
monitoring period were orientated towards investigation of the 
intruder animal (52.712.1% of total behaviours) or it's environment 
(19.511.1%). Investigation of the intruder occasionally led to 
aggressive acts against that animal (17.412.1%), while the 
remainder of the motivational categories occurred with low intensities 
(flight-escape, 4.510.3%; maintenance, 3.510.4%; f1ight-submit, 
2.510.4%).
5.5.1.1.2 Intruder animals
Intruder animals predominantly exhibited flight behaviour (42%) in 
response to its investigation by the resident animal. Flight 
behaviour may be subdivided depending whether the interaction of the 
animals results in their spatial seperation (i.e. flight-escape, 
30.511.0%) or remaining in close contact, whereupon the intruder 
animal succumbs to the resident animals activity (i.e. f1ight-submit, 

























Exploration Investigation Aggression Submit Maintenance
Figure 5.2 Behavioural profile of resident and intruder rats during 
social interaction.
V alues indicate mean (Isem) percentage of total 
behaviours for each motivational category, where N=H 
experiments (8 animals per experiment).
Open columns; resident rats. Hatched columns; intruder 
r a t s .
X2 = 5 8 8 6 , df =5, p<0.001
Total number of behaviours: Resident rats, 2993^372;
Intruder rats, 2608T329
m o
activity towards the new environment (32.621.7%), together with 
lower levels of investigatory behaviour directed at the resident 
animal (13.321.3%). Intruder animals demonstrated only low levels 
of maintenance behaviour (6.320.*!%) and aggressive behaviour 
(5.220.8%) directed at the resident rat.
5.5.1.2 Intruder-alone behaviours
Fig. 5.3 summarizes the behavioural profile exhibited by 7 intruder 
rats when placed into the home cage from which the resident animal 
had been removed.
Intruder animals in the absence of the resident animal exhibited 
predominantly exploratory behaviours, (87.722.2%; rearing and 
locomotor activity, 57.222.8% and 30.521.6% respectively) with 
isolated, low-intensity periods of grooming and consummatory (i.e. 
maintenance) behaviours (9.320.7% and 2.920.4% respectively).
5.5.2 Effect of acute drug treatment on the social interaction 
behavioural profiles of resident and non-drugged intruder rats
5.5.2.1 Clomipramine
The behavioural profiles exhibited by resident rats following 30 
minutes subcutaneous pre-treatment with H20, 1ml Kg-1 or 
clomipramine, 10-90 umol Kg_1and by non-drugged intruder rats, and 
the total number of behaviours observed for each group are summarized 
in Fig. 5.4 and Table 5.4 respectively.
5.5.2.1.1 Resident animals
Clomipramine, 10-90 umol Kg-1 sc., induced a dose-related reduction 









































Figure 5.3 Intruder-alone behaviours.
C o lumns indicate mean (*sem) percentage of total number 
of b eh a viours for each motivational category.
N=7 animals
Total number of behaviours; 237T14
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directed towards the conspecific intruder, concomitant with 
dose-related increases in both f1ight-submit and flight-escape 
behaviours. Clomipramine, 90, but not 10 or 30, umol Kg-1, 
significantly increased the level of environmental exploration. 
Clomipramine, 10-90 umol Kg-1, had no effect on the level of 
investigatory behaviour directed at the intruder rat nor on the level 
of maintenance behaviour.
Only clomipramine, 90 umol Kg-1, significantly reduced the total 
number of behaviours exhibited by the resident rat.
5.5.2.1.2 Intruder animals
The levels of both f1ight-submit and flight-escape behaviours 
exhibited by intruder rats progressively decreased, while that of 
exploratory behaviour progressively increased, with increasing doses 
of clomipramine, 10-90 umol Kg-1, administered to the resident rat. 
In addition, the level of investigatory behaviour directed at the 
resident rat increased (although not significantly) following 
treatment of the resident rat with clomipramine, 30 and 90 umol 
Kg-1. The levels of aggressive and maintenance behaviours and the 
total number of behaviours exhibited by intruder rats showed no 
consistent change in response to the clomipramine-induced change in 
the behavioural profile of resident rats.
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Figure 5.^ Effect of acute treatment with clomipramine on the
behavioural profile exhibited by resident and non-treated intruder
rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (H20. 1 ml Kg-1 sc).
10, 30, 90, indicate clomipramine doses (umol Kg-1 sc).
Pre-treatment time=30 min.
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H20 10 30 90
Resident *43*4221 *417216 376230 3*402 26a
Intruder 3*48229 365233 37822*4 360226
Table 5.*4 Effect of acute clomipramine on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.
MWUT : a, p<0.05 compared to respective vehicle treatment.
1*45
5.5.2.2 Fluoxetine
The behavioural profiles exhibited by resident rats following 30 
minutes subcutaneous pre-treatment with 0.1M tartaric acid, 1ml 
Kg-1, or fluoxetine, 1.1-10 umol Kg-1, and by non-drugged intruder 
rats, and the total number of behaviours observed for each group are 
summarized in Fig. 5.5 and Table 5.5 respectively.
5.5.2.2.1 Resident animals
Fluoxetine, 1.1 and 3.3 umol Kg-1 sc, induced a dose-related 
reduction in the level of aggression (ID50 = 3 umol Kg-1 
approximately) directed towards the conspecific intruder concomitant 
with a dose-related increase in the level of flight-escape behaviour. 
Fluoxetine, 10 umol Kg-1 sc also significantly reduced the level of 
aggressive behaviour and significantly increased the level of 
flight-escape behaviour, but only to those levels observed following 
fluoxetine, 3.3 umol Kg-1 sc. Fluoxetine, 1.1-10 umol Kg-1 sc, 
induced a dose-related increase in the level of flight-submit 
behaviour which was only significant following treatment with the 
highest dose tested. Fluoxetine, 10, but not 1.1 or 3.3 umol Kg-1 
sc, significantly reduced the level of investigation directed at the 
conspecific intruder. No significant effect of fluoxetine treatment 
was observed on environmental exploratory behaviour, maintenance 
behaviour nor the total number of behaviours observed at any of the 
doses tested.
5.5.2.2.2 Intruder animals
No consistent or significant change was observed in the behavioural 
profile nor in the total number of behaviours exhibited by 
non-drugged intruder rats during social interaction with resident
1H6
Figure 5.5 Effect of acute treatment with fluoxetine on the
behavioural profile exhibited by resident and non-treated intruder
rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (0.1M tartaric acid, 1 ml Kg-1 sc).
1.1, 3.3, 10, indicate fluoxetine doses (umol Kg-1 sc).
Pre-treatment time=30 min.
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rats following treatment of the latter with fluoxetine, 1.1-10 umol 
Kg-1 sc.
Fluoxetine
umol Kg-1 sc .
Tartrate 1 . 1 3.3 10
Resident 491247 574233 538225 594231
Intruder 446233 475226 483232 459232
Table 5.5 Effect of acute fluoxetine on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.




The behavioural profiles exhibited by resident rats following 30 
minutes subcutaneous pre-treatment with H20, 1ml Kg-1, or 
iprindole, 1-9 umol Kg-1, and by non-drugged intruder rats, and 
the total number of behaviours observed for each group are summarized 
in Fig. 5.6 and Table 5.6 respectively.
5.5.2.3.1 Resident animals
Iprindole, 1-9 umol Kg-1 sc, induced a dose-related reduction in the 
level of aggression (lDso = 3.82 (2.50,6.25) umol Kg-1) directed at 
the conspecific intruder concomitant with a dose-related increase in 
the level of flight-escape behaviour. At these doses iprindole also 
appeared to increase the level of fIight-submit behaviour in a 
dose-related manner but no significant effect was observed at any of 
the doses tested. Iprindole treatment had little or no effect on the 
levels of environmental exploration, investigation of the 
conspecific intruder, maintenance behaviours nor the total number of 
behaviours exhibited during social interaction.
5.5.2.3.2 Intruder animals
Only the level of flight-submit behaviour exhibited by intruder rats 
was progressively reduced during social interaction with resident 
rats treated with iprindole, 1-9 umol Kg-1 sc., although no 
significant differences from control levels were observed. No 
significant change in any of the other motivational categories was 
observed for intruder rats during social interaction with resident 
rats treated with iprindole. 1-9 umol Kg-1 sc.
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Figure 5.6 Effect of acute treatment with iprindole on the
behavioural profile exhibited by resident and non-treated intruder
rats during social interaction.
Open columns. resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (H20, 1 ml Kg-1 sc).
1, 3, 9, indicate iprindole doses (umol Kg-1 sc).
Pre-treatment time=30 min.
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The total number of behaviours exhibited by intruder rats were only 
significantly reduced during social interaction with resident rats 
treated with iprindole, 9 umol Kg-1 sc.
Iprindole 
umol Kg-1 sc.
H20 1 3 9
Resident 66H231 657:35 697273 686275
Intruder H99229 48922H HH2239 381239a
Table 5.6 Effect of acute iprindole on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.
MWUT : a, p<0.05 compared to respective vehicle treatment.
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5.5.2.1! Mianserin
The behavioural profiles exhibited by resident rats following 30 
minutes subcutaneous pre-treatment with H20, 1ml Kg-1, or 
mianserin, 0.33-3 umol Kg-1, and by non-drugged intruder rats, and 
the total number of behaviours observed for each group are summarized 
in Fig. 5.7 and Table 5.7 respectively.
5.5.2.H.1 Resident animals
Mianserin, 0.33-3 umol Kg'1 sc., induced a dose-related decrease in 
the level of aggressive behaviour (lDso = 1.19 (0.16,17.4) umol Kg-1) 
directed at the conspecific intruder concomitant with a dose-related 
increase in the level of flight-escape behaviour. At the same doses 
mianserin induced slight increases in the level of flight-submit 
behaviour although none reached significance nor appeared to be 
related to dose. Mianserin had no significant effect on 
environmental exploration, investigation of the conspecific 
intruder, maintenance behaviour nor the total number of behaviours 
observed during social interaction.
5.5.2.4.2 Intruder animals
Intruder rats exhibited no significant change in the level of any of 
the motivational categories during social interaction with resident 
rats treated with mianserin at any of the doses tested, even though 
flight-submit behaviour was slightly lower during social interaction 
with resident rats treated with mianserin, 1 and 3 umol Kg-1 sc.
The total number of behaviours exhibited by intruder rats were 
significantly lower during social interaction with resident rats
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Figure 5.7 Effect of acute treatment with mianserin on the
behavioural profile exhibited by resident and non-treated intruder
rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (H20, 1 ml Kg-1 sc).
.33, 1, 3, indicate mianserin doses (umol Kg-1 sc).
Pre-treatment time=30 min.
MWUT : * p<0.05, ** p<0.01 compared to respective vehicle treatment.
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treated with mianserin, 1 umol Kg-1 sc., but not during social 
interaction with resident rats treated with mianserin, 0.33 or 3 
umol Kg-1 sc.
Mianserin
umo1 Kg 1 sc.
H20 0.33 1 3
Resident 487*22 516234 487212 520227
Intruder 507218 498222 449218a 498248
Table 5.7 Effect of acute mianserin on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.
MWUT : a, p<0.05 compared to respective vehicle treatment.
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5.5.2.5 Phenelzine
The behavioural profiles exhibited by resident rats following 30 
minutes subcutaneous pre-treatment with H20, 1ml Kg-1, or 
phenelzine, 1-9 umol Kg-1, and by non-drugged intruder rats, and 
the total number of behaviours observed for each group are summarized 
in Fig. 5.8 and Table 5.8 respectively.
5.5.2.5.1 Resident animals
Phenelzine, 1-9 umol Kg-1 sc., induced a dose-related decrease in 
the level of aggression (lDso = 5.69 (1.41,221.5) umol Kg-1) directed 
at the conspecific intruder concomitant with increases in both 
flight-escape and f1ight-submit behaviours (which appeared to be 
dose-related) although the latter failed to show any significant 
differences from the control level following treatment with any of 
the doses of phenelzine tested. Investigation of the conspecific 
intruder was slightly, albeit significantly, reduced following 
treatment with phenelzine, 3 umol Kg-1 sc., but not 1 or 9 umol 
Kg-1 sc. Phenelzine treatment, at any of the doses tested, failed 
to change the levels of the other motivational categories during 
social interaction or the total number of behaviours observed.
5.5.2.5.2 Intruder animals
Flight-escape behaviour exhibited by intruder rats was only 
significantly reduced during social interaction with resident rats 
treated with phenelzine, 3 umol Kg-1 sc. Flight-submit behaviour 
was slightly reduced during social interaction with resident rats 
treated with phenelzine, 1-9 umol Kg-1 sc., and the reduction in 
this behaviour appeared to be related to the dose administered to the 
resident rats, however none of the observed levels of this
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Figure 5.8 Effect of acute treatment with phenelzine on the
behavioural profile exhibited by resident and non-treated intruder
rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (H20, 1 ml Kg-1 sc).
1, 3, 9, indicate phenelzine doses (umol Kg-1 sc).
Pre-treatment time=30 min.

































motivational category were significantly different from control. 
Intruder rats showed little or no change in the level of 
environmental exploration, investigation of the conspecific 
resident, maintenance behaviour or the total number of behaviours 
observed during social interaction with resident rats treated with 
phenelzine at any of the doses tested.
Phenelzine 
umol Kg-1 sc.
H20 1 3 9
Resident 675259 680248 645264 717244
Intruder 492234 476221 482235 480225
Table 5.8 Effect of acute phenelzine on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.




The behavioural profiles exhibited by resident rats following 60 
minutes subcutaneous pre-treatment with 0.1M tartaric acid, 1ml 
Kg-1, or haloperidol, 0.11-1 umol Kg-1, and by non-drugged 
intruder rats, and the total number of behaviours observed for each 
group are summarized in Fig. 5.9 and Table 5.9 respectively.
5.5.2.6.1 Resident animals
Haloperidol, 0.11-1 umol Kg-1 sc., induced a dose-related reduction 
in both aggressive behaviour (IDso = 0.19 (0.09,0.33) umol Kg-1) 
directed at the conspecific intruder and the level of f1ight-submit 
behaviour (ID50 = 0.17 (0.003,0.75) umol Kg“1). Haloperidol, 0.33 
and 1 umol Kg-1 sc., induced a significant increase in both 
flight-escape and maintenance behaviours, although only the former 
appeared to be related to dose. Haloperidol, 0.11-1 umol Kg-1 sc., 
had little or no consistent or significant effect on either the level 
of environmental exploration or investigation of the conspecific 
intruder, however those same doses of haloperidol significantly and 
dose-relatedly reduced the total number of behaviours (IDso = 0.18 
(0.09,0.29) umol Kg-1) observed during social interaction.
5.5.2.6.2 Intruder animals
The behavioural profile of non-drugged intruder rats was observed to 
change quite markedly in response to the haloperidol-induced changes 
in the behavioural profile of resident rats. Thus aggressive, 
flight-escape and f1ight-submit behaviours were all observed to be 
markedly reduced, while conversely the levels of environmental 
exploration and maintenance behaviours were both markedly increased, 
during social interaction with resident rats treated with
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Figure 5.9 Effect of acute treatment with haloperidol on the 
behavioural profile exhibited by resident and non-treated intruder 
rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (0.1M tartaric acid, 1 ml Kg-1 sc).
.11, .33, 1, indicate haloperidol doses (umol Kg-1 sc).
Pre-treatment time=60 min.
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haloperidol, 0.11-1 umol Kg-1 sc.; effects which in all cases 
appeared to be related to the dose of haloperidol received by the 
resident rats. No variation was observed in the level of 
investigation of the conspecific resident exhibited by intruder rats 
regardless of the treatments received by the resident rats. The 
total number of behaviours exhibited by intruder rats was only 
significantly reduced during social interaction with resident rats 
treated with haloperidol, 1 umol Kg-1 sc.
Haloperidol 
umol Kg-1 sc. 
Tartrate 0.11 0.33 1
Resident 697247 466255b 214233c 126t23c
Intruder 489226 485236 408237 349224c
Table 5.9 Effect of acute haloperidol on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.




The behavioural profiles exhibited by resident rats following 30 
minutes subcutaneous pre-treatment with diazepam, 3.3-30 umol Kg-1, 
or vehicle, 1ml Kg-1 (see section H.6 for description), and by 
non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.10 and Table 5.10 
respectively.
5.5.2.7.1 Resident animals
Diazepam, 3.3-30 umol Kg-1 sc., induced a dose related increase in 
flight-escape and, possibly, f1ight-submit behaviours, although 
the latter were not significantly different from control. The same 
doses of diazepam decreased exploratory behaviour (lDso = 10 umol 
Kg-1 approximately) and increased maintenance behaviour, although 
the effects seen following 30 umol Kg-1 sc. showed little or no 
difference from those observed following 10 umol Kg-1 sc. Diazepam, 
10 and 30 umol Kg-1 sc., induced a dose-related reduction in the 
levels of both investigation (IDso = 92.8 (33.7,2133) umol Kg-1) and, 
more markedly, aggression (lDso - 8.73 (6.03,12.3) umol Kg-1) 
directed towards the conspecific intruder. Diazepam, 3.3-30 umol 
Kg-1 sc., induced a dose-related reduction in the total number of 
behaviours (ID50 = 7.26 (5.05,9.96) umol Kg-1) observed during social 
interaction.
5.5.2.7.2 Intruder animals
Intruder rats exhibited increased exploratory activity and decreased 
flight-escape and f1ight-submit behaviours during social interaction 
which appeared to be broadly related to the dose of diazepam 
administered to the resident rats. No significant change in the
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Figure 5.10 Effect of acute treatment with diazepam on the 
behavioural profile exhibited by resident and non-treated intruder 
rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
V, drug-vehicle (1 ml Kg"'1 sc), see section H.6 for description. 
3.3, 10, 30, indicate diazepam doses (umol Kg-1 sc).
Pre-treatment time=30 min.
MWUT : * p<0.05, ** p<0.01, *** p<0.001 compared to respective
vehicle treatment.
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level of investigation or aggressive behaviour directed at the 
conspecific resident rats, or in the level of maintenance behaviour 
exhibited by non-drugged intruder rats, was observed during social 
interaction regardless of the dose of diazepam administered to 
resident rats. The total number of behaviours exhibited by intruder 
rats were significantly reduced during social interaction with 
resident rats treated with diazepam, 10 and 30 umol Kg-1 sc. in a 
manner related to the dose of diazepam administered to the resident 
rats.
Diazepam 
umol Kg-1 sc. 
Vehicle 3.3 10 30
Resident 680239 517230a 199238c 145227c
Intruder 493223 532232 394224a 346220c
Table 5.10 Effect of acute diazepam on the total number of 
behaviours exhibited by resident and non-treated intruder rats during 
social interaction.
Values indicate mean and sem for 8 animals per group.
MWUT : a, p<0.05; c, p<0.001 compared to respective vehicle 
treatment.
163
Table 5.11 summarizes the minimum-effective doses of the compounds 
examined on the behavioural profile of resident rats together with 
the reason for its choice. Each of the identified doses was then 
administered daily to resident rats to examine the effect of chronic 
drug administration on the behavioural profile exhibited by resident 
rats during social interaction. These results, together with the 
effects of chronic administration of the relevant drug-vehicles, are 















Reduced aggressive behaviour, f1ight-submit
behaviour and total number of behaviours 
exhibited
Reduced exploration and total number of 
behaviours exhibited; increased 
flight-escape behaviour
Table 5.11 Minimum-effective doses on rodent social behaviour
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5.5.3 Effect of chronic (1*4 day) drug or vehicle treatment on the 
social interaction behaviour of resident and non-drugged 
intruder rats
5.5.3.1 H20
The behavioural profiles exhibited by resident rats treated 
chronically with H20, and non-drugged intruder rats, and the total 
number of behaviours observed for each group are summarized in Fig. 
5.11 and Table 5.12 respectively. This group was used to control 
those experiments involving chronic treatment with clomipramine, 
iprindole, mianserin and phenelzine.
5.5.3.1.1 Resident animals
Chronic treatment with H20 had no effect on the levels of 
environmental exploration, maintenance behaviour, investigation or 
aggression directed at the conspecific intruder. Flight-submit 
behaviour showed a slight, non-significant, increase from 3.710.8% 
at pre-treatment to 6.811.5% and 5.511.2% at days 7 and 1H of H20 
treatment respectively, while flight-escape behaviour was slightly, 
but significantly, increased from 7.111.6% at pre-treatment to 
13.211.7% and 10.911.3% at days 7 and 1H of H20 treatment 
respectively, p<0.05 in both cases. Following the cessation of H20 
treatment no significant change in the levels of exploratory, 
investigatory, aggressive or maintenance behaviours were observed 
although a further increase in f1ight-submit behaviour (to 8.811.9%, 
p<0.05 compared to pre-treatment level) was observed. Flight-escape 
behaviour at 7 days post-treatment was still significantly elevated 
compared to pre-treatment levels. The total number of behaviours 
exhibited by resident rats during social interaction was not 
significantly different from pre-treatment levels either during
165
treatment or at 7 days post-treatment
5 .5 .3.1.2 Intruder animals
Untreated intruder rats demonstrated no var ia b il i ty  in the observed 
levels of aggression directed at the treated resident rats, 
f 1ight-submit or flight-escape behaviours either during treatment or 
at 7 days following the cessation of treatment of resident rats with 
H 20. During the course of the experiment, intruder rats showed 
reduced environmental exploration and main te n an c e behaviour, and 
increased investigation of the treated resident rats together with a 
slight, but non-significant, increase in the total number of 
behaviours exhibited during social interaction; these changes, 
however, do not appear to be related to the period of H 20 treatment 
of the resident rats.
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Figure 5.11 Effect of chronic treatment with H20 on the behavioural 
profile exhibited by resident and non-treated intruder rats during 
social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 uL day-1 in vivo 
0 Pre-treatment
D7 7 days treatment
D14 : 14 days treatment
7 7 days post-treatment
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Treatment days 
Group 0 D7 DIM 7
Resident 483:33 532:36 539:36 537:36
Intruder 457:27 521:33 517:25 521:21
Table 5.12 The total number of behaviours exhibited by resident 
treated chronically with subcutaneous HzO, and non-treated intruder 
rats during social interaction.
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 uL day-1 in vivo 
0 : Pre-treatment
D7 : 7 days treatment
D14 : 14 days treatment
7 : 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with clomipramine, target dose 10 umol Kg-1 day-1 sc., 
and non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.12 and Table 5.13 
respectively.
5.5.3.2.1 Resident animals
Resident rats treated chronically with clomipramine, target dose 10 
umol Kg-1 day-1 sc., showed no change in the levels of investigation 
of the conspecific or flight-escape behaviour at 7 days of drug 
treatment. At both 7 and 1*4 days of clomipramine treatment, 
however, resident rats demonstrated a marked increase in the level 
of aggression directed at the conspecific intruder, from 12.211.7% 
at pre-treatment to 20.123.1% (p<0.05) and 23.021.7% (p<0.01) at 
days 7 and 14 of clomipramine treatment respectively, concomitant 
with a slight increase in f1ight-submit behaviour from 2.220.8% at 
pre-treatment to 3.920.6% (p<0.05) and 4.221.1% (not significant) 
at days 7 and 14 of treatment respectively, and significant 
decreases in both environmental exploration and maintenance behaviour 
at 14 days of treatment; from 23.423.0% and 3.820.6% at 
pre-treatment to 13.321.0% and 2.220.5% respectively (p<0.05 in 
both cases). Seven days after the end of clomipramine treatment the 
levels of aggression directed at the conspecific intruder and 
maintenance behaviour had both returned to the relative pre-treatment 
levels concomitant with a marked and significant increase in 
flight-escape behaviour (from 7.321.1% at pre-treatment and 
7.521.1% at day 14 of treatment to 14.921.8% at 7 days 
post-treatment, p<0.01 and p<0.001 respectively), and a further
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slight increase in f1ight-submit behaviour. Resident rats exhibited 
an increase in the total number of behaviours during social 
interaction at 7 (not significant) and 14 days of clomipramine 
treatment; this increase, although not significant, was still 
observed at 7 days following the cessation of drug treatment.
5.5.3.2.2 Intruder animals
During the period of clomipramine treatment of the resident rats, 
non-treated intruder animals showed a significant increase in the 
level of flight-submit behaviour (from 8.3*1.7% at pre-treatment to 
14.7^2.1% and 14.44*1.5% after 7 and 14 days of treatment 
respectively, p<0.05 in both cases), which partly returned to the 
cont*bl level (10.712.0%, not significant from pre-treatment level) 
at 7 days after treatment of the resident rats, but not in the level 
of flight-escape behaviour. In addition, intruder rats showed 
reduced maintenance behaviour during the period of drug treatment of 
the resident rats, but no change in the level of investigatory 
behaviour directed at the conspecific resident rats. 7 days after 
clomipramine treatment of the resident rats, however, the intruder 
rats showed a significant elevation in the level of investigation 
directed at the resident rats; from 15.211.5% at pre-treatment to 
24.6*3.7% (p<0.05). Throughout the period of the experiment 
intruder rats exhibited a progressive decrease in the level of 
environmental exploration in addition to increases in the total 
number of behaviours observed.
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Figure 5.12 Effect of chronic treatment with clomipramine, target 
dose 10 umol Kg-1 day-1, on the behavioural profile exhibited by 
resident and non-treated intruder rats during social interaction. 
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 : Pre-treatment Clomipramine dose; 10.8210.05 umol Kg“
D7 ; 7 days treatment Clomipramine dose; 10.2610.11 umol Kg-
D14 : 14 days treatment Clomipramine dose; 9.64*0.14 umol Kg-
7 : 7 days post-treatment
MWUT : * p<0.05, ** p<0.01, *** p<0.001 compared to pre-treatment
(day 0) except where indicated.
Exploration Maintenance
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Treatment days 
Group 0 D7 D14 7
Resident 402:34 473:29 504:26a 489:38
Intruder 418:29 483:26 511:38a 506:29
Table 5.13 The total number of behaviours exhibited by resident rats 
treated chronically with clomipramine, target dose 10 umol Kg-1 
day-1 sc., and non-treated intruder rats during social interaction. 
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 : Pre-treatment Clomipramine dose; 10.82:0.05 umol Kg-1
D7 : 7 days treatment Clomipramine dose; 10.26:0.11 umol Kg-1
D14 : 14 days treatment Clomipramine dose; 9.64:0.14 umol Kg-1
7 : 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with iprindole, target dose 3 umol Kg-1 day-1 sc., and 
non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.13 and Table 5.14 
respectively.
5.5.3.3.1 Resident animals
Resident rats treated chronically with iprindole, target dose 3 umol 
Kg-1 day-1 sc., exhibited a marked increase in the level of 
aggression directed at the conspecific intruder from 7.020.9% at 
pre-treatment to 16.820.8% (p<0.001) and 16.221.6% (p<0.01) at 7 
and 14 days of drug treatment respectively. Although no significant 
change was observed in any of the other motivational categories 
monitored, the data suggest slight reductions in both maintenance 
behaviour and investigation of the conspecific intruder, together 
with a slight, non-significant, increase in f1ight-submit 
behaviour. By 7 days following the cessation of drug treatment the 
level of aggression had returned to the pre-treatment level 
concomitant with significant increases in both f1ight-submit and 
flight-escape behaviours; from 1.620.4% and 12.621.4% at day 14 of 
drug treatment to 3.320.5% and 17.621.4% respectively, p<0.05 in 
both cases. Resident rats showed an increase, albeit not 
significant, in the total number of behaviours exhibited during 




During the period of iprindole treatment of the resident rats, 
non-treated intruder rats demonstrated a marked elevation in the 
level of f1ight-submit (from 3.820.6% at pre-treatment to 9.222.4%, 
p<0.05, and 9.521.8%, p<0.01, at days 7 and 14 of treatment
respectively), but not flight-escape, behaviour, concomitant with 
a slight reduction in both environmental exploration (which was 
significant at day 14 of drug treatment of the resident rats) and 
possibly, although not significantly, maintenance behaviour. No 
significant change was observed in the levels of either investigatory 
or aggressive behaviours exhibited by intruder rats during the period 
of iprindole treatment of the resident rats. 7 days after drug 
treatment of the resident rats, the intruder rats still exhibited 
elevated f1ight-submit behaviour and reduced environmental 
exploration, together with a significant elevation in aggressive 
behaviour (from 1.820.6% at pre-treatment to 4.621.0%, p<0.05)
directed at the resident rats. Intruder rats demonstrated a slight, 
progressive, but not significant decrease in investigation of the 
conspecific resident rats throughout the duration of the experiment. 
The total number of behaviours exhibited by intruder rats showed no 
variation throughout the duration of the experiment.
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Figure 5.13 Effect of chronic treatment with iprindole, target dose 
3 umol Kg-1 day-1 sc., on the behavioural profile exhibited by 
resident and non-treated intruder rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 10.368 uL day-1 in vivo
0 : Pre-treatment Iprindole dose; 3.29510.010 umol Kg-1
D7 : 7 days treatment Iprindole dose; 2.99410.019 umol Kg-1
D14 : 14 days treatment Iprindole dose; 2.76710.003 umol Kg-1
7 : 7 days post-treatment
MWUT ; * p<0.05, ** p<0 01, *** p<0.001 compared to pre-treatment










































Group 0 D7 D14 7
Resident 502249 516236 628256 591267
Intruder 437259 457247 483235 473234
Table 5.14 The total number of behaviours exhibited by resident rats 
treated chronically with iprindole, target dose 3 umol Kg-1 day-1 
sc., and non-treated intruder rats during social interaction.
Values indicate mean and sem for 8 animals per group.
Pump rate; 10.368 uL day-1 in vivo
0 ; Pre-treatment Iprindole dose; 3.29520.010 umol Kg-1
D7 : 7 days treatment Iprindole dose; 2.99420.019 umol Kg-1
D14 14 days treatment Iprindole dose; 2.76720.003 umol Kg-1
7 ; 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with mianserin, target dose 0.33 umol Kg-1 day-1 sc., 
and non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.14 and Table 5.15 
respectively.
5.5.3.4.1 Resident animals
Resident rats treated chronically with mianserin, target dose 0.33 
umol Kg-1 day-1 sc., demonstrated a progressive and significant 
increase in aggressive behaviour directed at the conspecific intruder 
from 8.710.7% at pre-treatment to 16.411.0% and 21.611.5%, 
p<0.001 in both cases, at 7 and 14 days of drug treatment 
respectively, concomitant with progressive, significant decreases 
in both f1ight-submit and flight-escape behaviour, from 4.811.5% 
and 11.810.6% at pre-treatment to 1.510.6% (p<0.05) and 5.110.9% 
(p<0.001) by day 14 of treatment, respectively, and possibly, 
although not significantly, in maintenance behaviour. 7 days after 
drug treatment the levels of aggression directed at the conspecific 
intruder, flight-escape and maintenance behaviours had fully 
returned to their pre-treatment levels, while the mianserin-induced 
reduction in f1ight-submit behaviour only partly, although 
significantly compared to the level observed at day 14 of drug 
treatment, returned to the pre-treatment level. No significant 
change was observed in the levels of environmental exploration or 
investigation of the conspecific intruder either at 7 or 14 days of 
mianserin treatment or indeed at 7 days after drug treatment. The 
total number of behaviours exhibited by resident rats showed no 
variation either during the period of mianserin treatment or at 7
days post-treatment.
5.5.3.4.2 Intruder animals
During the period of mianserin treatment of the resident rats, 
non-treated intruder rats exhibited a progressive increase in 
f1ight-submit behaviour and a slight increase in flight-escape 
behaviour, from 7,320.9% and 28.321.1% at pre-treatment to 
13.521.6% (p<0.01) and 35.322.0% (p<0.05) by day 14 of treatment 
respectively, concomitant with slight (although not significant) 
decreases in both maintenance behaviour and aggression directed at 
the conspecific resident rats. By 7 days following the cessation of 
drug treatment of the resident rats, the elevated level of 
f1ight-submit, and the slight reductions in both maintenance and 
aggressive behaviours, but not flight-escape behaviour, exhibited 
by intruder rats had returned either fully or partly to their 
respective pre-treatment levels. Throughout the duration of the 
experiment intruder rats demonstrated a progressive and significant 
decrease in environmental exploration concomitant with a progressive, 
albeit slight, increase in investigation of the conspecific resident 
rats. The total number of behaviours exhibited by intruder rats 
during social interaction were only slightly, but not significantly, 
reduced at both 14 days of mianserin treatment of the resident rats 
and at 7 days post-treatment.
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Figure 5.14 Effect of chronic treatment with mianserin, target dose 
0.33 umol Kg-1 day-1 sc., on the behavioural profile exhibited by
resident and non-treated intruder rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 ; Pre-treatment Mianserin dose; 0.36110.0012 umol Kg-1
D7 : 7 days treatment Mianserin dose; 0.32710.0018 umol Kg-1
D14 14 days treatment Mianserin dose; 0.30420.0034 umol Kg-1
7 : 7 days post-treatment
MWUT : * p<0.05, ** p<0.01, *** p<0.001 compared to pre-treatment
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Group 0 D7 D14 7
Resident 509:37 509:40 500:34 500:28
Intruder 490:15 473:38 431:31 436:30
Table 5.15 The total number of behaviours exhibited by resident rats 
treated chronically with mianserin, target dose 0.33 umol Kg-1 day-1 
sc., and non-treated intruder rats during social interaction.
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 : Pre-treatment Mianserin dose; 0.361:0.0012 umol Kg-1
D7 : 7 days treatment Mianserin dose; 0.327:0.0018 umol Kg-1
D14 : 14 days treatment Mianserin dose; 0.304:0.0034 umol Kg-1
7 : 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with phenelzine, target dose 1 umol Kg-1 day-1 sc., and 
non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.15 and Table 5.16 
respectively.
5.5.3.5.1 Resident animals
Resident rats treated chronically with phenelzine, target dose 1 
umol Kg-1 day-1 sc., exhibited a marked increase in the level of 
aggression directed at the conspecific intruder, from 7.521.0% at 
pre-treatment to 15.611.6% and 17.321.8% (p<0.01 in both cases) at 
7 and 14 days of drug treatment respectively, concomitant with a 
decrease in both maintenance and flight-escape behaviours, from 
8.420.6% and 17.621.4% at pre-treatment to 5.120.7% (p<0.01) and 
13.121.1% (p<0.05) at day 14 of treatment respectively. By 7 days 
post-treatment resident rats still exhibited a significant elevation 
in aggressive behaviour (12.021.3%; p>0.05 compared to the level
observed prior to phenelzine treatment) although this was 
significantly lower than the level observed at 14 days of phenelzine 
treatment. Indeed the levels of aggressive and flight-escape 
behaviours exhibited by resident rats were not observed to return 
fully to their respective pre-treatment levels until 14 days after 
phenelzine treatment. At this time post-phenelzine treatment the 
level of maintenance behaviour was still slightly, although not 
significantly, reduced compared to the level observed prior to drug 
treatment. No significant change in the levels of environmental 
exploration, investigation of the conspecific intruder or 
f1ight-submit behaviour was observed either during or following
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phenelzine treatment, although the data may suggest a slight 
elevation of f1ight-submit behaviour at day 14 after phenelzine 
treatment. The total number of behaviours exhibited by resident rats 
during social interaction were markedly raised both during and 
following chronic phenelzine treatment.
5.5.3.5.2 Intruder animals
During the period of phenelzine treatment of resident rats, 
non-treated intruder rats demonstrated increased levels in both 
flight-submit and flight escape behaviour, from 4.110.8% and 
28.611.8% at pre-treatment to 9.611.4% (p<0.05) and 39.412.7% (not 
significant) respectively, at day 14 of treatment, concomitant with 
reduced levels of environmental exploration, from 40.712.7% at 
pre-treatment to 24.311.6% (p<0.01) at day 14 of treatment. At 7 
days post-treatment of the resident rats, intruder rats still 
demonstrated elevated levels of both flight-submit and flight-escape 
behaviours and reduced levels of environmental exploration; indeed 
only the former showed any degree of reversal toward pre-treatment 
levels by 14 days after phenelzine treatment of the resident rats.
No significant change was observed in the levels of investigation or 
aggression directed at the conspecific resident rats, maintenance 
behaviour or the total number of behaviours exhibited by intruder 
rats during social interaction either during or following the period 
of drug treatment of the resident rats.
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Figure 5.15 Effect of chronic treatment with phenelzine, target 
dose 1 umol Kg-1 day-1 sc., on the behavioural profile exhibited by 
resident and non-treated intruder rats during social interaction. 
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.72 uL day-1 in vivo 
0 : Pre-treatment Phenelzine dose;
D7 : 7 days treatment Phenelzine dose;
D14 : 14 days treatment Phenelzine dose;
7 : 7 days post-treatment
14 : 14 days post-treatment
MWUT ; * p<0.05, ** p<0.01 compared to pre-treatment (day 0) except
where indicated.
1.09820.006 umo1 Kg 1 
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Treatment days 
Group 0 D7 D14 7 14
Resident 532:52 628:33 681:35a 777:47b 729*39a 
Intruder 444:38 538:19 499:19 449:38 457*29
Table 5.16 The total number of behaviours exhibited by resident rats 
treated chronically with phenelzine, target dose 1 umol Kg-1 day-1 
sc., and non-treated intruder rats during social interaction.
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.72 uL day 1 in vivo
0 : Pre-treatment Phenelzine dose; 1.098:0.006 umol Kg-1
D7 : 7 days treatment Phenelzine dose; 1.004:0.009 umol Kg-1
D14 14 days treatment Phenelzine dose; 0.909:0.010 umol Kg-1
7 : 7 days post-treatment
14 ; 14 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with 0.1M tartaric acid, and non-drugged intruder rats, 
and the total number of behaviours observed for each group are 
summarized in Fig. 5.16 and Table 5.17 respectively. This experiment 
was designed as the control for chronic administration of fluoxetine 
and haloperidol.
5.5.3.6.1 Resident animals
Chronic treatment with 0.1M tartaric acid had no significant effect 
on the levels of environmental exploration or maintenance behaviour 
either during treatment or at 7 days post-treatment. Although 
investigation of the conspecific intruder was reduced from 54.411.0% 
at pre-treatment to 44.811.3% (p<0.001) by day 7 of treatment, no 
significant change from the pre-treatment level was observed at 14 
days treatment or at 7 days post-treatment. Both f1ight-submit and 
flight-escape behaviours were increased from pre-treatment levels of 
1.7t0.3% and 12.521.5% to 5.720.8% and 21.821.4% (p<0.01 in both 
cases) respectively, at day 7 of treatment,
however flight-submit, but not flight-escape, behaviour returned to 
the pre-treatment level by day 14 of treatment. By day 7 
post-treatment both f1ight-submit and flight-escape behaviours were 
slightly, but not significantly, increased compared to their 
respective pre-treatment levels. Aggressive behaviour directed at 
the conspecific intruder progressively, although not significantly, 
decreased thoughout the duration of the experiment and would 
therefore not appear to be related to the duration of chronic 
treatment with tartaric acid. The total number of behaviours 
exhibited by resident rats during social interaction were not
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significantly different from pre-treatment either during tartaric 
acid treatment or at 7 days post-treatment.
5.5.3.6.2 Intruder animals
By 7 days of chronic treatment of the resident rats with tartaric 
acid, non-treated intruder rats demonstrated reduced environmental 
exploration from MO.813.6% at pre-treatment to 28.1*3.3% (p<0.05), 
which was maintained thoughout the duration of the experiment, and 
possibly maintenance behaviour (although not significantly) 
concomitant with significant increases in both investigation and 
aggression, from 13.3*2.1% and 2.610.9% at day 0 to 22.212.1% 
(p<0.05) and 9.621.1% (p<0.01) respectively, directed at the 
conspecific resident rats. By day 1H of the experiment however, the 
levels of investigation and aggression had returned, albeit partly 
in the case of investigation. to those levels observed at day 0. No 
significant change was observed in the level of flight-escape 
behaviour exhibited by intruder rats either during the period of 
tartaric acid treatment of resident rats or indeed at 7 days 
post-treatment, however f1ight-submit behaviour progressively 
(although not significantly) increased throughout the duration of the 
experiment.
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Figure 5.16 Effect of chronic treatment with 0.1M tartaric acid on 
the behavioural profile exhibited by resident and non-treated 
intruder rats during social interaction.
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 (n=4) and 10.584 (n=4) uL day-1 in vivo 
0 : Pre-treatment
D7 : 7 days treatment
D14 : 14 days treatment
7 : 7 days post-treatment
MWUT : * p<0.05, ** p<0.01, *** p<0.001 compared to pre-treatment
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Treatment days 
0 D7 D14 7
Resident 542247 652254 575267 552271
Intruder 485223 488234 440229 455253
Table 5.17 The total number of behaviours exhibited by resident rats 
treated chronically with 0.1M tartaric acid and non-treated intruder 
rats during social interaction.
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 (n=4) and 10.584 (n=4) uL day-1 in vivo 
0 : Pre-treatment
D7 : 7 days treatment
D14 : 14 days treatment
7 : 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with fluoxetine, target dose 1.1 umol Kg-1 day-1 sc., 
and non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.17 and Table 5.18 
respectively.
5.5.3.7.1 Resident animals
Resident rats treated chronically with fluoxetine, target dose 1.1 
umol Kg-1 day-1 sc., demonstrated a marked increase in the level of 
aggression directed at the conspecific intruder from 8.9*0.7% at 
pre-treatment to 20.211.3% and 19.521.9% (p<0.001 in both cases) at 
days 7 and 14 of fluoxetine treatment respectively, concomitant with 
slight, but not significant, decreases in environmental exploration 
and maintenance behaviour (day 7 of treatment only), investigation 
of the conspecific intruder (day 14 of treatment only), and 
flight-escape behaviour (days 7 and 14 of treatment). By 7 days 
following drug treatment the levels of environmental exploration, 
maintenance behaviour, aggression and flight-escape behaviour had 
returned to their respective pre-treatment levels, while the level 
of investigation was still slightly, but not significantly, 
reduced, and that of f 1 ight-submit behaviour was slightly, but not 
significantly, increased. Resident animals exhibited an increase, 
although not significant, in the total number of behaviours observed 
at both 7 and 14 days of treatment which returned to the 




Non-treated intruder rats demonstrated little or no significant 
change in the levels of maintenance behaviour, investigation or 
aggression directed at the conspecific resident rats, flight-escape 
behaviour or the total number of behaviours observed during social 
interaction either during the period of fluoxetine treatment of the 
resident rats, or indeed at 7 days post-treatment, compared to 
their respective levels at day 0. Intruder rats exhibited increased 
f 1ight-submit behaviour by day 7 of the experiment, although not 
significantly different from the level at day 0, which progressively 
returned towards the level observed at day 0 throughout the remainder 
of the experiment. In addition, intruder rats exhibited reduced 
environmental exploration from 34.625.6% at day 0 to 27.522.5% and 
25.92 3.2% (not significant in both cases) by days 7 and 14 
respectively, which was further reduced to 19.622.6% (p<0.05, 
compared to the level observed at day 0) by day 7 after fluoxetine 
treatment of the resident rats.
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Figure 5.17 Effect of chronic treatment with fluoxetine, target 
dose 1.1 umol Kg-1 day-1 sc., on the behavioural profile exhibited 
by resident and non-treated intruder rats during social interaction. 
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 (n=H) and 10.58H (n=H) uL day-1 in vivo 
0 : Pre-treatment Fluoxetine dose; 1.205*0.006 umol Kg-1
D7 : 7 days treatment Fluoxetine dose; 1.08510.010 umol Kg-1
D14 1H days treatment Fluoxetine dose; 0.995t0.022 umol Kg-1
7 : 7 days post-treatment
MWUT : * p<0.05, ** p<0.01, *** p<0.001 compared to pre-treatment 
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Treatment days 
0 D7 D14 7
Resident 485248 614241 576254 497236
Intruder 437233 460222 450240 399252
Table 5.18 The total number of behaviours exhibited by residenl 
treated chronically with fluoxetine, target dose 1.1 umol Kg-1 
sc., and non-treated intruder rats during social interaction. 
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 (n=4) and 10.584 (n=4) uL day-1 in vivo 
0 : Pre-treatment Fluoxetine dose; 1.20520.006 umol
D7 : 7 days treatment Fluoxetine dose; 1.08520.010 umol
D14 : 14 days treatment Fluoxetine dose; 0.99520.022 umol
7 : 7 days post-treatment









The behavioural profiles exhibited by resident rats treated 
chronically with haloperidol, target dose 0.11 umol Kg-1 day-1 sc., 
and non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig.5.18 and Table 5.19 
respectively.
5.5.3.8.1 Resident animals
Resident rats treated chronically with haloperidol, target dose 0.11 
umol Kg-1 day-1 sc., showed little or no change by day 7 of 
treatment in the levels of environmental exploration, maintenance 
behaviour, investigation of the conspecific intruder, 
f1ight-submit, flight escape behaviours or in the total number of 
behaviours observed during social interaction. By 14 days of drug 
treatment environmental exploration was significantly increased from 
13.8t2.1% at pre-treatment to 20.812.0% (p<0.05). Resident rats 
demonstrated a progressive reduction in the level of aggression 
directed at the conspecific intruder rats from 8.510.8% at 
pre-treatment to 6.8I0.7% (not significant) and 5.610.5% (p<0.05) 
by days 7 and 14 of haloperidol treatment respectively. By 7 days 
after drug treatment the level of aggression had returned to the 
level observed prior to drug treatment, while environmental 
exploration was further increased to 26.5t5.1% (p<0.05 compared to 
pre-treatment level) concomitant with a significant decrease in 
f1ight-submit behaviour from 3.8*0.6% at 14 days of treatment to 
1.2t0.5% (p<0.01). Compared to the values observed prior to 
haloperidol treatment the data suggest a slight, albeit not 
significant, reduction in both investigation of the conspecific 
intruder and flight-escape behaviour together with a slight increase
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in maintenance behaviour. The total number of behaviours exhibited 
by resident rats were only significantly reduced at 7 days 
post-treatment compared to that observed prior to haloperidol 
treatment.
5.5.3.8.2 Intruder animals
During the period of haloperidol treatment of resident rats, 
non-treated intruder rats demonstrated increased investigation of the
conspecific resident rats from 11.2^2.1% at day 0 to 19.8*3.0% and
22.1*3.5% (p<0.05 in both cases), at days 7 and 14 respectively,
but no significant change in the levels of aggression nor
f1ight-submit or flight-escape behaviour. By 7 days following 
haloperidol treatment of resident rats, intruder rats still 
exhibited elevated investigation of the conspecific resident rats, 
while there was a significant increase in flight-escape behaviour, a 
slight, albeit not significant, increase in f1ight-submit behaviour 
and a slight, not significant, reduction in aggressive behaviour.
In addition, throughout the experiment there was a progressive and 
significant decrease in environmental exploration and increase in 
maintenance behaviour exhibited by intruder rats. The total number 
of behaviours exhibited by intruder rats were only significantly 
reduced at 7 days following haloperidol treatment of the resident 
rats.
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Figure 5.18 Effect of chronic treatment with haloperidol, target 
dose 0.11 umol Kg-1 day-1 sc., on the behavioural profile exhibited 
by resident and non-treated intruder rats during social interaction. 
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 : Pre-treatment Haloperidol dose; 0.121HI0.0007 umol Kg-1
D7 ; 7 days treatment Haloperidol dose; 0.109H10.0011 umol Kg-1
D14 : 1H days treatment Haloperidol dose; 0.0982t0.0018 umol Kg-1
7 : 7 days post-treatment
MWUT : * p<0.05, ** p<0.01, *** p<0.001 compared to pre-treatment 
(day 0) except where indicated.
Exploration Maintenance









D 7 * D 1 4 ‘ 7
Investigation
X  T  T
D 1 4























0 D7 D1H 7
Resident 628125 651:46 574*39 450:49a
Intruder 538:25 486:23 487:39 326:50b
Table 5.19 The total number of behaviours exhibited by resident rats 
treated chronically with haloperidol, target dose 0.11 umol Kg-1 
day-1 sc., and non-treated intruder rats during social interaction. 
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 uL day"1 in vivo
0 : Pre-treatment Haloperidol dose; 0.1214:0.0007 umol Kg-1
D7 ; 7 days treatment Haloperidol dose; 0.1094:0.0011 umol Kg"1
D14 ; 14 days treatment Haloperidol dose; 0.0982:0.0018 umol Kg-1
7 : 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with diazepam-vehicle (see section 4.6 for details), and 
non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.19 and Table 5.20, 
respectively. This experiment was designed as the control for 
chronic administration of diazepam.
5.5.3.9.1 Resident animals
Compared to the respective levels observed prior to the onset of 
treatment, resident rats treated chronically with diazepam-vehicle 
sc., showed no significant variation in environmental exploration, 
maintenance behaviour, investigation or aggression directed at the 
conspecific intruder or flight-escape behaviour either during the 
period of treatment or indeed at 7 days following the cessation of 
treatment. Only the level of flight-submit behaviour was observed to 
increase progressively from 1.4%20.3% at pre-treatment to 3.110.8% 
(not significant) by day 14 of treatment, and this increase was 
maintained at day 7 post-treatment (2.810.5%, p<0.05 compared to
the pre-treatment level). The total number of behaviours exhibited by 
resident rats during social interaction were slightly, but not 
significantly, higher at days 7 and 14 of treatment compared to the 
level observed prior to treatment.
5.5.3.9.2 Intruder animals
During the period of treatment of resident rats with 
diazepam-vehicle, non-treated intruder rats demonstrated increased 
investigation of the conspecific resident rats from 9.611.5% at day 
0 to 13.621.6% (not significant) and 13.321.5% (p<0.05), at days 7
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and 14 respectively. Indeed the elevated level of investigatory 
behaviour exhibited by intruder rats was still apparent at 7 days 
following the treatment of resident rats. The data also suggest a 
slight, albeit non significant, increase in aggressive behaviour 
directed at the resident rats and a slight, progressive, 
non-significant, increase in f1ight-submit behaviour which returned 
towards the level observed at day 0 by 7 days following the treatment 
the resident rats. Compared to the levels exhibited at day 0, 
intruder rats exhibited reduced levels in both environmental 
exploration and maintenance behaviour from day 7 of treatment and for 
the duration of the experiment, although these effects were not 
significant. In addition, the total number of behaviours exhibited 
by intruder rats were slightly increased from day 7 and for the 
duration of the experiment compared to the level observed at day 0.
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Figure 5.19 Effect of chronic treatment with diazepam-vehicle (see 
section 4.6 for details) on the behavioural profile exhibited by 
resident and non-treated intruder rats during social interaction. 
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 10.584 uL day-1 in vivo 
0 : Pre-treatment
D7 : 7 days treatment
D14 : 14 days treatment
7 : 7 days post-treatment
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Treatment days 
0 D7 D14 7
Resident 485:57 589149 588254 543240
Intruder 400224 466241a 462242 472238
Table 5.20 The total number of behaviours exhibited by resident rats 
treated chronically with diazepam-vehicle (see section 4.6 for 
details) and non-treated intruder rats during social interaction. 
Values indicate mean and sem for 8 animals per group.
Pump rate; 10.584 uL day-1 in vivo 
0 : Pre-treatment
D7 : 7 days treatment
D14 : 14 days treatment
7 : 7 days post-treatment




The behavioural profiles exhibited by resident rats treated 
chronically with diazepam. target dose 3.3 umol Kg-1 day-1 sc., and 
non-drugged intruder rats, and the total number of behaviours 
observed for each group are summarized in Fig. 5.20 and Table 5.21 
respectively.
5.5.3.10.1 Resident animals
Resident rats treated chronically with diazepam, target dose 3.3 
umol Kg-1 day-1 sc., exhibited increased f1ight-submit and 
flight-escape behaviours, from 1.710.5% and 14.411.7% at 
pre-treatment to 5.5t1.7% (p<0.05) and 23.811.7% (p<0.01) by day 7 
of treatment respectively, concomitant with slight, albeit 
non-significant, reductions in the observed levels of investigation 
and aggression directed at the conspecific intruder rats. By 14 days 
of treatment both f1ight-submit and flight-escape behaviours were 
still significantly elevated compared to the respective levels 
observed prior to drug treatment. By 7 days following diazepam 
treatment the levels of flight-escape behaviour, investigation and 
aggression, but not f1ight-submit behaviour, had returned to those 
levels observed prior to drug treatment. No significant change was 
observed in the levels of environmental exploration or maintenance 
behaviour exhibited by resident rats either during, or indeed by 7 
days following, drug treatment. Throughout the experiment, 
resident rats exhibited a progressive increase in the total number of 
behaviours observed during social interaction.
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5.5.3.10.2 Intruder animals
By 7 days of chronic treatment of resident rats with diazepam, 
non-treated intruder rats exhibited increased investigation and 
aggression directed at the resident rats, from 11.8*1.3% and 
2.8*0.7% at day 0 to 18.3:2.3% (p<0.05) and 7.822.2% (not 
significant) respectively, concomitant with a reduction in the level 
of environmental exploration, from 43.223.4% at day 0 to 32.623.5% 
(p<0.05), however, little or no significant change was observed in 
the levels of maintenance behaviour nor f1ight-submit or 
flight-escape behaviours. By day 14 of the experiment environmental 
exploration had decreased even further (to 25.223.8%, p<0.01
compared to the level at day 0), investigation and aggression were 
both still slightly, but significantly, elevated, while both 
f1ight-submit and flight-escape behaviours were increased compared to 
the respective levels observed at day 7, from 5.321.0% and 
28.621.9% to 8.621.6% (not significant) and 35.821.8% (p<0.05) 
respectively. By 7 days following diazepam treatment of resident 
rats, intruder rats exhibited a further reduction in the level of 
environmental exploration, concomitant with further increases in the 
levels of f1ight-submit and flight-escape behaviours. Investigation 
of the conspecific resident rats was still significantly elevated at 
this time, however the elevated level of aggression, exhibited by 
intruder rats during the period of drug treatment of resident rats, 
had returned towards the level observed at day 0. No significant 
variation was observed in the level of maintenance behaviour nor in 
the total number of behaviours exhibited by intruder rats either 
during or following the period of diazepam treatment of resident rats 
compared to the levels observed at day 0.
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Figure 5.20 Effect of chronic treatment with diazepam, target dose 
3.3 umol Kg-1 day-1 sc., on the behavioural profile exhibited by 
resident and non-treated intruder rats during social interaction. 
Open columns, resident rats. Hatched columns, intruder rats. 
Columns indicate mean (and sem) percentage of total behaviours for 
each motivational category.
N=8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 : Pre-treatment Diazepam dose; 3.598*0.014 umol Kg-1
D7 : 7 days treatment Diazepam dose; 3.29210.042 umol Kg-1
D14 : 14 days treatment Diazepam dose; 3.026*0.050 umol Kg-1
7 : 7 days post-treatment













































0 D7 D14 7
Resident 599224 659252 710233a 762234b
Intruder 476216 476227 471240 460224
Table 5.21 The total number of behaviours exhibited by resident rats 
treated chronically with diazepam, target dose 3.3 umol Kg-1 day-1 
sc., and non-treated intruder rats during social interaction.
Values indicate mean and sem for 8 animals per group.
Pump rate; 9.678 uL day-1 in vivo
0 : Pre-treatment Diazepam dose; 3.59820.014 umol Kg-1
D7 : 7 days treatment Diazepam dose; 3.29220.042 umol Kg-1
D14 : 14 days treatment Diazepam dose; 3.02620.050 umol Kg-1
7 : 7 days post-treatment




The major problem in observing animal behaviour and, more 
importantly, when using social behaviour as a pharmacological tool, 
is to ensure that the subject animals will perform not only at an 
adequate rate but also at the time required by the experimenter. 
Before any of the drug studies in this investigation were performed 
number of decisions were made as to how to manipulate the 
environmental conditions to maximize the performance of the subjects 
Thus social interaction experiments, between animals that were 
unfamiliar to each other, were performed following short-term 
isolation of the resident animal, during the dark phase of the 
light/dark cycle (although the area was under low illumination to 
enable video recording of the resulting social behaviour) when 
rodents are most active and in familiar conditions (i.e. the home 
cage of the resident animal). At all other times during the course 
of each experiment both resident and intruder animals were housed in 
social groups, since only then could the relative rank position of 
each animal be maintained (see section 5.2.1.1).
As many postures as possible were recorded during play-back of the 
video recording - since the limitations of such experiments are not 
the type or frequency of the behaviours exhibited but that which the 
observer can recognise and record - in order to approach as closely 
as possible a complete description of the profile of behaviour 
exhibited by each animal. It may be argued that the simple count of 
the total number of postures within any motivational category (used 
in these studies to represent the behavioural profiles) 
underestimates the importance of behavioural elements that last a 
relatively long period of time. For example, Aggressive Groom,
Crouch, Locomotion and the maintenance behaviours may last for many 
seconds, whereas Attack. Retreat, Threat/Thrust and Flag and Evade 
are usually of less than one second in duration. Also, the 
motivational categories contain varying numbers of behavioural 
elements such that it might be argued that this method of collating 
behavioural data is biased towards those categories containing a 
higher number of behavioural elements. In practice, however, the 
use of total values for each motivational category is not a serious 
problem since firstly, the longer the duration of a particular 
behavioural element, the less time is available for any other 
behaviour to be exhibited and thus the elements of long duration 
occupy a relatively greater proportion of the total number of 
behaviours exhibited; and secondly, where the motivational 
categories contain fewer behavioural elements, those elements are 
usually of longer duration and occur more frequently, e.g. 
locomotion and rearing. Other workers (e.g. File and Hyde, 1978) 
express data produced by similar experimental paradigms in terms of 
time spent in social interaction. Whether data expressed in the time 
domain yields more information is open to speculation since this 
method yields no indication of the type of behaviours expressed 
either during social interaction or when the animals are spatially 
separated. Expressing the data for each motivational category in 
terms of the percentage of the total number of behaviours observed, 
rather than as the summation of the absolute number of occurrences of 
the behavioural elements within a motivational category, allows 
identification of the changes in the distribution of behaviour 
regardless of the total number of behaviours exhibited. The 
resulting levels of activity exhibited by both resident and intruder 
animals, invariably between 0.5 and 2 postures per second throughout
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the 10 minute monitoring period, provided an adequate "window" of 
activity for each motivational category monitored, even where the 
pre-treatment level of a particular motivational category was low 
(i.e. <2% of the total number of behaviours exhibited). The 
environmental conditions in which these investigations were performed 
were therefore adequate to meet the aims of the investigation.
In comparing sets of multi-distributed data it is usual to subject 
the data to X2 analysis, since this statistical technique does not 
rely on the data being normally distributed and makes little 
assumption about the magnitude of the data collected. While being 
perfectly valid for the comparison between the behavioural profiles 
of resident and intruder animals exhibited during social interaction, 
the validity is lost when applied to the analysis of drug effects on 
one group of animals since it ignores the variation in response 
between individual animals to a particular dose of the drug being 
studied. In addition X2 treats the motivational categories as 
independent and may therefore suggest several effects where there is 
really no more than one. Thus while such a test accurately locates 
the behaviour in which two groups of animals differ it nearly always 
over-estimates the significance of such differences. It is 
impossible to claim that the method used in these investigations 
identified and recorded every single behaviour or posture exhibited 
by the animals studied. Rather the data was gathered by sampling the 
behaviours exhibited during social interaction. A major criticism of 
this method is that it is subjective since the data collected is 
entirely dependent on the ability of the observer to identify 
correctly each behavioural element. It is therefore not possible to 
state that the data obtained by this method is normally distributed.
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For this reason the non-parametric Mann-Whitney U-test was employed 
to determine significant drug effects on rodent social behaviour.
The changes in the behavioural profiles exhibited by resident rats 
following either acute or chronic drug treatment, and indeed the 
indirect effects on the behaviour of intruder rats, were consistent 
between animals within each treatment group. Any conclusions arrived 
at by using the Mann-Whitney U-test are therefore believed to be 
broadly correct.
It is readily apparent that the behavioural profiles exhibited by 
resident and intruder animals are markedly different. Resident 
animals predominantly exhibit investigatory behaviour of the intruder 
conspecific, which occasionally progresses to aggressive acts 
directed at the intruder, while the intruder animals predominantly 
exhibit flight-escape behaviour rather than submissive postures in 
response to the investigation and aggression shown by the resident 
animals. This is indicative of the territorial advantage enjoyed by 
the resident animal brought about by short-term isolation together 
with the fact that social interaction occurs in the resident animals 
home cage. Resident animals are therefore inherently more dominant
than the conspecific intruders.
The balance between the levels of f1ight-submit and flight-escape 
behaviour exhibited by intruder animals depends on the size of the 
area in which social interaction takes place (Grant, 1963); the
smaller the area the lower the opportunity for the intruder animal to
escape the attention of the resident animal. Intruder animals also 
show high levels of exploratory behaviour of the cage. The behaviour 
of intruder animals observed in a cage from which the resident animal
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had been removed is primarily exploratory (88% of total behaviours). 
This indicates that environmental exploration is the primary 
objective of animals introduced into a potentially hazardous 
environment. Any reduction from this level of exploration observed 
during social interaction is indicative not only of the presence of 
the resident rats but also of the degree of attention received by the 
intruder.
The majority of grooming behaviours (i.e. licking, scratching and 
washing) observed in these studies for either animal invariably 
occurred immediately following social interaction and were both 
vigorous and of short duration. Resident animals demonstrated 
grooming behaviour when the opportunity to direct investigatory 
behaviour or aggression at the conspecific was frustrated (either by 
the conspecific showing flight-escape behaviour or becoming 
aggressive towards the resident rat). Intruder rats exhibited 
grooming behaviour when the opportunity to evade the investigation or 
aggression of the resident rats was thwarted. In both instances the 
grooming behaviour is indicative of Displacement Activity (Grant and 
Mackintosh, 1963; Silverman, 1965) implying motivational conflict. 
Displacement activities occur when an animal either desires to 
perform a certain behaviour but is frustrated from doing so and thus 
displays an alternative behaviour which appears quite irrelevant, or 
where two or more incompatible drives are strongly activated (e.g. 
attack and flight) such that each drive prevents the expression of 
the other (Bastock et al., 1953).
The effects of acute drug treatment of resident rats on the 
behavioural profiles exhibited by resident and non-treated intruder
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rats are summarized in Table 5.22. Acute treatment of the resident 
rats with any of the drugs tested predominantly reduced the level of 
aggression directed at the intruder rats concomitant with increased 
flight-escape rather than f1ight-submit behaviour.
Figure 5.21 compares the dose-response curves of the compounds on 
aggressive behaviour exhibited by resident rats; the resulting order 
of potency being haloperidol >> mianserin > fluoxetine = iprindole > 
phenelzine > diazepam > clomipramine. When considered as a group the 
antidepressants induced no other consistent effects on the 
behavioural profile of resident rats. However, acute treatment with 
the antipsychotic haloperidol or the anxiolytic diazepam both reduced 
the total number of behaviours exhibited by the resident rats and 
increased the proportion of maintenance behaviours concomitant with 
the aforementioned reduction in aggressive behaviour. In addition, 
haloperidol concomitantly reduced f1ight-submit behaviour, while 
diazepam concomitantly reduced the level of environmental exploration 
and slightly reduced the level of investigatory behaviour directed at 
the conspecific intruder.
With the exception of diazepam, the drug-induced reduction in 
aggressive behaviour was not associated with reduced investigation of 
the conspecific intruder. This suggests that the antidepressants and 
haloperidol reduce the probability of the resident animals behaviour 
progressing from investigation of the conspecific to aggression, 
while for diazepam the reduced aggression was due, at least in part, 
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Table 5.22 Summary profile of drug-induced effects following acute 
treatment on rodent social behaviour exhibited by treated resident 
rats and non-treated intruder conspecifics.
Motivational Categories
a, b , c
Blank
E. Exploration; M, Maintenance;
I. Investigation; A, Aggression;
FS, Flight-submit; FE, Flight-escape 
T, Total number of behaviours. 
Ascending doses of drug (umol Kg-1 sc); 











Diazepam, 3.3, 10, 30
Significant increase (p<0.05) 








Figure 5.21 Effect of acute treatment with psychotropic drugs on 
aggressive behaviour exhibited by resident rats during social 
interaction.
Each point represents mean (and sem) percentage reduction from 
aggression exhibited by resident rats treated with drug-vehicle. 




▲ Clomipramine, 29.5 (14.3,60.0)
■ Fluoxetine, 3#
+ Iprindole. 3.82 (2.50,6.25)
• Mianserin, 1.19 (0.16,17.4)
▼ Phenelzine, 5.69 (1.41,221.5)
A Haloperidol, 0.19 (0.09,0.33)
O Diazepam, 8.73 (6.03,12.3)
IDso values were calculated by use of the least-squares method.




Mean %  change (sem) in proportional aggression.
Non-treated intruder rats demonstrated little or no consistent change 
in their behavioural profile when in social interaction with resident 
rats treated acutely with any of the antidepressants. When in social 
interaction with resident rats treated with either haloperidol or 
diazepam, however, intruder rats demonstrated markedly reduced 
levels of both f1ight-submit and flight-escape behaviours and marked 
elevations in the level of environmental exploration. The reduced 
levels of social interaction instigated by the resident rats thus 
allows the intruder conspecific to exhibit its primary motivational 
target of environmental exploration rather than exhibiting aggressive 
behaviour directed at the conspecific resident. Aggressive behaviour 
exhibited by intruder rats was usually limited in response to 
investigation or aggression exhibited by the resident animal and is 
thus indicative of defensive behaviour (Blanchard and Blanchard,
1977; Blanchard et al., 1977). In addition, both groups of
intruder rats demonstrated a reduction in the total number of 
behaviours in response to that observed in the corresponding resident 
group of rats. These observations indicate that haloperidol and 
diazepam both have far broader effects on rodent social behaviour 
than the antidepressants at doses that are equi-potent on aggressive 
behaviour.
The IDso values for haloperidol or diazepam on aggressive behaviour 
exhibited by resident rats are nearly identical to those determined 
for the drug-induced reduction in the total number of behaviours (see 
sections 5.5.2.6.1 and 5.5.2.7.1 respectively). This would suggest 
that the reduction in aggressive behaviour induced by haloperidol or 
diazepam is due to the onset of overt sedation; the indirect effect 
of which is to allow the non-treated intruder rats to exhibit
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increased environmental exploration. This being so the 
antidepressant-induced reduction in aggressive behaviour would appear 
to be a specific effect. This suggestion, however, is somewhat 
tentative. Aggressive behaviour occurs towards the final stages of 
the behavioural pathway (see Fig. 5.22), and may therefore be more 
sensitive to the sedative effects of psychotropic compounds. 
Drug-induced reduction in the level of aggressive behaviour may 
therefore be simply a more sensitive measure of the onset of 
drug-induced overt sedation. Exploratory locomotor activity in 
rodents has been suggested to be a sensitive measure of the possible 
sedative effects of psychotropic drugs (Brown et al., 1985).
Experiments were therefore performed using this animal model to 
examine whether the drug-induced reduction in aggressive behaviour 
may be attributable to the onset of overt sedation and are described 
in chapter 6.
In summary, acute treatment of resident rats with the 
antidepressants resulted primarily in a reduction in the intensity of 
social interaction which, it is suggested, may be indicative of 
decreased social drive. Acute treatment with haloperidol, however, 
reduced both the intensity and level of social interaction while the 
effects observed following acute treatment with diazepam are 
attributable to reduced levels of social interaction only. The data 
suggest, albeit tentatively, that the antidepressant-induced 
reduction in aggressive behaviour may be a specific effect on rodent 
social behaviour and not due to the onset of overt sedation, while 
the effects on rodent behaviour following haloperidol or diazepam 
treatment may be due to motor impairment induced by the sedative 
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F igure 5.22 Simplified schematic representation of the p at hways of 
social behaviour of the rat.
Individual postures and behaviours are grouped a c co r di n g to 
motivational category. Closed arrows indicate the normal p rogression  
of behaviours. Open arrows indicate displacement activity.
Adapted from Grant (1963).
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The effects of chronic drug or drug-vehicle treatment of resident 
rats on the behavioural profiles exhibited by resident and 
non-treated intruder rats are summarized in Table 5.23. Resident 
rats treated chronically with the drug-vehicles H20 or 0.1M tartaric 
acid exhibited increased flight-escape or f1ight-submit behaviour 
respectively. It is difficult to attribute such changes in the 
behavioural profile of the resident rats to the treatment schedules, 
rather the increased flight behaviours were probably due to the 
increased investigation exhibited by the intruder rats. Intruder 
rats also exhibited increased aggressive behaviour during social 
interaction with resident rats treated chronically with tartaric 
acid. Resident rats treated chronically with diazepam-vehicle, 
however, showed little or no variation in their behavioural profile 
during treatment even though the respective non-treated intruder rats 
exhibited increased investigation. These observations suggest that 
as a result of the repeat testing regimes intruder rats, which prior 
to day 0 are unaccustomed to the experimental method, become 
increasingly conditioned to social interaction with unknown resident 
animals in the latters home cage since it is known that previous 
social experience may condition the subsequent social behaviour in an 
agonistic situation (Baenninger, 1974; Bolhuis et al., 1984). It
is suggested that such conditioning of intruder animals results in a 
reduction in the degree of territorial advantage enjoyed by the 
resident rats.
Chronic treatment of the resident rats with the antidepressants 
predominantly increased the level of aggression directed at the 
intruder conspecifics without concomitant increases in the level of 
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Table 5.23 Summary profile of drug-induced effects following chronic 
treatment on rodent social behaviour exhibited by resident rats and 
non-treated intruder conspecifics.







E, Exploration; M, Maintenance;
I. Investigation; A, Aggression;
FS, Flight-submit; FE, Flight-escape 
T, Total number of behaviours.
Day 7 of drug treatment 
Day 14 of drug treatment 




behaviour of the resident rats the non-treated intruder animals (with 
the exception of those in social interaction with resident rats 
treated with fluoxetine) exhibited increased f1ight-submit rather 
than flight-escape behaviour concomitant with decreased environmental 
exploration. Conversely neither chronic treatment with haloperidol 
nor diazepam increased the aggressive behaviour of resident rats, 
indeed such behaviour was reduced during haloperidol treatment. With 
the exception of resident rats treated chronically with the MAOI 
phenelzine the elevated levels of aggression returned to near 
pre-treatment levels by 7 days after drug treatment. The elevated 
level of aggression exhibited by resident rats treated chronically 
with phenelzine, however, only returned to the pre-treatment level 
at 1H days post-dose. These observations indicate that clomipramine, 
fluoxetine, iprindole and mianserin induce similar overall changes 
in the social behaviour of rats that are entirely dependent on the 
continued presence of the drug. Phenelzine, however, is an 
irreversible inhibitor of MAO such that full MAO activity may only be 
regained following the synthesis of new enzyme, which in the rat 
takes about 1H days. The effects of chronic phenelzine treatment on 
rodent behaviour therefore appear to have a direct biochemical 
correlate. The fact that the elevated levels of aggression returned 
to near-baseline levels post-treatment is surprising since aggressive 
behaviour is self-reinforcing (Baenninger, 197H; Taylor, 1979) and 
thus the level of aggressive behaviour exhibited post-treatment would 
be expected to be higher than that observed prior to drug treatment.
Resident rats treated chronically with haloperidol demonstrated 
elevated levels of environmental exploration which were further 
increased 7 days following the cessation of drug treatment such that
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it is difficult to attribute this change in behaviour to drug 
treatment. Conversely the reduced level of aggressive behaviour 
observed at day 14 of drug treatment returned to the pre-treatment 
level by 7 days following the cessation of treatment concomitant with 
a comparatively large reduction in f1ight-submit behaviour. Chronic 
haloperidol treatment therefore appears to reduce the intensity of 
social interaction which, unlike the effects induced by acute 
treatment, is not associated with concomitant decreased 
f1ight-submit behaviour or the total number of behaviours observed 
nor with concomitant increased flight-escape behaviour. This in turn 
allows the non-treated intruder rats to exhibit investigatory 
behaviour of the conspecific resident rats.
Chronic diazepam treatment of resident rats resulted in increased 
flight-submit and flight-escape behaviour, however only the latter 
returned to the pre-treatment level by 7 days post-treatment.
Resident rats therefore appear more likely to exhibit flight 
behaviour following social interaction during chronic diazepam 
treatment even though the level of agonistic activity exhibited by 
such animals was not significantly modified. Since intruder animals 
in social interaction with diazepam-treated resident rats exhibited 
increased investigatory activity of the latter this suggests that, 
like the effect of chronic haloperidol treatment, similar treatment 
with diazepam also reduces the intensity, but not the level, of 
social interaction.
The elevated levels of aggression induced by chronic antidepressant 
treatment were not associated with increased levels of investigation 
nor consistent increases in the total number of behaviours observed.
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This suggests that such treatment increases the probability of the 
resident animals behaviour progressing from investigation to 
aggression directed at the conspecific (see Fig. 5.22). Such changes 
in rodent behaviour are indicative of an increase in the intensity of 
social interaction brought about by increased social drive rather 
than an increase in the basal level of activity. The effects of 
chronic antidepressant treatment on the basal levels of rodent 
activity (as indicated by the effect of such drug treatment on 
exploratory locomotor activity in rats) and a more applicable animal 
model of the social drive of rats (as indicated by the hierarchical 
position of individual rats within a social group) are described in 
chapters 6 and 7 respectively.
In summary, chronic treatment of resident rats with the 
antidepressants, but not haloperidol or diazepam, primarily results 
in increased aggressive behaviour which, it is suggested, is a 
manifestation of increased social drive in this species.
Furthermore, acute and chronic antidepressant treatments induce 
diametrically different effects on rodent social behaviour. It is 
known that chronic antidepressant treatments induce profound changes 
in the biochemistry of central neurotransmitters (e.g. 5-HT, NA and 
GABA; see section 1.5). It is therefore further suggested that the 
behavioural effects observed during chronic antidepressant treatment 
in these studies may result from long-term drug-induced changes in 
the function of central neurotransmitter systems which control rodent 
social behaviour.
The relationship of these results to the effects of acute and chronic 
treatment of antidepressants on exploratory locomotor activity and
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social drive in rats together with their implications in relation to 
published investigations by other workers are discussed in detail in 
chapter 8.
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CHAPTER 6 EXPLORATORY LOCOMOTOR ACTIVITY IN THE RAT
CHAPTER 6 EXPLORATORY LOCOMOTOR ACTIVITY IN THE RAT
6.1 Introduction
Many centrally-acting pharmacological agents (e.g. antidepressants, 
antipsychotics, anxiolytics, tranquilizers etc.) are sedative when 
given acutely and, although sedation may be required under certain 
circumstances, such an effect is usually classified under the 
heading of unwanted side-effects. Studies on the
psychopharmacological manipulation of overt animal behaviour patterns 
must always account for the possible induction of sedation, which 
may be induced by a variety of pharmacological mechanisms, since 
many behavioural models are sensitive to the sedative effects of such 
compounds which may confuse the experimental results unless 
adequately controlled.
Drug-induced suppression of exploratory locomotor activity (ELA), 
where animals are introduced to a novel environment, or spontaneous 
locomotor activity, where animals have previously been habituated to 
the experimental environment, in rats or mice, have long been used 
to identify the potential sedative effects of psychotropic agents.
ELA in mice has been demonstrated to be susceptible to inhibition by 
a range of compounds from different pharmacological classes, and in 
some cases the mechanism of action may be determined by the use of 
specific pharmacological antagonists; suppression of ELA induced by 
DA-autoreceptor agonists, alpha2-NA agonists and the 
benzodiazepines, chlordiazepoxide and diazepam, may be reversed by 
spiperone (DA antagonist), idazoxan (alpha2-NA antagonist) and Ro 
15-1788 (benzodiazepine antagonist) respectively (Brown et al.,
1985). Acute treatment with clomipramine, fluoxetine, iprindole, 
mianserin, phenelzine, haloperidol or diazepam demonstrably reduced
the level of aggression exhibited by resident rats in the social 
interaction test (section 5.5.2), which may be due to the onset of 
overt sedation, while chronic treatment with those compounds 
clinically labelled antidepressant, but not haloperidol or diazepam, 
increased the level of aggression (section 5.5.3). In order to 
determine whether or not the drug-induced reduction in aggressive 
behaviour of resident rats observed following acute treatment could 
be attributed to the onset of overt sedation, experiments were 
designed to identify the sedative potential of each compound on ELA 
of the rat. In addition, the level of ELA of the rat was monitored 
following chronic administration of each compound, at those doses 
employed in the social interaction experiments, to determine whether 
the increase in aggression observed following chronic treatment with 




Male Wister rats were taken from stock on weaning and housed under 
reverse-day1ight conditions (12h. on/12h. off, lights on 2000) for 5 
weeks prior to each experiment, with standard laboratory chow 
(Labsure CRM diet) and water available ad libitum. All animals used 
in these studies were naive to the locomotor activity monitoring 
cabinet and only used on one occasion.
6.2.2 Basic Methodology
Locomotor activity experiments were carried out between 1100h and 
1300h. Locomotor activity was measured in a microcomputer-controlled 
activity monitor containing 7 infrared photocell units (see section
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4.H.2.3 for description) for the 10 min period immediately following 
introduction of the rat into the activity monitor. The total number 
of counts were recorded every minute.
6.2.2.1 Effect of acute drug treatment on ELA of the rat
All animals were housed in groups of 12 prior to the experiment.
Rats were subcutaneously treated with test drug or vehicle either 30 
min (clomipramine, fluoxetine, iprindole, mianserin, phenelzine 
or diazepam) or 60 min (haloperidol) prior to introduction to the 
activity monitor. Each experiment was performed over 2 consecutive 
days with the doses of each compound administered in random order.
6.2.2.2 Effect of chronic drug or drug-vehicle treatment on ELA of 
the rat
All animals were housed in groups of 6 prior to the experiment.
1 week prior to testing the rats were anaesthetised and an osmotic 
mini-pump, containing drug or drug-vehicle, implanted 
subcutaneous ly (see section H.5 for implantation procedure) . All 
animals within each group received identical drug (clomipramine, 
fluoxetine, iprindole. mianserin, phenelzine or haloperidol) or 
drug-vehicle, H20 or 0.1M tartaric acid, treatment. On the day of 
testing, the exploratory locomotor activity of each animal was 
determined as described above. The effects of chronic diazepam or 
diazepam-vehicle on ELA in rats were not examined.
6.3 Statistical analysis
The data for each treatment group were collated and the mean number 
of counts and sem over the 10 min monitoring period calculated. 
Significant differences from respective controls were identified
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using Dunnett's test for multiple comparisons. Regression data were 
analysed and ID50 values with 95% confidence limits determined by 
analysis of variance including correction for variance of respective 
controls.
6.4 Results
6.4.1 Effect of acute drug treatment on ELA of the rat
The effect of acute drug treatments on ELA of the rat are summarized 
i n Tab 1e 6.1.
No significant effect on ELA of the rat was observed following acute 
subcutaneous treatment with clomipramine, 10-90 umol Kg-1, 
fluoxetine, 1.1-10 umol Kg-1, iprindole or phenelzine, 1-9 umol
Kg-1 in both cases. Mianserin, 3, but not 0.33 or 1, umol Kg-1 
sc, significantly increased ELA (+28114%, p<0.05). Only acute
subcutaneous treatment with either haloperidol or diazepam induced 
highly significant dose-related decreases in ELA (regression analysis 
of variance F ratios of 58.9 and 47.6 respectively, df=15,1 p<0.001 
in both cases); IDso values, 0.18 and 8.6 umol Kg-1 respectively.
6.4.2 Effect of chronic drug or drug-vehicle treatment on ELA of 
the rat
The effects of chronic drug treatment on ELA of the rat are 
summarized in Table 6.2.
None of the chronic drug treatments induced a significant change in 
the level of ELA compared to the level observed following chronic 
treatment with the respective vehicle control.
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30 154: 6 -20: 7
90 141:10 -24: 4
Fluoxetine Tartrate 202:10
1.1 221:31 + 9:15
3.3 188:11 - 7: 6
10 188:13 - 7: 7
Iprindole H20 229:26
1 202:30 -12:13
3 224:28 - 2:12
9 249:39 + 9:17
Mianserin H20 197:26
0.33 202:22 + 2:11
1 229:23 +16:11
3 252:28a +28:14
Phene 1zine H20 157:25
1 178:24 +14:15
3 156:17 : 0:11
9 143:17 - 9:11
Haloperidol Tartrate 245:12
0.11 153:14b -38: 6
0.33 87:12b -65: 5
1 26: 8b -89: 3
Diazepam Vehicle 218:11
3.3 159:13b -26: 6
10 93:13b -57: 6
30 48: 8b -78: 4
IDb o Regression

















Table 6.1 Effect of acute drug treatment on ELA of rats.
Values indicate mean and sem for 6 animals per group. % change; 
percentage change from vehicle control. Tartrate concentration = 
0.1M; see section 4.6 for description of diazepam-vehicle.
Dunnett's test; a, p<0.05; b, p<0.01. All other values not 
significant from vehicle control
IDso values with 95% confidence limits and regression data were 
determined by analysis of variance including correction for variance 
of controls. F ratio; c, p<0.001, where df=15,1
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Drug Pump rate Dose Counts
(uL day-1) (umol Kg-1 day-1) (Mean2sem)




Phene 1zine 1 197226
0.1M Tartaric acid 26.88 188226
Fluoxetine 1 . 1 180212
Haloperidol 0.11 202222
Table 6.2 Exploratory locomotor activity of rats following 7 days 
chronic subcutaneous treatment with drug or drug-vehicle.
Values indicate mean and sem for 6 animals per group.




Earlier experiments have demonstrated that acute treatment with 
clomipramine, fluoxetine, iprindole, mianserin, phenelzine,
haloperidol or diazepam reduced the level of aggression exhibited by 
resident rats in the social interaction test (section 5.5.2), 
whereas, with the exception of haloperidol and diazepam, chronic 
treatment induced significantly increased aggressive behaviour 
(section 5.5.3). However, whether such drug-induced changes 
observed following acute treatment are indicative of the onset of 
overt sedation, or whether the increased aggression observed during 
chronic administration of the antidepressants is due to a 
drug-induced increase in basal rodent activity are not known.
It has been demonstrated that exploratory locomotor activity in mice, 
where the level of locomotion is stimulated by the novel environment, 
is a sensitive animal model to examine the ability of psychotropic 
drugs to induce overt sedation (Brown et al., 1985). Experiments
were performed using this animal model in the rat to examine the 
sedative potential of acute treatment with these compounds at those 
doses employed in the social interaction test. Only acute treatment 
with haloperidol or diazepam induced dose-related inhibitions in the 
level of ELA indicating that both compounds induce overt sedation at 
those doses used. The dose-response curves obtained following acute 
treatment with these compounds on ELA are compared to those obtained 
on aggressive behaviour and the total number of behaviours exhibited 
by resident rats during social interaction in figures 6.1 to 6.7.
The data indicate that clomipramine (Fig. 6.1), fluoxetine (Fig. 
6.2), iprindole (Fig. 6.3), mianserin (Fig. 6.4) and phenelzine 
(Fig. 6.5) were more potent on aggressive behaviour than on ELA or
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the total number of behaviours exhibited during social interaction. 
Conversely, both haloperidol (Fig. 6.6) and diazepam (Fig. 6.7) 
exhibited equi-potent effects on all three parameters respectively. 
The data therefore indicate that the reduction in aggressive 
behaviour exhibited by resident rats following acute treatment with 
haloperidol or diazepam, but not the antidepressants, is due to the 
onset of overt sedation. In addition, acute treatment with any of 
the compounds exhibited very similar effects on ELA and the total 
number of behaviours observed during social interaction. This 
indicates that measurement of the total number of behaviours 
exhibited during social interaction yields the same information 
regarding the sedative potential of psychotropic drugs as the 
measurment of ELA. Measurement of the total number of behaviours 
exhibited by resident rats therefore provides an indication of any 
sedative effects of psychotropic compounds that may influence social 
behaviour and is inherent in the social interaction test. The 
reduction in aggressive behaviour exhibited by resident rats during 
social interaction following acute treatment with the antidepressants 
therefore appears to be a specific effect on rodent social behaviour.
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Figure 6.1 Effect of acute treatment with clomipramine on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N=8) and total number of 
behaviours (N=8) were identified by MWUT (* p<0.05, *** p<0.001).
Exploratory locomotor activity (N=6); all values not significantly 
different from control (Dunnett's test).
IDso umol Kg-1 
(95% limits)
Aggression 29.5 (14.3,60.0)
Total number of behaviours >90
Exploratory locomotor activity >90
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Figure 6.2 Effect of acute treatment with fluoxetine on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N-8) and total number of 
behaviours (N=8) were identified by MWUT (* p<0.05).
Exploratory locomotor activity (N=6); all values not significantly 
different from control (Dunnett’s test).
IDso umol Kg-1 
(95% limits) 
Aggression 3#
Total number of behaviours >10
Exploratory locomotor activity >10




























Figure 6.3 Effect of acute treatment with iprindole on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N=8) and total number of 
behaviours (N=8) were identified by MWUT (** p<0.01, *** p<0.001).
Exploratory locomotor activity (N=6); all values not significantly 
different from control (Dunnett’s test).
IDso umol Kg-1 
(95% limits)
Aggression 3.82 (2.50,6.25)
Total number of behaviours >9.0
Exploratory locomotor activity >9.0
Aggression IDso value was calculated by the least-squares method.
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Figure 6.1! Effect of acute treatment with mianserin on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N=8) and total number of 
behaviours (N=8) were identified by MWUT (** p<0.01).
Significant changes in exploratory locomotor activity (N=6) were 
identified by Dunnett's test (* p<0.05).
IDso umol Kg-"1 
(95% limits)
Aggression 1.19 (0.16,17.4)
Total number of behaviours >3
Exploratory locomotor activity >3































Figure 6.5 Effect of acute treatment with phenelzine on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N=8) and total number of 
behaviours (N=8) were identified by MWUT (* p<0.05, ** p<0.01).
Exploratory locomotor activity (N=6); all values not significantly 
different from control (Dunnett's test).
IDso umol Kg-1 
(95% limits)
Aggression 5.69 (1.41,221.5)
Total number of behaviours >9
Exploratory locomotor activity >9
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Figure 6.6 Effect of acute treatment with haloperidol on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N=8) and total number of 
behaviours (N=8) were identified by MWUT (** p<0.01, *** p<0.001).
Significant changes in exploratory locomotor activity (N=6) were 
identified by Dunnett's test (** p<0.01).
IDso umol Kg-1 
(95% limits)
Aggression 0.19 (0.09,0.33)
Total number of behaviours 0.18 (0.09,0.29)
Exploratory locomotor activity 0.18 (0.12,0.26)
IDso values for aggression and total number of behaviours were 
calculated by the least-squares method.
IDso value for exploratory locomotor activity was calculated by 





































Figure 6.7 Effect of acute treatment with diazepam on aggressive 
behaviour and the total number of behaviours exhibited by resident 
rats during social interaction, and exploratory locomotor activity 
in the rat.
Closed triangles, aggression; closed circles, total number of 
behaviours; closed squares, exploratory locomotor activity.
Values indicate mean (and sem) percentage change from behaviour 
exhibited by vehicle-treated control rats.
Significant changes in aggression (N=8) and total number of 
behaviours (N=8) were identified by MWUT (* p<0.05, ** p<0.01, ***
p<0.001).
Significant changes in exploratory locomotor activity (N=6) were 
identified by Dunnett’s test (** p<0.01).
IDso umol Kg-1 
(95% limits)
Aggression 8.73 (6.03,12.3)
Total number of behaviours 7.26 (5.05,9.96)
Exploratory locomotor activity 8.59 (5.75,12.5)
IDso values for aggression and total number of behaviours were 
calculated by the least-squares method.
IDso value for exploratory locomotor activity was calculated by 
































In a separate series of experiments the effects of chronic treatment 
with clomipramine, fluoxetine, iprindole, mianserin, phenelzine 
or haloperidol on the ELA of rats were examined at those doses 
employed in the social interaction test. Animals receiving identical 
treatments were housed together to maintain a constant social 
structure during drug treatment. This was felt to be important since 
previous studies have demonstrated that chronic antidepressant 
treatment increases aggressive behaviour (see section 5.5.3).
Housing animals receiving such treatments with those receiving 
treatments which do not increase aggressive behaviour (i.e. 
haloperidol, H20 or 0.1M tartaric acid) may subject the latter to 
undue social stress which, it was feared, might alter their ability 
to perform exploratory locomotion.
The data indicate that chronic treatment with any of the compounds 
tested had little effect on the basal level of ELA of rats.
Likewise, this suggests that the increase in aggressive behaviour 
exhibited during social interaction by resident rats receiving 
chronic antidepressant treatment was not due to an increase in the 
basal level of activity of rats. It may be argued that the use of 
ELA in rats to examine the ability of compounds to increase the basal 
level of activity of rats is not applicable since the activity of the 
subjects is already stimulated by the novel environment. The use of 
this animal model is defended, however, since environmental 
stimulation also occurs in the social interaction test by the 
presence of the intruder conspecific. ELA in rats, rather than the 
measurement of locomotor activity exhibited by rats habituated to the 
locomotor activity monitor, therefore mirrors more closely 
environmental stimulation inherent in the social interaction test.
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Further experiments to examine the effects of chronic antidepressant 
treatment on the social drive of rats (as indicated by the 
hierarchical position of individual rats within a social group) are 
described in chapter 7.
In summary, acute treatment with those antidepressants studied in 
these investigations had little or no effect on the level ELA of 
rats. The reduced level of aggressive behaviour exhibited by 
resident rats in the social interaction test therefore appears to be 
due to a specific reduction in the intensity of social drive of rats, 
while that following acute treatment with haloperidol or diazepam 
appears to be as direct consequence of overt sedation. Conversely, 
since chronic treatment with these compounds had no effect on the 
level of ELA, the increased aggressive behaviour exhibited by 
resident rats receiving identical treatments during social 
interaction is probably due to a specific increase in the intensity 
of social drive as opposed to an increase in the basal level of 
activity.
The relationship of these results to the effects of acute and chronic 
treatment of antidepressants on the social behaviour of rats together 
with their implications in relation to published investigations by 
other workers are discussed in detail in chapter 8.
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CHAPTER 7 RANK ORDER STUDIES IN THE RAT
rank order with a transitive dominance relationship, if animal A 
dominates animal B and B dominates C, then A dominates C. In 
non-linear rank orders at least one triadic dominance relationship 
must be intransitive such that if animal A dominates B and B 
dominates C, then C dominates A. Thus, while linear hierarchies 
are composed purely of transitive dominance relationships, 
non-linear hierarchies are composed of triads with both transitive 
and intransitive dominance relationships where the latter indicate a 
cyclical social structure.
An integral component of the establishment of rank order between male 
rats is the level of aggressive behaviour exhibited by each animal 
(Chance and Silverman, 1964). Thus the level of aggressive 
behaviour exhibited at grouping determines each animals' relative 
position within the social hierarchy, with higher aggressors 
attaining higher rank positions. Grant and Chance (1958) identified 
the rank order of caged laboratory rats by monitoring the full 
submissive posture exhibited by subordinate rats in response to the 
aggressive behaviour exhibited by a more dominant conspecific. Using 
this posture to identify not only the end point of a particular 
social interaction but also the dominant and subordinate rats within 
that interaction, they demonstrated that housing rats in groups of 
less than 6 animals per group allows for a stabilized linear rank 
order to be established for at least 6 weeks from 3 weeks following 
initial grouping. These observations imply that the level of 
aggression exhibited by each individual animal was relatively 
constant from one recording to the next. In addition Grant and 
Chance (1958) suggested that subordinate males are attracted to those 
rats of more dominant status; indicating that social drive is
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towards the higher positions of the social structure. This being 
true, the level of aggression exhibited by a particular animal is an 
indicator of the relative level of social drive. The question 
remains, however, whether pharmacological manipulation of overt 
aggression may modify an animal’s relative position within the 
hierarchical structure. This aspect of behavioural pharmacology has 
received scant attention in the literature. Indeed, in very few 
studies has the pharmacological manipulation of rodent rank order 
been attempted. Poshivalov (1979) suggested that psychotropic drugs 
of different classes (caffeine, diazepam, droperidol and mescaline) 
have different effects on the stability of dominant/subordinate 
relationships in mice, and that prolonged administration of drugs 
which suppress the level of aggression exhibited by dominant mice 
results in an inversion of the hierarchical structure. Thus the 
reduction in social drive induced as a result of decreased aggression 
is manifest as a reduction in rank position. Conversely, Malatynska 
and Kostowski (1984) demonstrated that chronic treatment of dominant 
rats with the antidepressants imipramine, amitriptyline, 
desipramine, mianserin and clomipramine per se increased the \Jas 
determined by the respective duration of eating time) between paired 
rats. Similarly, chronic treatment with non-antidepressant drugs, 
i.e. yohimbine, amphetamine and pimozide, also increased the 
dominance-subordination relationship.
Previous studies have demonstrated that chronic treatment with 
antidepressants results in increased aggressive behaviour (see 
section 5.5.3), which, it is suggested, is indicative of increased 
social drive. The following studies were performed to examine the 
effect of chronic treatment with clomipramine or mianserin, at doses
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which demonstrably increase aggression, on the relative rank 




Grant and Chance (1958) demonstrated that groups of 3 to 5 rats 
exhibited stable linear social hierarchies. To ease the logistics of 
monitoring the social behaviour of grouped animals it was decided to 
observe the behaviour of rats maintained in groups of 3 (i.e. 
triads).
In monitoring the social behaviour of grouped animals it is important 
that the test situation optimizes the level of social interaction to 
enable sufficient data to be collected to withstand critical 
statistical analysis. Rats are nocturnal and observations of their 
circadian locomotor activity throughout the light/dark phase (Fig
7.1) indicate that while such animals are quiescent during the light 
phase, locomotor activity occurs immediately at the onset of 
darkness. To enable more than one group of animals to be observed on 
any one day the groups of rats were housed in environmental cabinets 
so that the onset of the dark phase for each group could be 
controlled. However, each cage had to be removed from the 
environmental cabinet and placed in the recording cabinet to allow 
the recording of social behaviour on to video tape for analysis at a 
later date. This resulted in the subject animals exhibiting 
exploratory activity of the recording cabinet for at least 30 min 
following the change of environment. Subject animals were therefore 
allowed to acclimatize to the recording cabinet during the last 60
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Figure 7.1 Circadian locomotor activity of grouped rats monitored 
continuously over 48h.
Vertical axis: locomotor activity counts per 15 min epoch for
grouped rats (N=3). Horizontal axis: time in hours (2Hh clock).
Rats were housed under a 12h/12h light-dark cycle (lights on 0700, 
lights off 1900). Black band indicates dark period.
12 18 0 6 12 18 0 Time
— — ■  ...  — (24h clock)
Light/Dark Cycle (12:12, Lights on 0700)
min of the light phase, by which time they were invariably 
quiescent, prior to the room lights being turned off at the start of 
the dark phase. Pilot observations of triads (data not shown) 
indicated that during the initial 30 min of the dark phase periods of 
intense social interaction occurred involving all animals in the 
group. By HO min, however, the social interaction was replaced by 
increasing periods of exploration, grooming and consummatory 
behaviour. Observations to assess the rank order of caged rats were 
therefore performed on groups of 3 rats at the onset of the dark 
phase for a 30 min period.
Pilot studies employed the method of Grant and Chance (1958), i.e. 
incidence of full submissive posture, to identify the dominant and 
subordinate animal in each social interaction. It was readily 
apparent, however, that the full submissive posture occurred only 
very rarely (data not shown); subordinate animals were more likely 
to exhibit flight-escape behaviour. The method of identifying the 
dominant and subordinate animals within a particular social 
interaction was therefore reappraised (see section 7.3).
7.2.1.2 Subjects
2 weeks after weaning groups of 3 male Wister rats were taken from 
stock and housed in light- and sound-attenuating environmental 
cabinets under a 12h:12h light-dark schedule for 2 weeks prior to 
each experiment (see sections H.2 and H.3.1), with standard 
laboratory chow (Labsure CRM diet) and water available ad libitum.
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7.2.2 Basic Methodology
The animals, still in their home cage, were removed from the 
environmental cabinet 1h before the onset of the dark phase and the 
cage positioned inside the behavioural recording cabinet (see section
4.4.1 for description). At the start of the dark phase the room 
lights were turned off and the behaviour of the animals recorded 
under low intensity (2 lux illumination) red light on video tape, 
via an infrared camera positioned immediately above the recording 
cabinet, for the following 30 min. for analysis at a later date. 
Immediately following the recording period the cage was replaced in 
the environmental cabinet.
7.2.2.1 Preliminary observations on the stability of the 
hierarchical structure of rats maintained in triads
In this series of experiments the social behaviour of 3 groups of 3 
rats per group was recorded from the onset of the dark phase on 3 
successive days of the week (Mon-Wed) over 6 consecutive weeks.
During the week prior to the experiment each group cage was placed in 
the recording cabinet, under those conditions described above 
(section 7.2.2), on 3 successive days to allow habituation to the 
recording apparatus. None of the animals within any group received 
any drug treatment.
7.2.2.2 Effect of chronic drug or drug-vehicle treatment on the 
rank position of sub-dominant rats
In these experiments the social behaviour of the grouped rats was 




Week Mon Tue Wed
1 + 2  : Acclimatization to recording environment
3 : - 8 - 7  -6
4 -1 implant pumps D1
5 D6 D7 D8
6 D13 D14 +1
(remove pumps)
7 + 6 + 7  +8
Table 7.1 Experimental scheme indicating the recording sessions and 
operating days for the implantation or removal of mini-osmotic pumps. 
-8, -7, -6,-1 : Pre-implantation recording sessions.
D1, D6, D7, D8, D13, D14 : Recording sessions following implantation.
+1, +6, +7, +8 : Recording sessions following removal of
osmotic mini-pumps.
2H6
The hierarchical positions of the rats within each group were 
assigned according to the rank order obtained on the day immediately 
prior to the subcutaneous implantation of the mini-pumps, i.e. day 
-1, week 4. Only those animals in the subdominant position received 
pumps containing drug (clomipramine, 10 umol Kg-1 day-1, or 
mianserin, 0.33 umol Kg-1 day-1) or vehicle (H20). Rats in the 
dominant or subordinate rank positions were sham-operated and 
received a subcutaneous implant of a sterilised exhausted pump 
recovered from a previous control experiment where H20 was the 
control vehicle used. Implantation of the pumps was carried-out 
according to the method described in section 4.5, following which 
all animals were returned to their respective environmental cabinets. 
Immediately after the recording session on treatment day 14 (i.e.
D14, week 6) all animals were anaesthetised and the mini-pumps 
removed; the animals were then returned to their respective 
environmental cabinets.
7.3 Assessment of the hierarchical structure of rats
Chance and Silverman (1964) suggest the establishment and maintenance 
of rank order between caged rats is dependent on the degree of overt 
aggressive behaviour exhibited by each group member. Measurement of 
the individual elements of aggressive behaviour (as used in the 
social interaction studies, section 5.1.1), however, is not 
applicable to the assessment of rank position for each animal since 
the data contains no information regarding the relationship of 
aggressive behaviour to the overall level of dominance attained 
during social interaction. The level of dominance may only be 
determined by considering the proportion of success in terms of the 
total number of social interactions (Craig, 1986), and thus
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definitions of dominance that stress the results of agonistic 
encounters are of greater heuristic value (Benton. 1982). Thus in 
these experiments only those social interactions which resulted in 
one animal being demonstrably identified as the "winner" and the 
other the "loser were recorded. Interactions where no discernible 
winner or loser could be identified were ignored. Grant and Chance 
(1958) used similar criteria for identifying the winner and loser of 
a single social interaction by noting the incidence of full 
submissive posture exhibited by the less dominant rat. Such postures 
indicate the end point of the f1ight-submit behavioural pathway (Fig.
7.2), but animals observed in the pilot studies of this 
investigation very rarely, if at all, demonstrated the full 
submissive posture. Rather, animals demonstrated flight-escape 
behaviour in response to the aggressive posturing of a cage partner 
and as such were dee^med to be the loser of that social interaction. 
In some cases animals demonstrated evasive behaviour prior to any 
approach by the aggressor. In these instances the result of the 
social interaction was recorded as long as the more dominant animal 
could be identified.
In both preliminary and drug studies the rank position of each group 
member was determined as follows. The number of wins and losses for 
each animal was calculated. The number of wins for each animal was 
then expressed as a percentage of the total number of social 
interactions involving that animal. The percentage value indicates 
the success level achieved during social interaction and the higher 
the success level the higher the rank position of that group member. 
The highest value indicates the dominant animal, designated alpha; 











Figure 7.2 Simplified schematic representation of the pathways of 
social behaviour of the rat.
Individual behaviours or postures are grouped acc o rd i ng  to 
motivational category. Closed arrows indicate the normal p r og r ession 
of behaviours. Open arrows indicate displacement activity.
Adapted from Grant (1963).
2*49
and the lowest success value indicates the subordinate animal, 
designated gamma. The rank position of each group member may then be 
assigned as indicated in sections 7.3.1 and 7.3.2. Table 7.2 










Number Wins Loses Total Success Rank
1 43 68 111 38.7 Subordinate
2 56 33 89 62.9 Dominant
3 56 54 110 50.9 Sub-dominan
Table 7.2 Example of data arising from rank order studies of triads. 
Top panel: The numbers below the "winner" and "loser" columns
indicate the particular animals involved in social interaction.




In order to determine the stability of rank order in caged rats the 
rank orders for each group were assigned on the basis of the rank 
positions determined from the total data. Thus, at the end of the 6 
week experimental period the total number of wins and losses for each 
animal in each group over the duration of the experiment were 
determined and the percentage success level calculated. Each animal 
within any group then held that rank regardless of the rank position 
indicated during any particular recording.
7.3.2 Drug studies
The hierarchical positions of the animals within each group were 
assigned according to the rank order obtained on day -1, week 4 (see 
section 7.2.2.2 and Table 7.1) and held that designation for the 
duration of the experiment.
7.*4 Statistical analysis 
7.4.1 Preliminary studies
Only three groups of animals were observed in this investigation on 
the hierarchical structure of triads. Since the data size is small 
the application of non-parametric statistical analysis is not 
applicable.
7.4.2 Drug studies
The non-parametric Mann-Whitney U-test was used to compare the 
success values for each rank position to those values obtained 
immediately prior to the onset of drug or drug-vehicle administration 
(i.e. day -1, week 4).
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7.5 Results
7.5.1 Preliminary observations on the stability of the hierarchical 
structure of rats maintained in triads
Fig. 7.3 summarizes the mean (Isem) success values, for each 
recording day, of the rank positions assigned according to the 
hierarchical structure determined from the total data for each group. 
The data demonstrates that the hierarchical stucture of the 3 groups 
of rats maintained in triads is essentially linear in nature and 
stable not only from one recording day to the next but also 
throughout the duration of the experiment. Only during weeks 1 and 5 
was the hierarchical stucture observed to deviate from the rank 
positions assigned from the total data. At all other recording times 
each animal within a particular group maintained its designated rank 
position. Even though only a limited number of groups were studied 
in this preliminary, quantitative, investigation the stability of 
the rank positions over time indicates that the conclusions above are 
broadly correct.
In the light of these observations the groups observed in the drug 
studies were allowed 2 weeks of acclimatization to the recording 
apparatus.
7.5.2 Effect of chronic drug or drug-vehicle treatment on the rank 
position of sub-dominant rats.
Table 7.3 and Fig. 7.H summarize the hierarchical structure, in
terms of the success values for each rank position assigned 
immediately prior to chronic drug or drug-vehicle treatment, for
each treatment group throughout the duration of the experiment.
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Figure 7.3 Stability of the hierarchical structure of grouped rats. 
Columns indicate the mean (and sem) success values for each rank 
position assigned according to the hierarchical structure determined 
from the total data for each group. The assigned rank positions were 
then used to determine the mean success level for each rank position 
on each recording day regardless of the actual rank position attained 
by an individual rat on that day.
Alpha, dominant; beta, subdominant; gamma, subordinate.
N=3 animals per group.
The behaviour of grouped animals was recorded 3 days a week
(Mon, monday; Tue, tuesday; Wed, Wednesday) over a 6 week period
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Table 7.3 Effect of chronic clomipramine or mianserin treatment of 
subdominant group members on the social hierarchy of rats maintained 
in triads.
Hierarchical structure: Rank positions were assigned according to
the success values obtained on day -1; alpha, dominant; beta, 
subdominant; gamma, subordinate.
Values indicate mean (1 sem) success.
N=5 groups per treatment.
Treatment schedule.
-7, -6, -1 : Days pre-implantation
D1, D6, D7, Days of drug treatment
D8, D13, D1H
+1, +6, +7, +8: Days post-treatment
Subdominant rats: H20, 9.72 ul day-1 sc (N=2) and 9.68 ul day-1 sc
(N=3); clomipramine, 10 umol Kg-1 day-1 sc; mianserin, 0.33 umol 
Kg-1 day-1 sc.
Dominant and subordinate rats were sham operated.
* Duration of treatment.
MWUT: a, p<0.05; b, p<0.01; compared to values on day -1.
c, p<0.05; d, p<0.01; compared to values on day +1.
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Figure 7.4 Effect of chronic treatment with clomipramine or 
mianserin of subdominant group members on the hierarchical structure 
of rats maintained in triads.
Hierarchical structure: Rank positions were assigned according to
the success values obtained on the day immediately preceding 
implantation of the mini-pumps (i.e. day -1, week 4; see Table 7.1). 
Alpha, dominant; beta, subdominant; gamma, subordinate.
Columns indicate mean (1 sem) success.
N=5 groups per treatment.
For treatment schedule see Table 7.1 and legend to Table 7.3.
Pre 7, pre-treatment day 7 (i.e. -7, week 3).
Pre 1, pre-treatment day 1 (i.e. -1, week 4).
Drug 1, drug treatment day 1 (i.e. D1, week 4).
Drug 7, drug treatment day 7 (i.e. D7, week 5).
Drug 14, drug treatment day 14 (i.e. D14, week 6).
Post 1, post-treatment day 1 (i.e. +1, week 6).
Post 7, post-treatment day 7 (i.e. +7, week 7).
Dominant and subordinate rats were sham operated.
MWUT: Drug 7, Drug 14 and Post 1; * p<0.05, ** p<0.01; compared
to values on day Pre 1.
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In those groups where the subdominant animals were treated 
chronically with water no change in the social hierarchy of the 
triads was observed throughout the duration of the experiment. 
Likewise, the social hierarchy of those groups where the subdominant 
animals received chronic clomipramine or mianserin treatment 
demonstrated little disruption in the hierarchical structure at day 1 
of drug treatment. By day 6, however, subdominant rats treated 
chronically with either clomipramine or mianserin exhibited 
significant increases in their success levels, from 48.423.5% and 
49.822.2% at day -1 to 57.412.1% and 58.221.4% respectively 
(p<0.05 in both cases), concomitant with significant decreases in 
the success level of the respective Sham-operated dominant rats, 
from 72.024.3% and 67.823.2% at day -1 to 56.021.7% and 56.021.0% 
respectively (p<0.01 in both cases). The observed modification of the 
social hierarchy was maintained throughout the period of drug 
treatment and was still present at day 1 following the cessation of 
drug aministration. Little or no change was observed in the success 
level of Sham-operated subordinate animals where the subdominant 
group member received chronic clomipramine or mianserin treatment.
By day 6 following drug treatment the hierarchical structure for each 




Housing rodent colonies in closed communities (where the group 
members are in continuous social intercourse) allows a hierarchical 
structure to develop between the members of the group. In order to 
determine the rank positions of each group member the social 
behaviours pertinent to the maintenance of the hierarchy must be 
observed and recorded. As with the majority of ethological 
experiments, the major problem is to ensure that the animals will 
perform at the time required by the observer. In these studies the 
social behaviour of triads of rats were observed during the initial 
30 min of the dark phase of the light-dark cycle since during this 
time intense social interaction occurs involving all animals within 
the group. Such behaviour was observed to occur ritualistically at 
the onset of every dark phase and performs the function of 
maintaining the social structure of the group.
Preliminary observations of the social structure of rats grouped in 
triads indicated that the nature of the hierarchical structure is 
both linear and stable over the six week observation period. Such 
observations are in accord with those of Grant and Chance (1958). 
The magnitude of the data arising from these studies and the 
stability of the success values obtained for each rank position 
indicate that the hierarchical structure of rats may well provide a 
suitable robust animal model in which to study the effects of 
psychotropic drugs on social structure.
Chance and Silverman (196H) suggest that the level of aggression 
exhibited by individual animals is an integral component in the 
development of hierarchical structure between male rats. In
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addition, Poshivalov (1979) demonstrated that reducing the level of 
overt aggressive behaviour in mice by chronic treatment with 
psychotropic drugs results in the disruption of the hierarchical 
structure. These observations indicate that overt aggressive 
behaviour exhibited by group members plays an important role in the 
manifestation of social drive. Furthermore, chronic antidepressant 
treatment has previously been shown to increase the
dominance-subordination relationship between paired rats (Malatynska 
and Kostowski, 1984). With the exception of the two studies cited 
above this area of ethology has received scant attention by 
behavioural pharmacology; for example, there is no published data 
on the effect of increased aggressive behaviour exhibited by a 
non-dominant group member on the hierarchical structure of that 
group.
Earlier studies in this investigation (see sections 5.5.2 and 5.5.3) 
demonstrated that chronic, but not acute, treatment with examples 
of antidepressants, but not the antipsychotic haloperidol nor the 
anxiolytic diazepam, increased aggressive behaviour exhibited by 
resident rats during social interaction with unknown intruder 
conspecifics. Since similar chronic treatment regimes had no effect 
on the level of exploratory locomotor activity exhibited by rats (see 
section 6.4.2) it was suggested that the increased level of 
aggressive behaviour was indicative of increased social drive rather 
than increased basal activity. In these studies chronic treatment of 
subdominant rats with clomipramine or mianserin, at doses known to 
increase aggressive behaviour, increased the relative rank position 
of the treated animals at the expense of the level of dominance 
enjoyed by the dominant group member. Inversion of the relative rank
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positions for the dominant and drug-treated subdominant did not 
occur, however, rather both animals exhibited parity of rank 
position. The rank position of subordinate group members was not 
affected by drug treatment of the subdominant rats. By comparison, 
the hierarchical structure of those groups of rats where the 
subdominant member received chronic treatment with water 
(drug-vehicle) remained constant throughout the duration of the 
experiment. The modification of the social structure induced by 
clomipramine or mianserin was dependent on chronic treatment since no 
effect was observed on day 1 of treatment and was still present on 
day 1 following the cessation of drug treatment. However, the 
pre-treatment hierarchical structure was recovered by day 6 
post-dose. The time-course of the clomipramine- or mianserin-induced 
modification of social hierarchy closely correlates to that observed 
in the social interaction studies. The effects of chronic 
clomipramine or mianserin treatment on the rodent social hierarchy 
therefore appear related to their ability to induce overt aggressive 
behaviour.
The results of this study support the suggestion of Grant and Chance 
(1958) that animals in lower rank positions are attracted towards the 
higher ranks of the social structure; thus the direction of social 
drive is towards the more dominant ranks. In addition, the level of 
aggressive behaviour is an important component in determining the 
relative rank position of individual animals (as suggested by Chance 
and Silverman, 1964).
In conclusion, therefore, the results of this investigation support 
the suggestion that the hierarchical structure of rodents provides a
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suitable animal model by which the effects of psychotropic drugs on 
social drive may be examined. In addition, the data indicate that 
chronic treatment with the antidepressants clomipramine and mianserin 
increases social drive, which. in rats at least, is manifest as 
increased aggressive behaviour. In the social interaction studies 
increased aggression was also observed following chronic treatment 
with the antidepressants fluoxetine, iprindole and phenelzine. In 
the light of these studies such drug-induced change in rodent 
behaviour may also be indicative of increased social drive.
The relationship of these results to the general effects of acute and 
chronic treatment with antidepressants on rodent social behaviour and 
their implications with respect to published investigations by other 




Before attempting to evaluate the relevance of the effects of acute 
and chronic antidepressant treatment on the social behaviour and 
exploratory locomotor activity of rats, in the broad context of the 
current theories on the clinical mode of action of antidepresants and 
the aetiology of depression, it may be useful to summarise the aims 
and major conclusions of these studies.
The investigations described in chapters 5, 6 and 7 follow a logical
progression of thought.
The aim of the social interaction studies, described in chapter 5, 
was to compare the acute and chronic effects of psychotropic agents 
(principally examples of antidepressants) on the endogenous patterns 
of social behaviour of rats.
The results indicated that acute and chronic antidepressant treatment 
have diametrically different effects on endogenous patterns of social 
behaviour in rats.
Acute treatment with the antidepressants clomipramine, fluoxetine, 
iprindole, mianserin or phenelzine decreased aggressive behaviour 
exhibited by resident rats but concomitantly increased flight 
behaviour at doses which had little or no effect on the total number 
of behavioural elements observed during social interaction with an 
unknown conspecific. The antipsychotic haloperidol or the anxiolytic 
diazepam also reduced aggressive behaviour but only at doses which 
concomitantly decreased the total number of behavioural elements 
observed. Acute treatment with haloperidol also concomitantly
reduced f1ight-submit behaviour while diazepam concomitantly reduced 
environmental exploratory behaviour.
The broad effects on social behaviour observed following acute 
treatment with halopridol or diazepam suggested that such effects may 
be due to the onset of overt sedation. The data therefore implied 
that the selective effects on aggressive behaviour observed following 
acute antidepressant treatment may possibly be indicative of a 
specific effect on rodent social behaviour (i.e. reduced social 
drive) . At this stage of the investigation this suggestion was 
somewhat tentative for the following reason: the aggressive elements
of rodent social behaviour occur at the later stages of the 
behavioural pathways (Grant, 1963) and thus aggressive postures may 
simply be more sensitive to the sedative effects of psychotropic 
compounds. Such data per se may not therefore suggest that acute 
treatment with antidepressants has a specific effect on rodent social 
behaviour. Exploratory locomotor activity of rodents is known to be 
sensitive to the sedative effects of psychotropic agents (Brown et 
al., 1985) and this animal model was employed to assess the sedative
potential of these compounds.
Chronic treatment with the antidepressants, but not haloperidol or 
diazepam, at minimal effective doses on social behaviour when given 
acutely, increased the overt aggressive behaviour exhibited by 
resident rats without consistently affecting the total number of 
behavioural elements observed during social interaction. It was 
suggested that this change in rodent social behaviour may be 
indicative of increased social drive. This explanation was further 
examined by observing the effect of clomipramine or mianserin,
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administered chronically to subdominant rats, on the general 
hierarchical structure of grouped rats. An alternative explanation, 
however, was that such drug treatment simply increased the basal 
level of activity of the treated rats. This possibility was 
addressed by monitoring the exploratory locomotor activity rats 
following chronic treatment with the antidepressants or haloperidol.
The aim of the exploratory locomotor activity studies, described in 
chapter 6, was to assess the sedative potential of the 
antidepressants and haloperidol and diazepam following acute 
treatment. In addition, the ability of chronic antidepressant or 
haloperidol treatment to modify the basal level of exploratory 
locomotion of rats was examined.
Acute treatment with haloperidol and diazepam, but not the 
antidepressants, reduced exploratory locomotor activity at doses 
previously demonstrated to reduce both aggressive behaviour and the 
total number of behavioural elements exhibited by resident rats 
during social interaction. Since the doses of haloperidol and 
diazepam used in these studies were demonstrably sedative, it was 
concluded that the effect of these two compounds on the social 
behaviour of resident rats was due to the onset of overt sedation. 
Both haloperidol and diazepam exhibited equi-potent effects in their 
ability to reduce exploratory locomotor activity and the total number 
of behaviours observed during social interaction. Thus measurement 
of the total number of behaviours provides identical information 
regarding the sedative potential of compounds as the measurement of 
exploratory locomotion. The social interaction test therefore 
provides an inbuilt control for the incidence of overt sedation.
The reduction in aggressive behaviour observed following acute 
treatment with the antidepressants therefore appears to be a specific 
effect on rodent social behaviour.
Chronic treatment with either the antidepressants or haloperidol had 
no effect on the basal level of exploratory locomotor activity of 
rats. The increase in aggressive behaviour exhibited by resident 
rats during chronic antidepressant treatment therefore was not 
related to an increase in basal activity but, possibly, indicative 
of increased social drive. Whether such an effect could be 
attributed to increased social drive was examined in a more relevant 
animal model by studying the effect chronic treatment of subdominant 
rats with clomipramine or mianserin on the hierarchical structure of 
grouped rats.
The investigation involving assessment of the hierarchical structure 
of rats was designed under the premise that the rank position of an 
individual group member was indicative of that animals’ level of 
social drive. If the increase in overt aggressive behaviour 
exhibited by resident rats during chronic antidepressant treatment in 
the social interaction test was a manifestation of increased social 
drive then similar drug treatment should increase the relative rank 
position of an individual animal within a social group. The primary 
aim of this study, described in chapter 7, was therefore to examine 
the effect of chronic antidepressant treatment on a particular group 
members rank position.
Chronic treatment with clomipramine or mianserin increased the 
apparent success level of subdominant rats during social interaction
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with the conspecific group members at the expense of the success 
level exhibited by dominant rats. The subdominant animals receiving 
chronic drug treatment did not become the most dominant group member, 
rather such animals achieved parity of rank position with the 
formally dominant members. This study indicates therefore that the 
increased aggressive behaviour induced by chronic antidepressant 
treatment is indicative of increased social drive.
In conclusion, the diametrically different effects of acute and 
chronic antidepressant treatment on the endogenous patterns of social 
behaviour of resident rats are indicative of decreased and increased 
social drive respectively, which, in this species at least, is 
manifest by the appropriate changes in overt aggressive behaviour.
Moyer (1968) described 7 different forms of aggressive behaviour 
dependent on the current environmental and social situation (see also 
Eichelman, 1978).
1 Predatory; aggressive behaviour is evoked by the presence of a
natural object of prey, e.g. frog-attack and possibly muricide 
(mouse-killing) and filicide (pup-killing) by adult rats 
(Baenninger, 1978; Blanchard and Blanchard, 1977).
2 Intermale; aggressive behaviour directed at a male conspecific to
which the attacker has not become habituated, e.g. between male
conspecifics in the social interaction test and possibly muricide 
in rats. Also termed conspecific attack (Blanchard and Blanchard,
1977).
3 Fear-induced; usually preceded by attempts to escape and is
dependent on the degree of confinement of the defensive animal
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(also described as defensive aggressive), e.g. aggression 
exhibited by rats during non-evasive footshock and aggressive 
behaviour exhibited by intruder rats following investigation by 
resident conspecifics during social interaction.
4 Irritable; the stimulus for this type of aggressive behaviour is 
the presence of any attackable object or organism. Muricide, 
fil/icide and shock-induced aggression in rats may be included in 
this category.
5 Territorial; occurs in an area in which the animal has 
established itself. The territorial stimulus is essential to this 
aggressive behaviour and its intensity decreases as the attacking 
subject gets further away from its own territory or becomes 
habituated to the intruder. For example, isolation-induced 
aggression exhibited by resident rats in the social interaction 
test.
6 Maternal; usually exhibited by females in defence of the young.
7 Inst’umental; demonstrated by an increase in the tendency to 
engage in destructive behaviour when that behaviour has been 
reinforced in the past, e.g. shock-induced aggression in rats.
Aggressive behaviour may be categorised more simply into Affective 
and Predatory aggression depending on the incidence of accompanying 
marked sympathetic arousal (Eichelman, 1978; and references cited 
therein) .
The aggressive behaviour exhibited by resident rats following 
short-term isolation and directed at the conspecific intruder in the 
social interaction test is a composite of inter-male and territorial 
aggressive behaviour (since social interaction occurs between male 
conspecifics and in the resident animals’ home cage). Such
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aggressive behaviour has been termed affective aggression (Moyer,
1968; Eichelman, 1978) since it is associated with pronounced 
sympathetic arousal. Moyer’s classification of aggressive behaviours 
are not therefore mutually exclusive. While aggression may not be a 
unitary concept (Moyer, 1968; Bernstein and Moyer, 1970) the 
possibility exists that the different forms of aggressive behaviour 
differ only in their intensity and are dependent on the experimental 
situation (see Rodgers and Brown, 1976), implying that the 
underlying neuronal substrates mediating aggressive behaviour are 
common to each or at least intei— related.
The neuronal substrates controlling aggressive behaviour in the cat 
have been well reviewed by Clemente and Chase (1973). While the 
phylogenetic differences between the cat and rat are readily accepted 
both animals exhibit analogous behaviours related to aggression (both 
offensive and defensive) and flight in addition to homologous brain 
centres and neuronal circuits. It would not be unreasonable to 
assume some degree of similarity between the central systems 
controlling aggression in the cat to those systems in other 
vertebrates including the rat and man.
Electrolytic lesions of the amygdala reduce both shock-induced 
aggression (Anand et al, 1977; Eichelman, 1971; Vochteloo and
Koolhaas, 1987; where fighting, exhibited as stereotyped boxing 
behaviour, occurs between paired rats on electrical stimulation of 
the cage floor), and the level of social interaction and dominance 
in rats (Bunnell, 1966). In studies where more specific 
electrolytic lesions of the amygdaloid complex were produced 
Zagrodzka and Fonberg (1978) demonstrated that electrolytic lesions
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of the ventromedial, but not dorsolateral, amygdala abolished 
predatory behaviour in cats. In addition, an extensive study 
(Miczek et al., 1974) demonstrated that electrolytic lesions of the
periamygdaloid cortex, cortical amygdaloid nucleus or bed nucleus of 
the stria terminal is (the dorsal amygdaloid efferent pathway), but 
not lesions of the lateral or central amygdaloid nuclei, reduced or 
eliminated attacks or signs of dominance in fights induced by social 
isolation and food competition in rats, but had little or no effect 
on shock-induced aggression or muricide. Conversely, only lesions of 
the lateral or central nuclei reduced shock-induced aggression.
These observations are in contrast to those of Horovitz et al.
(1966), who had previously shown that centromedial lesions of the 
amygdala blocked muricide behaviour in rats, but in agreement with 
the experiments of Bermond (1982), where lesions of the stria 
terminal is and its bed nucleus resulted in reduced conspecific 
aggression. The findings of Miczek et al. (1974) suggest that 
decreased conspecific aggression may be ascribed to cortical nucleus 
damage, however their results may also reflect attenuated flight 
behaviour since Kemble et al. (1984) demonstrated that lesions in the 
medial area of the amygdala which spared the medial nucleus resulted 
in reduced flight behaviour of wild rats, while those lesions which 
included damage to the medial nucleus reduced defensive behaviour. 
Taken together these results indicate that the amygdala is intimately 
involved in the mediation of aggressive, flight and defence systems 
and that within the amygdala there is a high level of differential 
organisation of these behaviours.
Specific areas of the hypothalamus are also involved in the 
modulation of aggressive behaviour. Electrolytic lesions of the
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lateral hypothalamus reduces fighting in rats (Anand et al . , 1977),
while electrical stimulation induces predatory attack in cats 
(Hutchinson and Renfrew, 1966; Proshansky and Bandler, 1975;
Shaikh et al., 1984) and intraspecific aggression in rats (Mos et
al., 1982), and stimulation of the ventrolateral hypothalamus
elicits both muricide and filicide in rats (Woodworth, 1971). 
Proshansky and Bandler (1975) also demonstrated that electrical 
stimulation of the midbrain tegmental area mimicked, but unilateral 
electrolytic lesions of the mid-brain attack sites abolished, 
predatory attack resulting from hypothalamic stimulation. These 
results indicate a hypothalamic-midbrain interaction via the 
medial-forebrain bundle. In addition, Shaikh et al. (1985) showed 
that the predatory behaviour of cats induced by lateral hypothalamic 
stimulation may be suppressed by stimulation of the medial aspect of 
the tegmentum but facilitated by stimulation of the lateral 
tegmentum. Lesions of the ventromedial hypothalamus have been shown 
to increase shock-induced aggression in rats (Eichelman, 1971), 
which is supported by the observations of Olivier (1977) who 
demonstrated that rats with anterior ventromedial hypothalamic 
lesions exhibited increased defensive aggressive behaviours, similar 
to those behaviours seen in the shock-induced aggression test, while 
rats with posterior ventromedial hypothalamic lesions exhibited 
increased offensive intermale aggression. These results indicate 
that the anterior and posterior ventromedial hypothalamic areas exert 
inhibitory control over defensive and offensive aggressive behaviours 
respectively. Conversely, electrical stimulation of the 
ventromedial hypothalamus of cats has been shown to induce affective 
defensive aggressive behaviour in cats (Pott et al., 1987; Shaikh
et al., 1985). The work of Pott et al. (1987) suggests that
r
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behaviour induced by stimulation of the ventromedial hypothalamus may 
be modulated by the central gray such that the dorsal aspect 
suppresses affective defence while the ventral region facilitates 
such apparently aggressive behaviour.
Electrolytic lesions of the septum and hippocampus have been 
demonstrated to increase shock-induced fighting in rats (Eichelman, 
1971). The increase in shock-induced aggression following septal 
lesions is supported by the experiments of Anand et al. (1977).
Other areas within the CNS are also involved in maintaining the 
integrity of the aforementioned structures pertinent to the 
modulation of aggressive behaviour. The main and accessory olfactory 
bulbs send ipsilateral projections to the cortical amygdaloid region 
(Macrides and Davis, 1983). Surgical olfactory bulbectomy has been 
demonstrated to result in degenerating fibres in the anterior 
hippocampus, the corticomedial nuclei, of the amygdala, the bed 
nucleus of the stria terminal is and the pre-optic area of the 
hypothalamus associated with a series of behavioural changes 
characterised by hyperactivity and hyper-reactivity (Cairncross et 
al., 1979). Behaviourally, olfactory bulbectomy of rats has been
shown to induce muricide (Malick, 1976).
The amygdala, hypothalamus and septum also receive projections from 
the dorsal and medial raphe (Steinbusch and Nieuwenhuys, 1983). 
Electolytic lesions of both the dorsal and median raphe induce
muricide in rats (Grant et al., 1973) concomitant with reduced 5-HT
function in the forebrain. The dorsal and median raphe exercise
synergistic inhibitory control over muricide behaviour since if only
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one of the nuclei is lesioned then muricide does not occur; it is 
only when both nuclei are lesioned that muricide is induced (Vergnes,
1978).
In summary, the central structures controlling aggressive behaviour 
appear to be functionally and anatomically related. The focal 
structure in aggressive behavioural patterns appears to be the 
hypothalamus since its destruction disrupts both spontaneous and 
induced aggression. Different agonistic behavioural patterns may be 
elicited by electrical stimulation of specific areas of the 
hypothalamus. Thus attack behaviour may be induced by stimulation of 
the lateral and dorsomedial areas; defensive behaviour by 
stimulation of the ventromedial area of the anterior, middle and 
posterior nuclei; and flight behaviour by stimulation near or within 
the dorsomedial nucleus (Clemente and Chase, 1973). Lesion studies 
indicate that these hypothalamic nuclei are interconnected such that 
destruction of one of these areas results in the summated expression 
of behaviours resulting from the remaining areas. The amygdala 
modulates the activity of the ventromedial neurons of the 
hypothalamus via the inhibitory dorsal amygdaloid efferent pathway 
(stria terminalis), originating from cell bodies in the 
corticomedial nuclei of the amygdala, and the ventral amygdalofugal 
pathway, originating from cell bodies of the basolateral area of the 
amygdala (Shiosaka et al., 1983), which is initially excitatory but 
then inhibitory on neurons of the hypothalamus (Clemente and Chase,
1973). The septum inhibits general agonistic patterns by suppressing 
aggressive behaviour of both amygdaloid and hypothalamic origin. The 
mid-brain then relays the information from the hypothalamic/ 
amygdaloid/septal axis, presumably to the brain stem and common
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spinal paths for the visceral and somatic motor expression of 
behaviour.
5-HT, NA and DA (among other neurotransmitters) are known 
transmitters within the amygdala, hypothalamus and septum.
The 5-HT innervation of the amygdala arises from cell bodies located 
principally in the dorsal raphe nucleus while the noradrenergic and 
dopaminergic terminals probably originate from the locus coeruleus 
(LC) and ventral tegmental area (VTA) respectively. The hypothalamus 
receives serotonergic innervation from the median and dorsal raphe, 
noradrenergic input from the lateral tegmental cell bodies and 
dopaminergic innervation from the VTA. Lastly, the septum receives 
substantial noradrenergic input from both the lateral tegmental and 
dorsal medullary systems, and serotonergic input from the 
mesencephalic raphe nuclei via the ventral ascending (mesolimbic) 
pathway which enters the medial forebrain bundle in the lateral 
hypothalamus (Clemente and Chase, 1973; Cooper et al., 1978;
Lindvall and Bjorklund, 1983; Shiosaka et al., 1983; Silverman
and Pickard, 1983; Steinbusch and Nieuwenhuys, 1983).
The involvement of 5-HT, NA and, possibly, DA in the mediation of 
aggressive behaviour in rodents has also been suggested by both 
pharmacological and biochemical studies.
Para-chlorophenylaftiine (pCPA) reduces 5-HT levels in the CNS by 
irreversible inactivation of tryptophan hydroxylase (Jequier et al., 
1967), the rate limiting enzymic step of 5-HT biosynthesis. 
Administration of pCPA to rats induces predatory aggression directed
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at mice (Kreiskott and Hoffman, 1975) and frogs (McLain et al.,
1974) which may be so intense as to result in muricide (Berzsenyi et
al., 1983; Gibbons et al., 1978a; McLain et al., 1974; Miczek
et al., 1975; Paxinos et al., 1977; Rolinski, 1975b) and
filicide (Copenhaver et al., 1978; Miczek et al., 1975). Muricide
may also be induced following treatment with fenfluramine (Gibbons et 
al., 1978b) which is neurotoxic to cells of the raphe nuclei and
reduces brain 5-HT (Harvey et al., 1977). Conspecific aggressive
behaviour of male resident rats is also increased following pCPA 
administration (Rolinski, 1975b). In a study by Vergnes et al. 
(1986) pCPA was demonstrated to have different effects on offensive 
and defensive aggression. Thus resident rats treated with pCPA 
exhibited increasd aggressive behaviour directed at a conspecific 
intruder but had no significant effect on the level of aggression 
exhibited by the intruder animals. In addition, pCPA has been shown 
to have either little or no effect on shock-induced aggression (which 
is indicative of defensive aggressive behaviour) in rats (Conner et 
al., 1970; McLain et al., 1974) or to increase such aggressive
behaviour (Sheard et al., 1977). Furthermore, Sheard et al. (1977)
also demonstrated that low doses of LSD given peripherally, which
were previously demonstrated to inhibit the firing rate of raphe 
neurons and decrease the release of 5-HT, enhanced shock-induced 
aggression. Experiments examining the effect of serotonergic agents 
on shock-induced aggression should be treated with care since 5-HT 
plays an important role in the mediation of pain sensitivity.
Rodgers (1977) demonstrated that direct application of 5-HT to the 
corticomedial amygdala decreased, while the 5-HT2 antagonist 
methysergide increased, shock-induced aggression. 5-HT and 
methysergide were also shown to increase and decrease respectively
pain thresholds in the "f1 inch-jump" test. The serotonergic 
compounds therefore indirectly affected shock-induced aggressive 
behaviour by alterations in the animals sensitivity to the 
electroshock. Administration of pCPA has also been demonstrated to 
increase aggression in wild mice (Matte and Tornow, 1978) and 
potentiate the affective aggression exhibited by cats induced by 
electrical stimulation of the ventral-medial hypothalamus (Katz and 
Thomas, 1976). In these latter experiments the induction of 
offensive, but not defensive, aggressive behaviour appears to be 
associated with a marked reduction (by at least 80%) in the level of 
5-HT in the CNS. If 5-HT is intimately involved in the modulation of 
aggressive behaviour then pharmacological manipulation with agents 
which specifically restore or increase central 5-HT activity would be 
expected to reverse the effects of pCPA-treatment on aggressive 
behaviour.
Acute treatment with 5-HTP, the immediate precursor of 5-HT, 
reduces pCPA-induced muricide (Gibbons et al., 1978a; Kulkarni et
al., 1973; Miczek et al., 1975; Paxinos et al., 1977) and
filicide (Copenhaver et al., 1978). Muricide may also be reduced by
L-tryptophan, the dietary precursor of 5-HTP, and quipazine 
(Gibbons et al., 1978b). Ouipazine is an antagonist at 5-HT
terminal autoreceptors (5-HT1B binding site; Engel et al., 1986)
stimulation of which is thought to mediate 5-HT’s inhibitory effect 
on its own release (Conn and Sanders-Bush, 1987). Blockade of these
receptors by quipazine presumably leads to increased 5-HT release via 
inhibition of the negative feedback system. Furthermore, blockade 
of the 5-HT re-uptake system into presynaptic terminals of rat brain 
by fluoxetine, which results in increased synaptic concentration of
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5-HT, also reduces muricidal behaviour (Berzsenyi et al . , 1983;
Gibbons et al., 1978b). These results suggest an inhibitory effect 
of 5-HT over predatory and affective aggression (i.e. offensive 
behaviour) but little or no effect over defensive behaviour.
Intraventricular or intracerebral administration of 6-OHDA produces 
an extensive depletion of brain noradrenaline and dopamine and a 
degeneration of central catecholamine-containing neurons (Cooper et 
al., 1978). Rats treated intraventricularly with 6-OHDA exhibit
increased shock-induced aggressive behaviour (Sorenson and Gordon,
1975) suggesting that NA and/or DA may be involved in the expression 
of defensive aggressive behaviour. Conversely, McLain et al . (197*4) 
showed that treatment of rats with alpha-methy1-para-tyrosine (aMpT), 
which reduces the brain concentration of both NA and DA by inhibiting 
tyrosine hydroxylase (the rate limiting step in the biosynthesis of 
the catecholamines), had little or no effect on shock-induced 
aggression but effectively increased the frequency of muricide.
These conflicting results on shock-induced aggression may simply 
reflect the time-course and treatment regimes of both experiments. 
Sorenson and Gordon (1975) allowed a two week period to elapse before 
shock-induced fighting was assessed during which the chemical 
sympathectomy (destruction of the NA and DA nerve terminals) would 
allow denervative supersensitivity to develop, while McLain et al. 
(197*4) administered aMpT over a three day period to obtain maximal 
depletion of central catecholamine stores. In another series of 
experiments, Anand et al. (1977) demonstrated that 3h pre-treatment 
with reserpine, at which time the degranulation induced by reserpine 
would cause the release of both NA and DA, reduced shock-induced 
fighting while acute treatment with the dopamine agonist apomorphine,
the catecholamine precursor L-DOPA and amantidine (which increases 
the synthesis and release of DA) all increased fighting behaviour. 
Conversely, acute treatment with imipramine (which blocks NA 
re-uptake) reduced shock-induced fighting. In accordance with these 
observations, Geyer and Segal (1974) observed that 
intraventricularly administered NA decreased, while DA increased, 
shock-induced fighting in rats. These results indicate a 
facilitatory effect of DA, but an inhibitory effect of NA, in 
shock-induced fighting behaviour in rats. DA has also been 
implicated, albeit indirectly, in the facilitation of intermale 
aggressive behaviour in rats. Baggio and Ferrari (1983) demonstrated 
that intraperitoneal administration of lisuride (a dopamine agonist) 
induced fighting behaviour which was blocked by pre-treatment with 
haloperidol (DA antagonist) but not methysergide (5-HT2 antagonist).
The overall impression of recent investigations into the 
neurotransmitters controlling aggressive behaviour indicates that 
5-HT and NA e^ert an inhibitory effect over aggression while DA 
experts a facilitation of aggressive behaviour. However it should be 
remembered that other neurotransmitters, e.g. acetylcholine, GABA 
and numerous peptides, may also be involved in the modulation of 
aggressive behaviour (see Eichelman, 1979; Eichelman and Thoa,
1973; Poshivalov, 1982; Romaniuk and Golebiewski, 1977).
A reduction in central serotonergic and/or noradrenergic activity or 
an increase in dopaminergic activity thus invariably increases 
aggressive behaviour in rodents. Long term isolation of mice or rats 
results in marked changes in rodent behaviour (Valzelli, 1978;
Spevak et al., 1973). In mice isolated for H weeks the behavioural
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change is characterised by increased aggressive behaviour (DaVanzo et 
al., 1966) which appears to be associated with reduced 5-HT and NA
turnover and increased DA turnover (Valzelli, 1978) even though 
little or no change was observed in the brain levels of these 
monoamines (DaVanzo et al., 1966; Valzelli, 1974). Isolation of
rats from 2-3 weeks of age results in modified sexual and social 
behaviour by day 104-129 (Spevak et al., 1973) and by 10-12 months
of isolation the complex behavioural syndrome is characterised not by 
increased aggressive behaviour but, in part, by elevated locomotor 
activity (Garzon et al., 1979). In a study by Valzelli (1974) only
40% of adult male wistar rats showed muricide behaviour after 6 weeks 
of isolation, while other animals from this strain exhibited either 
"friendly” or "indifferent" behavioural patterns towards intruder 
mice. Sprague-Dawley or Buffalo strains of rat showed no aggressive 
(i.e muricide) behaviour. This study also demonstrated that, as 
with mice, isolation did not modify the levels of brain amines of 
muricidal rats, however, 5-HT turnover was reduced but NA turnover 
was increased while DA turnover was unchanged (Valzelli, 1974).
The biochemical changes induced by long term isolation which results 
in increased aggressive behaviour thus support the argument that 
aggressive behaviour may be associated with reduced central 
serotonergic and possibly noradrenergic activity or increased 
dopaminergic activity.
The current series of experiments have demonstrated different effects 
of acute and chronic treatment with examples of antidepresants on 
rodent social behaviour. Thus acute treatment reduced affective 
aggressive behaviour at doses which were not inherently sedative,
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while, conversely, chronic treatment increased aggressive 
behaviour. These antidepressant-induced effects on endogenous 
patterns of rodent social behaviour are indicative of decreased and 
increased social drive respectively. Likewise, it has previously 
been reported that acute treatment with examples of antidepressants 
and, in addition, amphetamine-1 ike compounds and antihistaminics 
selectively reduced muricide behaviour in rats at doses which were 
not associated with overt sedation (Horovitz et al., 1966).
Similarly Delini-Stula and Vassout (1979) demonstrated that 
non-sedative doses of antidepressants reduced both muricide behaviour 
in rats and long-term (4-8 weeks) isolation-induced aggression in 
mice but had little or no effect on shock-induced aggression in rats. 
In the same study examples of neuroleptics and anxiolytics (diazepam 
and oxazepam) only reduced aggressive behaviour (muricide and either 
isolation-induced fighting in mice or shock-induced aggression in 
rats respectively) at doses which were inherently sedative. Such 
results compare favourably with the results obtained in this study 
not only for the acute effects of antidepressant treatment but also 
for the effects of haloperidol and diazepam on rodent social 
behaviour. Acute treatment with antidepressants, stimulants, 
anticholinergics and antihistaminics have also been demonstrated to 
reduce muricide behaviour exhibited by both spontaneous killer rats 
and olfactory bulb lesion-induced killer rats (Malick, 1976), while 
acute treatment with fluoxetine demonstrably reduced pCPA-induced 
muricide behaviour in rats (Berzsenyi et al., 1983; Gibbons et al., 
1978b). In contrast to Delini-Stula and Vassout (1979), Crowley 
(1972) showed that acute treatment with the antidepressant imipramine 
(10 and 20 mg Kg-1) reduced shock-induced fighting, while Sheard et 
al. (1977) demonstrated that 5 mg Kg-1 of either clomipramine or
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desipramine reduced the LSD-induced potentiation of shock-induced 
aggressive behaviour at doses which did not affect shock-induced
5
aggression per se. The effects of tricyclic antidepresants on 
shock-induced aggression therefore appear to be somewhat equivocal.
The hyper-aggressive behaviour of mice following long-term isolation 
may be reduced specifically (i.e. at doses which show no 
neurotoxicity or locomotor impairment) by numerous pharmacological 
classes of compounds administered acutely (DaVanzo et al., 1966;
Malick, 1979), e.g. neuroleptics, antidepressants, 
anticholinergics, antihistaminics (effects of which may well be 
linked to associated anticholinergic activity) and drugs which either 
deplete 5-HT (i.e. pCPA) or are 5-HT antagonists (e.g. mianserin, 
methiothepin or methysergide). Conversely anxiolytics, sedatives or 
hypnotics, narcotic analgesics, muscle relaxants and 
anticonvulsants reduced aggression induced by long term isolation 
non-selectively (see also Valzelli et al., 1967). The ability of
acute treatment with pCPA to reduce aggressive behaviour in long term 
isolated mice (which is supported by Rolinski, 1975a) is surprising 
considering that similar treatment in non-isolated rodents induces 
aggressive behaviour. Similarly, aMpT also reduced aggressive 
behaviour in long term isolated mice (Rolinski, 1975a) but induced 
muricide in rats (McLain et al., 1974). These diametrically
different results are probably due to either species differences, 
the treatment regimes used or the biochemical changes in mice 
observed following long term isolation (Valzelli, 1978). As noted 
previously, long term isolation of rats (10-12 months) results in a 
complex behavioural syndrome where locomotor activity is elevated 
compared to non-isolated controls (Garzon et al., 1979). In
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isolated rats TCA’s (amitriptyline, clomipramine, desipramine and 
doxepin), atypical antidepressants (viloxazine and trazodone) and 
MAOI’s (phenelzine and clorgyline) all reduced the elevated locomotor 
activity at doses which did not modify rotarod performance (Garzon et 
al., 1979). Conversely, in the same studies, neuroleptics
(chlorpromazine and haloperidol) and anxiolytics (chlordiazepoxide 
and diazepam) had no effect at non-sedative doses.
Table 8.1 compares the relative potencies of the drugs examined in 
the current series of experiments to those on other models of 
aggressive behaviour quoted (where available) from the literature 
cited above. The table indicates that clomipramine and diazepam 
exhibit near-equal potencies on the various forms of aggressive 
behaviour. Fluoxetine, iprindole, mianserin (its potency on 
isolation-induced aggressive behaviour in mice excepted), phenelzine 
and haloperidol, however, are all far more potent (between 1 and 2 
orders of magnitude) on aggressive behaviour exhibited by resident 
animals during social interaction with an unknown conspecific 
intruder than on the other animal models of rodent aggressive 
behaviour. With only two exceptions, the cited studies administered 
each drug intraperitoneally compared to the subcutaneous route used 
in the current studies. However, it is not thought that the 
respective pharmacokinetic properties would explain the large 














































Table 8.1 Comparison of the IDso values of antidepressant drugs, 
haloperidol and diazepam on rodent aggressive behaviour.
IDso values; mg Kg-1 ip (unless route specified)
Species; rat (unless specified)
SI; social interaction studies (mg Kg-1 values were calculated from 
the umol Kg-1 values presented in the text)
*; pCPA-induced muricide
References cited, a, Berzsenyi et al. (1983); b, DaVanzo et al. 
(1966); c, Delini-Stula and Vassout (1979); d, Gibbons et al. 
(1978b); e, Horovitz et al. (1966); f, Malick (1979) and 
references cited therein
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The results of the present study generally confirm those of other 
workers that acute treatment with antidepressants specifically 
reduced aggressive behaviour in rats without inducing motor 
impairment. It should be noted, however, that this study has 
demonstrated such drug-induced effects without resorting to the 
extreme methods of inducing aggressive behaviour such as pCPA-, 
aMpT- or olfactory bulb lesion-induced muricide, shock-induced 
aggression or aggression resulting from long-term isolation. In 
addition, the social interaction test as described in this thesis 
appears to be an extremely sensitive measure of the effects of acute 
psychotropic drug treatment on endogenous patterns of rodent social 
behaviour and especially sensitive to the anti-aggressive properties 
of psychotropic compounds following acute treatment than other animal 
models of aggression.
Whether the antidepressant-induced reduction in aggressive behaviour 
is a specific effect only exhibited by the antidepressants is open to 
question since similar drug-profiles have been obtained for examples 
of amphetamine-1 ike compounds, anticholinergics and antihistaminics 
(Horovitz et al., 1966; Malick, 1976). The anti-aggressive
properties of psychotropic compounds have often been used as an 
argument for their potential anxiolytic activity, e.g. McMillen et 
al. (1987) extolled the anxiolytic potential of gepirone after 
identifying its anti-aggressive properties on the behaviour of 
long-term isolated mice. If this argument is valid then the 
specific reduction in aggressive behaviour observed following acute 
antidepressant treatment in these studies would be indicative of 
anxiolytic activity. As Rodgers and Waters (1985) have argued, and 
in consideration of the effects of numerous classes of psychotropic
282
drugs on the different forms of aggressive behaviour expressed by 
rodents outlined above, to employ the drug-induced inhibition of 
aggressive behaviour per se as an argument for anxiolytic activity 
is invalid. No claim is therefore made that the specific effect of 
on rodent social behaviour observed in these studies following acute 
antidepressant treatment is indicative of anxiolytic activity.
It is widely accepted that in the clinic at least 2-3 weeks of 
continuous antidepresant treatment is required before any beneficial 
effects may be observed (Oswald et al., 1972). It is thus 
remarkable that pharmacologists/biochemists in general have largely 
ignored this fact and have been quite content to theorize on the mode 
of action of antidepressants on the basis of animal studies utilizing 
acute drug-treatment regimes. Very few extensive studies on the 
effect of chronic antidepressant treatment on rodent social behaviour 
(in its many guises) have therefore been published. Even so, a 
surprisingly clear picture emerges given the paucity of published 
data (see by Vogel et al., 1986).
Valdman and Poshivalov (1986) demonstrated that chronic (7 day) 
treatment of mice with fluoxetine and iproniazid (both at 10 mg Kg-1 
day-1) largely restored intraspecies social behaviour during social 
interaction following behavioural depression induced by reserpine.
In the same studies, similar treatment regimes with trazodone, 
pyrazidol and clomipramine (but not zimelidine) reversed both the 
suppression of aggressive behaviour and the increased defensive 
behaviour of dominant mice induced by nociceptive electrical 
stimulation given repeatedly over 1M days. Likewise, the social 
interaction experiments of Wiliner et al. (1981) showed that rats
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treated chronically (7 day) with desipramine (20 mg Kg 1 day 1) were 
more likely than controls to attack a conspecific intruder.
Elevated aggressive behaviour has also been observed in the 
shock-induced fighting model following chronic treatment of rats with 
antidepressants. Prasad and Sheard (1982) showed that rats treated 
with desipramine (15 mg Kg-1 day-1) exhibited increased fighting 
after 14 days of treatment. Conversely, lithium reduced fighting 
behaviour when administered over 14 days via the drinking water (20 
mEq L-1) . Similarly, Mogilnicka and Przewlocka (1981) demonstrated 
increased shock-induced fighting in rats that had received 10 days 
treatment with 10 mg Kg-1 day-1 (given twice daily) of amitriptyline, 
imipramine, iprindole or mianserin. Increased shock-induced 
aggressive behaviour was also observed by Eichelman and Barchas 
(1975) following 3-5 days of treatment with imipramine, 
amitriptyline and desipramine (10 mg Kg-1 day-1) and from 30 hours 
following the start of treatment with the MAOI's iproniazid (150 mg 
Kg-1 day-1), nialamide (100 mg Kg-1 day-1) and pargyline (20 mg Kg-1 
day-1). Although it has previously been argued that shock-induced 
aggressive behaviour of rats by electro-shock is indicative of 
defensive behaviour this should not be taken to indicate increased 
submission, rather, such behaviour is indicative of aggressive 
activity but in the defensive context. It should be noted here that 
during social interaction rats treated chronically with desipramine, 
although more likely to attack the conspecific intruder, were also 
more likely to submit when attacked (Wiliner et al., 1981). At odds
with these observations is the report by Cairncross et al. (1979) 
which indicated that the hyperactivity and hyper-reactivity induced 
by olfactory bulbectomy were reversed (i.e. animals became
normalised) following chronic <10-14 day) treatment with 
amitriptyline, iprindole, mianserin, nomifensine and viloxazine 
but not with the MAOI tranylcypramine. It should also be noted, 
however, that sham-operated rats exhibited higher irritability 
scores following chronic treatment with mianserin (5 mg Kg-1 day-1) 
than those receiving saline control.
Maj and co-workers have extensively studied the effect of acute and 
chronic psychotropic drug treatment on the aggressive behaviour of 
mice and rats induced by acute treatment with clonidine 
(alpha-adrenoceptor agonist) or apomorphine (DA agonist) 
respectively. In their mouse studies ** mice (from the same home 
cage) were placed in a glass cylinder immediately following treatment 
with clonidine, 20 mg Kg-1, and the number of biting attacks 
observed over 1 hour recorded. In the rat studies 2 rats (from the 
same home cage) were paired in wire cages 10 min. after treatment 
with apomorphine, 5 mg Kg-1, and the number of fighting pairs 
recorded. Fighting behaviour in rats was defined when both rats 
assumed a mutual upright (boxing) posture, identical to that 
observed during shock-induced aggression, or when one rat forced its 
partner to adopt a submissive posture. These studies (Maj, 1984;
Maj et al., 1979; 1980; 1981; 1982) showed that chronic (14 day)
treatment with TCA’s, MAOI's and atypical antidepressants invariably 
increased clonidine- and/or apomorphine-induced aggressive behaviour 
at doses that either reduced drug-induced aggressive behaviour or had 
no effect when given acutely. The only exceptions were observed in 
the mouse experiments with antidepressants which reportedly exhibit 
5-HT specificity, i.e. fluoxetine, which decreased 
clonidine-induced aggressive behaviour following acute and chronic
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treatment; citalopram, which reduced aggressive behaviour after 
acute administration but had no effect when given chronically; and 
fluvoxamine, which had no effect following acute or chronic 
administration. Interestingly, the serotonin antagonist, 
pizotifen, and the neuroleptics, thioridazine and 
trans-flupenthixol, also increased clonidine-induced aggressive 
behaviour when given chronically; this effect was thought by Maj and 
co-workers to be due to the noradrenolytic activity possessed by 
these compounds (Maj et al., 1982). Clonidine-induced aggressive
behaviour in mice is thought to be mediated via alpha1-adrenoceptors 
(sic) and thus the potentiation of such behaviour observed following 
chronic antidepressant treatment was argued to be due to enhanced 
central noradrenergic activity (Maj, 198H). These workers also 
observed that the potentiation of apomorphine-induced fighting 
behaviour observed following chronic amitriptyline treatment could be 
blocked by acute treatment with either phenoxybenzamine 
(alpha-adrenoceptor antagonist) or spiperone (DA antagonist) but not 
by metergoline (5-HT2 antagonist). In addition, acute treatment 
with phenoxybenzamine potentiated, while spiperone blocked, the 
apomorphine-induced stereotypy exhibited by rats treated chronically 
with amitriptyline. On the basis of the antagonist activity of 
phenoxybenzamine it was argued that the potentiation of 
apomorphine-induced fighting by chronic antidepressant treatment was 
due to increased noradrenergic transmission (Maj et al., 1979). The
mechanism(s) involved in the mediation of apomorphine-induced 
aggression, however, are far from clear. For example, small doses 
of clonidine (0.125 mg Kg-1) are sufficient to potentiate 
apomorphine-induced aggression (Gianutsos et al., 1976).
Furthermore, both morphine and the neuroleptics haloperidol and
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oxyperomide demonstrably decrease such behaviour and, while the
effect of morphine is sensitive to naloxone, the anti-aggressive
properties of oxyperomide may be blocked by the cholinergic
antagonist dexetimide or potentiated by the muscarinic agonist
pilocarpine (Gianutsos and Lai, 1976). The initial impressions from
the work of Maj and co-workers are encouraging since these workers
appear to have identified a degree of commonality between the
chemically-disparate group of compounds labelled antidepressant,
with the exception of those compounds with serotonergic specificity
(i.e. fluoxetine, fluvoxamine and citalopram). These animal models
of aggression may well prove to be invaluable in identifying
potential antidepressants whose effects are mediated via changes in
e
noradrenergic, but not serotonergic, transmission. Unfortunatly, 
however, the work of Maj and co-workers is open to criticism. None 
of the published experiments quoted above appear to be adequately 
controlled since all these reports failed to indicate the effect of 
chronic psychotropic drug treatment per se on the aggressive 
behaviour of mice or rats using their experimental methods. 
Conversely, the present study has demonstrated that chronic 
antidepressant treatment per se promotes aggressive behaviour in 
rats. The apparent potentiation of clonidine- or apomorphine-induced 
aggressive behaviour identified by Maj and co-workers following 
chronic antidepressant treatment may therefore simply be due to an 
additive effect of the two treatment regimes on rodent behaviour 
induced by separate mechanisms.
All of the chronic drug-treatment studies cited above employed one or 
more of the antidepressants examined in the current series of 
experiments. In each case, however, the drug in question was
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administered via bolus intraperitoneal injection at 10 mg Kg-1 either 
daily over 7 days (clomipramine and fluoxetine; Valdman and 
Poshivalov, 1986) or 10 days (iprindole and mianserin; Mogilnicka 
and Przewlocka, 1981; clomipramine, iprindole and mianserin; Maj 
et al., 1979) or bi-daily (iprindole and mianserin; Maj et al . ,
1980; fluoxetine, Maj et al., 1981). No comparable data is
available for phenelzine. In the social interaction experiments 
reported here, however, resident rats received mini-osmotic pumps 
implanted subcutaneously in order to administer target doses (defined 
as the minimally-effeetive dose identified when given acutely) 
continuously over 2H hours, i.e. clomipramine (3.1H mg Kg-1 day-1), 
fluoxetine (0.3H), iprindole (0.86) and mianserin (0.087); the mg 
Kg-1 values were calculated from the umol Kg-1 values reported in the 
text. With the exception of clomipramine, the antidepressants 
examined demonstrably increased the aggressive behaviour of resident 
rats at doses between 1-2 orders of magnitude lower than those 
employed in the cited literature. The social interaction test 
therefore appears to be a more sensitive test of the effects of 
chronic antidepressant treatment on rodent behaviour than those 
animal models cited above.
The results of the present study generally confirm those of other 
workers that chronic treatment with the chemically-disparate 
antidepressants specifically increases aggressive behaviour in rats. 
As with the acute drug-treatment social interaction studies, 
however, such drug-induced changes in rodent behaviour were observed 
without resorting to extreme models of inducing (or reducing) 
aggressive behaviour. In addition, the level of aggression 
exhibited by resident rats during social interaction appears to be an
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extremely sensitive measure of the ability of chronic antidepressant 
treatment to increase social drive. Indeed, as discussed in the 
review by File and Tucker (1986), aggression is the only type of 
rodent social behaviour consistently increased following chronic 
treatment with antidepressants; no clear generalisation of effect 
has been observed in studies examining the effect of chronic 
antidepressant treatment regimes on drug-discrimination, measures of 
reward and punishment (intracranial self-stimulation or intake of 
food and water), exploratory locomotion or the various measures of 
the response to acute or chronic stress.
As previously discussed, aggression in rodents may be induced by 
reducing central 5-HT and/or noradrenergic activity or increasing 
dopaminergic activity, or, conversely, reduced by increasing 
central 5-HT and/or noradrenergic function or decreasing dopaminergic 
activity. By implication therefore, the inhibitory effects of acute 
antidepressant treatment on rodent aggression may be associated with 
an ability to increase serotonergic and/or noradrenergic function 
which (with the exception of iprindole, where the acute mode of 
action has yet to be elucidated) is in accordance with the accepted 
modes of action of the majority of antidepressants, i.e. inhibition 
of transmitter re-uptake or MAO activity, or blockade of pre-synaptic 
alpha2-adrenoceptors (mianserin) all of which result in increased 
synaptic concentration of the neurotransmitter. In addition, the 
argu/ment also implies that increased aggressive behaviour induced by 
chronic antidepressant treatment is associated with decreased 
serotonergic and/or noradrenergic function or increased dopaminergic 
activity. Before discussing the implications of such findings to the 
commonly-accepted theories on the aetiology of depression it is
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pertinent at this juncture to attempt to relate the observed 
behavioural changes induced by acute and chronic antidepressant 
treatment in rodents to the clinical efficacy of such compounds used 
in the treatment of affective disorders.
Prior to successful clinical treatment depressed patients are unable 
to cope with the everyday stresses of normal life but as the 
treatment progresses so the individual’s responses to external 
environmental and social stimuli change. It has long been thought by 
psychiatrists that at least part of the symptomology of depression is 
manifest as inwardly-directed aggression, i.e. aggression directed 
against oneself, the ultimate expression of which is suicide. One 
measure which attempts to quantify the relative levels of inwardly- 
and outwardly-directed aggression is the Hostility and Direction of 
Hostility Questionnaire (HDHQ; see Priest et al., 1980, and
references cited therein). Data arising from the HDHO is grouped 
into 2 intropunitive scales (i.e. self-criticism and guilt) and 3 
extrapunitive scales (i.e. urge to act out hostility, criticism of 
others and projected hostility). Depressive illness is associated 
with relatively high levels on the intropunitive scales compared to 
those on the extrapunitive scales. A reduction in the intropunitive 
aspects of depression (such that the scores become biased towards the 
extrapunitive scales) is associated with remission from the illness. 
Kaplan et al . (1961) took the argument one stage further. They 
suggest that increased outwardly-directed aggression, manifested as 
increased physical and/or verbal activity associated with greater 
interaction with the environment and usually of a constructive 
nature, is an integral component of the recovery process from 
depression. Such changes in the patient’s response to external
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stimuli only occur during chronic antidepressant treatment and are 
not normally observed until 10-20 days of drug treatment have elapsed 
(Oswald et al., 1972). Although the argument involves a degree of
anthropomorphism the parallel between the observations of Kaplan and 
Priest and their respective co-workers to the data presented in this 
report is clear; chronic treatment with antidepressants increase 
certain manifestations of aggressive behaviour in both rodents and 
depressed human patients. If the parallel to the clinical situation 
were complete then would not acute treatment with antidepressants 
(i.e. the initial doses of clinical treatment), which in rodents 
decreases aggressive behaviour, exacerbate the depressive 
symptomology ?, and is there any evidence of such acute effects in 
the clinic ? Oswald et al. (1972) suggest that indeed this is the 
case. 12 normal male and female young adults indicated that during 
the first week of imipramine. 75 mg, administration they felt 
depressed in mood. By the third week of administration, however, 
their self-rated mood had returned to normal. In comparison, 
depressed patients frequently complain of feeling worse during the 
initial stages of drug treatment, but such complaints are either 
ignored, and categorised as side-effects (Oswald et al., 1972), or
simply not registered because of the inadequacies of the clinical 
rating system of depression used. The Hamilton Rating Scale (HRS; 
Hamilton, 1950) has been the most widely used method of assessing 
the severity of depression since its inception. Ratings are based on 
clinical interview which aims to cover the preceding week and 21 
items, including both mental and physical symptoms, are scored and 
the values summed to produce an overall rating of the severity of 
depression. Two major criticisms may be levelled at this method. 
Firstly, ratings cannot be made more frequently than at weekly
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intervals and, secondly, since the overall rating is a summation of 
scores, opposing movements of individual scores are hidden. Thus 
any increase in depressed mood, guilt or suicidal tendancy 
(indicative of increased depressive symptomology) may be effectively 
masked by reduced intensity of the somatic symptoms and increased 
drive. No net change in the HRS score is therefore seen until the 
majority of items show improvement and this probably accounts for the 
apparent lack of effect experienced during the initial stages of 
antidepressant therapy. A rating scale such as the HRS is therefore 
incapable of identifying specific changes in the individual items 
associated with the symptomology of depression especially during the 
initial stage of treatment. It is now accepted by some 
psychiatrists, however. that a potentially hazardous situation may 
arise during the initial stages of antidepressant treatment where the 
drive of a depressed patient is restored while the feelings of 
pessimism and hopelessness remain (Priest et al., 1980). With the
resurgence of activity a suicide attempt becomes a possibility 
especially during the early stages of treatment.
It may be argued, therefore, that the drug-induced changes in 
rodent social behaviour following both acute and chronic 
antidepressant treatment correspond quite closely to the time-course 
of antidepressant effects observed in the clinic. In addition, it 
has been argued (see above) that the increase in social drive, which 
in rats at least is manifested as increased aggressive behaviour, is 
associated with reduced serotonergic and possibly noradrenergic 
activity or increased dopaminergic activity in the brain. The 
argu/ment therefore implies that prior to antidepressant therapy 
central serotonergic/noradrenergic activity is abnormally high,
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while that of the central dopaminergic systems may be relatively 
reduced. If the argument is limited to the central pre-synaptic 
effects of antidepressants then it appears to oppose the classical 
theories on the monoamine hypothesis of depression postulated by 
Coppen (1967) and Schildkraut and Kety (1967) which, based on the 
ability of tricyclic antidepressants and MAOI’s to increase the 
synaptic concentration of central neurotransmitters, state that 
depression may be due to underactive serotonergic/noradrenergic 
systems (see section 1.6.2). The classical theories of depression, 
however, are based solely on pre-synaptic events and ignore both the
latency of clinical effect experienced with these drugs and the
plasticity of central monoaminergic systems. It must be assumed that 
administration of antidepressants over a long period of time modifies 
the relative balance of events involved in monoaminergic 
neurotransmission, thereby altering the net level of activity of the
neuronal network, which, at the synaptic level, is dictated by the
post-synaptic receptiveness and sensitivity of the second messenger 
systems (e.g. adenylate cyclase and phosphoinositidase C activity) 
regardless of the level of transmitter release. It has been 
demonstrated that chronic, but not acute, treatment with tricyclic 
antidepressants leads to decreased accumulation of cAMP stimulated by 
exogenous NA in rat cortical (Frazer and Mendels, 1977) and limbic 
(Vetulani et al., 1976a) structures. These observations indicate
either reduced sensitivity of receptors linked to the stimulatory 
G-protein of the adenylate cyclase second messenger system, i.e. 
beta-adrenoceptors (Lefkowitz and Hoffman, 1980; Strosberg et al., 
1982), or increased sensitivity of receptors linked to the 
inhibitory G-protein of the same system, e.g. alpha2-adrenoceptors 
(Exton, 1982) or 5-HT1A/1B/1D receptors (Conn and Sanders-Bush,
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1987; Fozard, 1987). Down-regulation of central beta-adrenoceptors 
alone would therefore account for the reduced accumulation of cAMP 
stimulated by exogenous NA, and indeed reduced beta-adrenoceptor 
number have been observed following chronic treatment with 
amitriptyline, desipramine. doxepin, imipramine, iprindole, 
mianserin and pargyline (Banerjee et al., 1977; Mishra et al.,
1980; Peroutka and Snyder, 1980). In addition, Crews and Smith 
(1978) showed that chronic treatment with desipramine decreased the 
sensitivity of pre-synaptic alpha2-adrenoceptors which mediate the 
negative feedback system regulating the release of further 
transmitter. Thus down-regulation of pre-synaptic 
alpha2-adrenoceptors or continual blockade of these receptors by, 
for example, mianserin would lead to the increased outflow and hence 
synaptic concentration of NA resulting in post-synaptic 
beta-adrenoceptor subsensitivity.
Likewise post-synaptic 5-HT2 receptors, linked to the stimulatory 
G-protein of phosphoinositidase C system (Minchin, 1977; Fozard, 
1987), are also down-regulated by chronic treatment with 
amitriptyline, desipramine, imipramine, iprindole and pargyline 
(Peroutka and Snyder, 1980), probably in response to the increased 
synaptic concentration of serotonin.
'to
For both central noradrenergic and seronergic systems, therefore, 
there is evidence of down-regulation following chronic antidepressant 
treatment, implying that in depression the second messenger systems 
may be relatively over-sensitive to endogenous NA or 5-HT. The 
antidepressant-induced beta-adrenoceptor and/or 5-HT2 receptor 
subsensitivity therefore indicate a return to normality. This latter
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hypothesis on the underlying causes of affective disorders and the 
mode of action by which antidepressants produce amelioration of 
depression provides the basis of the alternative monoamine hypothesis 
first forwarded by Vetulani, Sulser and colleagues (Vetulani et al., 
1976a; Sulser et al., 1978; see also section 1.6.2). The relative
merits of both the classical and alternative hypotheses have been the 
topic of major discussion in the literature (e.g. van Praag,
1981a) and the overriding impression is that the two hypotheses have 
each been treated as mutually exclusive. In fact both hypotheses may 
be mutually complementary. If the second messenger systems in 
depression are indeed over-sensitive to the synaptic transmitter 
levels then negative feedback systems would come into play to reduce 
further transmitter release. To re-dress the balance post-synaptic 
receptor stimulation must first be increased (by, for example, 
increasing the synaptic concentration of the endogenous 
neurotransmitter, thus giving rise to the classical hypothesis) in 
order to induce down-regulation of the post-synaptic receptors, 
thereby reducing the sensitivity of the second messenger systems 
(i.e. alternative hypothesis) to a level lower than that prior to 
antidepressant treatment.
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CHAPTER 9 CIRCADIAN RHYTHM OF LOCOMOTOR ACTIVITY IN RATS
CHAPTER 9 CIRCADIAN RHYTHM OF LOCOMOTOR ACTIVITY IN RATS
9.1 Introduction
The clinical evidence implicating circadian rhythm abnormalities in 
affective disorders, which led to the suggestion by some workers 
that certain forms of depression may be produced by a disruption or 
de-synchronization of circadian rhythms (Wehr and Wirz-Justice,
1982; Wehr et al., 1982; Kripke, 1983; Wehr, 1988), have
already been described (see section 1.6.3). These observations led 
Wehr and Wirz-Justice (1982) to propose that if phase-advances of 
circadian rhythms were a primary pathophysiological mechanism of some 
depressive states then the clinical efficacy of antidepressants may 
depend on an ability to induce a phase-delay in those circadian 
systems abnormally advanced.
The presence of a circadian rhythm in the locomotor activity of 
rodents is well established and has been shown to be modified by some 
antidepressant drugs. Thus, clorgyline, imipramine and lithium 
carbonate have each been demonstrated to lengthen the free-running 
activity rhythm of hamsters (Wirz-Justice and Campbell, 1982; 
Wirz-Justice, 1983, and references cited therein) or blinded rats 
(Kripke and Wyborney, 1980). In addition, imipramine promoted the 
dissociation of the activity rhythms (Wirz-Justice and Campbell, 
1982). Whether the ability to induce a phase-delay or dissociation 
in certain circadian rhythms is an ability shared by the group of 
compounds labelled antidepressant has not been established. The 
purpose of the following experiments was to determine whether the 
antidepressants clomipramine, fluoxetine and mianserin shared the 
ability to modify circadian rhythmicity by examining the effect of 
chronic treatment with these compounds on the free-running circadian
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locomotor activity rhythm of rats.
9.2 Materials and Methods
9.2.1 Subjects
Male Wistar rats, 175-200g at the start of each experiment, were 
taken from stock and housed either singly or in groups of three in 
the respective locomotor activity monitors (see section 4.3 and 4.4) 
In the case of the grouped experiments the animals within each group 
were weight-matched.
9.2.2 Experimental Design
When monitoring the overall circadian locomotor activity of animals 
maintained in isolation or in groups it is important to use a 
reliable, robust system that provides an accurate measure of 
activity, together with control over the environmental conditions, 
while still allowing the animals to exhibit their normal behaviour 
patterns. Various behavioural parameters have been used to study 
circadian activity in rodents (e.g. locomotor activity, feeding and 
drinking behaviour) the most common of which appears to be locomotor 
activity. Different tools have been used to measure circadian 
locomotor activity (e.g. running wheels, horizontal activity 
electromagnetic sensors) but such systems may influence the results 
of animal experiments for free-running rhythms (Yamada et al.,
1986). The use of infrared photocells to obtain an index of 
locomotor activity in both acute and long-term studies is becoming 
more common and such a system has been used in the following studies 
Infrared photocell systems have advantages over other locomotor 
activity monitors in that they do not require excessive exercise as
with running wheels, nor are they so sensitive as to record periods 
of activity not associated with locomotion, such as a change of 
resting body posture or grooming activity, which may be a problem 
with sensitive electromagnetic sensors. For a description of the 
infrared photocell systems used in these studies together with the 
practical considerations required when using such systems see section 
4.4.2.
9.2.2.1 Environmental Cabinets
All experiments described in this chapter were performed with the 
subjects housed iq environmental cabinets, described in section 
4.3., containing the relevant locomotor activity monitor (section
4.4.2) .
9.2.2.2 Measurement of Locomotor Activity
Details of the programmes used to capture, store and analyse 
circadian locomotor data have been presented by Marshall et al. 
(1985); see also section 4.4.2.4. In all of the following 
experiments activity scores were aggregated every 15 min throughout 
the duration of each experiment and stored on floppy-disk for 
analysis at a later date.
9.2.2.3 Drug Treatment
Drugs were administered orally via the drinking water. Where animals 
were housed individually, water consumption was measured every 2-3 
days, taking care not to disturb the subjects. In the case of 
grouped animals, water consumption was usually measured daily since 
the reservoir was positioned externally to the environmental cabinet. 
In all cases the concentration of the drug solution provided was
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modified according to the daily volume consumed since the previous 
measurement together with the assumed weight gain of the subjects 
during the duration of each experiment (obtained from previously 
determined growth-curves) in order to approach as closely as possible 
the desired dosage. In the grouped experiments the drug 
concentrations were calculated on the basis of the assumed total 
weight of the group with the further assumption that drinking volume 
was evenly distributed between the subjects. The daily target dosage 
of each test drug used in these studies (i.e. clomipramine, 20 mg 
Kg "“1 base; fluoxetine, 2 and 6 mg Kg-1 pfb and mianserin, 2 mg 
Kg-1 base) was based on previous data for clomipramine (Martin,
1982), the relative potency on rodent social behaviour (see sections
5.5.2 and 5.5.3), and estimates of clinical equivalence (see section 
3.3). Clomipramine and mianserin were administered for at least 20 
days while fluoxetine was administered for at least 30 days. All 
drugs were presented as described in section 4.6. Prior to and 
following drug treatment all animals received polished water (as 
defined in section 4.6) as the standard drinking solution. In 
control studies animals received polished water throughout the 
duration of the experiment. The effect of chronic treatment with 
each drug was examined on at least two occasions in both isolated and 
grouped animals.
9.2.2.4 Duration of Experiments
As discussed previously (sections 3.2 and 9.2.2.3) the duration of 
each experiment was determined not only by the duration of drug 
treatment but also by the data requirements of the Time-Series 
analysis employed (see also section 9.2.3).
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Thus each experiment was divided into blocks of data (each of at 
least 10 days in duration) as follows;







D : D 





Drug (clo, mian, fluox)
Drug (clo, mian, fluox)
None (Post-dose; clo, mian) 
Drug (fluox)
None (Post-dose; fluox)6 D:D
L:D; Normal lighting (12h/12h, lights on 0700 or 0800)
D:D; Constant dark (isolated animals) or constant low-intensity red
light (6 lux; grouped animals),
clo, clomipramine; mian, mianserin; fluox, fluoxetine.
In some experiments the initial 10 day period of L:D was omitted. 
Generally, both isolated and grouped animals were allowed a few days 
acclimatization to the respective activity monitor under L:D 
conditions. Following the post-drug monitoring period all animals 
were maintained under L:D or D:L (i.e. reverse-1ighting conditions) 
prior to the termination of the experiment.
9.2.3 Data Analysis
Circadian locomotor activity experiments produce a plethora of data 
which must be collated and analysed. In addition some means of 
visual representation of the data must be produced. In these studies 
the data has been presented graphically by means of actograms 
(section 9.2.3.1) or by subjecting the data to Time-Series 
(periodogram) analysis to identify the periods of rhythmicity of 
locomotor activity (section 9.2.3.2). For brevity, the graphical
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representations of the data or spectral analysis will only be 
provided to illustrate particular results.
9.2.3.1 Actograms
An actogram is a visual display of the data activity distribution 
over 2Hh, double-plotted to facilitate visual inspection. Each bar 
in the actogram represents a sampling interval where the number of 
locomotor activity counts are equal to or higher than the 
predetermined threshold. Actograms using a constant threshold value 
produce a high-pass filter effect on the data. This may be perfectly 
satisfactory where the distribution of data is constant from day to 
day. The use of actograms employing a constant threshold on data 
where the daily distribution of the data changes is open to 
criticism, however, since the threshold may be set in order that 
the actogram produces the impression of circadian activity required 
by the experimenter. A far more acceptable method of producing 
actograms is to allow the data to determine the threshold level on 
which the actogram is plotted. This may be achieved by determining 
either the mean or semi-quartile values of the activity distribution 
calculated over a predetermined period (e.g daily) of the experiment. 
Circadian locomotor activity data is highly skewed (see appendix B.H) 
and for this reason the use of the mean of daily activity as the 
threshold value is unacceptable. The actograms presented in these 
studies employed the calculated daily median of locomotor activity as 
the threshold of activity from which the actogram was plotted.
9.2.3.2 Time-Series analysis
A time series is a collection of observations made sequentially in 
time. In these studies the applicability of two methods of
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time-series analysis, i.e. periodogram analysis and autocovariance 
function analysis, have been applied to circadian locomotor activity 
data. A simple derivation of the relevant equations is given in 
appendix B, together with a short discussion on the merits of each 
method.
Autocovariance function analysis assumes that the data is normally 
distributed (i.e. equally distributed about the sample mean). 
Circadian locomotor activity data arising from both individual and 
grouped animals are highly skewed however, and thus the raw data 
obtained in these studies must be transformed in order to normalize, 
as far as possible, its distribution (see appendix B.H). Only then 
may this method of time-series analysis be applied. Cube-root 
transformation invariably normalizes the distribution of the data 
arising from grouped animals but also results in a drastic reduction 
in the magnitude of the locomotor activity peaks. The resulting 
flattening of the activity profile reduces the ability of this method 
to identify significant periods of rhythmicity. In addition, in the 
studies described here the magnitude of the data arising from 
individual animal experiments is poor such that the majority of 
epochs contain zero measures of locomotor activity; root 
transformation of the data does not result in normalizing the 
distribution and is thus not applicable. The use of autocovariance 
function analysis to either raw locomotor activity data or following 
cube-root transformation is therefore highly questionable.
Conversely, periodogram analysis makes no assumption on the 
distribution of the data and thus may be applied to the raw data.






During L:D conditions all isolated rats exhibited an entrained 
circadian rhythm of locomotor activity with a fundamental period of 
between 23.75h and 24.75h as determined by periodogram analysis 
(Table 9.1). Visual inspection of the actograms (an example of which 
is given in Fig. 9.1 together with the derived periodograms in Fig.
9.2) suggests that on exposure to D:D all animals exhibited a 
free-running circadian rhythm of locomotor activity with a 
fundamental period slightly greater than 24h. , which was maintained 
throughout the experiment until the re-introduction of the 12h./12h. 
light-dark cycle. Periodogram analysis of sequential 10 day periods 
during D:D indicates the fundamental period of circadian locomotor 
activity to be 24t0.25h. (Table 9.1) and the circadian rhythm of 
locomotor activity exhibited during D:D to be essentially consistent 
(see Fig. 9.2) with, in the majority of cases, no evidence of 
rhythm disruption.
9.3.1.2 Grouped animals
Grouped animals exhibited an entrained circadian rhythm of locomotor 
activity during L:D (12h. lights on/12h. lights off) with a 
fundamental period of 24h. (Table 9.2) as determined by periodogram 
analysis. During D:D grouped animals exhibited a free-running rhythm 
with an initial fundamental period of 24.5h., which gradually 
increased during each experiment. No spontaneous breakdown in the 
circadian rhythm (i.e. disruption) was observed. An example actogram 
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Table 9.1 Periodogram analysis of the circadian rhythm of locomotor 
activity expressed by untreated individual rats.
L:D, normal lighting (12h 1ight/12h dark) days 1-12; D:D, constant
darkness from day 13; values in parenthesis indicate days used for 
spectral analysis
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for animal 2 are shown
in Figs 9.1 and 9.2 respectively.
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Figure 9.1 Actogram of the circadian rhythm of locomotor activity 
expressed by an untreated isolated rat.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h 1ight/12h dark, lights on 0800), days 1-12. 
Constant darkness, days 13-53.






































Figure 9.2 Periodogram analysis : Circadian locomotor activity of an 
untreated isolated rat.
For actogram, see Fig. 9.1.
Abscissa: Period length (h). Ordinate: Relative power (*10H).
a) Normal daylight (12h 1ight/12h dark), days 1-8.
b) Constant darkness, days 13-22.
c) Constant darkness, days 23-32.
d) Constant darkness, days 33-42.
e) Constant darkness, days 43-52.




















Conditions Predominant Periods (h)
Group (days)
L : D (1-10) (8.00) 2*4.00
D : D (12-21) 2*4.50
D : D (2*4-33) 2*4.50
D : D (3*4-*43) 24.75
D : D (*45-5*4) 25.00
L ; D (1-10) (8.00,12.00, 21.25) 2*4.00
D : D (12-21) 2*4.50
D : D (2*4-33) 2*4.75
D:D (3*4-*43) 2*4.75
D:D (*45-5*4) 2*4.75
Table 9.2 Periodogram analysis of the circadian rhythm of locomotor 
activity expressed by untreated grouped rats.
L:D, normal lighting (12h light/12h dark) days 1-11; D:D, constant 
low-intensity red light from day 12; values in parenthesis indicate 
days used for spectral analysis.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for group 1 are shown 
in Figs 9.3 and 9.*4 respectively.
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Figure 9.3 Actogram of the circadian rhythm of locomotor activity 
expressed by untreated grouped (N=3) rats.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h light/12h dark. lights on 0800), days 1-11. 
Constant low-intensity red light, days 12-58.





































Figure 9.4 Periodogram analysis : Circadian locomotor activity of 
untreated grouped rats (N=3).
For actogram, see Fig. 9.3.
Abscissa: Period length (h). Ordinate: Relative power (*10M).
a) Normal daylight (12h light/12h dark), days 1-10.
b) Constant low-intensity red light, days 12-21.
c) Constant low-intensi ty red light, days 2*1-33.
d) Constant low-intensity red light, days 34-43.
e) Constant low-intensity red light, days 45-54.
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Visual inspection of the actograms and periodogram analysis (an 
example of which is given in Fig. 9.5 together with the derived 
periodograms in Fig. 9.6) suggests that the fundamental period of 
circadian locomotor activity was essentially maintained during 
chronic clomipramine treatment (Table 9.3). The actograms provide no 
evidence of phase-shift of the circadian locomotor activity induced 
by the onset of clomipramine treatment. Compared to the 
pre-treatment period, however, periodogram analysis suggests that 
the circadian rhythm of locomotor activity became slightly disrupted 
during clomipramne treatment as indicated by the occurrence of 
activity peaks with a period shorter than and including 16h. (Table 
9.3). Following clomipramine treatment the disruption of the 
circadian rhythm became even more marked.
9.3.2.2 Grouped animals
Inspection of the actograms and periodogram analysis suggests that 
chronic clomipramine treatment of grouped animals induced a gradual, 
progressive, disruption of the circadian rhythm of locomotor 
activity, which was especially marked during the second 10-day 
period of drug treatment, without modifying the fundamental period 
of the circadian rhythm (Table 9.4; see also the example actogram 
and the derived periodograms provided in Figs. 9.7 and 9.8 
respectively). Closer inspection of the actograms suggests that the 
disruption of locomotor activity occurred from about day 7 of 
clomipramine treatment (Fig. 9.7). Following clomipramine treatment 
the disruption of the circadian rhythm was even more apparent. The 
actograms provided no evidence of phase-shift of the circadian
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locomotor activity induced by the onset of clomipramine treatment.
Lighting Drug
Conditions Treatment Predominant Periods (h)
Animal (days)
D :D (4-13) Pre (4.00, 4.75, 8.00) 24.00
D :D (15-24) 1-10 (2.25, 4.75, 8.00) 23.75
(12.00)
D:D (25-34) 11-20 (4.00, 11.75, 16.00) 24.00
D :D (36-45) Post (4.00, 4.75, 6.00) 24.50
(18.75)
D :D (4-13) Pre (4.00) 23.75
D :D (15-24) 1-10 (4.75, 8.00, 12.00) 23.75
D :D (25-34) 11-20 (4.00, 8.00, 11.75) 24.00
D :D (36-45) Post (4.00, 6.00, 9.50) 24.00
(19.25)
Table 9.3 Periodogram analysis of the effect of chronic 
clomipramine, 20 mg Kg-1 day-1 po, on the circadian rhythm of 
locomotor activity expressed by individual rats.
D:D, constant darkness from day 4; values in parenthesis indicate 
days used for spectral analysis.
Drug treatment days 14-35 inclusive.
Pre, pre-treatment period.
1-10, 11-20; period of drug treatment.
Post, post-treatment period.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for animal 2 are shown 
in Figs 9.5 and 9.6 respectively.
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Figure 9.5 Actogram of the circadian rhythm of locomotor activity
expressed by an isolated rat treated chronically with clomipramine,
20 mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h light/12h dark, lights on 0800), days 1-3. 
Constant darkness, days 4-55.
Normal lighting (as above), days 56-60.








































Figure 9.6 Periodogram analysis : Circadian locomotor activity of
isolated rats treated chronically with clomipramine, 20 mg Kg-1
day-1 po.
For actogram, see Fig. 9.5.
Abscissa: Period length (h). Ordinate: Relative power (*10H).
a) Constant darkness, days 4-13 (pre-treatment).
b) Constant darkness, days 15-24 (drug treatment days 1-10).
c) Constant darkness, days 25-34 (drug treatment days 11-20).
d) Constant darkness, days 36-45 (post-treatment).
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Lighting Drug
Conditions Treatment Predominant Periods (h)
Group (days)
L :D (1-10) (8.00) 24.00
D :D (12-21) Pre (8.25) 24.25
D ;D (24-33) 1-10 (8.25) 24.75
D :D (34-43) 11-20 (4.00, 8.25) 25.00
D :D (45-54) Post (3.50, 4.00, 4.75) 24.75
(6.00. 12.00)
L:D (1-10) 24.00
D :D (12-21) Pre 24.75
D ;D (24-33) 1-10 24.50
D :D (34-43) 11-20 (3.50, 4.25, 4.75) 24.25
(12.25)
D :D (45-54) Post (3.50, 4.25) 24.25
Table 9.4 Periodogram analysis of the effect of chronic 
clomipramine, 20 mg Kg-1 day-1 po, on the circadian rhythm of 
locomotor activity expressed by grouped rats.
L:D, normal lighting (12h light/12h dark) days 1-10; D:D, constant 
low-intensity red light from day 11; values in parenthesis indicate 
experimental days used for spectral analysis.
Drug treatment days 23-44 inclusive.
Pre, pre-treatment period.
1-10, 11-20, period of drug treatment.
Post, post-treatment period.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for group 1 are shown 
in Figs 9.7 and 9.8 respectively.
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Figure 3.7 Actogram of the circadian rhythm of lotomotor Activity
expressed by grouped rats (N=3) treated chronically with
clomipramine. 20 mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min)
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h 1ight/12h dark. lights on 0800), days 1-10. 
Constant low-intensity red light, days 11-58.
Normal lighting (as above), days 59-62.
Drug treatment, days 23-HH inclusive.
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Figure 9.8 Periodogram analysis : Circadian locomotor activity of
grouped rats (N=3) treated chronically with clomipramine, 20 mg Kg'
day-1 po.
For actogram, see Fig. 9.7.
Abscissa: Period length (h). Ordinate: Relative power (* 10**).
a) Normal daylight (12h 1ight/12h dark), days 1-10.
b) Constant low-intensity red light, days 12-21 (pre-treatment).
c) Constant low-intensity red light, days 24-33 (drug treatment
days 1-10).
d) Constant low-intensity red light, days 34-43 (drug treatment
days 11-20).
e) Constant low-intensity red light, days 45-54 (post-treatment).

























Inspection of the actograms and periodogram analysis suggests that 
chronic fluoxetine treatment of isolated animals induced a slight 
disruption of the circadian rhythm of locomotor activity during the 
first 20 days of treatment with little or no effect on the 
fundamental period length (see example actogram and derived 
periodograms provided in Figs. 9.9 and 9.10 respectively and Table
9.5). From 21 to 30 days of drug treatment, however, the 
disruption of the circadian rhythm of locomotor activity was more 
marked as indicated by the numerous activity peaks of period length 
less than and including 21.25h., together with a slight increase in 
the fundamental period length (Table 9.5). During the 10-day period 
following the cessation of drug treatment periodogram analysis 
suggests that the circadian rhythm of locomotor activity splits into 
two rhythms of 6h and 24h. period length. The actograms provided no 
evidence of phase-shift of the circadian locomotor activity induced 
by the onset of fluoxetine treatment.
9.3.3.2 Grouped animals
Chronic fluoxetine treatment of grouped animals had little or no 
effect upon the circadian rhythm of locomotor activity during the 
first 20 days of treatment (see example actogram and derived 
periodograms provided in Figs. 9.11 and 9.12 respectively and Table
9.6). From 21 to 30 days of drug treatment, however, the circadian 
rhythm of locomotor activity was markedly disrupted; which in one 
group of animals resulted in primary rhythms of 8.25h., 12.5h. and 
24.25h. (see actogram and derived periodograms provided in Figs. 9.13 
and 9.14 respectively and Table 9.6). Periodogram analysis of the
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initial 10-day period following drug treatment suggests that the 
circadian rhythm regained some degree of stability compared to the 
level of disruption observed during the latter stages of chronic drug 
treatment (see Figs. 9.12 and 9.1M). The actograms provided no 
evidence of phase-shift of the circadian locomotor activity induced 
by the onset of fluoxetine treatment.
318
Lighting Drug
Conditions Treatment Predominant Periods (h)
(days)
D :D (4-13) Pre (8.00) 23,75
D :D (15-24) 1-10 23.75
D :D (25-34) 11-20 23.75
D :D (35-44) 21-30 24.00
D :D (46-55) Post 24.00
D :D (4-13) Pre (8.00) 23.75
D :D (15-24) 1-10 (8.00) 24.00
D :D (25-34) 11-20 24.00
D :D (35-44) 21-30 (4.00, 6.00, 7.25) 
(8.25, 10.00, 12.25) 
(15.50, 19.00, 21.25)
24.50
D ;D (46-55) Post (4.00, 12.00) 6.00
24.00
Table 9.5 Periodogram analysis of the effect of chronic fluoxetine,
2 mg Kg-1 day-1 po, on the circadian rhythm of locomotor activity
expressed by individual rats.
D:D, constant darkness from day 4; values in parenthesis indicate 
days used for spectral analysis.
Drug treatment days 14-45 inclusive.
Pre, pre-treatment period.
1-10, 11-20, 21-30; period of drug treatment.
Post, post-treatment period.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for animal 2 are shown
in Figs 9.9 and 9.10 respectively.
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Figure 9.9 Actogram of the circadian rhythm of locomotor activity
expressed by an isolated rat treated chronically with fluoxetine, 2
mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h light/12h dark, lights on 0800), days 1-3. 
Constant darkness, days 4-55.
Normal lighting (as above), days 56-60.













































Figure 9.10 Periodogram analysis : Circadian locomotor activity of
an isolated rat treated chronically with fluoxetine, 2 mg Kg-1 day-
po.
For actogram, see Fig. 9.9.
Abscissa: Period length (h). Ordinate: Relative power (*10**).
a) Constant darkness, days 4-13 (pre-treatment).
b) Constant darkness, days 15-24 (drug treatment days 1-10).
c) Constant darkness, days 25-34 (drug treatment days 11-20).
d) Constant darkness, days 35-44 (drug treatment days 21-30).
e) Constant darkness, days 46-55 (post-treatment).
























D:: D (5-14) Pre
D:: D (16-25) 1-10
D;: D (26-35) 11-20
D:: D (36-45) 21-30
D:: D (48-57) Post
* D:: D (1-10) Pre
D::D (12-21) 1-10
D:: D (22-31) 11-20
D:: D (32-41) 21-30
D : D (42-51) Post
D : D (5-14) Pre
D : D (16-25) 1-10
D: D (26-35) 11-20




















Table 9.6 Periodogram analysis of the effect of chronic fluoxetine,
2 or 6(*) mg Kg-1 day-1 po, on the circadian rhythm of locomotor 
activity expressed by grouped rats.
D:D, constant low-intensity red light from day 1; values in 
parenthesis indicate days used for spectral analysis.
Drug treatment days 15-47 inclusive groups 1 and 3, days 12-41 
inclusive group 2.
Pre, pre-treatment period.
1-10, 11-20, 21-30; period of drug treatment.
Post, post-treatment period.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for groups 1 and 2 are 
shown in Figs 9.11 and 9.12, and Figs 9.13 and 9.14 respectively.
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Figure 9.11 Actogram of the circadian rhythm of locomotor activity
expressed by grouped rats (N=3) treated chronically with fluoxetine,
2 mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Constant low-intensity red light, days 1-59.
Reverse lighting (12h light/12h dark, lights on 2000), days 60-63. 















































Figure 9.12 Periodogram analysis : Circadian locomotor activity of
grouped rats (N=3) treated chronically with fluoxetine, 2 mg Kg-1
day-1 po.
For actogram, see Fig. 9.11.
Abscissa: Period length (h). Ordinate: Relative power (*10H).
a) Constant low-intensity red light, days 5-14 (pre-treatment).
b) Constant low-intensity red light, days 16-25 (drug treatment
days 1-10).
c) Constant low-intensity red light, days 26-35 (drug treatment 
days 11-20).
d) Constant low-intensity red light, days 36-45 (drug treatment
days 21-30).
e) Constant low-intensity red light, days 48-57 (post-treatment).
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Figure 9.13 Actogram of the circadian rhythm of locomotor activity
expressed by grouped rats (N=3) treated chronically with fluoxetine,
2 mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Constant low-intensity red light, days 1-51.































Figure 9.14 Periodogram analysis : Circadian locomotor activity of
grouped rats (N=3) treated chronically with fluoxetine, 2 mg Kg-1
day-1 po.
For actogram, see Fig. 9.13.
Abscissa: Period length (h). Ordinate: Relative power (*10M).
a) Constant low-intensity red light, days 1-10 (pre-treatment).
b) Constant low-intensity red light, days 12-21 (drug treatment
days 1-10).
c) Constant low-intensity red light, days 22-31 (drug treatment
days 11-20).
d) Constant low-intensity red light, days 32-41 (drug treatment
days 21-30).
e) Constant low-intensity red light, days 42-51 (post-treatment).
























Chronic mianserin treatment had no effect on the circadian rhythm of 
locomotor activity exhibited by individual animals (see example 
actogram and derived periodograms provided in Figs. 9.15 and 9.16 
respectively and Table 9.7). Following drug treatment, however, 
periodogram analysis suggests some disruption of the circadian 
rhythm. The actograms provided no evidence of phase-shift of the 
circadian locomotor activity induced by the onset of mianserin 
treatment.
9.3.4.2 Grouped animals
Chronic mianserin treatment of grouped animals had no effect on the 
circadian rhythm of locomotor activity during the period of drug 
treatment (see example actogram and derived periodograms provided in 
Figs. 9.17 and 9.18 respectively and Table 9.8). In one group of 
animals, however, there was some evidence of circadian rhythm 
disruption following drug treatment (see Table 9.8). The actograms 
provided no evidence of phase-shift of the circadian locomotor 






D:: D (*4-13) Pre 23 .75
D:: D (15-2*4) 1-10 (8 .00) 23 .75
D:: D (25-3*4) 11-20 2*4.00
D:: D (36-*45) Post (*4■ 75. 8.50. 9.00) *4.25
(9 .50. 13.75, 19.50) 2*4.75
D:: D (*4-13) Pre (3 .00. 3.75, *4.75) 2*4.25
(8 .00. 11.75)
D:: D ( 15-2*4) 1-10 (8 .00, 12.00) 2*4.25
D:: D (25-3*4) 11-20 (6 .00. 20.75) 23 .75
D;: D (36-*45) Post (*4.00, 5.00,6.00) 2*4.50
(8 .50, 9.50, 12.00)
Table 9.7 Periodogram analysis of the effect of chronic mianserin,
2 mg Kg-1 day-1 po, on the circadian rhythm of locomotor activity
expressed by individual rats.
D:D, constant darkness from day *4; values in parenthesis indicate 
days used for spectral analysis.
Drug treatment days 1*4-35 inclusive.
Pre, pre-treatment period
1-10, 11-20; period of drug treatment.
Post, post-treatment period.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived periodogram functions for animal 2 are shown
in Figs 9.15 and 9.16 respectively.
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Figure 9.15 Actogram of the circadian rhythm of locomotor activity
expressed by an isolated rat treated chronically with mianserin, 2
mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h light/12h dark, lights on 0800), days 1-3. 
Constant darkness, days H-55.
Normal lighting (as above), days 56-60.











































































Figure 9.16 Periodogram analysis : Circadian locomotor activity of
an isolated rat treated chronically with mianserin, 2 mg Kg-1 day-1
po.
For actogram, see Fig. 9.15.
Abscissa: Period length (h). Ordinate: Relative power (*10M).
a) Constant darkness, days 4-13 (pre-treatment).
b) Constant darkness, days 15-24 (drug treatment days 1-10).
c) Constant darkness, days 25-34 (drug treatment days 11-20).
d) Constant darkness, days 36-45 (post-treatment).
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Lighting Drug
Conditions Treatment Predominant Periods (h)
Group (days)
L : D (1-10) (8.00, 12.25) 24.00
D : D (12-21) Pre (8.25) 24.50
D : D (24-33) 1-10 24.75
D : D (34-43) 11-20 25.00
D : D (45-54) Post 25.00
L : D (1-10) (8.00, 12.00) 24.00
D : D (12-21) Pre (8.25, 12.25) 24.75
D : D (24-33) 1-10 24.75
D : D (34-43) 11-20 (8.25) 24.75
D : D (45-54) Post (5.75, 6.25, 7.25) 23.75
(12.25, 16.50, 18.00)
(21.50)
Table 9.8 Periodogram analysis of the effect of chronic mianserin,
2 mg Kg-1 day-1 po, on the circadian rhythm of locomotor activity 
expressed by grouped rats.
L:D, normal lighting (12h light/12h dark) days 1-10; D:D, constant
low-intensity red light from day 11; values in parenthesis indicate 
days used for spectral analysis.
Drug treatment days 23-44 inclusive.
Pre, pre-treatment period.
1-10, 11-20; period of drug treatment.
Post, post-treatment period.
Periodogram analysis; values indicate the fundamental and secondary 
(in parenthesis) periods of rhythmic activity.
The actogram and derived peri°dogram functions for group 1 are shown
in Figs 9.17 and 9.18 respectively.
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Figure 9.17 Actogram of the circadian rhythm of locomotor activity
expressed by grouped rats (N=3) treated chronically with mianserin,
2 mg Kg-1 day-1 po.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the median threshold indicated to the 
right of the actogram.
Normal lighting (12h light/12h dark, lights on 0800), days 1-10. 
Constant low-intensity red light, days 11-57.
Drug treatment, days 23-H4 inclusive.
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Figure 9.18 Periodogram analysis : Circadian locomotor activity of
grouped rats (N=3) treated chronically with mianserin. 2 mg Kg-1
day-1 po.
For actogram, see Fig. 9.17.
Abscissa: Period length (h). Ordinate: Relative power (*10H).
a) Normal daylight (12h 1ight/12h dark), days 1-10.
b) Constant low-intensity red light, days 12-21 (pre-treatment).
c) Constant low-intensity red light, days 2H-33 (drug treatment
days 1-10).
d) Constant low-intensity red light, days 3H-H3 (drug treatment
days 11-20).
e) Constant low-intensity red light, days M5-54 (post-treatment).
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The aim of these studies was to test the hypothesis that an ability 
to modify the free-running circadian locomotor activity rhythms of 
rats was shared by the antidepressants clomipramine, fluoxetine and 
mianserin. Apart from relying on visual inspection of the resulting 
actograms to identify changes in the circadian rhythmicity of 
locomotor activity, the data was also subjected to periodogram 
analysis to determine the periodicity of the rhythmic components. In 
general the fundamental period of rhythmic locomotor activity 
determined by periodogram analysis agreed with inspection of the 
actograms. Periodogram analysis therefore appears to be a suitable 
method of time series analysis by which such data may be analysed.
One major problem with all methods of time series analysis, however, 
is the need for extensive data covering at least 10 cycles of 
activity, which in these studies is equal to a 10-day period. For
the derived periodogram function to be an accurate representation of 
the data the profile of locomotor activity must be constant during 
the period required for analysis. The method of time series analysis 
can only therefore identify long term, not transient, changes in 
locomotor rhythmicity. Thus if antidepressant drug treatments have 
the ability to induce changes in the circadian rhythm of locomotor 
activity then such changes must be maintained throughout the period
required in order for accurate identification by periodogram
analysis. For this reason the methodology required that each 
experiment be accordingly subdivided into successive 10 day periods. 
Furthermore, the resolution of the periods of activity identified by 
periodogram analysis is dependent on the number of cycles of that 
period within the duration of the data analysed. Thus, in a 10 day 
sample (i.e. 240 hours) there are 10 cycles of 24h period length.
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while there are less than 10 cycles of rhythmic activity with period 
lengths greater than 24h, but correspondingly more than 10 cycles of 
rhythmic activiy with period lengths less than 24h (e.g. 20 cycles of 
period length 12h; 40 cycles of period length 6h). For this reason
the shorter the period length the greater the resolution of the 
corresponding peaks in the periodogram function (see appendix B.5). 
Thus the accuracy of the peak in the periodogram function 
corresponding to the fundamental period of rhythmic activity will 
always be less than that of the peaks corresponding to rhythmic 
activity of shorter period length.
The locomotor activity monitor used to measure the activity of 
animals housed in groups proved to be more than adequate in that, 
with few exceptions, the daily median number of locomotor activity 
counts per epoch (i.e 15 min.) were generally greater than 20. In 
the individual experiments, however, the activity monitors provided 
comparatively low measures of locomotor activity with the daily 
median number of counts per epoch being invariably between 0 and 1. 
Periodogram analysis of data arising from grouped animals housed 
under L:D or D:D (constant low-intensity red light) prior to drug 
treatment invariably produced well-defined spectra with comparatively 
very low noise levels. Conversely, the noise level of the 
periodogram function derived from individual animals housed under L:D 
or D:D (constant darkness) prior to drug treatment appeared much 
higher. The paucity of the data arising from the individual studies 
probably accounts for the reduced resolution of the periodogram 
analysis (both in terms of the noise level and accuracy of the 
peaks). To increase the magnitude of the number of counts per epoch 
(i.e. increase the sensitivity of the monitor) it is recommended that
either the position of the single infrared cell be re-appraised or 
more infrared cells be provided for each monitor.
The actograms presented in these studies demonstrate the
characteristic properties of true circadian rhythms. Under L:D 
conditions (i.e. 12h light/12h dark) the locomotor activity exhibited 
by both individual and grouped animals is entrained to the light-dark 
cycle. For the grouped animal studies at least, such observations 
are supported by periodogram analysis which identified the 
fundamental period of rhythmicity to be exactly 24h in all cases.
For individual animals, however, periodogram analysis identified 
the fundamental period to be within the range of 23.75h. to 2H.75h 
even though the actograms suggested an entrained 24h rhythm of 
locomotor activity. The inaccuracy of the derived periodogram 
function from individual animals is thought to be due to the paucity 
of data obtained in these studies. When constant conditions are 
imposed (i.e. constant darkness or constant low-intensity red light)
the locomotor activity rhythm of both individual and grouped animals
free-runs with a cycling period regulated by the intrinsic 
pacemakers, possible contributing environmental and, in the case of 
grouped animals, social factors. Both the actograms and periodogram 
function indicate the period of the free-running rhythm of grouped 
animals to be longer than that exhibited by individuals. The reason 
for this finding is not known. However, it is suggested that the 
observation may indicate the involvement of social factors in the 
expression of circadian locomotor activity rhythms exhibited by rats 
housed in groups. In a number of cases the periodogram function 
derived from both individual or grouped animals, housed under L:D or 
D:D, also indicated secondary peaks corresponding to the harmonic
components of the fundamental period. The appearance or 
disappearance of the harmonic components should not be assumed to 
indicate changes in the circadian rhythm of locomotor activity, but 
rather indicate changes in the shape of the wave-form of activity 
over 24h. During L:D conditions locomotor activity is entrained to 
the dark-phase. If activity occurred immediately on transition from 
light to dark and the level of activity remained constant throughout 
the dark phase, but activity stopped immediately on the transition 
from dark to light with no activity occurring during the light phase, 
then the shape of the wave-form of activity over 24h would 
approximate to a square-wave. Fourier analysis, on which the 
periodogram function is based (see Chatfield, 1985), assumes that 
all complex wave-forms are composed of a number of sine-waves that 
differ in frequency, amplitude and phase. Periodogram analysis 
identifies the frequency and relative amplitude of the component 
sine-waves within a complex wave-form. Furthermore, periodogram 
analysis of square-waves demonstrates that square-waves are composed 
of the fundamental sine-wave and the odd-numbered harmonic 
sine-waves. In comparison, the periodogram function of a pure 
sine-wave only identifies the fundamental frequency of that sine-wave 
(see appendix B.5 for a comparison of the periodogram functions 
derived from sine-waves and square-waves). The appearance or 
disappearance of harmonic components in the periodogram function thus 
indicate a change in the overall shape of the wave-form of activity. 
In these studies, periodogram analysis of locomotor activity 
exhibited by rats housed under constant conditions generally 
indicates a reduction in the harmonic content of the periodogram 
function compared to that obtained when the same animals were housed 
under a light-dark schedule. This indicates that following
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transition from L:D to D:D the shape of the wave-form of activity 
over 2Hh changes from a wave-form which tends to a square-wave under 
L:D to one which tends more towards a sine-wave under D:D. The 
change in the shape of the wave-form of activity following changes in 
the lighting conditions indicates that during L:D conditions light 
exerts a masking effect on both the leading and trailing edges of 
locomotor activity expressed during the dark phase. The masking, as 
opposed to entraining, effects of light have been discussed by 
Aschoff (1988). The masking effect of light during L:D is also 
indicated in the actograms. The duration of activity during L:D is 
generally limited to the duration of the dark phase (i.e. 12h) . 
However, during D:D the duration of the activity period gradually 
increases with, generally, the end of activity occurring at a 
slightly later time point than would be expected from the time of 
activity onset (e.g. see Fig 9.3).
Under constant conditions the locomotor activity rhythms of control 
(i.e. non-drugged) animals, housed either individually or in groups, 
continued to free-run for at least HO days with little or no 
variation in either the resulting actograms or derived periodogram 
function. In all cases where examined, the free-running rhythm of 
control animals, housed either singly or in groups, re-entrained 
within 2-3 days following the introduction of L:D or D:L conditions 
(see Figs. 9.1, 9.3, 9.5, 9.7, 9.9, 9.11 and 9.15). In addition
all control animals exhibited little or no variation in the total 
daily number of locomotor activity counts throughout the duration of 
the experiments (data not shown). However, the daily water 
consumption of all control animals gradually reduced throughout the 
experiments to approximately 80% of the starting volume by the end of
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the experiment (data not shown). Periodogram analysis showed that 
chronic treatment with mianserin had no effect on the circadian 
rhythm of locomotor activity expressed by either individual or 
grouped animals when compared to the relevant non-drug treated 
animals. Indeed it was only after mianserin treatment that a 
disruption of the free-running rhythm was observed. Conversely, in
comparison to the relevant controls, chronic administration of 
clomipramine or fluoxetine to either individual or grouped animals 
resulted in a disruption of the circadian rhythm of locomotor 
activity during the second or third 10-day period of drug treatment 
respectively, as indicated by the increased magnitude of peaks 
especially between 3 and 8 hours. Indeed in one experiment 
fluoxetine treatment of grouped rats resulted in rhythm breakdown to 
ultradian components with a primary period of 8.25h. No evidence of 
drug-induced phase shift was observed following any of the drug 
treatments. In all cases of rhythmic disruption, either during or,
in the case of mianserin, following drug treatment the circadian 
rhythm of locomotor activity re-entrained within 2-3 days following 
the introduction of L:D or D:L conditions. The daily total of 
locomotor activity counts for all drug treated animals showed little 
or no variation throughout the course of each experiment (data not 
shown). However, as with the control animals, the volume of 
fluoxetine or mianserin drug solutions consumed gradually reduced 
throughout the duration of each experiment. Conversely, the fluid 
intake of animals presented with clomipramine was immediately reduced 
by up to 20% but returned to the expected level imbibed by the 
control animals at the same time point of the experiment following 
the cessation of drug treatment (data not shown). It may be argued 
that the reduced fluid intake of animals treated with clomipramine
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may have contributed to the observed disruption of the circadian 
rhythm of locomotor activity, however, animals treated with 
fluoxetine also demonstrated rhythm disruption without reduced fluid 
intake. In these experiments therefore, the rhythm disruption 
observed during clomipramine or fluoxetine treatment would appear to 
be a drug effect rather than as a consequence of reduced fluid 
intake. In addition, such drug-ir.duced changes in the circadian 
rhythm of locomotor activity may be demonstrated in both isolated and 
grouped animals. It should be noted, however, that the final 
pattern of locomotor activity exhibited by grouped animals is a 
composite of the individual expression of locomotor activity. In 
these experiments groups of 3 rats were used and it is not 
unreasonable to assume some slight variation between their 
fundamental free-running periods, or indeed in the relative 
phase-position of each animal's circadian rhythm of locomotor 
activity, even though the dominant group member may be expected to 
dictate the free-running rhythm of the group. Thus 3 slightly 
different rhythms contribute to the final pattern of activity. In 
this context the apparent disruption of the circadian rhythm of 
locomotor activity induced by clomipramine or fluoxetine in grouped 
animals may be due to a general increased phase separation of the 
individual rhythms. Thus the results for the effects of clomipramine 
and fluoxetine on the circadian rhythmicity of grouped animals per se 
should be treated with caution even though they are in agreement with 
those obtained from isolated animals.
The doses of the drugs used in these studies were based, as far as 
possible, on clinical equivalence. The observations that 
clomipramine and fluoxetine both induced disruption of the circadian
3H0
rhythm of locomotor activity of both isolated and grouped rats are 
generally in agreement with the effect of chronic imipramine or 
zimelidine on the free-running circadian locomotor activity of 
hamsters (Wirz-Justice and Campbell, 1982) or rats (Martin, 1982) 
respectively. Conversely, the lack of effect of mianserin, 
together with the observation that none of the drug treatments 
induced a phase-delay in the onset of the activity phase of the 
subjects sleep-wake cycle, would not support the hypothesis that an 
ability to alter circadian rhythms of locomotor actvity is shared by 
the group of compounds clinically labelled antidepressant. Likewise, 
Mitchell et al. (1987) observed that repeated electroshock had no 
effect on the circadian rhythm of locomotor activity exhibited by 
rats or mice. An ability to modify circadian rhythms of locomotor 
activity would not therefore appear to be a predictor or necessary 
characteristic of antidepressant efficacy.
The major criticism of the experiments described here is that they 
have no theoretical basis with respect to the circadian rhythm 
abnormalities observed in some depressed patients. In these 
experiments the phase-position of the circadian rhythm of locomotor 
activity was in its normal position with respect to other circadian 
rhythms, while in some depressed patients some circadian rhythms are 
thought to have an abnormal phase-angle to other circadian rhythms 
(see Wehr and Wirz-Justice, 1982). If antidepressant efficacy is 
indeed related to an ability to re-align abnormally positioned 
circadian rhythms then the animal model employed in these studies is 
not suitable to examine such drug-induced effects. If animal models 
of circadian rhythms are to be employed to identify the underlying 
mechanisms by which antidepressants modify circadian rhythms, or
indeed in the identification and development of potential 
antidepressants, then a suitable animal model needs to be developed 
which has a closer theoretical relationship to the circadian rhythm 
abnormalities observed in some depressed patients. Until such an 
animal model is developed it is unlikely that any direct relationship 
between antidepressant efficacy and an ability of antidepressant 
treatments to modify circadian rhythms will be identified.
The implications of the results of these studies, together with 
those obtained from the examination of the effect of chronic 
antidepressant treatment on rodent social behaviour, and suggestions 
for further work are discussed in chapter 10.
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CHAPTER 10 GENERAL DISCUSSION
CHAPTER 10 GENERAL DISCUSSION
The results presented in this thesis have been extensively discussed 
in each of the relevant chapters. The purpose of this final 
discussion is to provide a general comment on both the methods 
employed and the results obtained during these studies and, 
furthermore, to suggest areas where further investigation would be 
of particular benefit.
10.1 Rodent Social Behaviour
The main bulk of this thesis has been concerned with the effect of 
antidepressant treatment on rodent social behaviour. These studies 
(see chapters 5-7) demonstrated that the effect of psychotropic drug
treatment per se on patterns of both rodent social behaviour and
rodent social hierarchy may be quantifiably examined. The results of 
these studies have been extensively discussed in chapter 8. Since 
the antidepressants were the only class of psychotropic compound 
which specifically modified aggressive behaviour it is concluded that 
the specific, diametrically different, effects of acute and chronic 
antidepressant treatment on rodent aggressive behaviour are 
indicative of a specific reduction and increase in social drive 
respectively. These results are especially impressive considering 
six major points. Firstly, a common effect of antidepressant
treatment has been demonstrated even though the drugs studied differ
markedly in chemical structure and known acute pharmacology.
Secondly, a common effect was observed following either acute 
treatment, where only the antidepressants specifically reduced 
rodent aggressive behaviour at non-sedative doses, or chronic 
treatment, where only the antidepressants increased rodent 
aggressive behaviour. It is generally accepted that acute treatment
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with antidepre/ants reduce rodent agressive behaviour (see chapter 
8). These observations also support the argument of File and Tucker 
(1986) who noted that the literature indicates increased aggressive 
behaviour to be a common behavioural effect following chronic, but 
not acute, antidepressant treatment of rats. Thirdly, the order of 
potency of the antidepressants identified by the studies described 
here generally correspond to that in the clinic. Fourthly, the 
antidepressant-induced increase in rodent aggressive behaviour was 
only observed following chronic treatment which is consistent with 
the clinical latency of these compounds (see Oswald et al., 1972).
Fifthly, the time required for the drug-induced increase in 
aggressive behaviour observed during chronic treatment with the 
irreversible MAOI, phenelzine, to return to the observed 
pre-treatment level following the cessation of drug treatment, i.e. 
by 14 rather than 7 days as observed following chronic treatment with 
the other antidepressants, suggests that the return to the 
pre-treatment aggression level is due to the recovery of central 
monoamine oxidase activity. Lastly, the ability of acute and 
chronic antidepressant treatment to decrease and increase rodent 
aggressive behaviour, respectively, is paralleled by clinical 
observations where an initial reduction in mood is often observed 
(Oswald et al., 1972), but may be overlooked due to the
inadequacies of the rating system used, or misinterpreted and 
categorised as a side-effect (see chapter 8), while continuous 
antidepressant therapy results in increased outwardly-directed 
(extrapunitive) aggression (Priest et al., 1980) which is manifest
as increased physical and/or verbal activity associated with greater 
interaction with the environment (Kaplan et al., 1961). The latter
clinical observations are indicative of increased social drive on the
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part of the patient which, furthermore, is an integral component of 
remission from depression.
The ability of acute antidepressant treatment to reduce rodent 
aggressive behaviour is presumably mediated by the ability of these 
compounds to increase central serotonergic and/or noradrenergic 
function, even though the acute mode of action for iprindole remains 
to be elucidated (see section 1.4). This view is supported by the 
literature which indicates that increasing central serotonergic or 
noradrenergic function generally reduces rodent aggressive behaviour 
even though various types of rodent aggressive behaviour have been 
identified (see Moyer, 1968), indicating that various neuronal 
substrates may mediate such behaviour (see chapter 8). Furthermore, 
the literature also indicates that reducing central serotonergic or 
noradrenergic function increases rodent aggressive behaviour, 
presumably including that induced by chronic antidepressant treatment 
reported here (see chapter 8), These observations have a major 
implication for the aetiology of depression. If the close 
correspondence between the ability of antidepressants to modify the 
social drive of both laboratory rodents and depressed patients is 
accepted, then the studies reported here imply that remission from 
depression is associated with reduced central serotonergic and/or 
noradrenergic function which, in turn, suggests that depression may 
be a consequence of increased central serotonergic and/or 
noradrenergic function. Indeed, the literature suggests possible 
mechanisms by which central serotonergic and noradrenergic function 
may be reduced; thereby, possibly, mediating the ability of 
chronic antidepressant treatment to increase rodent aggressive 
behaviour. Firstly, post-synaptic 5-HT2 receptors are
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down-regulated following chronic antidepressant treatment (see 
section 1.4.5). Secondly, chronic antidepressant treatment also 
induces a down-regulation of central post-synaptic beta-adrenoceptors 
and/or a subsensitivity of the NA-dependent adenylate cyclase system 
(see section 1.4.5); effects possibly associated with a 
desensitization of the pre-synaptic alpha2-adrenoceptor mediated 
negative feedback system.
It is generally concluded, therefore, that the antidepressant- 
induced modification of rodent social drive corresponds to the 
behavioural changes exhibited by depressed patients during the 
time-course of antidepressant treatment. It follows that examination 
of the acute and chronic effects of antidepressants in the social 
interaction test described in this report will predict antidepressant 
efficacy and drug potency. Thus the results reported here auger well 
for the clinical prospects of the potential antidepressant, 
fluoxetine. It should be noted that the ability of the social 
interaction test to predict antidepressant efficacy does not rely on 
an ability to modify, firstly, abnormal animal behaviours or 
biochemical deficits assumed to be consistent with a single facet of 
the pathology of depression or, secondly, largely abnormal 
behaviours induced by exotic experimental paradigms which generally 
have a questionable theoretical relationship to depression. The 
social interaction test described here has obvious potential utility 
for both basic academic research and the industrial screening of 
potential antidepressant compounds.
These views may appear somewhat premature considering the limited 
number of antidepressants examined thus far. Future studies should
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concentrate, at least initially, on examining the effects of acute 
and chronic administration of clinically-established antidepressant 
treatments (including electroconvulsive shock), in comparison to 
other psychotropic compounds with no known antidepressant efficacy, 
on the behavioural profile exhibited by rats during social 
interaction; since only by the accumulation of data will the 
hypothesis that increased aggressive behaviour is a common 
behavioural effect induced by chronic antidepressant treatment be 
supported (or refuted !). Once the ability of this animal model to 
predict antidepressant efficacy is accepted then alternative, less 
common, antidepressant treatments may be examined. The D2-DA 
antagonist flupenthixol, beta2-adrenoceptor agonists such as 
salbutamol, and GABA agonists have all been reported to possess 
antidepressant efficacy (see Iversen and Mackay, 1979; Mindham, 
1979; Lloyd et al., 1983). Examination of the acute and chronic
treatment effects of these compounds on rodent social behaviour may 
confirm the general ability of this animal model to predict 
antidepressant efficacy regardless of the acute pharmacology of the 
compound being examined. Furthermore, this animal model may prove 
extremely useful in predicting the potential anicdepressant efficacy 
of novel compounds.
In addition to the obvious predictive value regarding various 
antidepressant treatments, this animal model may also prove 
extremely useful in identifying the central mechanisms underlying 
antidepressant efficacy. Initially, the pharmacology of the 
antidepressant-induced modification of aggressive behaviour may be 
examined. The reduction in aggressive behaviour induced by acute 
antidepressant treatment is presumably mediated by increased
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serotonergic or noradrenergic function. The use of various 
pharmacological agents, such as specific 5-HT and NA antagonists 
administered at maximal doses which do not modify the behavioural 
profile of rats per se, should enable the monoamine system(s) which 
mediate the antidepressant-induced reduction in rodent aggressive 
behaviour to be identified. Conversely, if reduced serotonergic or 
noradrenergic function mediates the increase in rodent aggressive 
behaviour observed during chronic antidepressant treatment, then 
acute treatment with agents which increase central serotonergic or 
noradrenergic function (i.e. with specific 5-HT or NA agonists) would 
be expected to reverse the antidepressant-induced increase in rodent 
aggressive behaviour. Assuming that central serotonergic neurons are 
intimately involved in the control of aggressive behaviour (see 
chapter 8) then the introduction of specific pharmacological agents 
for the ever-increasing number of 5-HT receptor subtypes should help 
elucidate which 5-HT receptor subtypes are involved in the mediation 
of increased aggressive behaviour during chronic antidepressant 
treatment.
Central serotonergic and noradrenergic neurons within the 
hypothalamic/amygdaloid/septal axis appear to mediate control over 
the ultimate expression of aggressive behaviour (see chapter 8). 
Direct application of pharmacological agents with specific actions on 
monoamine systems into these sub-cortical brain areas should help 
elucidate which monoamine systems and brain areas are intimately 
involved in mediating the behavioural effects of acute and chronic 
antidepressant treatment. Likewise, similar information may be 
obtained following measurement of, firstly, monoamine and 
metabolite levels by, for example, high performance liquid
3H8
chromatography with electrochemical detection (see Marsden and 
Joseph, 1986); secondly, in vivo levels of extracellular 5-HT and
NA by, for example, intracerebral microdialysis (see Routledge and
Marsden, 1987; Sleight et al., 1988) or voltammetry (see Crespi et
al., 1988; Marsden et al., 1988); and, lastly, central 5-HT-
and NA-sensitive adenylate cyclase activity and phosphatidyl inositol 
turnover in these brain areas. Such biochemical studies should be
performed, in conjunction with behavioural testing, prior to,
during and following antidepressant treatment as applicable. A 
number of studies have demonstrated that chronic antidepressant 
treatments induce a down-regulation of specific monoamine receptors 
(i.e. alpha2- and beta-adrenoceptors, 5-HT2 receptors) and a
subsensitivity of the NA-sensitive adenylate cyclase system (see 
section 1.4.5 for discussion). Generally, such studies have 
understandably employed brain tissue that either has a high density 
of the receptor subtype or is rich in the second messenger system 
being studied. For example, the cerebral cortex has commonly been 
employed to study the radioligand-binding characteristics of alpha-,- 
and alpha2-adrenoceptors, beta-adrenoceptors, 5-HT-, and 5-HT2 
receptors (see, for example, Savage.et al.. 1979; Peroutka and 
Snyder, 1980; Savage et al., 1980a, 1980b; Se11inger-Barnette et
al., 1980; Blackshear and Sanders-Bush, 1982; Clements-Jewery and
Robson, 1982; Mogilnicka et al., 1987; Sethy et al . , 1983),
while the limbic forebrain (which contains the septal nuclei,
olfactory tubercules, olfactory nuclei, accumbens nuclei and 
anterior parts of the anterior amygdaloid nuclei) has commonly been 
employed to study the NA-dependent adenylate cyclase system (see, 
for example, Vetulani et al., 1976a; Mishra et al., 1981). If
the primary target of antidepressant drug action is shown to be the
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hypothalamic/amygdaloid/septal axis, then it is clear that more 
relevant data regarding the mechanisms involved in the efficacy of 
antidepressants would be obtained if the suggested pharmacological 
and biochemical studies outlined above concentrated on examining the 
effect of antidepressant treatment on monoamine function in these 
sub-cortical brain areas.
10.2 Circadian Rhythms of Locomotor Activity
A far smaller proportion of this thesis has been concerned with the 
effect of chronic antidepressant treatment on the circadian rhythms 
of locomotor activity in rats and the applicability of time-series 
analysis to the resulting data (see chapter 9). The results of these 
studies suggest that while periodogram analysis may be employed to 
identify changes in the rhythmic components of circadian locomotor 
activity (which may not always be obviously apparent in the resulting 
actogram), an ability to modify the free-running circadian locomotor 
activity rhythms of rodents is neither a predictor nor necessary 
characteristic of antidepressant efficacy. This conclusion was 
reached considering, firstly, the difference between the latency of 
clomipramine and fluoxetine to induce disruption of the free-running 
circadian rhythms of locomotor activity; secondly, the inability of 
clomipramine and fluoxetine to induce a phase-shift in the 
free-running circadian locomotor activity rhythm; and, lastly, the 
total lack of effect of mianserin. It should be noted that as far as 
possible the three compounds studies were administered at 
c1inically-equivalent doses. If the antidepressant efficacy of these 
compounds is related to an ability to modify circadian rhythms, then 
it is reasonable to expect a degree of commonality between the 
effects of the three compounds in this animal model. This expectation
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assumes that the use of the animal model employed in these studies is 
justified which, as previously discussed (section 9.H), is not the 
case. Furthermore, each daily dose of the compounds used in these 
studies was far greater than that which induced an increase in the 
agg'essive behaviour of resident rats during social interaction. This 
suggests that one major problem with the experimental design used in 
these studies may possibly be the presentation of the drug in the 
drinking water since in this case the subject chooses when to drink 
(or not !) - thereby exercising complete control over the timing of 
drug administration - and, furthermore, it must be assumed that the 
drug becomes widely distributed through-out the CNS. Perhaps a 
better method would be to administer the drug directly to the central 
pacemaker systems (e.g. the SCN) via indwelling cannulae linked to 
automatic drug delivery systems (e.g. subcutaneously implanted 
osmotic mini pumps). Such a method of drug delivery would allow the 
operator to decide to administer the drug either continuously or in 
pulses. A second major problem lies in the assumption that the 
underlying mechanisms generating the normal free-running circadian 
rhythms of locomotor activity are susceptible to antidepressant drug 
action. It has been suggested by some workers (e.g. see Wehr and 
Wirz-Justice, 1982) that the phase-position of certain circadian 
rhythms are advanced in relation to other circadian rhythms in some 
depressed patients. The desynchronization between circadian rhythms 
is then manifest in the depressive symptamology. The clinical 
observations therefore indicate that it is the phase-relationship 
between circadian rhythms which is important rather than an 
individual circadian rhythm per se. The experimental design used in 
these studies would be greatly improved by the additional, 
simultaneous, monitoring of feeding and drinking behaviour,
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temperature and, for grouped rats, social behaviour. Thus the 
effect of antidepressant treatment on the phase-relationship between 
various free-running circadian rhythms may be examined. Such an 
experimental paradigm may not be particularly relevant if the various 
circadian rhythms maintain their relative phase-position to each 
other, even when allowed to free-run under constant environmental 
conditions. If one or more of the circadian rhythms may be either 
disrupted or abnormally phase-positioned (perhaps by periodic food or 
water deprivation; see Stephan, 198H; Clarke and Coleman, 1986; 
Stephan, 1986a, 1986b, 1986c) then, it is argued, the animal
model would have a greater degree of relevance to the circadian 
rhythm abnormalities observed in some depressed patients.
10.3 Conclusions
The studies on rodent social behaviour have clearly demonstrated 
that the ability of chronic antidepressant treatment to increase 
social drive in rodents may be a behavioural affect common to the 
chemically-disparate group of compounds labelled antidepressant. It 
is further argued that the rodent social interaction model employed 
in these behavioural studies predicts antidepressant efficacy and 
drug potency without relying on either an interaction with 
pharmacological tools or exotic experimental paradigms. Conversely, 
it is also concluded that an ability to modify the free-running 
circadian locomotor activity rhythms of rodents is neither a 
predictor nor necessary chft-acter ist ic of antidepressant efficacy.
The social interaction model described in this thesis provides a 
method by which antidepressant efficacy may be examined which may 
lead to a greater understanding of the mechanisms involved in the 
clinical efficacy of antidepressant treatment.
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Appendix A Capture of Rodent Social Interaction Behaviours.
A , 1 Description
Monitoring rodent social behaviour is necessarily both intense and 
time consuming. There are over HO various elements of rodent 
behaviour as described by Silverman (1965) which may be grouped into 
motivational categories. Silverman i/fdentified H 'residual' 
behaviours (i.e. those with no identifiable motivational category) 
which occur very rarely and these have been excluded from the 
analysis. The various elements of behaviour may change very quickly 
and hence it is impossible for the observer to record the behaviour 
of both animals concurrently. To overcome this problem the period of 
social interaction was recorded on to video tape for analysis at a 
later date, thus enabling the observer to record each animals 
behaviour in turn. The program, written in BASIC for use with a BBC 
microcomputer, was written specifically to aid recording of rodent 
social activity. Each of the behavioural elements identified by 
Silverman may be input into the computer by means of a 2 letter 
abbreviation (Table A.1). The program continuously compares the 
input abbreviation against a check-1ist of acceptable abbreviations, 
provided in the DATA statements, and ignores any unacceptable input. 
The abbreviations may be altered according to the requirements of the 
experimenter. Once accepted the abbreviation is stored in the 
computers memory together with the time of observation. The program 
also monitors the duration of the recording period to ensure a 
constant monitoring period between animals and experiments. The 
program has been designed to accept the sequential behaviours of one 
animal at a time and is then automatically re-run in order to monitor 
the second animal’s behaviour. At the end of each experiment the
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data is stored on disk for retrieval at a later date. 
A listing of the program is provided in section A.2.
Category Behaviour Abbreviation
i) Exploration Explore EX
Rear RE
ii) Investigation Approach AA






Walk round / circle / side WR
Stretched attention SA
Tail rattle RA
















v) Flight-Submit Defensive upright DU
Defensive sideways DS
Submit SU




Under food hopper UN
Attend AT
Table A.1 Rodent Social Interaction Behaviours.
Listing
10REM Started 20-Nov-85
20REM LAST UP-DATE 01-01-86
25REM ECONET VERSION 15-HAY-86( 04-04-87)
30REM C.R.I.B. : Program to Capture Rodent Interaction Behaviours. 
80CLS
90PRINT"This program is designed to capture”
100PRINT"data on Rodent Interaction Behaviours”
110PRINT"obtained from the social interaction"’"test and recorded 
on to video tape."
113PRINT’"The program is designed to accept"’"behavioural
abbreviations as they occur"'"and is automatically re-run to
collect data for the second animal in the group."
120PRINT"P.J.Mitche11 November 1985"
130PRINT"Bath University"







210PRINT"This program accepts new data input via"’"the keyboard or 
retrieves data"’"previously stored on disc by
this"’"program. 'New data is automatically stored"’"on disc
and printed out."
220PRINT’’"***************** MENU *****************"
230PRINT’TAB(12)"N - New Data"
240PRINTTAB(12)"R - Retrieve Data"
250PRINTTAB(12)"E - Exit Program"
260PRINT’'"****************************************"
270G=GET
2801F G=78 THEN PROCnew:G0T0200 
2901F G=82 THEN PROCretrieve:G0T0200 
3001F G=69 THEN END









4001F 0=1 THEN PROCdefine

















660INPUT"Type in full file specification"'”(including drive and 
directory if required) ”''file$
670X=0PENIN file$
680INPUTEX,date$,animalS,panimal$,treats,pretime$,endepoch,M 
690F0R 1=1 TO (2*B)
700INPUT£X,D$(l)
71ONEXT I 










8H0REPEAT:READ B$:B=B+1:UNTIL B$=”zzzz":B=B-1 
850REST0RE
900DIM D$(2*B),FQ(2*B),L(1250),B$(1250)
903F0R 1=1 TO 2 
905A=0
91OREPEAT:READ B$:A=A+1
920IF 1=1 THEN D$(A)=STR$(I)+" "+B$











1370REM TS = TIME START : ON <S>
1380REM TE = TIME EPOCH END : ON <CR> OR 10 MINS MAX
1390REM T1 = TIME BEHAVIOUR START : ON BEHAVIOUR ABBREVIATION
1H20REM LATENCY = T1-TS
1H30M=0
14H5F0R R=1 TO 2
1HH7IF R=2 PRINT”Rewind tape to start of epoch  to analyse second
animals behaviour."
1450PRINT’"Press S to start the clock. ”
1H60REPEAT
1H70G=GET









1665G=ASC(G$):IF G=13 THEN TE=TIME:
endepoch=(TE-TS)/100:PRINT'"Length of epoch= "endepoch" 
secs.":G0T01910 
1670Z=Z+1
1680IF Z=1 THEN T1=TIME:first$=G$






1735IF I>2*B THEN PRINT."Behaviour NOT KNOWN !":PRINT CHR$(7): 
GOTO 1745 
1740C=INSTR(total$.D$(I))
1745UNTIL C=1 OR I>2*B





1840IF ((T-TS)/100)>600 THEN endepoch=(T-TS)/100:PRINT'"Lenght of 


















2660PRINT TAB(15)"Length of Epoch ";endepoch;" secs"’
2662M=0:I=0:N=0:C=0
2664REPEAT M=M+1:UNTIL L(M)=0:M=M-1
2666F0R 1=1 TO (2*B)
2668IF 1=1 THEN PRINT TAB(9);"Test animal "animalS 
2670IF I=B+1 THEN PRINT'TAB(9);"Partner animal "panimalS 
2672@%=&05
2673IF 1=1 OR I=(B+1) THEN PRINT
TAB(8);"-------------------------------------------------------------
2674IF 1=1 OR I=(B+1) THEN PRINT 
TAB(10)"N";TAB(16)"D$"TAB(22)"F0"TAB(34)"Latencies"
2675IF 1=1 OR I=(B+1) THEN PRINT
TAB(8):"-------------------------------------------------------------
2676PRINT TAB(6)I;TAB(15);D$(I);
2678F0R N=1 TO M
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2680C=INSTR(D$(I),B$(N))




2705IF FQ(I)=0 THEN PRINT TAB(34)"Zero Observations."
2710IF F0(I)>0 THEN PROClatencies(I,H)




TAB(8) ; "-------------------------------------------------------------- "
2725PRINT TAB(9)"Total number of observations = "M 
2726F0R X=1 TO B:Y=Y+FQ(X):NEXT X:PRINT TAB(9)"Observations for Test 
animal = "Y:Y=0
2728F0R X=(B+1) TO (2*B):Y=Y+FQ(X):NEXT X:PRINT TAB(9)"Observations











2765F0R N=1 TO M 
2770C=INSTR(D$(I),B$(N))
2775IF C=1 THEN Z=Z+1 
2780IF Z>5 THEN Z=1










2880PRINT'"Data to be stored"'"under file ";file$
2890INPUT'"Do you wish to change"’"the file specification ";Y$




2930F0R 1=1 TO (2*B)
2940PRINT£X,D$(l)
2950NEXT I 







3030REM PROC DIM CLEAR
30H0REM *****************************
3050DEF PROCdimclear 
3060F0R 1=1 TO (2*B)
3070F0(I)=0 
3080NEXT I 









3460PRINT'"Type in the behaviour abreviation"’"each time that 
behaviour is observed."
3540PRINT'"Press <CR> to indicate epoch end."**'• •*»•»* 












3670PRINT' "1) Exploration 2) Investigation"
3675PRINT” and Mating"
3680PRINT' "EX EXplore AA AproAch"
3690PRINT"RE REar IG nose and"'"
InvestiGate"
3700PRINT" 3) Maintenance FL FoLlow"
371OPRINT" SS Sniff"
3720PRINT" WG Wash Groom MT MounT"
3730PRINT"LG Lick Groom AM Attempt Mount"
3740PRINT" SG Scratch TF To-Fro"
3750PRINT" SK ShaKe <Walk Round"
3760PRINT" LP Lick Penis WR <circle"
3770PRINT" DI Dig <side"
3780PRINT" EC Eat SA Stretched Atten
RA tail RAttle"
3820PRINT' '"Press <space-bar> to continue.";
3830REPEAT:G=GET;UNTIL G=32:CLS
3835PRINT"4) Aggression 5) Flight-Escape"’
3837PRINT"AP Aggressive RT ReTreat"
3840PRINT" Posture FE Flag/Evade"
3842PRINT" AG Aggressive CC CrouCh"
3844PRINT" Groom EV EleVated crouch
3845PRINT" BT BiTe UN UNder hopper"
3847PRINT" PL PuLl AT ATtend"
3850PRINT"TT Threat and"




3856PRINT'’OU Offensive DU Def ensive
3858PRINT' Upright Upright”




















Appendix B Time Series Analysis of Circadian Rhythms of Locomotor 
Activity 
B.1 Introduction
A time series is a collection of observations made sequentially in 
time, and methods of analysing time series constitute an important 
area of statistics. In this report time series analysis has been 
applied to the circadian locomotor activity of rats in order to 
identify the periodicity of the behaviour (although the basic
principles equally apply to any area where observations indicate a
periodic change of a parameter over time). For background reading on 
the subject of time series analysis and its application to 
chronobiology the reader is directed to Chatfield (1985) and De Prins 
et al. (1986), respectively. For the purpose of this report the 
application of time series analysis to rodent circadian locomotor 
activity will be limited to a discussion of the applicability of the 
calculated periodogram and autocovariance functions. Initially both 
methods of time series analysis will be described, followed by a 
discussion on the relative merits of both methods when applied to the 
circadian rhythms of rodent locomotor activity.
B.2 Periodogram analysis.
The periodogram was invented in 1898 by Sir Arthur Schuster. He was
fitting a model with one frequency, f, of the form
xt = Acos27tft + Bsin27tft + e*
to the set of points xQ . x1f x2 , x3 . . . . xT_ , where A and B are 
constants and e* is a set of zero mean, variance , normally
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distributed independent errors.
The least-squares estimates of A and B are 
X = 2/T2 xtcos27C ftfO
B = 2 /TE Xt;Sin27X f t
fc-O
If we take the periodic function (i.e. without e*), and take it's 
sum of squares using the estimates for A and B, then we obtain
T-l
U (Acos2?x'f t + Bsin2z<ft)2
t«o
This quantity will be proportional to the total energy of the series 
at the frequency f.
Dividing the quantity by Hr< gives the definition of the periodogram, 
denoted by 1(f). Thus,
1(f) = 1/27T T |(£xt;cos2f t )2 + (Sxt:Sin2f t)2\
( 6*0 <»o )
This produces a set of A's and B's for each frequency in the harmonic 
series estimated by Aj and BJt and thus at each frequency,
I (f j) = T/*w[(Aj)2/2 + (Bj)2/2J 
Thus the total variability (T©"2) accounted for by each frequency is 
proportional to the squares of the amplitude at that frequency.
The equation
I (t) = 1 /N7t j^XtCos^ Tf t/T)j2 +j2x*sin(2 7* t/T)j2 
where t = 1, 2, 3...N
xt = observation at time t 
T = period of interest, 
extends the periodogram to enable any period to be analysed rather 
than just relying on the harmonic series.
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B.3 Autocovariance Function Analysis.
B.3.1 Autocorrelation Coefficients
An important guide into the properties of a time series is provided 
by a series of quantities called sample autocorrelation coefficients. 
These measure the correlation between observations at different 
distances (k) apart and is given by the equation.
rk is called the autocorrelation coefficient at lag k.
In practice the autocorrelation coefficients are usually calculated 
by computing the series of autocovariance coefficients, Ck, which 
are defined as.
i.e. the autocovariance coefficient at lag k.
Plotting Ck against k produces the variogram.
From the values of Ck we may derive the autocorrelation coefficients
rk, where rk = Ck/C0
Plotting rk against k produces the correlogram.
B.3.2 Relationship between the periodogram and the autocovariance 
function.
The periodogram is defined as
also cos(2rrt/T) = cos(27< pt/N)
and sin(27^t/T) = sin(2rfpt/N)
thus 27tt/T = 2 tt pt/N
and 11T = p/N
The periodogram may therefore be written as
I(wp) = |ZjXtcos(2/< pt/N)|2 +|^xt;sin(27< pt/N)j
however, wp = 2rfp/N for integer values of p, where p/N = the 
number of cycles per time interval.
Thus,
I(wp) = 1/NrtjSx* " x)coswpt|2+ x)sinwpt|2
= 1/Nrf ^(xt - x)(x» - x)(cosWpt cosWpS + sinWpt sinwps)
t*»
H-H
Since Ck = ^(x, “ *)(xt*k " x)/N
t* i
and cosWpk = coswpt coswp(t+k) + sinwpt sinwp(t+k)
then by substitution.
I(wp) = (C0 + 2 ^ C kcoswpk) In
i.e. the autocovariance function at wp
When the periodogram is expressed in this form it appears as an
obvious estimate of the power spectrum where
*0
f(w) = (Vo + 2 E^coswk)/* 
k=i
Here Vo and Vk are replaced by their estimates C0 and Ck 
respectively for values of k up to (N-1).
MOO
Thus the periodogram is the discrete Fourier transform of the 
complete sample autocovariance function. However the precision of Ck 
decreases as k increases and so it is reasonable to give less weight 
to the values of Ck as k increases.
An estimator which has this property is
f(w) = (AoCo + 2 X kCkcoswk) l7f 
where Jl0 and Ak are a set of weights called lag windows and M (which 
is <N) is called the truncation point.
In comparing the summary equations for l(wp) and f(w) it can be seen 
that the values of Ck for M<k<N are no longer used, while values of 
Ck for k<M are weighted by a factor of X k
A lag window which may be used is the Tukey window which acts as a
low pass filter and is defined as
I k = (1+cos k/M)12
where k = 0,1,2 M
and | o  is where k = 0 (i.e. X o =
B.4 Application of periodogram and autocovariance function analysis
to circadian rhythms of locomotor activity 
The autocovariance function assumes that the data is normally 
distributed (i.e. the sample mean equals the sample median). However 
the distribution of the data arising from the circadian locomotor 
activity studies, of both single and grouped animals described in 
this report, is highly skewed (see Figs. B.1a and B.1b 
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In order to approximate the data to a normal distribution prior to 
determining the autocorrelation coefficients it is thePfore 
necessary to transform the raw data so that the sample mean tends 
toward the sample median. Fig. B.2 shows the mean/median ratio 
plotted against the root transformation factors 1 to 5 of the data 
used in Fig. B.1b (obtained from grouped animals housed under normal 
daylight. Invariably a simple cube-root transformation results in 
the sample mean approaching the sample median and thus satisfies the 
demands made by this method of analysis. Fig B.3 shows the 
distribution of data, obtained from grouped animals, following 
cube-root transformation. However, as shown in Fig. B.4, the 
cube-root transformation results in a drastic reduction in the 
magnitude of the data such that the rhythmic nature of locomotor 
activity is not so well defined. In the experiments where rats were 
individually housed the distribution of the data, in addition to the 
skewness, was such that invariably the sample median was less than 1 
count per epoch (i.e. the majority of epochs contained zero counts. 
Fig B.1a). In this data sample, 494 of the 960 epochs (i.e. >50%) 
contained zero counts and therefore cube-root transformation to 
normalize the distribution of the data was not applicable. For these 
reasons the applicability of autocovariance function analysis to 
circadian locomotor activity is highly questionable. Conversely, 
periodogram analysis makes no assumptions about the distribution of 
data and thus may be applied to the raw locomotor activity data.
A listing of the program to determine the periodogram function of 
circadian locomotor activity, specifically for use on a BBC 
microcomputer in conjunction with data files produced by Marshall's 
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Fig. B.3 H i s t o g r a m  of locomotor activity following cube-root 
t ra n sf o rm a ti o n : Grouped rats
4 0 5
Fig. B.H Comparison between the absolute locomotor activity counts 
following cube-root transformation : Grouped (N=3) rats
a) Original data
b) Cube-root transformed data 
Abscissa : Time (2Hh clock)
Ordinate : Locomotor activity counts
Data indicates locomotor activity counts collected over 2Hh 
Rats housed under L:D conditions (lights on 0800)
0 6 12 18 





B.5 Practical considerations of periodogram analysis.
Adequate time series analysis inherently involves manipulation of 
large amounts of data. It is therefore important to determine the 
amount of data required by these methods in order to gain meaningful I 
results. Periodogram profiles were determined from 2, 5, 10 and 20 
days samples of data obtained from rats housed in groups under normal 
daylight conditions (Fig. B.5). Analysis of just 2 days data 
produces very wide curves with poorly defined peaks (Fig. B.5a). 
Increasing the number of days to 5, slightly increases the 
resolution of the main peaks but also increases the level of apparent 
noise, especially for periods less than 8 hours, and produces new 
peaks, some of which may be spurious, in the same area (Fig. B.5b). 
Analysis of 10 days data produces well defined peaks for the 
fundamantal period and its harmonics (Fig. B.5c). However, there 
are three peaks between 18 and 22 hours, initially hidden, which 
appear as the resolution of the periodogram is increased.
Periodogram analysis of 20 days data produces very well defined peaks 
with little or no apparent noise or spurious peaks (Fig. B.5d). From 
a practical viewpoint however, the analysis of 20 days data has three 
major drawbacks. Firstly, the duration of the periodogram analysis 
on this amount of data is approximately 4 hours (the programme was 
written in BASIC and is therefore rather slow, see section B.6). 
Secondly, a requirement of 20 days data for each stage of the 
experiment results in very long experiments. Thirdly, if any 
drug-induced effects upon circadian locomotor activity cannot be 
maintained for 20 days then the ability of periodogram analysis to 
identify significant changes in activity is reduced. It was 
therefore decided to accept the shortcomings of analysing over 10
407
Fig. B.5 Periodogram analysis : Locomotor activity expressed by 
grouped rats (N=3) housed under L:D.
Abscissa: Period length (h). Ordinate: Relative power (*103 ).
a, 2 days (192 epochs)
b, 5 days (480 epochs)
c, 10 days (960 epochs)
d, 20 days (1920 epochs)
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day periods and design the locomotor studies accordingly (see section 
9.2.2.H). In order to standardize the analysis of data the 
periodogram function was determined on 10 day samples of data in all 
cases.
A major problem with periodogram function analysis is it readily 
identifies the harmonic components of the rhythms fundamental period, 
which may confuse interpretation of the derived function. The 
harmonic components of a waveform are those with periods that are 
integer multiples of the fundamental. Simple sine waves do not 
contain any harmonics. Examples of the derived periodogram function 
following analysis of sine waves with fundamental periods of 24h,
12h, 6h and 3h are shown in Fig B.6. In each case the periodogram 
shows a single peak indicating the period of the rhythm. By 
comparison, the derived periodogram function following analysis of 
square waves, with fundamental periods of 2Mh, 12h, 6h and 3h, 
identifies not only the fundamental period but also the harmonic 
components of the waveforms (Fig B.7). In each example the peaks of 
the periodogram function of the square waves indicate the odd 
harmonics of the fundamental period, i.e. 3rd, 5th, 7th,
9th...etc. The occurrence of harmonic components therefore indicate 
the shape of the waveform being analysed. When periodogram function 
analysis is applied to circadian rhythms of locomotor activity the 
harmonic components thus indicate the general daily wave pattern of 
locomotion and their generation or disappearance should not be 
assumed to indicate large changes in the rhythmicity of circadian 
activity. Conversely, relatively small peaks (compared to the 
fundamental) in the periodogram function that occur at periods which
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Fig. B.6 Periodogram function derived from sine waves.
Abscissa: Period length (h) . Ordinate: Relative power (*103).
Data sample equivalent to 2H0h of 15min epochs (960 data points) in 
each case.
a, Fundamental period =
b. Fundamental period =
c. Fundamental period =
d, Fundamental period =
2Hh (No. of cycles = 10)
12h (No. of cycles = 20)
6h (No. of cycles = 40)






























Fig. B .7 Periodogram function derived from square waves. 
Abscissa: Period length (h). Ordinate: Relative power (*103).
Data sample equivalent to 240h of 15min epochs (960 data points) in 
each case.
a. Fundamental period = 24h (No. of cycles = 10)
b, Fundamental period = 12h (No. of cycles = 20)
c. Fundamental period = 6h (No. of cycles = 40)
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are not integer multiples of the fundamental period may indicate 
relatively large changes in the circadian rhythm of locomotor 
activity. The analysis of square waves indicates the basic premise 
of Fourier analysis, i.e. that all complex waveforms are composed of 
a series of sine waves that differ in their period (i.e. frequency), 
amplitude and relative phase position.
The periodograms shown in Figs. B.6 and B.7, following analysis of 
sine and square waves respectively, were each derived from the 
equivalent of 10 days data and indicate that the resolution of each 
peak is dependent upon the number of cycles of that period contained 
in the data sample. In addition, analysis of cosine waves with 
fundamental periods of 24h, 12h, 6h and 3h produces periodogram
functions identical to those obtained following analysis of sine 
waves (data not shown). The derived periodogram function per se 
therefore contains no information regarding the relative phase 
position of the component sine waves.
Thus while the use of the periclogram function may prove useful in 
identifying the rhythmic components of circadian locomotor activity 
the interpretation of the derived periodogram function should always 
be treated with care.
412
B .6 Listing
10REM ROUTINE TO CALCULATE AND PLOT THE FRQUENCY SPECTRA OF RODENT 
LOCOMOTOR ACTIVITIES. P.J. MITCHELL APRIL 1986; UNIVERSITY OF 
BATH
20REM LAST UPDATE 14-MAY-86 
25REM PERIODOGRAM ANALYSIS 
30










140PRINT TAB(12)CHR$(141)"*** MENU ***"
150PRINT'STRING$(39,"*”)
160PRINT'’*"N...Analysis of New data"
170PRINT'"R...Retrieval of spectra file from disc"
180PRINT'"E ...Exit programme"
190PRINT’’’STRING$(39,"*")









280PRINT TAB(O.O)"ORIGINAL DATA FILE INFORMATION."
290PR0CINFOOUT
300PRINT TAB(11,12)"Spectral Analysis."
3 10PRINT TAB (3 ,.14);"Days ";SDAY%;" to ";EDAY%;" completed."
320PRINT TAB(3,16)"Spectral data stored on file ";File$





380PRINT'"THIS PROGRAM CALCULATES THE POWER"*"SPECTRA OF LOCOMOTOR
ACTIVITY COLLECTED BYLOCOAND STORED ON DISK"







460IF NBX%>1 THEN BN%=FNR("WHICH BOX/CELL DO YOU WISH TO 
ANALYSE",11,1,NBX%) ELSE BN%=1 
470PR0CCL(11)
413
M80PRINT TAB(0,11)"SEQUENTIAL ANALYSIS FROM DAY TO 
DAY":PROCsequential 
H90F0R DAY%=SDAY% TO EDAY%
500IF NBX%>1 PRINT TAB(5,19)"PROCESSING BOX ";BN%





560PRINT TAB(0,21)"DATA TO BE STORED IN FILE "File$
570IF FNYNC'IS THIS FILE NAME O.K.",23)="N" THEN PROCCL(23):PRINT 
TAB(0,23)"TYPE IN NEW FILE NAME INPUT File$:PROCCL(23).PRINT 







6H0REM"**PROC TO LOAD DISK INFO**"
650REM ****************************
660DEF PROCDISKINFO
670IF G$="N" THEN NF$=FNLT("NAME OF FILE TO PLOT",8,0,7)
680IF G$="R" THEN NF$=FNLT("NAME OF FILE TO PLOT",8,0,9)
6901F NF$<>"" AND (ASC(NF$)<65 OR ASC(NF$)>123) THEN PRINT
TAB{0,2H)CHR$(7)"FILENAMES SHOULD START WITH A LETTER"GOTO 670 
700DR$=":1."
71OF%=OPENUP(DR$+NF$)
7201F F%<>0 THEN 790
730IF DR$=":1." THEN DR$=":3.": GOTO 710 







8001 NPUT£F%, NBX%, ED%, NBR%, SD%, LCD%, SI %















960PRINT’"NO. of Boxes/Cells in use ";NBX%
970PRINT'"Start Day ";SD%" End Day ";LCD%+1




1020PRINT TAB(0,11)"OBTAINING POINTER VALUES - PLEASE WAIT"
1030PTR£F%=1000 
1040PT%( 1) = 1000 
1045PDAY%=SD%



































1380TDAY%=BGET£F%:IF TDAY%=0 GOTO 1470 
1390HR%=BGET£F%
1400MN%=BGET£F%
1410IF HR%=0 AND TDAY%=DAY%+1 THEN HR%=24 
1420MN%=MN%/SI%










1530F0R I%=2 TO 30*SMN%
415
1540@%=&2020A
1550PRINT TAB(0,23)"PROCESSING TIME PERIOD ";I%/SMN%
1560A=0:B=0











1680PRINT TAB(15)"SPECTRAL ANALYSIS OF LOCOMOTOR ACTIVITY DATA." 
1690PRINT TAB(15) STRING$(45,"="):PRINT’
1700PRINT"0riginal data file information."
1710PRINT STRINGS( 3 1 :PRINT
1720PR0CINFOOUT
1730PRINT’
1740PRINT TAB(25) ”*** SPECTRAL ANALYSIS. ***"'
1750PRINT TAB(25)"Box/Cel 1 NO. ";BN%
1760PRINT TAB(25)"Analysis Start Day ”;SDAY%
1770PRINT TAB(25)"Analysis End Day ";EDAY%
1780PRINT TAB(25)"Maximum Period 30 Hrs."
1790PRINT TAB(25)"SPECTRAL DATA FILE ";File$






1850F0R I%=2 TO column%+1 
1860@%=&6:PRINT TAB(0)1%;
1870@%=&2020A:PRINT TAB(9)I%/SMN% TAB(2M)MAG(1%);
1880IF I%=column%+1 GOTO 1910 
189O0%=&6:PRINT TAB(43) I%+column%;





1940IF G$="R" GOTO 2050
1950Total=0:sd=0




2000F0R I%=1 TO NDAYS%*24*SMN%
2010sd=sd+ABS(SAMPLE%(1%)-MEAN)
2020NEXT 1%
2030sd = sdI(NDAYS%* 2 4 * SMN%-1)
2040crit=(sd*5.99/P2)
2050PRINT "Mean= "MEAN 
2060PRINT "S .D .= "sd 
2070PRINT "95% = "crit 
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2670DEF PROCyaxis 
2680M0VE 107,93:DRAW 107,843 








2770F0R 1=2 TO 30*SMN%

















2950PRINT TAB(0,0)"Maximum counts per epoch = ";max% 




































3300INPUT TAB(0,0)"DO YOU REQUIRE A PRINT-OUT ";DUMP$;
3310PR0CCL(0)
3320PRINT TAB(11,0)"SPECTRAL ANALYSIS";




3370REM**"PROC TO HANDLE I/O"**
3380REM**************************





3450F0R II%=1 TO LEN(N$)
3460IF ASC(MID$(N$ ,11%,1))=46 THEN 3480
3470IF ASC(MID$(N$,11%.1))<48 OR ASC(MID$(N$,11%,1))>57 FG%=1 
3480NEXT 11%
3*190IF FG%=1 THEN PRINT TAB(0,24)CHR$(7)"REDO NON NUMERIC CHARACTER 
DETECTED"GOTO 3410 
3500IF VAL(N$)>=B AND VAL(N$)<=T THEN =VAL(N$)








35901F Q$="Y" OR Q$="y” THEN ="Y"
36001F Q$="N" OR Q$="n" THEN ="N"








37001F LEN(Q$)=0 AND B>0 THEN PRINT TAB(0,24)CHR$(7)"NULL ANSWER NOT 
ACCEPTABLE";.GOTO 3670 
3710IF LEN(Q$)<B OR LEN(Q$)>T THEN PRINT TAB(0,24)CHR$(7)”MUST HAVE 
















38601F ERR=17 THEN CLOSEPO
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